Kawashima N, Gurnari C, Bravo-Perez C, Kubota Y, Pagliuca S, Guarnera L, Williams ND, Durmaz A, Ahmed A, Dima D, Ullah F, Carraway HE, Singh A, Visconte V, Maciejewski JP. Clonal hematopoiesis in large granular lymphocytic leukemia. Leukemia. 2025 Feb;39(2):451-459. doi: 10.1038/s41375-024-02460-y. Epub 2024 Nov 21. PubMed PMID: 39572711. 2025 13.4 39572711
Salmanton-Garcia J, Marchesi F, Navratil M, Piukovics K, Del Principe MI, Criscuolo M, Bilgin YM, Fracchiolla NS, Vena A, Romano A, Falces-Romero I, Sgherza N, Heras-Fernando I, Biernat MM, Petzer V, Zak P, Weinbergerova B, Samarkos M, Erben N, van Praet J, Lopez-Garcia A, Labrador J, Lahmer T, Drgona L, Merelli M, Cuccaro A, Martin-Perez S, Davila-Valls J, Farina F, Cattaneo C, Pinczes LI, Magyari F, Espigado I, Buquicchio C, Vinh DC, Stoma I, Cernan M, Prezioso L, Papa MV, Plantefeve G, Khedr RA, Batinic J, Magliano G, Erdem S, Khostelidi S, Colovic N, Nappi D, Garcia-Ramirez P, Gora J, Callejas-Charavia M, Tlusty J, Bakker M, Wojtyniak E, Antic D, Magdziak A, Dargenio M, Idrizovic L, Pantic N, Stojanoski Z, Eisa N, Otasevic V, Marchetti M, Mackenzie E, Garcia-Vidal C, Aujayeb A, Almasari A, Miranda-Castillo C, Gavriilaki E, Coppola N, Busca A, Adzic-Vukicevic T, Schonlein M, Hersby DS, Grafe SK, Glenthoj A, Aiello TF, Cvetanoski M, Mitrovic M, Cerchione C, Prin R, Varricchio G, Arellano E, Cordoba R, Mayer J, Visek B, Wolf D, Anastasopoulou AN, Delia M, Musto P, Leotta D, Bavastro M, Limongelli A, Sciume M, van den Ven L, Fianchi L, Brunetti SC, Drozd-Sokolowska J, Dabrowska-Iwanicka A, Cornely OA, Pagano L. Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023-2024: EPICOVIDEHA-EPIFLUEHA Report. Am J Hematol. 2025 Mar;100(3):358-374. doi: 10.1002/ajh.27565. Epub 2024 Dec 23. PubMed PMID: 39715069; PubMed Central PMCID: PMC11803548. 2025 9.9 39715069
Guarnera L, Gurnari C, Bravo-Perez C, Durmaz A, Williams ND, Awada H, Kawashima N, Ahmed A, Unlu S, Ogbue OD, Haddad C, Mandala A, Kubota Y, Bodo J, Crane GM, Rogers HJ, Maciejewski JP, Visconte V. Non canonical c-CBL mutations define a specific phenotype of myeloid neoplasia. Leukemia. 2025 Mar;39(3):748-751. doi: 10.1038/s41375-024-02429-x. Epub 2025 Jan 5. No abstract available. PubMed PMID: 39755843; PubMed Central PMCID: PMC11879845. 2025 13.4 39755843
Jimenez-Vicente C, Esteve J, Baile-Gonzalez M, Perez-Lopez E, Martin Calvo C, Aparicio C, Oiartzabal Ormategi I, Esquirol A, Pena-Munoz F, Fernandez-Luis S, Heras Fernando I, Gonzalez-Rodriguez AP, Lopez-Garcia A, Lopez-Lorenzo JL, Torrado T, Saez Marin AJ, Acosta Fleytas C, Garcia L, Villar S, Filaferro S, Balsalobre P, Pascual Cascon MJ, Salas MQ. Allo-HCT refined ELN 2022 risk classification: validation of the Adverse-Plus risk group in AML patients undergoing allogeneic hematopoietic cell transplantation within the Spanish Group for Hematopoietic Cell Transplantation (GETH-TC). Blood Cancer J. 2025 Mar 21;15(1):42. doi: 10.1038/s41408-025-01223-x. PubMed PMID: 40118819; PubMed Central PMCID: PMC11928450. 2025 11.6 40118819
Di Buduo CA, Abbonante V, Malara A, Balduini A, Waller AK, Watson SP, Martin EM, Bridge L, Gibbins J, Hers I, Masson C, Eckly A, Poulter NS, Martinez-Garcia B, Aguila S, Gresele P, Momi S, Amstrong P, Rondina M, Troitino S, Garcia A, Bastida JM, Quilez AM, Fuentes AS, Rivera J, Torres-Ruiz R, Ojeda-Walczuk P, Morgan NV, Morena B, Ramaekers K, Tran M, De Wispelaere K, Freson K, Bergmeier W, Greinacher A, He F, Oh S, Di Paola J, Semple JW, Lozano ML, Llamas P, Ward C. Illustrated capsules from the Advanced Course in Platelet Research. Res Pract Thromb Haemost. 2025 Feb 27;9(2):102715. doi: 10.1016/j.rpth.2025.102715. eCollection 2025 Feb. PubMed PMID: 40177221; PubMed Central PMCID: PMC11964540. 2025 3.4 40177221
Sanchez-Fuentes A, Perez-Botero J, Bastida JM, Rivera J. Diagnosis of Inherited Platelet Disorders: Clinical Evaluation and Functional and Molecular Assays. Biomolecules. 2025 Jun 10;15(6):846. doi: 10.3390/biom15060846. PubMed PMID: 40563486; PubMed Central PMCID: PMC12191158. 2025 4.8 40563486
Lasa M, Gonzalez C, Notarfranchi L, Zherniakova A, Alignani D, Burgos L, Calasanz MJ, Rodriguez-Otero P, Perez JJ, Gomez C, Gonzalez de la Calle V, de Arriba F, Palomera L, Alvarez Rivas MA, Clavero E, Ocio EM, Gonzalez-Rodriguez AP, Lakhwani S, Ibanez A, Oriol A, Sureda A, Rosinol L, Siewert C, Orfao A, Lahuerta JJ, Blade J, Mateos MV, San-Miguel JF, Cedena MT, Martinez-Lopez J, Puig N, Paiva B. Ultrasensitive detection of circulating multiple myeloma cells by next-generation flow after immunomagnetic enrichment. Blood. 2025 Aug 21;146(8):964-970. doi: 10.1182/blood.2025029234. PubMed PMID: 40403320. 2025 23.1 40403320
Redondo PC, Granados MP, Fernandez E, Collado-Perez MA, Teruel-Montoya R, Ferrer-Marin F, Berna-Erro A. EFCAB13 is a Novel Age-Dependent Promotor of SOCE in Blood Platelets and Megakaryoblastic MEG-01 Cells. Thromb Haemost. 2025 Sep 19. doi: 10.1055/a-2689-7785. Online ahead of print. PubMed PMID: 40972679. 2025 4.3 40972679
Rodriguez-Alen A, Moscardo A, Bastida JM, Rivera J. Molecular Pathogenesis of Inherited Platelet Dysfunction. Biomolecules. 2025 Oct 30;15(11):1528. doi: 10.3390/biom15111528. PubMed PMID: 41301446; PubMed Central PMCID: PMC12649936. 2025 4.8 41301446
Lloret-Madrid P, Boluda B, Martinez-Lopez J, Bergua J, Rodriguez Arboli E, Labrador J, Sossa C, Gil C, Algarra L, Lavilla-Rubira E, Serrano J, de Rueda B, Ibanez F, Gonzalez Gonzalez BJ, Amigo ML, Garcia Belmonte D, Rodriguez-Medina C, Gomez-Roncero MI, Colorado M, Lopez Lorenzo JL, Tormo M, Arce Fernandez O, Cano-Ferri I, Solana-Altabella A, Foncillas MA, Alfonso Pierola A, Vives S, Nunez MV, Lopez-Vidal H, Perez-Santaolalla E, Hermosin Ramos L, Garcia Boyero R, Llorente Gonzalez L, Roldan A, Calderon SC, Infante JB, Olave T, Garcia-Suarez J, de Laiglesia A, Rodriguez-Veiga R, Trigo F, Martinez-Cuadron D, Montesinos P. Treatment patterns and outcomes in secondary acute myeloid leukemia arising after hypomethylating agents: PETHEMA registry study. Cancer. 2025 Jan 1;131(1):e35696. doi: 10.1002/cncr.35696. PubMed PMID: 39748608. 2025 5.1 39748608
Ramirez MJ, Pujol R, Minguillon J, Bogliolo M, Persico I, Cavero D, de la Cal A, Rio P, Navarro S, Casado JA, Bailador A, de la Fuente AS, de Heredia ML, Almazan F, Antelo ML, Argiles B, Badell I, Baragano M, Belendez C, Bermudez M, Bernues M, Buedo MI, Carrasco E, Catala A, Costa D, Cuesta I, Fernandez-Delgado R, Fernandez-Teijeiro A, Figuera A, Garcia M, Gondra A, Gonzalez M, Muniz SG, Hernandez-Rodriguez I, Ibanez F, Kelleher NJ, Lendinez F, Lopez M, Lopez-Almaraz R, Marchante I, Mendoza C, Nieto J, Ojeda E, Payan-Pernia S, Pelaez I, de Soto IP, Portugal R, Ramos-Arroyo MA, Regueiro A, Rodriguez A, Rosell J, Saez R, Sanchez J, Sanchez M, Senent M, Tapia M, Trujillo-Quintero JP, Vagace JM, Verdu-Amoros J, Verdugo V, Vidales I, Villarreal J, Diaz-de-Heredia C, Sevilla J, Bueren JA, Surralles J. Prognostic significance of mutation type and chromosome fragility in Fanconi anemia. Am J Hematol. 2025 Feb;100(2):272-284. doi: 10.1002/ajh.27520. Epub 2024 Nov 19. PubMed PMID: 39562502; PubMed Central PMCID: PMC11705201. 2025 9.9 39562502
Lasa M, Notarfranchi L, Agullo C, Gonzalez C, Castro S, Perez JJ, Burgos L, Guerrero C, Calasanz MJ, Flores-Montero J, Oriol A, Bargay J, Rios R, Cabanas V, Cabrera C, Martinez-Martinez R, Encinas C, De Arriba F, Hernandez MT, Palomera L, Orfao A, Martinez-Lopez J, Mateos MV, San-Miguel J, Lahuerta JJ, Rosinol L, Blade J, Cedena MT, Puig N, Paiva B; PETHEMA/GEM Cooperative Group. Minimally Invasive Assessment of Peripheral Residual Disease During Maintenance or Observation in Transplant-Eligible Patients With Multiple Myeloma. J Clin Oncol. 2025 Jan 10;43(2):125-132. doi: 10.1200/JCO.24.00635. Epub 2024 Oct 1. PubMed PMID: 39353166. 2025 41.9 39353166
Garabet L, Rangberg A, Eriksson AM, Jonassen CM, Teruel-Montoya R, Lozano ML, Martinez C, Pettersen HH, Mathisen AB, Tjonnfjord E, Tran H, Brodin E, Tsykunova G, Gebhart J, Bussel J, Ghanima W. MicroRNA-199a-5p may be a diagnostic biomarker of primary ITP. Br J Haematol. 2025 Jan 7. doi: 10.1111/bjh.19987. Online ahead of print. PubMed PMID: 39776057. 2025 3.8 39776057
Bravo-Perez C, Corral J, Orlando C, Ignjatovic V, Ilonczai P, Bereczky Z. How we treat severe inherited antithrombin deficiency: lessons from cases homozygous for the Budapest 3 variant. J Thromb Haemost. 2025 May;23(5):1648-1656. doi: 10.1016/j.jtha.2025.01.015. Epub 2025 Feb 9. PubMed PMID: 39933654. 2025 5.0 39933654
María Luz Morales * ;Horacio Cano * ;Belén de la Morena-Barrio ;Joan-Lluis Vives-Corrons ;Ernesto José Cuenca-Zamora ;Pedro Garrido-Rodríguez ;Celeste Bento ;Janet Pereira ;Jorge Martínez Nieto ;Tzu-Hua Chen-Liang ;José Luis Fuster ;Sara Caracena ;María Luisa Lozano ;Raúl Teruel Montoya ;Javier Corral ;Francisca Ferrer-Marín. CALRins5-mediated clonal hematopoiesis causes severe hemolytic anemia in a female PGK1Ser320Asn. Blood Cancer Journal. 2025 Feb;15(1)-8. doi: 10.1038/s41408-025-01216-w;39893164. PMID: 39893164
Marin-Quilez A, Sanchez-Fuentes A, Zamora-Canovas A, Gomez-Gonzalez PL, Diaz-Ajenjo L, Benito R, Rodriguez-Alen A, Sevivas T, Murciano T, Murillo L, Butta NV, Revilla N, Campos R, Escribano P, Esteve J, Fernandez-Mosteirin N, Ferrer-Marin F, Hernandez L, Huerta-Aragones J, Leon A, Lopez-Duarte M, Lopez E, Martin-Salces M, Nomdedeu M, Ona R, Pelaez-Pleguezuelos I, Ramos F, Sebastian E, Serrano C, Sierra-Aisa C, Vidal-Laso R, Gonzalez-Porras JR, Lozano ML, Bastida JM, Rivera J. Insights into the clinical, platelet and genetic landscape of inherited thrombocytopenia with malignancy risk. Br J Haematol. 2025 Jul 16. doi: 10.1111/bjh.70001. Online ahead of print. PubMed PMID: 40670159. 2025 3.8 40670159
Arndt N, Falcinelli E, Zamora-Canovas A, Fuentes AS, Marin-Quilez A, Nieto-Hernandez MDM, Rivera J, Gresele P, Bury L. The co-inheritance of two ITGB3 variants with additive detrimental effects on platelets leads to variant Glanzmann thrombasthenia. Haematologica. 2025 Sep 25. doi: 10.3324/haematol.2025.288369. Online ahead of print. PubMed PMID: 40994361. 2025 7.9 40994361
Moreno DF, Oriol A, de la Rubia J, Hernandez MT, Inigo MB, Palomera L, de Arriba F, Gonzalez Y, Teruel AI, Pardo JL, Lopez de la Guia A, Sampol A, Rios-Tamayo R, Sureda A, Gutierrez NC, Calasanz MJ, Ramos MLM, Mateos MV, San Miguel J, Lahuerta JJ, Rosinol L; PETHEMA/GEM group. Is t(11;14) Always a Standard-Risk Cytogenetic Abnormality? Results From GEM05MENOS65 and GEM2012 PETHEMA/GEM Transplantation Trials. Clin Lymphoma Myeloma Leuk. 2025 Jul;25(7):494-504. doi: 10.1016/j.clml.2025.01.014. Epub 2025 Jan 25. PubMed PMID: 39955256. 2025 2.7 39955256
Van Laer C, Moore GW, Majumder R, Corral J, Freson K, Ignjatovic V, Orlando C. Survey on current practice in thrombophilia testing: from phenotype to genotype. Communication from the SSC of the ISTH. J Thromb Haemost. 2025 Nov 17:S1538-7836(25)00833-5. doi: 10.1016/j.jtha.2025.10.032. Online ahead of print. PubMed PMID: 41238194. 2025 5.0 41238194
Zamora-Canovas A, Marin-Quilez A, Diaz-Ajenjo L, Sanchez-Fuentes A, Gomez-Gonzalez PL, Crescente M, Fernandez-Mosteirin N, Padilla J, Gonzalez-Porras JR, Benito R, Lozano ML, Bastida JM, Rivera Pozo J. Characterization of Novel Variants in P2YRY12, GP6 and TBXAS1 in Patients with Lifelong History of Bleeding. Biomolecules. 2025 Nov 21;15(12):1639. doi: 10.3390/biom15121639. PubMed PMID: 41463295; PubMed Central PMCID: PMC12730773. 2025 4.8 41463295
Rodriguez-Veiga R, Gil C, Sobas M, Torres-Minana L, Botella C, De la Serna J, Bernal T, Salamero O, Otero C, Navarro-Vicente I, De Miguel C, Garrido A, Vives S, Bergua J, Perez-Encinas M, Algarra L, Gonzalez-Campos J, Gomez MDMC, Prates MV, Benavente C, Tormo M, Cervera M, Fazio P, Amutio ME, Garcia R, Pomares H, Vidriales B, Serrano J, Amigo ML, Rubio V, Almela A, Barrios M, Sossa-Melo CL, Paluszewska M, Novo A, Gromek T, Rodriguez-Macias G, Oleksiuk J, Lloret-Madrid P, Montesinos P. A scoring system to predict life-threatening thromboischemic events in patients with acute promyelocytic leukemia: the PETHEMA/PALG study. Haematologica. 2025 Nov 13. doi: 10.3324/haematol.2025.288112. Online ahead of print. PubMed PMID: 41230704. 2025 7.9 41230704
Gutierrez A, Zeberio I, Penalver FJ, Martinez-Barranco P, Perez S, Morillo D, Martin X, Nicolas C, Ferrero A, Jimenez-Ubieto A, Bastos-Oreiro M, Davila-Valls J, Calle MV, Perez M, Rodriguez G, Alonso A, Garcia-Noblejas A, Sanchez Arguello D, Knight T, Fernandez A, Lopez J, Perez De Oteyza J, Gonzalez de Villambrosia S, Perez E, Marin A, Navarro MB, Fernandez R, Gomez P, Hueso JA, Penarrubia Ponce MJ, Bravo P, Garcia-Belmonte D, De La Nuez H, Nistal S, Abrisqueta P, Ibanez F, Palomera L, Donato E, Provencio A, Infante MS, Gonzalez-Barca E. Tafasitamab plus lenalidomide as salvage therapy in diffuse large B-cell lymphoma: real-world experience from GELTAMO. Blood Adv. 2025 Oct 14;9(19):4924-4935. doi: 10.1182/bloodadvances.2025016661. PubMed PMID: 40668613; PubMed Central PMCID: PMC12508888. 2025 7.1 40668613
Kruijt M, de la Morena-Barrio ME, Corral J, Cobbaert CM, Ruhaak LR. Novel insights into antithrombin deficiency enabled by mass spectrometry-based precision diagnostics. J Thromb Haemost. 2025 Jan;23(1):210-221. doi: 10.1016/j.jtha.2024.10.005. Epub 2024 Oct 17. PubMed PMID: 39423957. 2025 5.0 39423957
Lundgren S, Huuhtanen J, Keranen M, Feng X, Patel BA, Ryland GL, Fox LC, Bravo-Perez C, Clemente M, Kerr C, Walldin G, Dufva O, Zaimoku Y, Tuononen T, Myllymaki M, Ebeling F, Jokinen E, Heinonen M, Kasanen T, Klievink J, Lahteenmaki H, Jaatinen T, Kytola S, Siitonen S, Dulau-Florea A, Braylan R, Heinaniemi M, Nakao S, Hellstrom-Lindberg E, Maciejewski JP, Blombery P, Young NS, Lahdesmaki H, Mustjoki S. Single-cell analysis of aplastic anemia reveals a convergence of NK and NK-like CD8+ T cells with a disease-associated TCR signature. Sci Transl Med. 2025 Feb 26;17(787):eadl6758. doi: 10.1126/scitranslmed.adl6758. Epub 2025 Feb 26. PubMed PMID: 40009697. 2025 14.6 40009697
Tang LV, Morange PE, Corral J, Ntaios G, Spyropoulos AC, Lip GYH, Douketis JD; International Thrombophilia Collaborative Initiative. Practical guideline for major hereditary thrombophilia. Innovation (Camb). 2025 Apr 1;6(6):100890. doi: 10.1016/j.xinn.2025.100890. eCollection 2025 Jun 2. No abstract available. PubMed PMID: 40528894; PubMed Central PMCID: PMC12169261. 2025 25.7 40528894
Moulis G, Chen F, Carli G, Ghanima W, Trautmann-Grill K, Stauch T, Schifferli A, Miah H, Rueter M, Ghiotto L, Georgi A, McDonald V, Zaja F, Pettersen HH, Kuhne T, Lozano ML, Gonzalez-Lopez TJ, Provan D, Michel M, Cooper N, Rodeghiero F. Use of second-line and beyond maintenance therapies in adult patients with primary immune thrombocytopenia in Europe: a parallel study of six prospective multicenter national registries. Haematologica. 2025 Jun 26. doi: 10.3324/haematol.2025.287408. Online ahead of print. PubMed PMID: 40568720. 2025 7.9 40568720
Chorao P, Avendano A, Heras I, Aiello F, Mico-Cerda M, Arrufat Bel A, Garcia-Gutierrez V, Olave MT, Gomez MA, Espigado I, Cuesta-Casas MA, Gonzalez-Santillana C, Hernandez-Rivas JA, Roldan-Perez A, Labrador J, Villalba M, Vazquez L, Garcia Vidal C, Martino R, Lopez-Jimenez J, Cedillo A, Solano C, Garcia-Cadenas I, Pinana JL; Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation Cell Therapy Group (GETH-TC). Co-infections during SARS-CoV-2 infection in hematologic patients and cell therapy recipients in the omicron era: a Spanish hematopoietic stem cell transplantation and cell therapy group study. BMC Infect Dis. 2025 Jul 25;25(1):944. doi: 10.1186/s12879-025-11302-w. PubMed PMID: 40713537; PubMed Central PMCID: PMC12291501. 2025 3.0 40713537
Guerrero C, Larrayoz MJ, Erdozain I, Puig N, Cedena MT, Maia C, Manu A, Gordillo N, Churruca O, Alignani D, Sarvide S, Vazquez I, Perez C, Oriol A, Rosinol L, Rios-Tamayo R, Gonzalez-Perez MS, Gonzalez-Rodriguez AP, de Arriba F, Moraleda JM, Martin J, Palomera L, Cabanas V, Calasanz MJ, Martinez-Lopez J, Mateos MV, Blade J, Lahuerta JJ, San-Miguel JF, Paiva B. Dynamics of Mutant Hematopoietic Progenitor Cells Are Not Associated with Clinical Outcomes in Multiple Myeloma. Blood Cancer Discov. 2025 May 5;6(3):203-216. doi: 10.1158/2643-3230.BCD-24-0274. PubMed PMID: 40232156; PubMed Central PMCID: PMC12050965. 2025 11.5 40232156
Cedena MT, Puig N, Paiva B, de la Puerta Rueda JE, Perez-Montana A, Casanova M, Brena Atienza J, Garcia A, de Arriba F, Martinez-Chamorro C, Sirvent M, Blanchard MJ, Alonso Fernandez R, Alvarez Rivas MA, Capote FJ, Garcia-Sanchez R, Perez JJ Sr, Rodriguez-Otero P, Lahuerta JJ, Martinez-Lopez J, Mateos MV, San-Miguel JF. Real-world evidence of measurable residual disease assessment in multiple myeloma. Blood Adv. 2025 Dec 11:bloodadvances.2025018454. doi: 10.1182/bloodadvances.2025018454. Online ahead of print. No abstract available. PubMed PMID: 41380099. 2025 7.1 41380099
Alfonso-Pierola A, Martinez-Cuadron D, Rodriguez-Veiga R, Gil C, Martinez-Sanchez P, Bernal T, Benavente C, Romero-Riquelme MA, Serrano-Lopez J, Bergua JM, Garcia-Boyero R, Tormo M, Herrera P, Sossa-Melo CL, Perez-Simon JA, Rodriguez-Medina C, Bass-Maturana MF, Lopez-Lorenzo JL, Algarra-Algarra L, Vidriales-Vicente B, Perez-Encinas M, Barrios-Garcia M, Vives S, Sayas-Lloris MJ, Capurro M, Hidalgo S, Olave M, Cuervo-Lozada D, Lavilla-Rubira E, Casado F, Mena-Duran A, Valero-Nunez M, Casado-Calderon S, Balerdi A, Torres V, Fernandez R, Noriega V, Stevenazzi M, Labrador J, Leon-Maldonado P, de Rueda-Ciller B, Arce-Fernandez O, Amigo ML, Raposo-Puglia JA, Sole M, Boluda B, Ayala R, Barragan E, Montesinos P; PETHEMA Group. Long-term benefits of autologous stem cell transplantation versus intensive chemotherapy consolidation for acute myeloid leukemia patients: A propensity score matching analysis from the PETHEMA AML registry. Leukemia. 2025 Nov;39(11):2686-2696. doi: 10.1038/s41375-025-02744-x. Epub 2025 Sep 1. PubMed PMID: 40890512; PubMed Central PMCID: PMC12589098. 2025 13.4 40890512
Coucelo M, Sargas C, Ayala R, Larrayoz MJ, Chillon MC, Soria E, Bilbao C, de la Torre EP, Amorim ML, Mirales A, Cionfrini A, Simoes AT, Oliveira AC, Rodriguez-Veiga R, Lloret-Madrid P, Mendizabal Y, Botella C, Bernal T, Bergua J, Algarra L, Tormo M, Martinez-Sanchez P, Serrano J, Alonso-Dominguez JM, Garcia R, Amigo ML, Herrera-Puente P, Sayas MJ, Abuin A, Martinez-Lopez J, Calasanz MJ, Garcia-Sanz R, Gutierrez N, Perez-Simon JA, Gomez Casares MT, Sanchez-Garcia J, Montesinos P, Barragan E; PETHEMA group. Interlaboratory cross validation of acute myeloid leukemia fusion genes and mutational targets detected by PCR: Performance of PETHEMA central laboratories. Leuk Res. 2025 Dec 19;160:108149. doi: 10.1016/j.leukres.2025.108149. Online ahead of print. PubMed PMID: 41443144. 2025 2.2 41443144
Castano-Diez S, Lopez-Guerra M, Zugasti I, Calvo X, Schulz FI, Avendano A, Mora E, Falantes J, Azaceta G, Ibanez M, Chen T, Notario C, Amer N, Palomo L, Pomares H, Vila J, Bernal Del Castillo T, Jimenez-Vicente C, Esteban D, Guijarro F, Alamo J, Cortes-Bullich A, Torrecillas-Mayayo V, Triguero A, Mont-de Torres L, Carcelero E, Cardus A, Germing U, Betz B, Rozman M, Arenillas L, Zamora L, Diez-Campelo M, Xicoy B, Esteve J, Diaz-Beya M. AML typical mutations (CEBPA, FLT3, NPM1) identify a high-risk chronic myelomonocytic leukemia independent of CPSS molecular. Blood Adv. 2025 Jan 14;9(1):39-53. doi: 10.1182/bloodadvances.2024013648. PubMed PMID: 39388660. 2025 7.1 39388660
Novoa-Jauregui S, Huber S, Gabarros-Subira M, Chen-Liang TH, Torres-Esquius S, Carrillo-Tornel S, Santiago M, Bernal Del Castillo T, Martin-Castillo I, Hernandez FM, Del Rey M, Liquori A, Tormo M, Cervera J, Bosch F, Valcarcel D, Haferlach C, Diez-Campelo M, Montoro MJ, Haferlach T, Jerez A. Myelodysplastic neoplasms with ring sideroblasts without SF3B1 mutations in adults: enrichment of germline variants in congenital sideroblastic anemia genes. Leukemia. 2025 May 7. doi: 10.1038/s41375-025-02629-z. Online ahead of print. No abstract available. PubMed PMID: 40335618. 2025 13.4 40335618
Bravo-Perez C, Gurnari C, Huuhtanen J, Kawashima N, Guarnera L, Mandala A, Williams ND, Haddad C, Witt M, Unlu S, Brady Z, Ogbue O, Orland M, Ahmed A, Kubota Y, Pagliuca S, Durmaz A, Mustjoki S, Visconte V, Maciejewski JP. Inborn errors of immunity underlie clonal T cell expansions in large granular lymphocyte leukemia. J Clin Invest. 2025 May 1;135(9):e184431. doi: 10.1172/JCI184431. eCollection 2025 May 1. PubMed PMID: 40309770; PubMed Central PMCID: PMC12043085. 2025 13.6 40309770
Cuenca-Guardiola J., de la Morena-Barrio B., Corral J., Fernández-Breis J.T. Advanced analysis of retrotransposon variation in the human genome with nanopore sequencing using RetroInspector. Scientific Reports. December 2025. 15. 10.1038/s41598-025-98847-7 2025 3.9 40281075
Corral J, Bravo-Perez C, Eugenia de la Morena-Barrio M. Hidden antithrombin defects: time to change and improve our thrombophilia diagnostic approach. J Thromb Haemost. 2025 Aug;23(8):2399-2402. doi: 10.1016/j.jtha.2025.05.021. No abstract available. PubMed PMID: 40738587. 2025 5.0 40738587
Monreal Bernal A, Berenguer Piqueras M, Ortiz Salvador P, Suarez Terron M, Bataller Alfonso A, Delgado Palacio S, Senent Peris ML, Roig Pellicer M, Villalba Valenzuela A, Benet Campos C, Espinosa Arnandi C, Fernandez Poveda E, Salido Fierez E, Rodenas Quinonero I, de Arriba de la Fuente F, Ortiz Andrade J, Marco Ayala J, Lozano ML, Ortuno FJ. Visceral leishmaniasis in heavily pretreated multiple myeloma patients a case series of 17 patients from the Mediterranean Coast of Spain. Ann Med. 2025 Dec;57(1):2514075. doi: 10.1080/07853890.2025.2514075. Epub 2025 Jun 5. PubMed PMID: 40470770; PubMed Central PMCID: PMC12143001. 2025 4.3 40470770
Gimenez E, Cadenas IG, Pinana JL, Albert E, Vazquez L, Avendano A, Cabrero M, Esquirol A, Martino R, Lopez-Jimenez J, Cuesta MA, Humala K, Villar S, Rovira M, Heras I, Zudaire T, Arroyo I, Zabalza A, Aguado B, Solano C, Navarro D; Spanish Group for Hematopoietic Transplantation (GETH). Cytomegalovirus DNA Doubling Time for Early Identification of Clinically Significant Infection Episodes in Allogeneic Hematopoietic Stem Cell Transplant Recipients Undergoing Primary Letermovir Prophylaxis: A Multicenter Study. Transpl Infect Dis. 2025 Jul 17:e70080. doi: 10.1111/tid.70080. Online ahead of print. PubMed PMID: 40674366. 2025 2.6 40674366
Manubens A, Paiva B, Gutierrez NC, Fernandez M, Calasanz MJ, Rosinol L, Oriol A, Blanchard MJ, Carrillo E, Benavente C, Martinez-Lopez J, Bargay J, Hernandez MT, de la Rubia J, Gonzalez Y, Paricio M, de Arriba F, Ocio EM, Teruel AI, de la Guia AL, Sirvent M, Gironella M, Sampol A, Arguinano JM, Cabrera C, Alegre A, Granell M, Cabanas V, Nunez-Cordoba JM, Mateos MV, Lahuerta JJ, San Miguel JF, Blade J, Rodriguez-Otero P. High-risk features of early relapse in newly-diagnosed multiple myeloma: The impact of cytogenetics and response to initial therapy. Hemasphere. 2025 Apr 24;9(4):e70127. doi: 10.1002/hem3.70127. eCollection 2025 Apr. PubMed PMID: 40276216; PubMed Central PMCID: PMC12020018. 2025 14.6 40276216
Guarnera L, Ahmed A, Bravo-Perez C, Ogbue OD, D'Addona M, Brady Z, Unlu S, Haddad C, Mandala A, Durmaz A, Gurnari C, Visconte V, Maciejewski JP. Anti-thymocyte globulin in immune-mediated cytopenias: A monocentric experience and literature review. Br J Haematol. 2025 Jun 12;207(1):284-8. doi: 10.1111/bjh.20165. Online ahead of print. PubMed PMID: 40509543; PubMed Central PMCID: PMC12234275. 2025 3.8 40509543
Lozano ML, Lambert MP, Al-Samkari H. Avatrombopag in immune thrombocytopenia and beyond: Current evidence and emerging perspectives. Blood Rev. 2025 Dec 28:101361. doi: 10.1016/j.blre.2025.101361. Online ahead of print. PubMed PMID: 41478740. 2025 5.7 41478740
Boluda B, Rodriguez-Veiga R, Sargas C, Ayala R, Larrayoz MJ, Chillon MC, Soria-Saldise E, Bilbao C, Prados de la Torre E, Navarro I, Martinez-Cuadron D, Gil C, Bernal T, Bergua J, Algarra L, Tormo M, Martinez-Sanchez P, Carrillo-Cruz E, Serrano J, Alonso-Dominguez JM, Garcia R, Amigo ML, Herrera-Puente P, Sayas MJ, Lavilla-Rubira E, Garcia-Perez MJ, Moran J, Perez-Santaolalla E, Alonso-Vence N, Oliva A, Lopez JA, Barrios M, Garcia-Fortes M, Olave MT, Labrador J, Martinez-Lopez J, Calasanz MJ, Garcia-Sanz R, Perez-Simon JA, Gomez-Casares MT, Sanchez-Garcia J, Mendizabal Y, Barragan E, Montesinos P; PETHEMA Group. Conventional PCR Versus Next Generation Sequencing for Diagnosis of FLT3, IDH and NPM1 Mutations in Acute Myeloid Leukemia: Results of the PETHEMA PCR-LMA Study. Cancers (Basel). 2025 Mar 1;17(5):854. doi: 10.3390/cancers17050854. PubMed PMID: 40075701; PubMed Central PMCID: PMC11898636. 2025 4.4 40075701
Marco-Ayala J, Chen T, Ortuno FJ, Lozano ML. Monolobated megakaryocytes and ring sideroblasts: A morphological prelude to multihit TP53 and complex karyotype. Br J Haematol. 2025 Nov 23. doi: 10.1111/bjh.70221. Online ahead of print. No abstract available. PubMed PMID: 41276967. 2025 3.8 41276967
Cabrera-Serrano AJ, Sánchez-Maldonado JM, Rodríguez-Sevilla JJ, Reyes-Zurita FJ, Collado R, Puiggros A, Cornejo-Calvo E, García-Martín P, Ter Horst R, Benavente Y, Jerez A, Landi S, Espinet B, Maffei R, López-Nevot MÁ, Ramos-Campoy S, González-Olmedo C, Chen-Liang TH, Moreno V, Jannus F, Marcos-Gragera R, Carretero-Fernández M, Sampaio-Marques B, Gámez I, García-Álvarez M, Camp NJ, Dierssen-Sotos T, Kamaso J, Pérez EM, Norman AD, Luppi M, Li Y, Alcoceba M, Campa D, de San José S, Marasca R, Ludovico P, Clay-Gilmour A, Canzian F, Ibañez M, Netea MG, McKay J, Casabonne D, Berndt SI, Slager SL, Sainz J. Identification of 4 autophagy-related genetic variants as risk factors for chronic lymphocytic leukemia. Blood Adv. 2025 Dec 9;9(23):6076-6089. doi: 10.1182/bloodadvances.2025017345. PMID: 40902075
Pérez-Lamas L, Segura Diaz A, García Delgado R, Álvarez-Larrán A, Senin MA, Mora E, Fox ML, Pastor Galan I, Azaceta G, Garrido Paniagua S, Pérez Lopez R, Trejos Carvajal DM, Angona A, Albo López C, Lorente Alegre P, Vara M, Vera Goñi JA, De Miguel Llorente D, Fernández Rodríguez Á, Marín Sanchez A, Hernando Megido A, Gómez Casares MT, Stuckey R, Carreño-Tarragona G, De Las Heras Rodriguez N, Xicoy B, Pérez Encinas M, Mata Serna R, Núñez Martin-Buitrago L, Ferrer Marín F, Amer Salas N, Guillén Rienda C, Velez P, Lamarca Eraso L, Martín S, Luts Khoroz I, De Cabo López E, Gil A, Martín-Consuegra Ramos S, Marco De Lucas F, Otero Martinez-Fornes MJ, Martín Mateos ML, Arquero T, Cabezudo Pérez E, López Gómez LA, Martínez Hellin Á, Tejedor A, Herrera de Pablo E, Mata Vazquez MI, Castillo Valero I, Fernández MJ, Aguilar C, Santaliestra M, García Menchon A, Navas Elorza B, Duran MA, Pérez Sala M, Hernández Santamaría T, Muñoz Jarreño MÁ, Dávila-Valls J, Torres Jiménez W, Gonzálvez Fernández JA, Torres Mantilla HA, Cobo Rodríguez T, Abuin Blanco A, Pérez F, Osorio Prendes S, Beneit Villena P, Peralta R, Herrera F, Cañamero Giro E, Jiménez Bárcenas R, Gasior Kabat M, González De Villa. Real world outcomes of momelotinib in myelofibrosis patients with anemia: results from the MOMGEMFIN study. Blood Cancer J. 2025 Apr 17;15(1):67. doi: 10.1038/s41408-025-01275-z. PMID: 40246837
Fiallo-Suárez DV, Stuckey R, Bilbao-Sieyro C, Tapia Torres M, Pérez-Ortíz L, Fernández F, Borsani O, Rumi E, Ianotto JC, Lekovic D, Ferrer-Marín F, Cuevas B, Kanduła Z, Gasior M, Álvarez-Larrán A, Lewandowski K, Senin A, Drozd-Sokołowska J, Sobas MA, Santoro M, Foncillas MA, Hernández-Boluda JC, Angona A, Carreño Gomez-Tarragona G, Mata-Vázquez MI, Fox ML, Del Orbe R, Vélez Tenza P, Vallansot R, Lemes-Castellano A, Gómez-Casares MT; Polish Acute Leukemia Group (PALG) and MPN Spanish Group (GEMFIN). Coexisting Myeloproliferative and Lymphoid Neoplasms: A European Multicenter Retrospective Study. Am J Hematol. 2026 Jan;101(1):156-159. doi: 10.1002/ajh.70105. Epub 2025 Oct 17. PMID: 41104715
Marco-Ayala J, Ortuño FJ. Appearances deceive: unmasking mantle cell lymphoma with prolymphocytic morphology. Blood. 2025 Apr 10;145(15):1701. doi: 10.1182/blood.2024027890. PMID: 40208646.
Klajmon A, Natorska J, Corral J, de la Morena-Barrio ME, Bravo-Perez C, Kopytek M, Jankowska U, Skupien-Rabian B, Hanarz M, Trelinski J, Zabczyk M. Reduced Plasma Selenoprotein P Is Associated With Type I Antithrombin Deficiency and a Prothrombotic State. Arch Pathol Lab Med. 2025 Jun 1;149(6):527-534. PubMed PMID: 39265995. 3.2 39265995
Munarriz D, López-Godino O, Martinez-Cibrian N, Albiol N, Brillembourg H, Navarro-Velázquez S, Español-Rego M, Casanueva S, García-Tomás L, Muñoz-Sanchez G, Alserawan L, Benitez-Ribas D, Magnano L, Correa JG, Rivero A, Mozas P, Gine E, Rodríguez-Lobato LG, Martínez-Roca A, Montoro-Lorite M, Ayora P, Esteve J, Frutos L, Balagué-Ponz O, Urbano-Ispizua A, González-Navarro EA, Juan M, Delgado J, Ortiz-Maldonado V. Combining CAR T-Cell Therapy and Nivolumab to Overcome Immune Resistance in THRLBCL: A Case Report. Int J Mol Sci. 2025 Sep 23;26(19):9265. doi: 10.3390/ijms26199265. PMID: 41096533; PMCID: PMC12524146.
Jiménez-Vicente C, Beneit P, Cano-Ferri I, Merchán B, Arnan M, Guiñón AG, Martínez-Bilbao C, Alfonso A, Martínez-Sánchez P, Alonso-Domínguez JM, López-Godino O, Castaño-Díez S, Zugasti I, Esteve J, Díaz-Beyá M, de la Fuente A. Enasidenib as treatment for AML with IDH2 mutation: multicenter real-life study of the early-access program in Spain. Ann Hematol. 2025 Sep;104(9):4863-4871. doi: 10.1007/s00277-025-06464-1. Epub 2025 Jul 12. PMID: 40650712; PMCID: PMC12552362.
Adrián Mosquera-Orgueira, Eduardo Arellano-Rodrigo, Marta Garrote, Iván Martín, Manuel Pérez-Encinas, María-Teresa Gómez-Casares, Alberto Hernández-Sánchez, Francisca Ferrer-Marín, Elvira Mor, Patricia Velez 8 Rosa Ayala, Anna Angona, Natalia de Las Heras, Elena Magro, Carlos Pérez-Míguez, Davide Crucitti, María-Isabel Mata-Vázquez, María-Laura Fox, Sonia González de Villambrosía, María-José Ramírez, Ana García, Valentín García-Gutiérrez, Amparo Cáceres, María-Antonia Durán, María-Alicia Senín, José-María Raya, José A González, Beatriz Cuevas, Blanca Xicoy, Jyoti Nangalia, Jesús M Hernández-Rivas, Beatriz Bellosillo, Alberto Álvarez-Larrán, Juan C Hernández-Boluda; Spanish MPN Group (GEMFIN). Integrating AIPSS-MF and molecular predictors: A comparative analysis of prognostic models for myelofibrosis. Hemasphere. 2024 Mar 20;8(3):e60. PMID: 38510992. F.I.: 7,6
Adrián Segura-Díaz, Ruth Stuckey, Yanira Florido, Marta Sobas, Alberto Álvarez-Larrán, Francisca Ferrer-Marín, Manuel Pérez-Encinas, Gonzalo Carreño-Tarragona, María L Fox, Barbara Tazón Vega, Beatriz Cuevas, Juan F López Rodríguez, Nuria Sánchez-Farías, Jesús M González-Martín, María T Gómez-Casares, Cristina Bilbao-Sieyro; Spanish MPN Group (GEMFIN)DNMT3A/TET2/ASXL1 Mutations are an Age-independent Thrombotic Risk Factor in Polycythemia Vera Patients: An Observational Study. Thromb Haemost. 2024 Jan 30. PMID: 38190984. F.I. 5,0.
Aguera Sanchez A, Martinez Diaz F, Pagan Munoz I, Martinez Perez M, Cano Marmol PLR, Martinez Martinez I, Zaragoza Huesca D, Garcia Molina F. Duodenal Pseudolipomatosis. Literature review and case report of a very unusual finding. Rev Esp Enferm Dig. 2024 Sep 5;119. doi: 10.17235/reed.2024.10673/2024. Online ahead of print. PubMed PMID: 39235188. F.I.:2.7
Berna-Erro A, Granados MP, Teruel-Montoya R, Ferrer-Marin F, Delgado E, Corbacho AJ, Fenandez E, Vazquez-Godoy MT, Tapia JA, Redondo PC. SARAF overexpression impairs thrombin-induced Ca2+ homeostasis in neonatal platelets. Br J Haematol. 2024 Mar;204(3):988-1004. doi: 10.1111/bjh.19210. Epub 2023 Dec 7. PubMed PMID: 38062782. F.I.:5.1
Borsellino B, Bravo-Perez C, Visconte V, Guarnera L. Thrombosis in Myeloid Malignancies: From CHIP to AML. Cardiovasc Hematol Disord Drug Targets. 2024;24(1):2-12. doi: 10.2174/011871529X307253240530060107. PubMed PMID: 38879768.
Bravo-Perez C, Cifuentes-Riquelme R, Padilla J, de la Morena-Barrio ME, Ortuno FJ, Garrido-Rodriguez P, Amigo ML, Heras I, Vicente V, Lozano ML, Teruel-Montoya R, de la Morena-Barrio B, Corral J. The whole is greater than the sum of its parts: Long-read sequencing for solving clinical problems in haematology. J Cell Mol Med. 2024 Jan 23. doi: 10.1111/jcmm.17961. Online ahead of print. No abstract available. PubMed PMID: 38260950. F.I.:4.3
Bravo-Perez C, Gurnari C. A tower of babel of acronyms? The shadowlands of MGUS/MBL/CHIP/TCUS. Semin Hematol. 2024 Feb;61(1):43-50. doi: 10.1053/j.seminhematol.2024.01.004. Epub 2024 Jan 19. PubMed PMID: 38350765. F.I.:5.0
Cuenca-Zamora EJ, Martinez C, Morales ML, Guijarro-Carrillo PJ, Lopez-Poveda MJ, Alcolea-Guardiola C, Vidal-Garrido N, Lozano ML, Gonzalez-Conejero R, Teruel-Montoya R, Ferrer-Marin F. Pacritinib prevents inflammation-driven myelofibrosis-like phenotype in a miR-146a-/- murine model. Biomed Pharmacother. 2024 Nov 26;181:117712. doi: 10.1016/j.biopha.2024.117712. Online ahead of print. PubMed PMID: 39603040. F.I.: 6,9
Cuenca-Zamora EJ, Guijarro-Carrillo PJ, Lopez-Poveda MJ, Morales ML, Lozano ML, Gonzalez-Conejero R, Martinez C, Teruel-Montoya R, Ferrer-Marin F. miR-146a-/- mice model reveals that NF-kappaB inhibition reverts inflammation-driven myelofibrosis-like phenotype. Am J Hematol. 2024 Jul;99(7):1326-1337. doi: 10.1002/ajh.27322. Epub 2024 Apr 22. PubMed PMID: 38646919. F.I.:10.1
Chion A, Byrne C, Atiq F, Doherty D, Aguila S, Fazavana J, Lopes P, Karampini E, Amin A, Preston RJS, Baker RI, McKinnon TAJ, Zhu S, Gilbert JC, Emsley J, Jilma B, O'Donnell JS. The aptamer BT200 blocks interaction of K1405-K1408 in the VWF-A1 domain with macrophage LRP1. Blood. 2024 Sep 26;144(13):1445-1456. doi: 10.1182/blood.2024024055. PubMed PMID: 38996211; PubMed Central PMCID: PMC11451302. F.I.:21.0
David Martínez-Cuadrón, Juan E Megías-Vericat, Cristina Gil, Teresa Bernal, Mar Tormo, Pilar Martínez-Sánchez, Carlos Rodríguez-Medina, Josefina Serrano, Pilar Herrera, José A Pérez Simón, María J Sayas, Juan Bergua, Esperanza Lavilla-Rubira, Maria Luz Amigo, Celina Benavente, Jose L López Lorenzo, Manuel M Pérez-Encinas, María B Vidriales, Mercedes Colorado, Beatriz De Rueda, Raimundo García-Boyero, Sandra Marini, Julio García-Suárez, María López-Pavía, Maria I Gómez-Roncero, Víctor Noriega, Aurelio López, Jorge Labrador, Ana Cabello, Claudia Sossa, Lorenzo Algarra, Mariana Stevenazzi, Antonio Solana-Altabella, Blanca Boluda, Pau Montesinos. Outcomes after intensive chemotherapy for secondary and myeloid-related changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry. Haematologica. 2024 Jan 1;109(1):115-128. PMID: 37199127 F.I.: 8,2
Diez-Campelo M, Lopez-Cadenas F, Xicoy B, Lumbreras E, Gonzalez T, Del Rey Gonzalez M, Sanchez-Garcia J, Coll Jorda R, Slama B, Hernandez-Rivas JA, Thepot S, Bernal T, Guerci-Bresler A, Bargay J, Amigo ML, Preudhomme C, Fenwarth L, Platzbecker U, Gotze KS, Arar A, Toribio S, Del Canizo C, Hernandez-Rivas JM, Fenaux P. Low dose lenalidomide versus placebo in non-transfusion dependent patients with low risk, del(5q) myelodysplastic syndromes (SintraREV): a randomised, double-blind, phase 3 trial. Lancet Haematol. 2024 Sep;11(9): e659-e670. doi: 10.1016/S2352-3026(24)00142-X. Epub 2024 Jul 18. PubMed PMID: 39033767. F.I.: 15,4
Fernandez-Suarez E, Gonzalez-Del Pozo M, Mendez-Vidal C, Martin-Sanchez M, Mena M, de la Morena-Barrio B, Corral J, Borrego S, Antinolo G. Long-read sequencing improves the genetic diagnosis of retinitis pigmentosa by identifying an Alu retrotransposon insertion in the EYS gene. Mob DNA. 2024 May 4;15(1):9. doi: 10.1186/s13100-024-00320-1. PubMed PMID: 38704576; PubMed Central PMCID: PMC11069205. F.I.:4.7.
Fonseca-Santos M, Bailen R, Lopez-Godino O, Herruzo-Delgado B, Bermudez MA, Garcia-Cadenas I, Huguet-Mas M, Ferra-Coll C, Esquirol A, Cortes-Rodriguez M, Yanez-Sansegundo L, Pascual-Cascon MJ, Heras I, Kwon M, Lopez-Corral L; Grupo Espanol de Trasplante Hematopoyetico y Terapia Celular. Characterization of Chronic Graft-versus-host Disease After Haploidentical Stem Cell Transplantation With Posttransplant Cyclophosphamide: A Study on Behalf of GETH-TC. Transplantation. 2024 Oct 1;108(10):2134-2143. doi: 10.1097/TP.0000000000005034. Epub 2024 Sep 24. PubMed PMID: 38685204. F.I.:5.3
Gonzalez-Calle V, Rodriguez-Otero P, Sureda A, De Arriba F, Reinoso M, Ribas P, Gonzalez-Rodriguez AP, Gonzalez Y, Oriol A, Martinez-Lopez J, Gonzalez MS, Hernandez MT, Sirvent M, Cedena T, Puig N, Paiva B, Blade J, Lahuerta JJ, San-Miguel JF, Mateos MV. Selinexor, daratumumab, bortezomib and dexamethasone for the treatment of patients with relapsed or refractory multiple myeloma: results of the phase II, nonrandomized, multicenter GEM-SELIBORDARA study. Haematologica. 2024 Jul 1;109(7):2219-2228. doi: 10.3324/haematol.2023.284089. PubMed PMID: 38356463; PubMed Central PMCID: PMC11215366. F.I.:8.2
Gonzalez-Lopez TJ, Bermejo-Vega N, Cardesa-Cabrera R, Martinez-Robles V, Aguilar-Monserrate G, Perez-Segura G, Domingo A, Luis-Navarro J, Lakhwani S, Acedo N, Lozano ML, Bernat S, Torres-Tienza A, Ruano A, Jarque I, Galan P, Benet C, Marcellini S, Jimenez-Barcenas R, Martinez-Carballeira D, De Miguel-Llorente D, Perona-Blazquez A, Gonzalez-Gascon I, Lopez-Ansoar E, Alonso-Alonso JM, Bengochea-Casado ML, Diaz-Galvez FJ, Moreto A, Moreno-Jimenez G, Hernandez-Martin R, de Cabo E, Davila-Valls J, Cuesta A, Pastoriza C, Hermida-Fernandez GJ, Garcia C, Pozas-Manas MA, Aguilar C, Fernandez-Jimenez D, Navas-Elorza B, Lopez-Santamaria Castro C, Lorenzo A, Ortin X, Garcia M, Piernas S, Diaz-Santa J, Soto I, Provan D, Garcia-Donas Gabaldon G. Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice. Blood. 2024 Aug 8;144(6):646-656. doi: 10.1182/blood.2024024250. PubMed PMID: 38843478. F.I.:21.0
Gordon J, Bravo-Perez C, Guarnera L, Unlu S, Kawashima N, Ahmed A, Haddad C, Kubota Y, Nautiyal I, Ullah F, Dima D, Williams ND, Kewan T, Bahaj W, Carraway HE, Yang CY, Gurnari C, Visconte V, Maciejewski JP. Non-canonical FLT3 alterations reveal novel germline FLT3 variants leading to somatic gene rescue mutations. Blood Cancer J. 2024 Jul 30;14(1):125. doi: 10.1038/s41408-024-01104-9. No abstract available. PubMed PMID: 39080258; PubMed Central PMCID: PMC11289469. F.I.:12,9
Guarnera L, D'Addona M, Bravo-Perez C, Visconte V. KMT2A Rearrangements in Leukemias: Molecular Aspects and Therapeutic Perspectives. Int J Mol Sci. 2024 Aug 20;25(16):9023. doi: 10.3390/ijms25169023. PubMed PMID: 39201709; PubMed Central PMCID: PMC11354696. F.I.:4.9
Hernandez-Sanchez A, Villaverde-Ramiro A, Arellano-Rodrigo E, Garrote M, Martin I, Mosquera-Orgueira A, Gomez-Casares MT, Ferrer-Marin F, Such E, Velez P, Ayala R, Angona A, de Las Heras N, Magro E, Mata-Vazquez MI, Fox ML, de Villambrosia SG, Ramirez MJ, Garcia A, Garcia-Gutierrez V, Caceres A, Duran MA, Senin A, Raya JM, Gonzalez JA, Cuevas B, Xicoy B, Perez-Encinas M, Bellosillo B, Alvarez-Larran A, Hernandez-Rivas JM, Hernandez-Boluda JC; Spanish MPN Group (GEMFIN). The prognostic impact of non-driver gene mutations and variant allele frequency in primary myelofibrosis. Am J Hematol. 2024 Apr;99(4):755-758. doi: 10.1002/ajh.27203. Epub 2024 Jan 30. PubMed PMID: 38291566. F.I.: 10,1.
Kawashima N, Gurnari C, Bravo-Perez C, Kubota Y, Pagliuca S, Guarnera L, Williams ND, Durmaz A, Ahmed A, Dima D, Ullah F, Carraway HE, Singh A, Visconte V, Maciejewski JP. Clonal hematopoiesis in large granular lymphocytic leukemia. Leukemia. 2024 Nov 21. doi: 10.1038/s41375-024-02460-y. Online ahead of print. PubMed PMID: 39572711. F.I.: 12,8. Labrador J, Martinez-Cuadron D, Boluda B, Serrano J, Gil C, Perez-Simon JA, Bernal T, Bergua JM, Martinez-Lopez J, Rodriguez-Medina C, Vidriales MB, Garcia-Boyero R, Algarra L, Polo M, Sayas MJ, Tormo M, Alonso-Dominguez JM, Herrera P, Lavilla E, Ramos F, Amigo ML, Vives-Polo S, Rodriguez-Macias G, Mena-Duran A, Perez-Encinas MM, Arce-Fernandez O, Cuello R, Sanchez-Garcia J, Gomez-Casares MT, Chillon MC, Calasanz MJ, Ayala R, Rodriguez-Veiga R, Barragan E, Montesinos P; PETHEMA Group. Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA Registry. Cancer. 2024 Oct 15;130(20):3436-3451. doi: 10.1002/cncr.35431. Epub 2024 Jun 19. PubMed PMID: 38896056. F.I.: 6,1.
Lakhwani S, Mateos MV, Martinez-Lopez J, Paiva B, Rosinol Dachs L, Martinez R, Oriol A, Bargay J, Gonzalez-Montes Y, Gironella M, Encinas C, Martin J, Jarque I, Granell M, Abella E, Garcia-Mateo A, Hernandez-Rivas JA, Ramila E, Krsnik I, Casado Montero LF, De Arriba F, Palomera L, Sampol A, Moraleda JM, Casanova M, Delgado P, Lafuente A, Amutio E, Lopez-Martinez A, Altes A, Ruiz MA, Alegre A, Lopez-Anglada L, De La Cruz J, Alonso Fernandez R, Blade Creixenti J, Lahuerta JJ, San-Miguel J, Hernandez MT. Immunoparesis recovery in newly diagnosed transplant ineligible multiple myeloma patients, an independent prognostic factor that complements minimal residual disease. Ann Hematol. 2024 Oct 23. doi: 10.1007/s00277-024-06031-0. Online ahead of print. PubMed PMID: 39438321. F.I.: 3,0.
Lasa M, Notarfranchi L, Agullo C, Gonzalez C, Castro S, Perez JJ, Burgos L, Guerrero C, Calasanz MJ, Flores-Montero J, Oriol A, Bargay J, Rios R, Cabanas V, Cabrera C, Martinez-Martinez R, Encinas C, De Arriba F, Hernandez MT, Palomera L, Orfao A, Martinez-Lopez J, Mateos MV, San-Miguel J, Lahuerta JJ, Rosinol L, Blade J, Cedena MT, Puig N, Paiva B; PETHEMA/GEM Cooperative Group. Minimally Invasive Assessment of Peripheral Residual Disease During Maintenance or Observation in Transplant-Eligible Patients With Multiple Myeloma. J Clin Oncol. 2024 Oct 1:JCO2400635. doi: 10.1200/JCO.24.00635. Online ahead of print. PubMed PMID: 39353166. F.I.: 42,1.
Marta Garrote , Mónica López-Guerra, Juan Carlos García-Pagán, Eduardo Arellano-Rodrigo, Francisca Ferrer-Marín, Juan Carlos Hernández-Boluda, Beatriz Bellosillo, Meritxell Nomdedeu, Virginia Hernández-Gea, Ana Triguero, Francesca Guijarro, José Álamo, Anna Baiges, Fanny Turon, Dolors Colomer, Francisco Cervantes , Alberto Alvarez-Larrán. Genomic classification and outcomes of young patients with polycythemia vera and essential thrombocythemia according to the presence of splanchnic vein thrombosis and its chronology. Ann Hematol. 2024 Mar;103(3):737-747. PMID: 38263537. F.I.: 3,0.
Marta Sobas, Wanda Knopinska-Posluszny, Beata Piątkowska-Jakubas, Flor García-Álvarez, María Elena Amutio Díez, Mar Caballero, David Martínez-Cuadrón, Eliana Aguiar, Jose González-Campos, Ana Garrido, Lorenzo Algarra, Olga Salamero, Javier de la Serna, Maria Jose Sayas, Manuel Mateo Perez-Encinas, Susana Vives, Belén Vidriales, Jorge Labrador, Ana Inés Prado, Lucía Celebrin, Jiri Mayer, Joana Brioso, Almudena de Laiglesia, Juan Miguel Bergua, Maria Luz Amigo, Carlos Rodriguez-Medina, Marta Polo, Agnieszka Pluta, Edyta Cichocka, Marek Skarupski, Miguel A Sanz, Agnieszka Wierzbowska, Pau Montesinos. Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experience. Ann Hematol. 2024 Feb;103(2):451-461. PMID: 38110588. F.I.: 4,3.
Mateos MV, Martinez-Lopez J, Rodriguez Otero P, Gonzalez-Calle V, Gonzalez MS, Oriol A, Gutierrez NC, Rios-Tamayo R, Rosinol L, Alvarez Rivas MA, Bargay J, Gonzalez-Rodriguez AP, Alegre A, Escalante F, Inigo Rodriguez MB, De La Rubia J, Teruel AI, de Arriba F, Palomera L, Hernandez MT, Lopez Jimenez J, Reinoso-Segura M, Garcia Mateo A, Ocio EM, Paiva B, Puig N, Cedena MT, Blade J, Lahuerta JJ, San-Miguel JF; Spanish Myeloma Group (GEM-Pethema). Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed by Transplant, KRd Consolidation, and Rd Maintenance. J Clin Oncol. 2024 Sep 20;42(27):3247-3256. doi: 10.1200/JCO.23.02771. Epub 2024 Jul 22. PubMed PMID: 39038268; PubMed Central PMCID: PMC11404760. F.I.:42.1
Medina-Herrera A, Vazquez I, Cuenca I, Rosa-Rosa JM, Ariceta B, Jimenez C, Fernandez-Mercado M, Larrayoz MJ, Gutierrez NC, Fernandez-Guijarro M, Gonzalez-Calle V, Rodriguez-Otero P, Oriol A, Rosinol L, Alegre A, Escalante F, De La Rubia J, Teruel AI, De Arriba F, Hernandez MT, Lopez-Jimenez J, Ocio EM, Puig N, Paiva B, Lahuerta JJ, Blade J, San Miguel JF, Mateos MV, Martinez-Lopez J, Calasanz MJ, Garcia-Sanz R; GEM/PETHEMA (Grupo Espanol de Mieloma/Programa para el Estudio de la Terapeutica en Hemopatias Malignas) cooperative study group. The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression. Blood Cancer J. 2024 Apr 29;14(1):74. doi: 10.1038/s41408-024-01053-3. PubMed PMID: 38684670; PubMed Central PMCID: PMC11059156. F.I.:12.9
Mora E, Montoro J, Balaguer A, Rovira M, Cabrero M, Heras I, Ribera JM, Antelo G, Martin AA, Lopez Godino O, Torrent A, Villalba M, Chorao P, Sanz MA, Sanz J; Grupo Espanol de Trasplante Hematopoyetico (GETH). Total body irradiation versus thiotepa/busulfan-based conditioning regimens for myeloablative allogeneic stem cell transplantation in adults with acute lymphoblastic leukemia. Bone Marrow Transplant. 2024 Aug;59(8):1137-1145. doi: 10.1038/s41409-024-02298-z. Epub 2024 May 16. PubMed PMID: 38755458. F.I.:4.5.
Ogbue O, Kewan T, Bravo-Perez C, Unlu S, Kawashima N, Williams ND, Ahmed A, Guarnera L, Gurnari C, Visconte V, Maciejewski JP. Hemolytic versus malproductive anemia in large granular lymphocytic leukemia. Leukemia. 2024 Aug;38(8):1839-1842. doi: 10.1038/s41375-024-02323-6. Epub 2024 Jul 9. No abstract available. PubMed PMID: 38982262; PubMed Central PMCID: PMC11286512. F.I.:12.8
Pastor-Galan I, Pereira A, Arellano-Rodrigo E, Martin I, Mosquera-Orgueira A, Gomez-Casares MT, Hernandez-Sanchez A, Ferrer-Marin F, Mora E, Velez P, Ayala R, Angona A, de Las Heras N, Magro E, Mata-Vazquez MI, Fox ML, Gonzalez de Villambrosia S, Ramirez MJ, Garcia A, Garcia-Gutierrez V, Caceres A, Duran MA, Senin MA, Raya JM, Gonzalez JA, Cuevas B, Xicoy B, Garrote M, Ferrer B, Perez-Encinas M, Hernandez-Rivas JM, Bellosillo B, Alvarez-Larran A, Hernandez-Boluda JC. Impact of somatic gene mutations on the risk of thrombosis in myelofibrosis. Leukemia. 2024 Nov;38(11):2483-2486. doi: 10.1038/s41375-024-02389-2. Epub 2024 Aug 30. No abstract available. PubMed PMID: 39215061. F.I.: 12,8
Plasencia Martinez JM, Garcia Tuells I, Bravo Perez C, Blanco Barrio A. Target sign in COVID-19, radiological interpretation and diagnostic contribution of digital thoracic tomosynthesis. Radiologia (Engl Ed). 2024 Apr;66 Suppl 1:S32-S39. doi: 10.1016/j.rxeng.2023.07.005. Epub 2024 Feb 15. PubMed PMID: 38642959.
Kawashima N, Kubota Y, Bravo-Perez C, Guarnera L, Williams ND, Durmaz A, Witt M, Ahmed A, Gurnari C, Maciejewski JP, Visconte V. Landscape of biallelic DNMT3A mutant myeloid neoplasms. J Hematol Oncol. 2024 Sep 27;17(1):87. doi: 10.1186/s13045-024-01607-9. PubMed PMID: 39334207; PubMed Central PMCID: PMC11438130. F.I.:29.5
Klajmon A, Natorska J, Corral J, de la Morena-Barrio ME, Bravo-Perez C, Kopytek M, Jankowska U, Skupien-Rabian B, Hanarz M, Trelinski J, Zabczyk M. Reduced Plasma Selenoprotein P Is Associated With Type I Antithrombin Deficiency and a Prothrombotic State. Arch Pathol Lab Med. 2024 Sep 13. doi: 10.5858/arpa.2024-0162-OA. Online ahead of print. PubMed PMID: 39265995. F.I.:3.7
Kwon M, Gomez-Centurion I, Oarbeascoa G, Torres M, Martinez AP, Suarez-Lledo M, Chinea A, Cascon MJP, Vazquez L, Espigado I, Izquierdo I, Parody R, Cadenas IG, Calbacho M, Sierra PG, Heras I, Yanez L, Torrent A, Bautista G, Gonzalez S, Roldan E, Vallejo JC, Bailen R, Borrero A, Lopez-Jimenez J, Casas MAC, Solano C; Spanish Group of Hematopoietic Stem Cell Transplantation and Cell Therapy (GETH-TC). Real-World Experience with Isavuconazole in Allogeneic Stem Cell Transplantation in Spain. Transplant Cell Ther. 2024 Oct;30(10):1033.e1-1033.e8. doi: 10.1016/j.jtct.2024.06.009. Epub 2024 Jun 12. PubMed PMID: 38871055. F.I.:3.6
Pinana JL, Vazquez L, Heras I, Aiello TF, Lopez-Corral L, Arroyo I, Soler-Espejo E, Garcia-Cadenas I, Garcia-Gutierrez V, Aroca C, Chorao P, Olave MT, Lopez-Jimenez J, Gomez MA, Arellano E, Cuesta-Casas M, Avendano-Pita A, Gonzalez-Santillana C, Hernandez-Rivas JA, Roldan-Perez A, Mico-Cerda M, Guerreiro M, Morell J, Rodriguez-Galvez P, Labrador J, Campos D, Cedillo A, Vidal CG, Martino R, Solano C. Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy. Front Oncol. 2024 Jun 19;14:1389345. doi: 10.3389/fonc.2024.1389345. eCollection 2024. PubMed PMID: 39015498; PubMed Central PMCID: PMC11250586. F.I.:3.5
Salas MQ, Cascos E, Lopez-Garcia A, Perez E, Baile-Gonzalez M, Martin Rodriguez C, Pascual Cascon MJ, Luque M, Esquirol A, Heras Fernando I, Pena-Munoz F, Oiartzabal Ormtegi I, Saez Marin AJ, Fernandez-Luis S, Dominguez-Garcia JJ, Villar Fernandez S, Fernandez de Sanmamed Giron M, Gonzalez Pinedo L, Garcia L, Gonzalez-Rodriguez AP, Torrado T, Filaferro S, Cedillo A, Orti G, Jurado Chacon M. Cardiac events after allo-HCT in patients with acute myeloid leukemia. Blood Adv. 2024 Nov 12;8(21):5497-5509. doi: 10.1182/bloodadvances.2024013535. PubMed PMID: 39178345; PubMed Central PMCID: PMC11538614. F.I.: 7,4.
Santaliestra M, Garrote M, Noya MS, Perez-Encinas M, Senin A, Perez-Lopez R, Ferrer-Marin F, Carreno-Tarragona G, Caballero G, Magro E, Velez P, Cortes Vazquez MA, Moreto A, Angona A, Pastor-Galan I, Guerra JM, Garcia Hernandez C, Mata MI, Stuckey R, Gomez-Casares MT, Fox L, Cuevas B, Garcia-Gutierrez V, Triguero A, Arellano-Rodrigo E, Hernandez-Boluda JC, Alvarez-Larran A. Prognostic value of response to first-line hydroxyurea according to IPSET stratification in essential thrombocythemia. Leukemia. 2024 Dec;38(12):2636-2643. doi: 10.1038/s41375-024-02416-2. Epub 2024 Sep 27. PubMed PMID: 39333760. F.I.: 12,8.
Rey-Bua B, Grande C, Sanchez Blanco JJ, Abrisqueta P, Gutierrez A, Ramirez Payer A, Gine E, Zeberio Etxetxipia I, Terol MJ, de la Cruz Vicente F, Andreu R, Ramirez MJ, de la Fuente A, Viguria MC, Penarrubia MJ, Jimenez-Ubieto A, Montes-Moreno S, Lopez-Guillermo A, Caballero MD, Martin Garcia-Sancho A. Ibrutinib in Combination with R-GemOx in Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma of Nongerminal Center B-cell-like Type: Phase II Clinical Trial of the Spanish GELTAMO Group. Clin Cancer Res. 2024 Sep 3;30(17):3704-3714. doi: 10.1158/1078-0432.CCR-24-0183. PubMed PMID: 38900037. F.I.:10
Salas MQ, Cascos E, Lopez-Garcia A, Perez-Lopez E, Baile-Gonzalez M, Lopez-Corral L, Pascual Cascon MJ, Luque M, Esquirol A, Heras Fernando I, Oiartzabal Ormtegi I, Saez Marin AJ, Pena-Munoz F, Fernandez-Luis S, Dominguez-Garcia JJ, Villar Fernandez S, Fernandez de Sanmamed Giron M, Gonzalez Pinedo L, Gonzalez-Rodriguez AP, Torrado T, Garcia L, Filaferro S, Cedillo A, Basalobre P, Orti G, Jurado Chacon M. Cardiac events occurring after allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide. Study conducted on behalf of the GETH-TC. Bone Marrow Transplant. 2024 Dec;59(12):1694-1703. PMID: 39277653. F.I.:4.5
Sanchez Canovas M, Garcia Torralba E, Blaya Boluda N, Sanchez Saura A, Puche Palao G, Sanchez Fuentes A, Martinez Montesinos L, Poveda Ganga C, Garcia Tomas L, Bayona Jimenez J, Cos Zapata A, Munoz Jurado CM, Pina Mingorance I, Caravaca Hernandez MA, Vicente Garcia V, Ayala de la Pena F. Thrombosis and infections associated with PICC in onco-hematological patients, what is their relevance? Clin Transl Oncol. 2024 Jun 12. doi: 10.1007/s12094-024-03548-8. Online ahead of print. PubMed PMID: 38865035. F.I.:2.8
Sílvia Marcé, Aleix Méndez, Blanca Xicoy, Natalia Estrada, Marta Cabezón, Antonella Luciana Sturla, Miriam Ratia García, Anna Angona, Paula Amat, Silvia Escribano Serrat, Emilia Scalzulli, Mireia Morgades, Alicia Senín, Juan Carlos Hernández-Boluda, Francisca Ferrer-Marín, Eduardo Anguita, Montserrat Cortés, Esther Plensa, Massimo Breccia, Valentín García-Gutierrez, Lurdes Zamora; Grupo Español de Leucemia Mieloide Crónica (GELMC). e14a2 Transcript Favors Treatment-Free Remission in Chronic Myeloid Leukemia When Associated with Longer Treatment with Tyrosine Kinase Inhibitors and Sustained Deep Molecular Response. J Clin Med. 2024 Jan 29;13(3):779. PMID: 38337473. F.I. 3,0.
Suarez EU, Boluda B, Lavilla E, Tormo M, Botella C, Gil C, Vives S, Rodriguez C, Serrano J, Sayas MJ, Martinez-Sanchez P, Ramos F, Bernal T, Algarra L, Bergua-Burgues JM, Perez-Simon JA, Herrera P, Barrios M, Noriega-Concepcion V, Raposo-Puglia JA, Ayala R, Barragan E, Martinez-Cuadron D, Amigo ML, Lopez-Lorenzo JL, Lazaro-Garcia A, Guimaraes JE, Colorado M, Garcia-Boyero R, De Rueda-Ciller B, Foncillas-Garcia M, Hong A, Labrador J, Alonso-Dominguez JM, Montesinos P; PETHEMA group. Do NPM1 and FLT3-ITD mutations modify prognosis in patients treated with non-intensive regimens? Ann Hematol. 2024 Aug;103(8):2845-2851. doi: 10.1007/s00277-024-05840-7. Epub 2024 Jun 17. PubMed PMID: 38884787. F.I.: 3,0
Torres-Esquius S, Beas F, Chen-Liang TH, Pomares H, Santiago M, Varela ND, Liquori A, Hernandez F, Xicoy B, Hermosin L, Arnan M, Tazon-Vega B, Blanco A, Cervera J, Diez-Campelo M, Lozano ML, Valcarcel D, Bosch F, Montoro MJ, Jerez A; GESMD centres. Germline assessment for alloHSCT candidates over 50 years: A 'Fast-Track' screening in myeloid neoplasms. Br J Haematol. 2024 Aug;205(2):503-509. doi: 10.1111/bjh.19460. Epub 2024 Apr 19. PubMed PMID: 38639421. F.I.:5.1
Vicente AI, Luna I, Ruiz JC, Remigia MJ, Jerez A, Lluch R, Llopis I, Marco MJ, Benet C, Alonso C, Linares MD, Serrano L, Orero MT, Ortuno FJ, Senent ML. WHO/ICC Classification for Myelodysplastic Neoplasms/Syndromes Performs Better for Subtype Cytomorphological Diagnosis? Diagnostics (Basel). 2024 Jul 29;14(15):1631. doi: 10.3390/diagnostics14151631. PubMed PMID: 39125507; PubMed Central PMCID: PMC 11312140 F.I.:3
Mingot-Castellano ME, Reguera-Ortega JL, Zafra Torres D, Hernani R, Lopez-Godino O, Guerreiro M, Herrero B, Lopez-Corral L, Luna A, Gonzalez-Pinedo L, Chinea-Rodriguez A, Africa-Martin A, Bailen R, Martinez-Cibrian N, Balsalobre P, Filaferro S, Alonso-Saladrigues A, Barba P, Perez-Martinez A, Calbacho M, Perez-Simon JA, Sanchez-Pina JM, On Behalf Of The Spanish Group Of Hematopoietic Transplant And Cell Therapy Geth-Tc. Use of Eltrombopag to Improve Thrombocytopenia and Tranfusion Requirement in Anti-CD19 CAR-T Cell-Treated Patients. J Clin Med. 2024 Aug 28;13(17):5117. doi: 10.3390/jcm13175117. PubMed PMID: 39274330; PubMed Central PMCID: PMC11396136.
Castano-Diez S, Lopez-Guerra M, Zugasti I, Calvo X, Schulz FI, Avendano A, Mora E, Falantes-Gonzalez JF, Azaceta G, Ibanez M, Chen-Liang TH, Notario Mc Donnell C, Amer-Salas N, Palomo L, Pomares H, Vila J, Bernal Del Castillo T, Jimenez-Vicente C, Esteban D, Guijarro F, Alamo Moreno JR, Cortes-Bullich A, Torrecillas-Mayayo V, Triguero A, Mont-de Torres L, Carcelero E, Cardus A, Germing U, Betz B, Rozman M, Arenillas L, Zamora L, Diez-Campelo M, Xicoy B, Esteve J, Diaz-Beya M. AML typical mutations (CEBPA, FLT3, and NPM1) identify a high-risk CMML independent of CPSS-Mol classification. Blood Adv. 2024 Oct 10: doi: 10.1182/bloodadvances.2024013648. Online ahead of print. PubMed PMID: 39388660.
Javier Marco-Ayala, Pedro Asensi Cantó, Marina Suarez, Brais Lamas, Marta Santiago, Inés Gómez, Mario Arnao, Jaime Sanz, Alberto Montava, Miguel Ángel Sanz, Javier de la Rubia, Pilar Solves. Single-Unit Transfusion Policy in Autologous Hematopoietic Stem Cell Transplantation: Less is Not Worse. Transfus Med Rev. 2024 Oct;38(4):150859. doi: 10.1016/j.tmrv.2024.150859. Epub 2024 Sep 14. PMID: 39383656
Isabel Ródenas Quiñonero, Javier Marco-Ayala, Tzu-Hua Chen-Lian, Fátima de la Cruz-Vicente, Tycho Baumann, José-Tomás Navarro, Alejandro Martín García-Sancho,Taida Martin-Santos, Javier López-Jiménez,Rafael Andreu, Ester Parra,Andrea Usas, David Alonso, Marta Fernández-González, Pablo Palomo Rumschisky, Laura Frutos, José Luis Navarro,Rosa María Alvarez-Perez, Pilar Sarandeses,Montserrat Cortes, Pilar Tamayo, Jon Uña, Alberto Martínez-Lorca, Cristina Ruiz,María Luisa Lozano, Francisco José Ortuño. The Value of Bone Marrow Assessment by FDG PET/CT, Biopsy and Aspirate in the Upfront Evaluation of Mantle Cell Lymphoma: A Nationwide Cohort Study. Cancers 2024 Dec 16. 16(24). 4189. https://doi.org/10.3390/cancers16244189
Gonzalez-Calle V, Rodriguez-Otero P, Calasanz MJ, Guijarro M, Martinez-Lopez J, Rosinol L, Hernandez MT, Teruel AI, Gironella M, Oriol A, de la Rubia J, Gonzalez-Rodriguez AP, Bargay J, de Arriba F, Palomera L, Gonzalez-Perez MS, Sureda A, Ocio E, Lahuerta JJ, Blade J, San Miguel JF, Mateos MV, Gutierrez NC. High-risk cytogenetic abnormalities in multiple myeloma: PETHEMA-GEM experience. Hemasphere. 2024 Dec 10;8(12):e70031. doi: 10.1002/hem3.70031. eCollection 2024 Dec. PubMed PMID: 39665068; PubMed Central PMCID: PMC11632121.
Puig N, Agullo C, Contreras T, Perez JJ, Aires I, Calasanz MJ, Garcia-Sanz R, Castro S, Martinez-Lopez J, Rodriguez-Otero P, Gonzalez-Calle V, Gonzalez MS, Oriol A, Gutierrez NC, Rios-Tamayo R, Rosinol L, Alvarez MA, Bargay J, Gonzalez-Rodriguez AP, Alegre A, Escalante F, Inigo MB, De la Rubia J, Teruel AI, De Arriba F, Palomera L, Hernandez MT, Lopez-Jimenez J, Reinoso M, Garcia-Mateo A, Ocio EM, Blade J, Lahuerta JJ, Cedena MT, Paiva B, Miguel JFS, Mateos MV. Single-point and kinetics of peripheral residual disease by mass spectrometry to predict outcome in patients with high-risk smoldering multiple myeloma included in the GEM-CESAR trial. Haematologica. 2024 Dec 1;109(12):4056-4066. doi: 10.3324/haematol.2024.285742. PubMed PMID: 38988266; PubMed Central PMCID: PMC11609803.
de Arriba de la Fuente F, Gironella Mesa M, Hernandez Garcia MT, Soler Campos JA, Herraez Rodriguez S, Moreno Belmonte MJ, Regueiro Lopez T, Gonzalez-Pardo M, Casanova Espinosa M, On Behalf Of The Carinae Study Investigators. Unravelling Transplant-Ineligible Newly Diagnosed Multiple Myeloma Treatment in Real-World Practice in Spain: The CARINAE Study. Pharmaceuticals (Basel). 2024 Sep 26;17(10):1272. doi: 10.3390/ph17101272. PubMed PMID: 39458913; PubMed Central PMCID: PMC11510635.
Guerrero, Camila; Puig, Noemi; Cedena, Maria-Teresa; Calasanz, Maria-Jose; Gutierrez, Norma C.; Fernandez, Manuela; Oriol, Albert; Rios-Tamayo, Rafael; Hernandez, Miguel-Teodoro; Martinez-Martinez, Rafael; Bargay, Joan; de Arriba, Felipe; Palomera, Luis; Gonzalez-Rodriguez, Ana Pilar; Perez, Marta -Sonia Gonzalez; Orfao, Alberto; Mateos, Maria -Victoria; Martinez-Lopez, Joaquin; Rosinol, Laura; Blade, Joan; Lahuerta, Juan -Jose; San-Miguel, Jesus F.; Paiva, Bruno. Predictors of unsustained measurable residual disease negativity in transplant-eligible patients with multiple myeloma. Blood. 2024 Feb 15;143(7):597-603. doi: 10.1182/blood.2023022083. PMID: 38048552, FI: 21,1
Salmanton-Garcia J, Marchesi F, Navratil M, Piukovics K, Del Principe MI, Criscuolo M, Bilgin YM, Fracchiolla NS, Vena A, Romano A, Falces-Romero I, Sgherza N, Heras-Fernando I, Biernat MM, Petzer V, Zak P, Weinbergerova B, Samarkos M, Erben N, van Praet J, Lopez-Garcia A, Labrador J, Lahmer T, Drgona L, Merelli M, Cuccaro A, Martin-Perez S, Davila-Valls J, Farina F, Cattaneo C, Pinczes LI, Magyari F, Espigado I, Buquicchio C, Vinh DC, Stoma I, Cernan M, Prezioso L, Papa MV, Plantefeve G, Khedr RA, Batinic J, Magliano G, Erdem S, Khostelidi S, Colovic N, Nappi D, Garcia-Ramirez P, Gora J, Callejas-Charavia M, Tlusty J, Bakker M, Wojtyniak E, Antic D, Magdziak A, Dargenio M, Idrizovic L, Pantic N, Stojanoski Z, Eisa N, Otasevic V, Marchetti M, Mackenzie E, Garcia-Vidal C, Aujayeb A, Almasari A, Miranda-Castillo C, Gavriilaki E, Coppola N, Busca A, Adzic-Vukicevic T, Schonlein M, Hersby DS, Grafe SK, Glenthoj A, Aiello TF, Cvetanoski M, Mitrovic M, Cerchione C, Prin R, Varricchio G, Arellano E, Cordoba R, Mayer J, Visek B, Wolf D, Anastasopoulou AN, Delia M, Musto P, Leotta D, Bavastro M, Limongelli A, Sciume M, van den Ven L, Fianchi L, Brunetti SC, Drozd-Sokolowska J, Dabrowska-Iwanicka A, Cornely OA, Pagano L. Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023-2024: EPICOVIDEHA-EPIFLUEHA Report. Am J Hematol. 2024 Dec 23. doi: 10.1002/ajh.27565. Online ahead of print. PubMed PMID: 39715069.
Aguila S, Gonzalez-Conejero R, Martinez C. microRNAs and thrombo-inflammation: relationship in sight. Curr Opin Hematol. 2024 May 1;31(3):140-147. doi: 10.1097/MOH.0000000000000803. Epub 2024 Jan 24. PubMed PMID: 38277182. F.I.:3.1
Bravo-Perez C, Blanco A, Revilla N, Cobos J, Salgado-Parente A, Asenjo S, Mendez R, Marti-Bonmati L, Bonanad S, Albillos JC, Castro N, Marcellini S, Lopez Sala P, Lasa M, Bastida JM, Infante MS, Corral MA, Pagan J, Llamas P, Rodriguez-Sevilla JJ, Rodriguez-Alen A, Sevivas TS, Morello D, Villar CG, Lojo S, Marco A, Simioni P, Vicente V, Lozano ML, de la Morena-Barrio ME, Garcia-Santos JM, Corral J; IVC Agenesis Study Group. Thrombotic risk and features of patients with inferior vena cava agenesis: a multicentre, retrospective, observational study. Lancet Haematol. 2024 Jun 12:S2352-3026(24)00138-8. doi: 10.1016/S2352-3026(24)00138-8. Online ahead of print. PubMed PMID: 38878784. F.I.:15.4
Garrido-Rodriguez P, Carmena-Bargueno M, de la Morena-Barrio ME, Bravo-Perez C, de la Morena-Barrio B, Cifuentes-Riquelme R, Lozano ML, Perez-Sanchez H, Corral J. Analysis of AlphaFold and molecular dynamics structure predictions of mutations in serpins. PLoS One. 2024 Jul 5;19(7):e0304451. doi: 10.1371/journal.pone.0304451. eCollection 2024. PubMed PMID: 38968282. F.I.:2.9
Klajmon A, Natorska J, Corral J, de la Morena-Barrio ME, Bravo-Pérez C, Kopytek M, Jankowska U, Skupien-Rabian B, Hanarz M, Treliński J, Ząbczyk M. Reduced Plasma Selenoprotein P Is Associated With Type I Antithrombin Deficiency and a Prothrombotic State. Arch Pathol Lab Med. 2024 Sep 13. doi: 10.5858/arpa.2024-0162-OA. Online ahead of print. PMID: 39265995. F.I,: 3,7.
Kruijt M, de la Morena-Barrio ME, Corral J, Cobbaert CM, Ruhaak LR. Novel insights into antithrombin deficiency enabled by mass spectrometry-based precision diagnostics. J Thromb Haemost. 2024 Oct 17:S1538-7836(24)00611-1. doi: 10.1016/j.jtha.2024.10.005. Online ahead of print. PubMed PMID: 39423957. F.I.: 5,5.
Liu ZJ, Thom C, Nitulescu II, Pelish HE, Rimsza LM, Teruel-Montoya R, Ferrer-Marin F, Shair MD, Sola-Visner M. CDK8/19 inhibition triggers a switch from mitosis to endomitosis in cord blood megakaryocytes. Br J Haematol. 2024 Oct 16. doi: 10.1111/bjh.19836. Online ahead of print. PubMed PMID: 39413769. F.I.: 5,1.
Marco-Rico A, Mantilla Pinilla AJ, Corral J, Marco-Vera P. Management of Thrombosis in a Patient with Three Thrombophilic Disorders. J Blood Med. 2024 Jul 24;15:305-312. doi: 10.2147/JBM.S466335. eCollection 2024. PMID: 39070969
Rojo-Carrillo JJ, Garrido-Rodriguez P, Llamas-Lopez M, Cifuentes-Riquelme R, Padilla J, Ramos-Molina B, Lozano ML, de la Morena-Barrio B, de la Morena-Barrio ME, Corral J. Landscape of antisense genes in the human genome and identification of new human hepatic antisense RNAs by long-read sequencing. BMC Genomics. 2024 Nov 27;25(1):1148. doi: 10.1186/s12864-024-11017-3. PubMed PMID: 39604851. F.I.: 3,5.
Teruel-Montoya R, Rivera J, Lozano ML. The importance of genetic variant cleaners: From patient to wet lab and back to clinical practice. Br J Haematol. 2024 Oct 7. doi: 10.1111/bjh.19818. Online ahead of print. PubMed PMID: 39375956. F.I.:5.1
Zamora-Cánovas A, de la Morena-Barrio B, Marín-Quilez A, Sierra-Aisa C, Male C, Fernández-Mosteirin N, Trapero-Marugán M, Padilla J, Garrido-Rodriguez P, Sánchez-Fuentes A, Rodríguez-Alen A, Gómez-González PL, Revilla N, de la Morena-Barrio ME, Bastida JM, Corral J, Rivera J, Lozano ML. Targeted long-read sequencing identifies and characterizes structural variants in cases of inherited platelet disorders. J Thromb Haemost. 2024 Mar;22(3):851-859. doi: 10.1016/j.jtha.2023.11.007. Epub 2023 Nov 24. PMID: 38007062. F.I.: 5,5.
Zaninetti C, Rivera J, Vater L, Ohlenforst S, Leinøe E, Böckelmann D, Freson K, Thiele T, Makhloufi H, Rath M, Eberl W, Wolff M, Freyer C, Wesche J, Zieger B, Felbor U, Heidel FH, Greinacher A. Aggregates of nonmuscular myosin IIA in erythrocytes associate with GATA1- and GFI1B-related thrombocytopenia. J Thromb Haemost. 2024 Apr;22(4):1179-1186. doi: 10.1016/j.jtha.2023.12.007. Epub 2023 Dec 15. PMID: 38103735. F.I.: 5,5.
Serrano-Gonzalo I, de Frutos LL, Lahoz-Gil C, Delgado-Mateos F, Fernández-Galán MÁ, Morales-Conejo M, Calle-Gordo MV, Ibarretxe-Gerediaga D, Madinaveitia-Ochoa A, Albarracin-Arraigosa A, Balanzat-Muñoz J, Correcher-Medina P, García-Frade LJ, Hernández-Rivas JM, Labbadia F, López-Dupla JM, Lozano-Almela ML, Mora-Casterá E, Noya-Pereira MS, Ruíz-Guinaldo MÁ, Del Mar Tormo-Díaz M, Vitoria-Miñana I, Arévalo-Vargas I, Andrade-Campos M, Giraldo P. Real life data: follow-up assessment on Spanish Gaucher disease patients treated with eliglustat. TRAZELGA project. Orphanet J Rare Dis. 2023 Dec 15;18(1):390. doi:10.1186/s13023-023-02939-4. PMID: 38102667.
Hurtado-Navarro L, Cuenca-Zamora EJ, Zamora L, Bellosillo B, Such E, Soler-Espejo E, Martínez-Banaclocha H, Hernández-Rivas JM, Marco-Ayala J, Martínez-Alarcón L, Linares-Latorre L, García-Ávila S, Amat-Martínez P, González T, Arnan M, Pomares-Marín H, Carreño-Tarragona G, Chen-Liang TH, Herranz MT, García-Palenciano C, Morales ML, Jerez A, Lozano ML, Teruel-Montoya R, Pelegrín P, Ferrer-Marín F. NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy. Cell Rep Med. 2023 Dec 19;4(12):101329. doi: 10.1016/j.xcrm.2023.101329. PMID: 38118408
Lozano ML. Expanding therapeutic options for patients with primary immune thrombocytopenia. Lancet Haematol. 2023 Jun;10(6):e390-e391. doi: 10.1016/S2352-3026(23)00063-7. Epub 2023 Apr 4. PMID: 37028434
Calleja JL, Delgado Sánchez O, Fuentes Pradera MÁ, Llop E, López Zárraga F, Lozano ML, Parra R, Turnes J. Recommendations for the future management of thrombocytopenia in patients with liver cirrhosis: A modified RAND/UCLA appropriateness method. Gastroenterol Hepatol. 2023 Apr 5:S0210-5705(23)00072-9. doi: 10.1016/j.gastrohep.2023.03.008. Online ahead of print. PMID: 37028757
Carreño-Tarragona G, Álvarez-Larrán A, Harrison C, Martínez-Ávila JC, Hernández-Boluda JC, Ferrer-Marín F, Radia DH, Mora E, Francis S, González-Martínez T, Goddard K, Pérez-Encinas M, Narayanan S, Raya JM, Singh V, Gutiérrez X, Toth P, Amat-Martínez P, Mcilwaine L, Alobaidi M, Mayani K, McGregor A, Stuckey R, Psaila B, Segura A, Alvares C, Davidson K, Osorio S, Cutting R, Sweeney CP, Rufián L, Moreno L, Cuenca I, Smith J, Morales ML, Gil-Manso R, Koutsavlis I, Wang L, Mead AJ, Rozman M, Martínez-López J, Ayala R, Cross NCP. CNL and aCML should be considered as a single entity based on molecular profiles and outcomes. Blood Adv. 2023 May 9;7(9):1672-1681. doi: 10.1182/bloodadvances.2022008204. PMID: 36375042
Morales ML, Ferrer-Marín F. Deepening Our Understanding of the Factors Affecting Landscape of Myeloproliferative Neoplasms: What Do We Know about Them? Cancers (Basel). 2023 Feb 20;15(4):1348. doi: 10.3390/cancers15041348. PMID: 36831689
Berna-Erro A, Ramesh G, Delgado E, Corbacho AJ, Ferrer-Marín F, Teruel R, Granados MP, Rosado JA, Redondo PC. CAPN1 (Calpain1)-Dependent Cleavage of STIM1 (Stromal Interaction Molecule 1) Results in an Enhanced SOCE (Store-Operated Calcium Entry) in Human Neonatal Platelets. Arterioscler Thromb Vasc Biol. 2023 May;43(5):e151-e170. doi: 10.1161/ATVBAHA.122.318015. Epub 2023 Mar 16. PMID: 36924231
Mosquera-Orgueira A, Pérez-Encinas M, Hernández-Sánchez A, González-Martínez T, Arellano-Rodrigo E, Martínez-Elicegui J, Villaverde-Ramiro Á, Raya JM, Ayala R, Ferrer-Marín F, Fox ML, Velez P, Mora E, Xicoy B, Mata-Vázquez MI, García-Fortes M, Angona A, Cuevas B, Senín MA, Ramírez-Payer A, Ramírez MJ, Pérez-López R, González de Villambrosía S, Martínez-Valverde C, Gómez-Casares MT, García-Hernández C, Gasior M, Bellosillo B, Steegmann JL, Álvarez-Larrán A, Hernández-Rivas JM, Hernández-Boluda JC. Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis. Hemasphere. 2022 Dec 20;7(1):e818. doi: 10.1097/HS9.0000000000000818. eCollection 2023 Jan. PMID: 36570691 Free PMC article.
Alvarez-Larrán A, Cuevas B, Velez P, Noya S, Caballero-Navarro G, Ferrer-Marín F, Carbonell S, Pérez-Encinas M, Gómez-Casares MT, Pérez-López R, Magro E, Moretó A, Pastor-Galán I, Angona A, Mata-Vázquez MI, Guerrero-Fernández L, Guerra JM, Carreño-Tarragona G, Fox L, Murillo I, García-Gutiérrez V, Mora E, Stuckey R, Arellano-Rodrigo E, Hernández-Boluda JC, Pereira A. Application of IPSET-thrombosis in 1366 Patients Prospectively Followed From the Spanish Registry of Essential Thrombocythemia. Hemasphere. 2023 Jul 18;7(8):e936. doi: 10.1097/HS9.0000000000000936. eCollection 2023 Aug. PMID: 37476303
Piñana JL, Heras I, Aiello TF, García-Cadenas I, Vazquez L, Lopez-Jimenez J, Chorão P, Aroca C, García-Vidal C, Arroyo I, Soler-Espejo E, López-Corral L, Avendaño-Pita A, Arrufat A, Garcia-Gutierrez V, Arellano E, Hernández-Medina L, González-Santillana C, Morell J, Hernández-Rivas JÁ, Rodriguez-Galvez P, Mico-Cerdá M, Guerreiro M, Campos D, Navarro D, Cedillo Á, Martino R, Solano C; Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC). Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients. Viruses. 2023 Oct 8;15(10):2066. doi: 10.3390/v15102066. PMID: 37896843
Piñana JL, Tridello G, Xhaard A, Wendel L, Montoro J, Vazquez L, Heras I, Ljungman P, Mikulska M, Salmenniemi U, Perez A, Kröger N, Cornelissen JJ, Sala E, Martino R, Geurten C, Byrne J, Maertens J, Kerre T, Martin M, Pascual MJ, Yeshurun M, Finke J, Groll AH, Shaw PJ, Blijlevens N, Arcese W, Ganser A, Suarez-Lledo M, Alzahrani M, Choi G, Forcade E, Paviglianiti A, Solano C, Wachowiak J, Zuckerman T, Bader P, Clausen J, Mayer J, Schroyens W, Metafuni E, Knelange N, Averbuch D, de la Camara R. Upper and/or lower respiratory tract infection caused by human metapneumovirus after allogeneic hematopoietic stem cell transplantation. J Infect Dis. 2023 Jul 13:jiad268. doi: 10.1093/infdis/jiad268. Online ahead of print. PMID: 37440459
Bailén R, Alenda R, Herruzo-Delgado B, Acosta-Fleitas C, Vallés A, Esquirol A, Fonseca M, Solán L, Sánchez-Vadillo I, Bautista G, Bento L, López-Godino O, Pérez-Martínez A, Torrent A, Zanabili J, Calbacho M, Moreno MÁ, Pascual-Cascón MJ, Guerra-Domínguez L, Chinea A, García-Cadenas I, López-Corral L, Boix-Giner F, López Lorenzo JL, Humala K, Duarte R, Sampol A, Heras I, Vicario JL, Balas A, Oarbeascoa G, Fernández-Caldas P, Anguita J, Kwon M. Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy. Front Immunol. 2023 May 26;14:1165759. doi: 10.3389/fimmu.2023.1165759. eCollection 2023. PMID: 37304258 Free PMC article.
Cruz D, Rodríguez-Romanos R, González-Bartulos M, García-Cadenas I, de la Cámara R, Heras I, Buño I, Santos N, Lloveras N, Velarde P, Tuset E, Martínez C, González M, Sanz GF, Ferrá C, Sampol A, Coll R, Pérez-Simón JA, López-Jiménez J, Jurado M, Gallardo D. LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors. Front Immunol. 2023 Jan 20;14:1066393. doi: 10.3389/fimmu.2023.1066393. eCollection 2023. PMID: 36742309 Free PMC article.
Robin M, Gras L, Koster L, Saccardi R, Finke J, Forcade E, Rovira M, Kobbe G, Reményi P, Apperley J, Smaranda A, Bay JO, Casper J, de Wreede LC, Giebel S, Grillo G, Heras I, Potter V, Tischer J, Trociukas I, Nachbaur D, Drozd-Sokolowska J, Raj K, Gurnari C, Yakoub-Agha I, Onida F, Scheid C, McLornan D. Are syngeneic donors a viable donor option in allogeneic haematopoietic cell transplantation for MDS? A brief report on behalf of the Chronic Malignancies Working Party of the EBMT and review of current literature. Bone Marrow Transplant. 2023 Aug;58(8):942-945. doi: 10.1038/s41409-023-01991-9. Epub 2023 Apr 25. PMID: 37185613 No abstract available.
Ljungman P, Tridello G, Piñana JL, Ciceri F, Sengeloev H, Kulagin A, Mielke S, Yegin ZA, Collin M, Einardottir S, Lepretre SD, Maertens J, Campos A, Metafuni E, Pichler H, Folber F, Solano C, Nicholson E, Yüksel MK, Carlson K, Aguado B, Besley C, Byrne J, Heras I, Dignan F, Kröger N, Robin C, Khan A, Lenhoff S, Grassi A, Dobsinska V, Miranda N, Jimenez MJ, Yonal-Hindilerden I, Wilson K, Averbuch D, Cesaro S, Xhaard A, Knelange N, Styczynski J, Mikulska M, de la Camara R. Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry. Front Immunol. 2023 Mar 7;14:1125824. doi: 10.3389/fimmu.2023.1125824. eCollection 2023. PMID: 36960069
Guerrero C, Puig N, Cedena MT, Calasanz MJ, Gutierrez NC, Fernandez M, Oriol A, Ríos-Tamayo R, Hernandez Garcia MT, Martínez-Martínez R, Bargay J, de Arriba F, Palomera L, Gonzalez-Rodriguez AP, Gonzalez Perez MS, Orfao A, Mateos MV, Martinez-Lopez J, Rosiñol L, Bladé J, Lahuerta JJ, San-Miguel J, Paiva B. Predictors of unsustained measurable residual disease negativity in transplant-eligible multiple myeloma patients. Blood. 2023 Dec 4:blood.2023022083. doi: 10.1182/blood.2023022083. PMID: 38048552
Lakhwani S, Rosiñol L, Puig N, Pico-Picos MA, Medina-González L, Martínez-López J, Paiva B, Cedena MT, Oriol A, Ríos-Tamayo R, Blanchard MJ, Jarque I, Bargay J, Moraleda JM, Carrillo-Cruz E, Sureda A, Krsnik I, González E, Casado LF, Martí JM, Encinas C, De Arriba F, Palomera L, Sampol A, González-Montes Y, Motlló C, De La Cruz J, Alonso R, Mateos MV, Bladé J, Lahuerta JJ, San-Miguel J, Hernández MT. Recovery of uninvolved heavy/light chain pair immunoparesis in newly diagnosed transplant-eligible myeloma patients complements the prognostic value of minimal residual disease detection. Haematologica. 2023 Nov 30. doi: 10.3324/haematol.2023.284154.PMID: 38031761
Burgos L, Tamariz-Amador LE, Puig N, Cedena MT, Guerrero C, Jelínek T, Johnson S, Milani P, Cordon L, Perez JJ, Lasa M, Termini R, Oriol A, Hernandez MT, Palomera L, Martinez-Martinez R, de la Rubia J, de Arriba F, Rios R, Gonzalez ME, Gironella M, Cabañas V, Casanova M, Krsnik I, Perez-Montaña A, González-Calle V, Rodriguez-Otero P, Maisnar V, Hajek R, Van Rhee F, Jimenez-Zepeda V, Palladini G, Merlini G, Orfao A, de la Cruz J, Martinez-Lopez J, Lahuerta JJ, Rosiñol L, Blade J, Mateos MV, San-Miguel JF, Paiva B; PETHEMA/GEM Cooperative Group. Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies. J Clin Oncol. 2023 Jun 1;41(16):3019-3031. doi: 10.1200/JCO.22.01916. Epub 2023 Mar 17. PMID: 36930848
Rosiñol L, Oriol A, Ríos-Tamayo R, Blanchard MJ, Jarque I, Bargay J, Hernandez Garcia MT, Cabañas V, Carrillo-Cruz E, Sureda A, Martinez-Lopez J, Krsnik I, Gonzalez ME, Casado Montero LF, Marti JM, Encinas C, de Arriba F, Palomera L, Sampol A, Gonzalez-Montes Y, Cabezudo E, Paiva B, Puig N, Cedena MT, de la Cruz J, Mateos MV, San-Miguel J, Lahuerta JJ, Bladé J. LENALIDOMIDE AND DEXAMETHASONE WITH OR WITHOUT IXAZOMIB MAINTENANCE TAILORED BY RESIDUAL DISEASE STATUS IN MYELOMA. Blood. 2023 Jul 28:blood.2022019531. doi: 10.1182/blood.2022019531. Online ahead of print. PMID: 37506339
Botta C, Perez C, Larrayoz M, Puig N, Cedena MT, Termini R, Goicoechea I, Rodriguez S, Zabaleta A, Lopez A, Sarvide S, Blanco L, Papetti DM, Nobile MS, Besozzi D, Gentile M, Correale P, Siragusa S, Oriol A, González-Garcia ME, Sureda A, de Arriba F, Rios Tamayo R, Moraleda JM, Gironella M, Hernandez MT, Bargay J, Palomera L, Pérez-Montaña A, Goldschmidt H, Avet-Loiseau H, Roccaro A, Orfao A, Martinez-Lopez J, Rosiñol L, Lahuerta JJ, Blade J, Mateos MV, San-Miguel JF, Martinez Climent JA, Paiva B; Programa Para el Estudio de la Terapéutica en Hemopatías Malignas/Grupo Español de Mieloma (PETHEMA/GEM) cooperative group; iMMunocell study group. Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance. Nat Commun. 2023 Sep 20;14(1):5825. doi: 10.1038/s41467-023-41562-6. PMID: 37730678 Free PMC article.
Puertas B, González-Calle V, Sureda A, Moreno MJ, Oriol A, González E, Rosiñol L, López J, Escalante F, Martínez-Lopez J, Carrillo E, Clavero E, Ríos-Tamayo R, Rey-Bua B, González-Rodríguez AP, Dourdil V, De Arriba F, González S, Pérez-de-Oteyza J, Hernández MT, García-Mateo A, Bargay J, Bladé J, Lahuerta JJ, San Miguel JF, Ocio EM, Mateos MV. Randomized phase II study of weekly carfilzomib 70 mg/m2 and dexamethasone with or without cyclophosphamide in relapsed and/or refractory multiple myeloma patients. Haematologica. 2023 Oct 1;108(10):2753-2763. doi: 10.3324/haematol.2022.282490. PMID: 37102598
Ferra Coll C, Morgades de la Fe M, Prieto García L, Vaz CP, Heras Fernando MI, Bailen Almorox R, Garcia-Cadenas I, Calabuig Muñoz M, Ripa TZ, Zanabili Al-Sibai J, Novoa S, Aguado B, Torrent Catarineu A, López-Godino O, Martino Bofarull R, Kwon M, Campos Júnior A, Caballero Barrigón D, Ribera Santasusana JM. Prognosis of patients with acute lymphoblastic leukaemia relapsing after allogeneic stem cell transplantation. Eur J Haematol. 2023 Jun;110(6):659-668. doi: 10.1111/ejh.13947. Epub 2023 Mar 18. PMID: 36813736
Mussetti A, Bento L, Bastos-Oreiro M, Rius-Sansalvador B, Albo C, Bailen R, Barba P, Benzaquén A, Briones J, Caballero AC, Campos A, Español I, Ferra C, López SG, González Sierra PA, Guerra LM, Hernani R, Iacoboni G, Jiménez-Ubieto A, Kwon M, Corral LL, López-Godino O, Munoz MCM, Martínez-Cibrián N, Gómez JM, Pérez-Ortega L, Ortí G, Ortiz-Maldonado V, Pascual MJ, Perera M, Perez A, Reguera JL, Sanchez JM, Sanz J, Torrent A, Yáñez L, Varela R, Echechipia IC, Caballero D, Sureda A. Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART era. Bone Marrow Transplant. 2023 Jun;58(6):673-679. doi: 10.1038/s41409-023-01949-x. Epub 2023 Mar 14. PMID: 36918682
Mussetti A, Bento L, Bastos-Oreiro M, Rius-Sansalvador B, Albo C, Bailen R, Barba P, Benzaquén A, Briones J, Caballero AC, Campos A, Español I, Ferra C, López SG, González Sierra PA, Guerra LM, Hernani R, Iacoboni G, Jiménez-Ubieto A, Kwon M, Corral LL, López-Godino O, Munoz MCM, Martínez-Cibrián N, Gómez JM, Pérez-Ortega L, Ortí G, Ortiz-Maldonado V, Pascual MJ, Perera M, Perez A, Reguera JL, Sanchez JM, Sanz J, Torrent A, Yáñez L, Varela R, Echechipia IC, Caballero D, Sureda A. Correction: Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART era. Bone Marrow Transplant. 2023 Jun;58(6):738. doi: 10.1038/s41409-023-01967-9. PMID: 37076611 No abstract available.
Medina I, Carpio C, Ruiz-Camps I, Albasanz-Puig A, Lopez-Godino O, Esperalba J, Beas F, Sanchez-Salinas M, Iacoboni G, Barba P. Adenovirus-induced hemorrhagic cystitis after CD19-targeted chimeric antigen receptor T-cell therapy in a patient with large B-cell lymphoma. Immunotherapy. 2023 Sep 18. doi: 10.2217/imt-2023-0111. Online ahead of print. PMID: 37718888
Bailén R, Alenda R, Herruzo-Delgado B, Acosta-Fleitas C, Vallés A, Esquirol A, Fonseca M, Solán L, Sánchez-Vadillo I, Bautista G, Bento L, López-Godino O, Pérez-Martínez A, Torrent A, Zanabili J, Calbacho M, Moreno MÁ, Pascual-Cascón MJ, Guerra-Domínguez L, Chinea A, García-Cadenas I, López-Corral L, Boix-Giner F, López Lorenzo JL, Humala K, Duarte R, Sampol A, Heras I, Vicario JL, Balas A, Oarbeascoa G, Fernández-Caldas P, Anguita J, Kwon M. Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy. Front Immunol. 2023 May 26;14:1165759. doi: 10.3389/fimmu.2023.1165759. eCollection 2023. PMID: 37304258
Torrent A, Morgades M, García-Calduch O, de Llano MPQ, Montesinos P, Navarro I, Hernández-Rivas JM, Bárez-García A, González-Campos J, Oiartzabal I, Valero M, Cervera M, Zudaire T, Albors-Ferreiro M, López-Godino O, Gil-Cortés C, Villalón L, Saldaña R, Ribera JM. Results of the compassionate program of inotuzumab ozogamicin for adult patients with relapsed or refractory acute lymphoblastic leukemia in Spain. Eur J Haematol. 2023 Sep;111(3):485-490. doi: 10.1111/ejh.14031. Epub 2023 Jun 28. PMID: 37381686
Isabel Ródenas-Quiñonero, Tzu Chen-Liang, Taida Martín-Santos, Antonio Salar, Marta Fernández-González, Carolina Celades, José-Tomás Navarro, Ana Belén Martínez-Garcia, Rafael Andreu, Aitana Balaguer, Alejandro Martin García-Sancho, Mónica Baile, Javier López-Jiménez, Juan Marquet-Palomanes, Ana Isabel Teruel, María José Terol, Carmen Benet, Laura Frutos, José Luis Navarro, Jon Uña, Marina Suarez, Montserrat Cortes, José Contreras, Cristina Ruiz, Pilar Tamayo, Jorge Mucientes, Pablo Sopena-Novales, Laura Reguilón-Gallego, José Javier Sánchez-Blanco, Elena Pérez-Ceballos, Andrés Jerez, Francisco José Ortuño . Accuracy and prognostic impact of FDG PET/CT and biopsy in bone marrow assessment of follicular lymphoma at diagnosis: A Nation-Wide cohort study. Cancer Med. 2023 Mar;12(6):6536-6546. doi: 10.1002/cam4.5424. Epub 2022 Nov 13. PMID: 36373169
Gonzalez Barca E, Tomás-Roca L, Esteve A, Rodriguez M, Gato L, Alonso-Alonso R, Martin Garcia-Sancho A, Cordoba R, Monter-Rovira A, Bastos-Oreiro M, Bergua Burgues JM, Sayas MJ, Viguria Alegria MC, Sanchez-Blanco JJ, Roig Pellicer M, Luzardo Henriquez HD, de Oña R, Cabezudo ME, Infante MS, Queizán Hernández JA, Sanz-Pamplona R, Blanco O, Mozos A, Climent F, Piris MA. Extranodal natural killer/T-cell lymphoma nasal type in a western population: Molecular profiling identifies new therapeutic targets. Am J Hematol. 2023 Jun;98(6):E134-E138. doi: 10.1002/ajh.26904. Epub 2023 Mar 16. PMID: 36882876
Bravo-Perez C, Guarnera L, Williams ND, Visconte V. Paroxysmal Nocturnal Hemoglobinuria: Biology and Treatment. Medicina (Kaunas). 2023 Sep 6;59(9):1612. doi: 10.3390/medicina59091612. PMID: 37763731
Guarnera L, Bravo-Perez C, Visconte V. Immunotherapy in Acute Myeloid Leukemia: A Literature Review of Emerging Strategies. Bioengineering (Basel). 2023 Oct 20;10(10):1228. doi: 10.3390/bioengineering10101228. PMID: 37892958
Martínez-Cuadrón D, Megías-Vericat JE, Gil C, Bernal T, Tormo M, Martínez-Sánchez P, Rodríguez-Medina C, Serrano J, Herrera P, Simón JAP, Sayas MJ, Bergua J, Lavilla-Rubira E, Amigo ML, Benavente C, Lorenzo JLL, Pérez-Encinas MM, Vidriales MB, Colorado M, De Rueda B, García-Boyero R, Marini S, García-Suárez J, López-Pavía M, Gómez-Roncero MI, Noriega V, López A, Labrador J, Cabello A, Sossa C, Algarra L, Stevenazzi M, Solana-Altabella A, Boluda B, Montesinos P. Outcomes after intensive chemotherapy for secondary and myeloidrelated changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry. Haematologica. 2023 May 18. doi: 10.3324/haematol.2022.282506. Online ahead of print. PMID: 37199127
Orts Paco JF, Sánchez Llinares JR, Cano Gracia H. Hemophagocytic syndrome secondary to Mediterranean spotted fever. Med Clin (Barc). 2023 Aug 25;161(4):180. doi: 10.1016/j.medcli.2023.04.011. Epub 2023 May 25. PMID: 37244859
Wang YH, Yao CY, Lin CC, Gurashi K, Amaral FMR, Bossenbroek H, Jerez A, Somervaille TCP, Binder M, Patnaik MM, Hou HA, Chou WC, Batta K, Wiseman DH, Tien HF. A three-gene leukaemic stem cell signature score is robustly prognostic in chronic myelomonocytic leukaemia. Br J Haematol. 2023 Apr;201(2):302-307. doi: 10.1111/bjh.18681. Epub 2023 Feb 6. PMID: 36746431
Macauda A, Briem K, Clay-Gilmour A, Cozen W, Försti A, Giaccherini M, Corradi C, Sainz J, Niazi Y, Ter Horst R, Li Y, Netea MG, Vogel U, Hemminki K, Slager SL, Varkonyi J, Andersen V, Iskierka-Jazdzewska E, Mártinez-Lopez J, Zaucha J, Camp NJ, Rajkumar SV, Druzd-Sitek A, Bhatti P, Chanock SJ, Kumar SK, Subocz E, Mazur G, Landi S, Machiela MJ, Jerez A, Norman AD, Hildebrandt MAT, Kadar K, Berndt SI, Ziv E, Buda G, Nagler A, Dumontet C, Raźny M, Watek M, Butrym A, Grzasko N, Dudzinski M, Rybicka-Ramos M, Matera EL, García-Sanz R, Goldschmidt H, Jamroziak K, Jurczyszyn A, Clavero E, Giles GG, Pelosini M, Zawirska D, Kruszewski M, Marques H, Haastrup E, Sánchez-Maldonado JM, Bertsch U, Rymko M, Raab MS, Brown EE, Hofmann JN, Vachon C, Campa D, Canzian F. Identification of novel genetic loci for risk of multiple myeloma by functional annotation.Leukemia. 2023 Sep 18. doi: 10.1038/s41375-023-02022-8. Online ahead of print. PMID: 37723249
Cabrera-Serrano AJ, Sánchez-Maldonado JM, Ter Horst R, Macauda A, García-Martín P, Benavente Y, Landi S, Clay-Gilmour A, Niazi Y, Espinet B, Rodríguez-Sevilla JJ, Pérez EM, Maffei R, Blanco G, Giaccherini M, Cerhan JR, Marasca R, López-Nevot MÁ, Chen-Liang T, Thomsen H, Gámez I, Campa D, Moreno V, de Sanjosé S, Marcos-Gragera R, García-Álvarez M, Dierssen-Sotos T, Jerez A, Butrym A, Norman AD, Luppi M, Slager SL, Hemminki K, Li Y, Berndt SI, Casabonne D, Alcoceba M, Puiggros A, Netea MG, Försti A, Canzian F, Sainz J. Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression? Int J Mol Sci. 2023 Apr 28;24(9):8005. doi: 10.3390/ijms24098005. PMID: 37175717
Castillo MI, Ribate VE, Muñoz CM, Santillana SG, Taboada SE, Casterá ME, Abinzano CMJ, Barranco IA, Nieto CR, Pampliega VM, Blanco ML, de Andrés ÁS, de Oteyza PJ, Del Castillo BT, Font GI, Jerez A., Díez-Campelo M, Sánchez AR, Vercet SC, Díaz TM; Grupo Español de Síndromes Mielodisplásicos (GESMD). Incidence and prognostic impact of U2AF1 mutations and other gene alterations in myelodysplastic neoplasms with isolated 20q deletion. Cancer Med. 2023 Aug;12(16):16788-16792. doi: 10.1002/cam4.6300. Epub 2023 Jul 5. PMID: 37403747
Soler-Espejo E, Marco-Ayala J, Chen-Liang TH, López-Poveda MJ, Teruel-Montoya R, Ortuño FJ. CD5+ follicular lymphoma rapidly transformed to high-grade B-cell lymphoma with double-hit: from BCL2 to MYC disruption. Blood Res. 2023 Mar 31;58(1):79-82. doi: 10.5045/br.2023.2023039. PMID: 36987619
Carrillo-Tornel S, Chen-Liang TH, Zurdo M, Puiggros A, Gómez-Llonín A, García-Malo MD, Cuenca-Zamora EJ, Ortuño FJ, López AMH, Espinet B, Jerez A. NOTCH1 mutation in chronic lymphocytic leukaemia is associated with an enhanced cell cycle G1/S transition and specific cyclin overexpression: Preclinical ground for targeted inhibition. Br J Haematol. 2023 May;201(3):470-479. doi: 10.1111/bjh.18609. Epub 2022 Dec 27. PMID: 36573331
Pagán-Escribano J, Corral J, Miñano A, Padilla J, Roldán V, Hernández-Vidal MJ, Lozano J, de la Morena-Barrio I, Vicente V, Lozano ML, Herranz MT, de la Morena-Barrio ME. Factor XI in Carriers of Antiphospholipid Antibodies: Elevated Levels Associated with Symptomatic Thrombotic Cases, While Low Levels Linked to Asymptomatic Cases. Int J Mol Sci. 2023 Nov 13;24(22):16270. doi: 10.3390/ijms242216270. PMID: 38003459
Cuenca-Guardiola J, Morena-Barrio B, Navarro-Manzano E, Stevens J, Ouwehand WH, Gleadall NS, Corral J, Fernández-Breis JT. Detection and annotation of transposable element insertions and deletions on the human genome using nanopore sequencing. iScience. 2023 Oct 14;26(11):108214. doi: 10.1016/j.isci.2023.108214. PMID: 37953943
de la Morena-Barrio B, Palomo Á, Padilla J, Martín-Fernández L, Rojo-Carrillo JJ, Cifuentes R, Bravo-Pérez C, Garrido-Rodríguez P, Miñano A, Rubio AM, Pagán J, Llamas M, Vicente V, Vidal F, Lozano ML, Corral J, de la Morena-Barrio ME. Impact of genetic structural variants in factor XI deficiency: identification, accurate characterization, and inferred mechanism by long-read sequencing. J Thromb Haemost. 2023 Jul;21(7):1779-1788. doi: 10.1016/j.jtha.2023.03.009. Epub 2023 Mar 20. PMID: 36940803
Lova A, Pagán J, de la Morena G, Vázquez DJ, Cerezo-Manchado JJ, Bravo-Pérez C, Miñano A, Tomás A, Vicente V, Lozano ML, Corral J, de la Morena-Barrio ME. Congenital factor XI deficiency and risk of heart failure in humans. J Thromb Haemost. 2023 Sep;21(9):2626-2629. doi: 10.1016/j.jtha.2023.06.013. Epub 2023 Jun 17. PMID: 37336435
Cifuentes R, Padilla J, de la Morena-Barrio ME, de la Morena-Barrio B, Bravo-Pérez C, Garrido-Rodríguez P, Llamas M, Miñano A, Vicente V, Lozano ML, Corral J. Usefulness and Limitations of Multiple Ligation-Dependent Probe Amplification in Antithrombin Deficiency. Int J Mol Sci. 2023 Mar 6;24(5):5023. doi: 10.3390/ijms24055023. PMID: 36902454
Natorska J, Corral J, de la Morena-Barrio ME, Bravo-Pérez C, Bagoly Z, Bereczky Z, Treliński J, Witkowski M, Klajmon A, Undas A, Ząbczyk M. Antithrombin Deficiency Is Associated with Prothrombotic Plasma Fibrin Clot Phenotype Thromb Haemost. 2023 Sep;123(9):880-891. doi: 10.1055/s-0043-1768712. Epub 2023 May 18. PMID: 37201530
Harrison SP, Siller R, Tanaka Y, Chollet ME, de la Morena-Barrio ME, Xiang Y, Patterson B, Andersen E, Bravo-Pérez C, Kempf H, Åsrud KS, Lunov O, Dejneka A, Mowinckel MC, Stavik B, Sandset PM, Melum E, Baumgarten S, Bonanini F, Kurek D, Mathapati S, Almaas R, Sharma K, Wilson SR, Skottvoll FS, Boger IC, Bogen IL, Nyman TA, Wu JJ, Bezrouk A, Cizkova D, Corral J, Mokry J, Zweigerdt R, Park IH, Sullivan GJ. Scalable production of tissue-like vascularized liver organoids from human PSCs. Exp Mol Med. 2023 Sep;55(9):2005-2024. doi: 10.1038/s12276-023-01074-1. Epub 2023 Sep 1. PMID: 37653039
Cuenca-Guardiola J, de la Morena-Barrio B, García JL, Sanchis-Juan A, Corral J, Fernández-Breis JT. Improvement of large copy number variant detection by whole genome nanopore sequencing. J Adv Res. 2023 Aug;50:145-158. doi: 10.1016/j.jare.2022.10.012. Epub 2022 Oct 30. PMID: 36323370
Weronska A, De la Morena-Barrio B, Goldman-Mazur S, De la Morena-Barrio ME, Padilla J, Miñano A, Garrido P, Treliński J, Potaczek DP, Szczepanek A, Undas A, Corral J, Wypasek E. Functional, biochemical, molecular and clinical characterization of antithrombin c.1157T>C (p.Ile386Thr), a recurrent Polish variant with a founder effect. Haematologica. 2023 Oct 1;108(10):2803-2807. doi: 10.3324/haematol.2022.282459. PMID: 37021543
Hunt BJ, Corral J, Simioni P. Should we consider gene therapy in severe inherited thrombophilia? Communication from the ISTH SSC Subcommittee on Physiological Anticoagulants and Thrombophilia. J Thromb Haemost. 2023 Sep;21(9):2620-2622. doi: 10.1016/j.jtha.2023.06.032. Epub 2023 Jul 8. PMID: 37429507
Zaninetti C, Rivera J, Vater L, Ohlenforst S, Leinøe E, Böckelmann D, Freson K, Thiele T, Makhloufi H, Rath M, Eberl W, Wolff M, Freyer C, Wesche J, Zieger B, Felbor U, Heidel FH, Greinacher A. Aggregates of non-muscular myosin IIA in erythrocytes associate with GATA1- and GFI1B-related thrombocytopenia. J Thromb Haemost. 2023 Dec 14:S1538-7836(23)00872-3. doi: 10.1016/j.jtha.2023.12.007. Online ahead of print. PMID: 38103735
Zamora-Cánovas A, de la Morena-Barrio B, Marín-Quilez A, Sierra-Aisa C, Male C, Fernández-Mosteirin N, Trapero-Marugán M, Padilla J, Garrido-Rodriguez P, Sánchez-Fuentes A, Rodríguez-Alen A, Gómez-González PL, Revilla N, de la Morena-Barrio ME, Bastida JM, Corral J, Rivera J, Lozano ML. Targeted long-read sequencing identifies and characterizes structural variants in cases of inherited platelet disorders. J Thromb Haemost. 2023 Nov 24:S1538-7836(23)00844-9. doi: 10.1016/j.jtha.2023.11.007. PMID: 38007062
Palma-Barqueros V, Bastida JM, López Andreo MJ, Zámora-Cánovas A, Zaninetti C, Ruiz-Pividal JF, Bohdan N, Padilla J, Teruel-Montoya R, Marín-Quilez A, Revilla N, Sánchez-Fuentes A, Rodriguez-Alen A, Benito R, Vicente V, Iturbe T, Greinacher A, Lozano ML, Rivera J; Grupo Español de Alteraciones Plaquetarias Congénitas (GEAPC); Spanish Society of Thrombosis and Haemostasis (SETH). Platelet transcriptome analysis in patients with germline RUNX1 mutations. J Thromb Haemost. 2023 May;21(5):1352-1365. doi: 10.1016/j.jtha.2023.01.023. Epub 2023 Feb 1. PMID: 36736831
Marín-Quílez A, Di Buduo CA, Díaz-Ajenjo L, Abbonante V, Vuelta E, Soprano PM, Miguel-García C, Santos-Mínguez S, Serramito-Gómez I, Ruiz-Sala P, Peñarrubia MJ, Pardal E, Hernández-Rivas JM, González-Porras JR, García-Tuñón I, Benito R, Rivera J, Balduini A, Bastida JM. Novel variants in GALE cause syndromic macrothrombocytopenia by disrupting glycosylation and thrombopoiesis. Blood. 2023 Jan 26;141(4):406-421. doi: 10.1182/blood.2022016995. PMID: 36395340
Marín-Quílez A, Díaz-Ajenjo L, Di Buduo CA, Zamora-Cánovas A, Lozano ML, Benito R, González-Porras JR, Balduini A, Rivera J, Bastida JM. Inherited Thrombocytopenia Caused by Variants in Crucial Genes for Glycosylation. Int J Mol Sci. 2023 Mar 7;24(6):5109. doi: 10.3390/ijms24065109. PMID: 36982178
Megy K, Downes K, Morel-Kopp MC, Bastida JM, Brooks S, Bury L, Leinoe E, Gomez K, Morgan NV, Othman M, Ouwehand WH, Botero JP, Rivera J, Schulze H, Trégouët DA, Freson K. Corrigendum to GoldVariants, a resource for sharing rare genetic variants detected in bleeding, thrombotic, and platelet disorders: Communication from the ISTH SSC Subcommittee on Genomics in Thrombosis and Hemostasis [J Thromb Haemost. 2021 Oct;19(10):2612-2617]. J Thromb Haemost. 2023 Apr;21(4):1067. doi: 10.1016/j.jtha.2023.01.021. Epub 2023 Feb 1. PMID: 36737374
Marín-Quílez A, Di Buduo CA, Benito R, Balduini A, Rivera J, Bastida JM. GALE variants associated with syndromic manifestations, macrothrombocytopenia, bleeding, and platelet dysfunction. Platelets. 2023 Dec;34(1):2176699. doi: 10.1080/09537104.2023.2176699. Epub 2023 Feb 27. PMID: 36846897 Free article.
Martinez-Navajas G, Ceron-Hernandez J, Simon I, Lupiañez P, Diaz-McLynn S, Perales S, Modlich U, Guerrero JA, Martin F, Sevivas T, Lozano ML, Rivera J, Ramos-Mejia V, Tersteeg C, Real PJ. Lentiviral gene therapy reverts GPIX expression and phenotype in Bernard-Soulier syndrome type C. Mol Ther Nucleic Acids. 2023 Jun 12;33:75-92. doi: 10.1016/j.omtn.2023.06.008. eCollection 2023 Sep 12. PMID: 37416759 Free PMC article.
Alessi MC, Coxon C, Ibrahim-Kosta M, Bacci M, Voisin S, Rivera J, Greinacher A, Raster J, Pulcinelli F, Devreese KMJ, Mullier F, McCormick AN, Frontroth JP, Pouplard C, Sachs UJ, Diaz I, Bermejo N, Camera M, Fontana P, Bauters A, Stepanian A, Cozzi MR, Sveshnikova AN, Faille D, Hollon W, Chitlur M, Casonato A, Lasne D, Lavenu-Bombled C, Fiore M, Hamidou B, Hurtaud-Roux MF, Saultier P, Goumidi L, Gresele P, Lordkipanidzé M. Multicenter evaluation of light transmission platelet aggregation reagents: communication from the ISTH SSC Subcommittee on Platelet Physiology. J Thromb Haemost. 2023 Sep;21(9):2596-2610. doi: 10.1016/j.jtha.2023.05.027. Epub 2023 Jun 16. PMID: 37331519
Zaninetti C, Leinøe E, Lozano ML, Rossing M, Bastida JM, Zetterberg E, Rivera J, Greinacher A. Validation of immunofluorescence analysis of blood smears in patients with inherited platelet disorders. J Thromb Haemost. 2023 Apr;21(4):1010-1019. doi: 10.1016/j.jtha.2022.12.031. Epub 2023 Jan 10. PMID: 36732160
de Los Reyes-García AM, Zapata-Martínez L, Águila S, Lozano ML, Martínez C, González-Conejero R. microRNAs as biomarkers of risk of major adverse cardiovascular events in atrial fibrillation. Front Cardiovasc Med. 2023 Feb 21;10:1135127. doi: 10.3389/fcvm.2023.1135127. eCollection 2023. PMID: 36895835 Free PMC article. Review.
Zapata-Martínez L, Águila S, de Los Reyes-García AM, Carrillo-Tornel S, Lozano ML, González-Conejero R, Martínez C. Inflammatory microRNAs in cardiovascular pathology: another brick in the wall. Front Immunol. 2023 May 18;14:1196104. doi: 10.3389/fimmu.2023.1196104. eCollection 2023. PMID: 37275892
Soler-Espejo E, Esteve-Pastor MA, Rivera-Caravaca JM, Roldan V, Marín F. Reducing bleeding risk in patients on oral anticoagulation therapy. Expert Rev Cardiovasc Ther. 2023 Jul-Dec;21(12):923-936. doi: 10.1080/14779072.2023.2275662. Epub 2023 Dec 13. PMID: 37905915
Rivera-Caravaca JM, Roldán V, Martínez-Montesinos L, Vicente V, Lip GYH, Marín F. The Atrial Fibrillation Better Care (ABC) Pathway and Clinical Outcomes in Patients with Atrial Fibrillation: the Prospective Murcia AF Project Phase II Cohort. J Gen Intern Med. 2023 Feb;38(2):315-323. doi: 10.1007/s11606-022-07567-5. Epub 2022 Apr 11. PMID: 35411538
Mandaglio-Collados D, López-Gálvez R, Ruiz-Alcaraz AJ, López-García C, Roldán V, Lip GYH, Marín F, Rivera-Caravaca JM. Impact of particulate matter on the incidence of atrial fibrillation and the risk of adverse clinical outcomes: A review. Sci Total Environ. 2023 Jul 1;880:163352. doi: 10.1016/j.scitotenv.2023.163352. Epub 2023 Apr 4. PMID: 37023806
López-Galvez R, Rivera-Caravaca JM, Roldán V, Orenes-Piñero E, Esteve-Pastor MA, López-García C, Saura D, González J, Lip GYH, Marín F. Imaging in atrial fibrillation: A way to assess atrial fibrosis and remodeling to assist decision-making. Am Heart J. 2023 Apr;258:1-16. doi: 10.1016/j.ahj.2022.12.007. Epub 2022 Dec 13. PMID: 36526006
Roldán V, Soler-Espejo E, Marin F. Predicting Bleeding in Cancer-Associated Venous Thromboembolism: Another Milestone Achieved. Thromb Haemost. 2023 Sep 11. doi: 10.1055/s-0043-1775582. Online ahead of print. PMID: 37696302
Martínez-Montesinos L, Rivera-Caravaca JM, Agewall S, Soler E, Lip GYH, Marín F, Roldán V. Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity? Biomed Pharmacother. 2023 Feb;158:114064. doi: 10.1016/j.biopha.2022.114064. Epub 2022 Dec 7. PMID: 36495662
Martín A, Calvo D, Llamas P, Roldán V, Cózar R, Fernández de Simón A, Ávila P, Del Arco C, Arbelo E, Piñera P, Coll-Vinent B. Workplace violence in hospital emergency departments and consequences for health care professionals and support staff: a cluster analysis. Emergencias. 2023 Oct;35(5):359-377. PMID: 37801418
Rodenas MC, Peñas-Martínez J, Pardo-Sánchez I, Zaragoza-Huesca D, Ortega-Sabater C, Peña-García J, Espín S, Ricote G, Montenegro S, Ayala-De La Peña F, Luengo-Gil G, Nieto A, García-Molina F, Vicente V, Bernardi F, Lozano ML, Mulero V, Pérez-Sánchez H, Carmona-Bayonas A, Martínez-Martínez I. Venetoclax is a potent hepsin inhibitor that reduces the metastatic and prothrombotic phenotypes of hepsin-expressing colorectal cancer cells. Front Mol Biosci. 2023 May 19;10:1182925. doi: 10.3389/fmolb.2023.1182925. eCollection 2023. PMID: 37275957 Free PMC article.
Zaragoza-Huesca D, Rodenas MC, Peñas-Martínez J, Pardo-Sánchez I, Peña-García J, Espín S, Ricote G, Nieto A, García-Molina F, Vicente V, Lozano ML, Carmona-Bayonas A, Mulero V, Pérez-Sánchez H, Martínez-Martínez I. Suramin, a drug for the treatment of trypanosomiasis, reduces the prothrombotic and metastatic phenotypes of colorectal cancer cells by inhibiting hepsin. Biomed Pharmacother. 2023 Dec;168:115814. doi: 10.1016/j.biopha.2023.115814. Epub 2023 Oct 31. PMID: 37918256
Carreño-Tarragona G, Alvarez-Larran A, Harrison CN, Martínez-Ávila JC, Hernandez-Boluda JC, Ferrer-Marin F, Radia DH, Mora Casterá E, Francis S, González-Martínez T, Goddard K, Perez-Encinas M, Narayanan S, Raya JM, Singh V, Toth P, Gutiérrez X, Amat Martinez P, McIlwaine L, Alobaidi M, Mayani K, McGregor A, Stuckey R, Psaila B, Segura A, Alvares CL, Davidson K, Osorio S, Cutting R, Sweeney CP, Rufian L, Moreno L, Cuenca I, Smith J, Morales ML, Gil-Manso R, Koutsavlis I, Wang L, Mead AJ, Rozman M, Martínez-López J, Ayala R, Cross NC. CNL and aCML should be considered as single entity based on molecular profiles and outcomes. Blood Adv. 2022 Nov 14:bloodadvances.2022008204. doi: 10.1182/bloodadvances.2022008204. Online ahead of print.PMID: 36375042
Ródenas-Quiñonero I, Chen-Liang T, Martín-Santos T, Salar A, Fernández-González M, Celades C, Navarro JT, Martínez-Garcia AB, Andreu R, Balaguer A, Martin García-Sancho A, Baile M, López-Jiménez J, Marquet-Palomanes J, Teruel AI, Terol MJ, Benet C, Frutos L, Navarro JL, Uña J, Suarez M, Cortes M, Contreras J, Ruiz C, Tamayo P, Mucientes J, Sopena-Novales P, Reguilón-Gallego L, Sánchez-Blanco JJ, Pérez-Ceballos E, Jerez A, Ortuño FJ. Accuracy and prognostic impact of FDG PET/CT and biopsy in bone marrow assessment of follicular lymphoma at diagnosis: A Nation-Wide cohort study. Cancer Med. 2022 Nov 13. doi: 10.1002/cam4.5424. Online ahead of print. PMID: 36373169
Estrada N, Zamora L, Ferrer-Marín F, Palomo L, García O, Vélez P, De la Fuente I, Sagüés M, Cabezón M, Cortés M, Vallansot RO, Senín-Magán MA, Boqué C, Xicoy B. Association between Germline Single-Nucleotide Variants in ADME Genes and Major Molecular Response to Imatinib in Chronic Myeloid Leukemia Patients. J Clin Med. 2022 Oct 21;11(20):6217. doi:10.3390/jcm11206217. PMID: 36294538
García-Torralba E, Bravo-Pérez C, Ortuño FJ. Unclassified Dots in the Blood Cell Counter Graphs from a Cancer Patient with Fever and Hypotension. Clin Chem. 2021 Aug 5;67(8):1162-1163. doi: 10.1093/clinchem/hvab050. PMID: 36103282
Ferrer-Marín F, Sola-Visner M.Neonatal platelet physiology and implications for transfusion. Platelets. 2022 Jan 2;33(1):14-22. doi: 10.1080/09537104.2021.1962837. Epub 2021 Aug 16. PMID: 34392772
Martínez-Cuadrón D, Megías-Vericat JE, Serrano J, Martínez-Sánchez P, Rodríguez-Arbolí E, Gil C, Aguiar E, Bergua J, López-Lorenzo JL, Bernal T, Espadana A, Colorado M, Rodríguez-Medina C, López-Pavía M, Tormo M, Algarra L, Amigo ML, Sayas MJ, Labrador J, Rodríguez-Gutiérrez JI, Benavente C, Costilla-Barriga L, García-Boyero R, Lavilla-Rubira E, Vives S, Herrera P, García-Belmonte D, Herráez MM, Vasconcelos Esteves G, Gómez-Roncero MI, Cabello A, Bautista G, Balerdi A, Mariz J, Boluda B, Sanz MÁ, Montesinos P. Treatment patterns and outcomes of 2310 patients with secondary acute myeloid leukemia: a PETHEMA registry study. Blood Adv. 2022 Feb 22;6(4):1278-1295. doi: 10.1182/bloodadvances.2021005335.PMID: 34794172
Guerrero C, Puig N, Cedena MT, Goicoechea I, Perez C, Garcés JJ, Botta C, Calasanz MJ, Gutierrez NC, Martin-Ramos ML, Oriol A, Rios R, Hernandez MT, Martinez-Martinez R, Bargay J, de Arriba F, Palomera L, Gonzalez-Rodriguez AP, Mosquera-Orgueira A, Gonzalez-Perez MS, Martinez-Lopez J, Lahuerta JJ, Rosiñol L, Blade J, Mateos MV, San-Miguel JF, Paiva B. A Machine Learning Model Based on Tumor and Immune Biomarkers to Predict Undetectable MRD and Survival Outcomes in Multiple Myeloma. Clin Cancer Res. 2022 Jun 13;28(12):2598-2609. doi: 10.1158/1078-0432.CCR-21-3430. PMID: 35063966
Bailén R, Pascual-Cascón MJ, Guerreiro M, López-Corral L, Chinea A, Bermúdez A, Sampol A, Heras I, García-Torres E, Torres M, Roca JR, Herruzo B, Sanz J, Fonseca M, Herrera P, Colorado M, Bento L, López-Godino O, Martín-Calvo C, Fernández-Caldas P, Marcos-Jubilar M, Sánchez-Ortega I, Solano C, Noriega V, Humala K, Oarbeascoa G, Díez-Martín JL, Kwon M; Grupo Español de Trasplante Hematopoyético y Terapia Celular (GETH). Post-Transplantation Cyclophosphamide After HLA Identical Compared to Haploidentical Donor Transplant in Acute Myeloid Leukemia: A Study on Behalf of GETH-TC.Transplant Cell Ther. 2022 Apr;28(4):204.e1-204.e10. doi: 10.1016/j.jtct.2022.01.020. Epub 2022 Jan 31. PMID: 35108627
Bishton M, Marshall S, Harchowal J, Salles G, Golfier C, Tucci A, Fernández AR, Sanchez Blanco JJ, Bocchia M, Kim S, Lee YN, Zinzani PL. The safety and clinical effectiveness of rapid infusion with CT-P10 in patients with non-Hodgkin's lymphoma or chronic lymphocytic leukemia: A retrospective non-interventional post-authorization safety study in Europe. Hematol Oncol. 2022 Aug;40(3):370-380. doi: 10.1002/hon.2978. Epub 2022 Mar 17. PMID: 35168291 Bravo-Pérez C, Carrillo-Tornel S, García-Torralba E, Jerez A.Persistent Large Granular Lymphocyte Clonal Expansions: "The Root of Many Evils"-And of Some Goodness. Cancers (Basel). 2022 Mar 5;14(5):1340. doi: 10.3390/cancers14051340. PMID: 35267648 Triguero A, Xicoy B, Zamora L, Jiménez MJ, García O, Calabuig M, Díaz-Beyá M, Arzuaga J, Ramos F, Medina A, Bernal T, Talarn C, Coll R, Collado R, Chen TH, Borrás J, Brunet S, Marchante I, Marco V, López-Cadenas F, Calbacho M, Simiele A, Cortés M, Cedena MT, Pedreño M, Aguilar C, Pedró C, Fernández M, Stoica C, Ribera JM, Sanz G. Response to azacitidine in patients with chronic myelomonocytic leukemia according to overlap myelodysplastic/myeloproliferative neoplasms criteria. Leuk Res. 2022 May;116:106836. doi: 10.1016/j.leukres.2022.106836. Epub 2022 Mar 26. PMID: 35405632 Alvarez-Larrán A, Garrote M, Ferrer-Marín F, Pérez-Encinas M, Mata-Vazquez MI, Bellosillo B, Arellano-Rodrigo E, Gómez M, García R, García-Gutiérrez V, Gasior M, Cuevas B, Angona A, Gómez-Casares MT, Martínez CM, Magro E, Ayala R, Del Orbe-Barreto R, Pérez-López R, Fox ML, Raya JM, Guerrero L, García-Hernández C, Caballero G, Murillo I, Xicoy B, Ramírez MJ, Carreño-Tarragona G, Hernández-Boluda JC, Pereira A; MPN Spanish Group (Grupo Español de Enfermedades Mieloproliferativas Filadelfia Negativas). Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea. Cancer. 2022 Jul 1;128(13):2441-2448. doi: 10.1002/cncr.34195. Epub 2022 Apr 13. PMID: 35417564 Encinas C, Hernandez-Rivas JÁ, Oriol A, Rosiñol L, Blanchard MJ, Bellón JM, García-Sanz R, de la Rubia J, de la Guía AL, Jímenez-Ubieto A, Jarque I, Iñigo B, Dourdil V, de Arriba F, Pérez-Ávila CC, Gonzalez Y, Hernández MT, Bargay J, Granell M, Rodríguez-Otero P, Silvent M, Cabrera C, Rios R, Alegre A, Gironella M, Gonzalez MS, Sureda A, Sampol A, Ocio EM, Krsnik I, García A, García-Mateo A, Soler JA, Martín J, Arguiñano JM, Mateos MV, Bladé J, San-Miguel JF, Lahuerta JJ, Martínez-López J; GEM/PETHEMA (Grupo Español de Mieloma/Programa para el Estudio de la Terapéutica en Hemopatías Malignas) cooperative study group. A simple score to predict early severe infections in patients with newly diagnosed multiple myeloma Blood Cancer J. 2022 Apr 19;12(4):68. doi: 10.1038/s41408-022-00652-2. PMID: 35440057 Sancho JM, Marín-Niebla A, Fernández S, Capote FJ, Cañigral C, Grande C, Donato E, Zeberio I, Puerta JM, Rivas A, Pérez-Ceballos E, Vale A, Martín García-Sancho A, Salar A, González-Barca E, Teruel A, Pastoriza C, Conde-Royo D, Sánchez-García J, Barrenetxea C, Arranz R, Hernández-Rivas JÁ, Ramírez MJ, Jiménez A, Rubio-Azpeitia E. IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice. Int J Hematol. 2022 Sep;116(3):381-392. doi: 10.1007/s12185-022-03367-z. Epub 2022 May 13. PMID: 35551632 García-Fortes M, Hernández-Boluda JC, Álvarez-Larrán A, Raya JM, Angona A, Estrada N, Fox L, Cuevas B, García-Hernández MC, Gómez-Casares MT, Ferrer-Marín F, Saavedra S, Cervantes F, García-Delgado R, On Behalf Of The Grupo Español de Enfermedades Mieloproliferativas Filadelfia Negativas Gemfin. Impact of Individual Comorbidities on Survival of Patients with Myelofibrosis. Cancers (Basel). 2022 May 9;14(9):2331. doi: 10.3390/cancers14092331. PMID: 35565461
García-Martín P, Díez AM, Maldonado JMS, Serrano AJC, Ter Horst R, Benavente Y, Landi S, Macauda A, Clay-Gilmour A, Hernández-Mohedo F, Niazi Y, González-Sierra P, Espinet B, Rodríguez-Sevilla JJ, Maffei R, Blanco G, Giaccherini M, Puiggros A, Cerhan J, Marasca R, Cañadas-Garre M, López-Nevot MÁ, Chen-Liang T, Thomsen H, Gámez I, Moreno V, Marcos-Gragera R, García-Álvarez M, Llorca J, Jerez A, Berndt S, Butrym A, Norman AD, Casabonne D, Luppi M, Slager SL, Hemminki K, Li Y, Alcoceba M, Campa D, Canzian F, de Sanjosé S, Försti A, Netea MG, Jurado M, Sainz J. Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study.Blood Cancer J. 2022 May 17;12(5):79. doi: 10.1038/s41408-022-00676-8.PMID: 35581176
Ortí G, García-Gutiérrez V, Bautista G, Ferrer-Marín F, Vallansot R, Xicoy B, Sánchez À, Simon I, Triguero A, Sierra M, Casado LF; Grupo Español de Leucemia Mieloide Crónica (GELMC). Tyrosine kinase inhibitor dose reduction during the management of accelerated phase chronic myeloid leukemia. Leuk Res. 2022 Oct;121:106923. doi: 10.1016/j.leukres.2022.106923. Epub 2022 Aug 4. PMID: 35933910
Martínez-Cuadrón D, Serrano J, Mariz J, Gil C, Tormo M, Martínez-Sánchez P, Rodríguez-Arbolí E, García-Boyero R, Rodríguez-Medina C, Martínez-Chamorro C, Polo M, Bergua J, Aguiar E, Amigo ML, Herrera P, Alonso-Domínguez JM, Bernal T, Espadana A, Sayas MJ, Algarra L, Vidriales MB, Vasconcelos G, Vives S, Pérez-Encinas MM, López A, Noriega V, García-Fortes M, Chillón MC, Rodríguez-Gutiérrez JI, Calasanz MJ, Labrador J, López JA, Boluda B, Rodríguez-Veiga R, Martínez-López J, Barragán E, Sanz MA, Montesinos P, On Behalf Of The Pethema Group. Characteristics and Outcomes of Adult Patients in the PETHEMA Registry with Relapsed or Refractory FLT3-ITD Mutation-Positive Acute Myeloid Leukemia. Cancers (Basel). 2022 Jun 6;14(11):2817. doi: 10.3390/cancers14112817. PMID: 35681796
Tamariz-Amador LE, Rodríguez-Otero P, Jiménez-Ubieto A, Rosiñol L, Oriol A, Ríos R, Sureda A, Blanchard MJ, Hernández MT, Cabañas Perianes V, Jarque I, Bargay J, Gironella M, De Arriba F, Palomera L, Gonzalez-Montes Y, Martí JM, Krsnik I, Arguiñano JM, González ME, Casado LF, González-Rodriguez AP, López-Anglada L, Puig N, Cedena MT, Paiva B, Mateos MV, San-Miguel J, Lahuerta JJ, Bladé J, Trocóniz IF. Prognostic Value of Serum Paraprotein Response Kinetics in Patients With Newly Diagnosed Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2022 Sep;22(9):e844-e852. doi: 10.1016/j.clml.2022.04.024. Epub 2022 May 5. PMID: 35688793
Gutierrez A, Bento L, Novelli S, Martin A, Gutierrez G, Queralt Salas M, Bastos-Oreiro M, Perez A, Hernani R, Cruz Viguria M, Lopez-Godino O, Montoro J, Piñana JL, Ferra C, Parody R, Martin C, Español I, Yañez L, Rodriguez G, Zanabili J, Herrera P, Varela MR, Sampol A, Solano C, Caballero D, On Behalf Of The Grupo Español de Trasplante de Progenitores Hematopoyéticos Geth And Grupo Español de Linfoma Y Trasplante Autólogo Geltamo. Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma; Insights into Its Potential Role in the Era of New Immunotherapeutic and Targeted Therapies: The GETH/GELTAMO Experience.Cancers (Basel). 2022 May 27;14(11):2673. doi: 10.3390/cancers14112673.PMID: 35681653
Puiggros A, Ramos-Campoy S, Kamaso J, de la Rosa M, Salido M, Melero C, Rodríguez-Rivera M, Bougeon S, Collado R, Gimeno E, García-Serra R, Alonso S, Moro-García MA, García-Malo MD, Calvo X, Arenillas L, Ferrer A, Mantere T, Hoischen A, Schoumans J, Espinet B. Optical Genome Mapping: A Promising New Tool to Assess Genomic Complexity in Chronic Lymphocytic Leukemia (CLL). Cancers (Basel). 2022 Jul 11;14(14):3376. doi: 10.3390/cancers14143376. PMID: 35884436
Sánchez R, Dorado S, Ruíz-Heredia Y, Martín-Muñoz A, Rosa-Rosa JM, Ribera J, García O, Jimenez-Ubieto A, Carreño-Tarragona G, Linares M, Rufián L, Juárez A, Carrillo J, Espino MJ, Cáceres M, Expósito S, Cuevas B, Vanegas R, Casado LF, Torrent A, Zamora L, Mercadal S, Coll R, Cervera M, Morgades M, Hernández-Rivas JÁ, Bravo P, Serí C, Anguita E, Barragán E, Sargas C, Ferrer-Marín F, Sánchez-Calero J, Sevilla J, Ruíz E, Villalón L, Del Mar Herráez M, Riaza R, Magro E, Steegman JL, Wang C, de Toledo P, García-Gutiérrez V, Ayala R, Ribera JM, Barrio S, Martínez-López J. Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA. Sci Rep. 2022 Jul 29;12(1):13057. doi: 10.1038/s41598-022-17271-3. PMID: 35906470
Santaliestra M, Ferrer-Marín F, Alvarez-Larrán A; MPN Spanish Group (GEMFIN). Review of the risk of thrombosis or bleeding upon abrupt anagrelide discontinuation in patients with essential thrombocythemia. Ann Hematol. 2022 Nov;101(11):2563-2564. doi: 10.1007/s00277-022-04956-y. Epub 2022 Aug 17.PMID: 35978180
Hernández-Boluda JC, Pastor-Galán I, Arellano-Rodrigo E, Raya JM, Pérez-Encinas M, Ayala R, Ferrer-Marín F, Velez P, Mora E, Fox ML, Hernández-Rivas JM, Xicoy B, Mata-Vázquez MI, García-Fortes M, Pérez-López R, Angona A, Cuevas B, Senín A, Ramírez MJ, Ramírez-Payer A, Gómez-Casares MT, Martínez-Valverde C, Magro E, Steegmann JL, Durán MA, García-Hernández C, Gasior M, de Villambrosia SG, Alvarez-Larrán A, Pereira A; Spanish MPN Group (GEMFIN). Predictors of thrombosis and bleeding in 1613 myelofibrosis patients from the Spanish Registry of Myelofibrosis. Br J Haematol. 2022 Sep 12. doi: 10.1111/bjh.18440. Online ahead of print. PMID: 36089912
Triguero A, Pedraza A, Pérez-Encinas M, Mata-Vázquez MI, Vélez P, Fox L, Gómez-Calafat M, García-Delgado R, Gasior M, Ferrer-Marín F, García-Gutiérrez V, Angona A, Gómez-Casares MT, Cuevas B, Martínez C, Pérez R, Raya JM, Guerrero L, Murillo I, Bellosillo B, Hernández-Boluda JC, Sanz C, Álvarez-Larrán A; On behalf of the MPN Spanish Group (GEMFIN). Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera. Ann Hematol. 2022 Oct;101(10):2231-2239. doi: 10.1007/s00277-022-04963-z. Epub 2022 Aug 30. PMID: 36042023
Termini R, Zihala D, Terpos E, Pérez-Montaña A, Jelinek T, Raab M, Weinhold N, Mai EK, Grab AL, Corre J, Vergez F, Sacco A, Chiarini M, Giustini V, Tucci A, Rodríguez S, Moreno C, Perez C, Maia C, Martin-Sanchez E, Guerrero C, Botta C, Garcés JJ, Lopez A, Tamariz-Amador LE, Prósper F, Bargay J, Cabezudo ME, Ocio EM, Hájek R, Martinez-Lopez J, Solano F, Iglesias R, Paiva A, Geraldes C, Matos Silva H, Gomez C, De Arriba F, Ludwig H, Garcia-Guiñon A, Casanova M, Alegre A, Cabañas V, Sirvent M, Oriol A, De la Rubia J, Hernández-Rivas JÁ, Palomera L, Sarasa M, Rios P, Puig N, Mateos MV, Flores-Montero J, Orfao A, Goldschmidt H, Avet-Loiseau H, Roccaro AM, San-Miguel JF, Paiva B. Circulating tumor and immune cells for minimally invasive risk stratification of smoldering multiple myeloma. Clin Cancer Res. 2022 Sep 8:CCR-22-1594. doi: 10.1158/1078-0432.CCR-22-1594. PMID: 36074126
Mateos MV, Hernández MT, Salvador C, Rubia J, de Arriba F, López-Corral L, Rosiñol L, Paiva B, Palomera L, Bargay J, Oriol A, Prosper F, López J, Arguiñano JM, Bladé J, Lahuerta JJ, San-Miguel J. Lenalidomide-dexamethasone versus observation in high-risk smoldering myeloma after 12 years of median follow-up time: A randomized, open-label study. Eur J Cancer. 2022 Oct;174:243-250. doi: 10.1016/j.ejca.2022.07.030. Epub 2022 Sep 5. PMID: 36067617
Mateos MV, Hernández MT, Salvador C, Rubia J, de Arriba F, López-Corral L, Rosiñol L, Paiva B, Palomera L, Bargay J, Oriol A, Prosper F, López J, Arguiñano JM, Bladé J, Lahuerta JJ, San-Miguel J.Lenalidomide-dexamethasone versus observation in high-risk smoldering myeloma after 12 years of median follow-up time: A randomized, open-label study. Eur J Cancer. 2022 Oct;174:243-250. doi: 10.1016/j.ejca.2022.07.030. Epub 2022 Sep 5. PMID: 36067617
Vilorio-Marqués L, Castañón Fernández C, Mora E, Gutiérrez L, Rey Bua B, Jiménez Lorenzo MJ, Díaz Beya M, Vara Pampliega M, Molero A, Sánchez-García J, Calabuig M, Cedena MT, Chen-Liang T, Díaz Santa JA, Padilla I, Hernández F, Díez R, Asensi P, Xicoy B, Sanz G, Valcárcel D, Diez-Campelo M, Bernal T. Relevance of infections on the outcomes of patients with myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia treated with hypomethylating agents: a cohort study from the GESMD. Ther Adv Hematol. 2022 Sep 29;13:20406207221127547. doi: 10.1177/20406207221127547. eCollection 2022. PMID: 36199837
Triguero A, Pedraza A, Perez-Encinas M, Mata-Vazquez MI, Vélez P, Fox L, Gomez-Calafat M, Garcia-Delgado R, Gasior M, Ferrer-Marin F, Garcia-Gutierrez V, Angona A, Gomez-Casares MT, Cuevas B, Martínez C, Pérez R, Raya JM, Guerrero L, Murillo I, Bellosillo B, Hernandez-Boluda JC, Sanz C, Alvarez-Larran A; On behalf of the MPN Spanish Group (GEMFIN). Correction to: Low‑risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera. Ann Hematol. 2022 Oct 20. doi: 10.1007/s00277-022-05005-4. Online ahead of print.PMID: 36264368.
Tang LV, Tao Y, Feng Y, Ma J, Lin W, Zhang Y, Zhang Y, Wu T, Cai Y, Lu H, Wei J, Corral J, Hu Y. Gene editing of human iPSCs rescues thrombophilia in hereditary antithrombin deficiency in mice. Sci Transl Med. 2022 Nov 30;14(673):eabq3202. doi: 10.1126/scitranslmed.abq3202. Epub 2022 Nov 30. PMID: 36449603
Marín-Quilez A, Di Buduo CA, Díaz-Ajenjo L, Abbonante V, Vuelta E, Soprano PMM, Miguel-García C, Santos-Mínguez S, Serramito-Gómez I, Ruiz-Sala P, Peñarrubia MJ, Pardal E, Hernández-Rivas JM, González-Porras JR, García-Tuñón I, Benito R, Rivera J, Balduini A, Bastida JM. Novel variants in GALE cause syndromic macrothrombocytopenia by disrupting glycosylation and thrombopoiesis. Blood. 2022 Nov 17:blood.2022016995. doi: 10.1182/blood.2022016995. Online ahead of print.PMID: 36395340
Barrachina MN, Izquierdo I, Hermida-Nogueira L, Morán LA, Pérez A, Arroyo AB, García-Barberá N, González-Conejero R, Troitiño S, Eble JA, Rivera J, Martínez C, Loza MI, Domínguez E, García Á The PI3Kδ Inhibitor Idelalisib Diminishes Platelet Function and Shows Antithrombotic Potential. Int J Mol Sci. 2021 Mar 24;22(7):3304. doi: 10.3390/ijms22073304. PMID: 33804911
Ding WY, Rivera-Caravaca JM, Marín F, Li G, Roldán V, Lip GYH.Number needed to treat for net effect of anticoagulation in atrial fibrillation: Real-world vs. clinical-trial evidence. Br J Clin Pharmacol. 2022 Jan;88(1):282-289. doi: 10.1111/bcp.14961. Epub 2021 Jul 13. PMID: 34192808
Páramo JA, Lozano ML, González-Porras JR, Mateo J.Current status of diagnosis and treatment of heparin-induced thrombocytopenia (HIT). Med Clin (Barc). 2022 Jan 21;158(2):82-89. doi: 10.1016/j.medcli.2021.05.020. Epub 2021 Jul 24. PMID: 34311973
Parrado A, Rubio G, Serrano M, De la Morena-Barrio ME, Ibáñez-Micó S, Ruiz-Lafuente N, Schwartz-Albiez R, Esteve-Solé A, Alsina L, Corral J, Hernández-Caselles T.Dissecting the transcriptional program of phosphomannomutase 2-deficient cells: Lymphoblastoide B cell lines as a valuable model for congenital disorders of glycosylation studies. Glycobiology. 2022 Mar 19;32(2):84-100. doi: 10.1093/glycob/cwab087. PMID: 34420056
Bravo-Pérez C, de la Morena-Barrio ME, de la Morena-Barrio B, Miñano A, Padilla J, Cifuentes R, Garrido P, Vicente V, Corral J Molecular and clinical characterization of transient antithrombin deficiency: A new concept in congenital thrombophilia. Am J Hematol. 2022 Feb 1;97(2):216-225. doi: 10.1002/ajh.26413. Epub 2021 Nov 24. PMID: 34800304
Jimenez-Marco T, Castrillo A, Hierro-Riu F, Vicente V, Rivera J Frozen and cold-stored platelets: reconsidered platelet products. Platelets. 2022 Jan 2;33(1):27-34. doi: 10.1080/09537104.2021.1967917. Epub 2021 Aug 22. PMID: 34423718
Lozano ML.New developments in the diagnosis of primary immune thrombocytopenia. Blood Coagul Fibrinolysis. 2022 Jan 1;33(Suppl 1):S5-S7. doi: 10.1097/MBC.0000000000001095. PMID: 34636811
Nowak W, Treliński J, Wypasek E, de la Morena-Barrio B, de la Morena-Barrio ME, Corral J.New SERPINC1 gene mutations in patients with antithrombin deficiency: antithrombin Lodz I, II, III, and IV. Pol Arch Intern Med. 2022 Jan 28;132(1):16158. doi: 10.20452/pamw.16158. Epub 2021 Dec 1. PMID: 34851072
Rivera-Caravaca JM, Ding WY, Marín F, Roldán V, Lip GYH; Christina J.-Y. Lee MD, PhD; Christian Torp-Pedersen MD, DMSc Prediction of ischemic stroke in different populations: a comparison of absolute stroke risk and CHA2DS2-VASc in real-world and clinical trial patients.. Eur J Intern Med. 2022 Apr;98:122-124. doi: 10.1016/j.ejim.2021.12.014. Epub 2021 Dec 21. PMID: 34952769
Zaragoza-Huesca D, Garrido-Rodríguez P, Jiménez-Fonseca P, Martínez de Castro E, Sánchez-Cánovas M, Visa L, Custodio A, Fernández-Montes A, Peñas-Martínez J, Morales Del Burgo P, Gallego J, Luengo-Gil G, Vicente V, Martínez-Martínez I, Carmona-Bayonas AIdentification of Thrombosis-Related Genes in Patients with Advanced Gastric Cancer: Data from AGAMENON-SEOM Registry. Biomedicines. 2022 Jan 11;10(1):148. Doi. 10.3390/biomedicines10010148. PMID: 35052827
Rivera J, Cid J.Editorial. Platelets. 2022 Jan 2;33(1):3-4. doi: 10.1080/09537104.2021.2010952. PMID: 35083955
Sánchez-Fuentes A, Rivera-Caravaca JM, López-Gálvez R, Marín F, Roldán V Non-vitamin K Antagonist Oral Anticoagulants and Drug-Food Interactions: Implications for Clinical Practice and Potential Role of Probiotics and Prebiotics.. Front Cardiovasc Med. 2022 Jan 17;8:787235. doi: 10.3389/fcvm.2021.787235. eCollection 2021.PMID: 35111826
Marín-Quílez A, Vuelta E, Díaz-Ajenjo L, Fernández-Infante C, García-Tuñón I, Benito R, Palma-Barqueros V, Hernández-Rivas JM, González-Porras JR, Rivera J, Bastida JM. A novel nonsense variant in TPM4 caused dominant macrothrombocytopenia, mild bleeding tendency and disrupted cytoskeleton remodeling. J Thromb Haemost. 2022 May;20(5):1248-1255. doi: 10.1111/jth.15672. Epub 2022 Feb 28. PMID: 35170221
Bouton MC, Corral J, Lucas AR.The Serpin Family in the Cardiovascular System. Front Cardiovasc Med. 2022 Feb 2;8:821490. doi: 10.3389/fcvm.2021.821490. eCollection 2021. PMID: 35187116 de la Morena-Barrio B, Orlando C, Sanchis-Juan A, García JL, Padilla J, de la Morena-Barrio ME, Puruunen M, Stouffs K, Cifuentes R, Borràs N, Bravo-Pérez C, Benito R, Cuenca-Guardiola J, Vicente V, Vidal F, Hernández-Rivas JM, Ouwehand W, Jochmans K, Corral J. Molecular Dissection of Structural Variations Involved in Antithrombin Deficiency. J Mol Diagn. 2022 May;24(5):462-475. doi: 10.1016/j.jmoldx.2022.01.009. Epub 2022 Feb 23. PMID: 35218943
Lozano ML, Rodeghiero F.Thrombopoietin receptor agonist in chemotherapy-induced thrombocytopenia. Lancet Haematol. 2022 Mar;9(3):e168-e169. doi: 10.1016/S2352-3026(22)00030-8.PMID: 35240068
Zaragoza-Huesca D, Martínez-Cortés C, Banegas-Luna AJ, Pérez-Garrido A, Vegara-Meseguer JM, Peñas-Martínez J, Rodenas MC, Espín S, Pérez-Sánchez H, Martínez-Martínez I. Identification of Kukoamine A, Zeaxanthin, and Clexane as New Furin Inhibitors. Int J Mol Sci. 2022 Mar 3;23(5):2796. doi: 10.3390/ijms23052796. PMID: 35269938
Moulis G, Cooper N, Ghanima W, González-López T, Kühne T, Lozano ML, Michel M, Provan D, Zaja F, Aladjidi N, Christiansen CF, Frederiksen H, Grainger J, McDonald V, Robinson S, Schifferli A, Rodeghiero F. Registries in immune thrombocytopenia (ITP) in Europe: the European Research Consortium on ITP (ERCI) network. Br J Haematol. 2022 Jun;197(5):633-638. doi: 10.1111/bjh.18111. Epub 2022 Mar 18. PMID: 35303315
Gorog DA, Gue YX, Chao TF, Fauchier L, Ferreiro JL, Huber K, Konstantinidis SV, Lane DA, Marin F, Oldgren J, Potpara T, Roldan V, Rubboli A, Sibbing D, Tse HF, Vilahur G, Lip GYH.Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society. Europace. 2022 Mar 22:euac020. doi: 10.1093/europace/euac020. Online ahead of print. PMID: 35323922
Roldán V, Martínez-Montesinos L, López-Gálvez R, García-Tomás L, Lip GYH, Rivera-Caravaca JM, Marín F Relation of the 'Atrial Fibrillation Better Care (ABC) Pathway' to the Quality of Anticoagulation in Atrial Fibrillation Patients Taking Vitamin K Antagonists. J Pers Med. 2022 Mar 17;12(3):487. doi: 10.3390/jpm12030487.PMID: 35330486
Ding WY, Rivera-Caravaca JM, Marin F, Roldán V, Lip GYH.Relationship between temporal rhythm-based classification of atrial fibrillation and stroke: real-world vs. clinical trial. J Thromb Thrombolysis. 2022 Jul;54(1):1-6. doi: 10.1007/s11239-022-02638-0. Epub 2022 Apr 15.PMID: 35426602
de la Morena-Barrio ME, Suchon P, Jacobsen EM, Iversen N, Miñano A, de la Morena-Barrio B, Bravo-Pérez C, Padilla J, Cifuentes R, Asenjo S, Deleuze JF, Trégouët DA, Lozano ML, Vicente V, Sandset PM, Morange PE, Corral J.Two SERPINC1 variants affecting N-glycosylation of Asn224 cause severe thrombophilia not detected by functional assays. Blood. 2022 Jul 14;140(2):140-151. doi: 10.1182/blood.2021014708. PMID: 35486842
Palma-Barqueros V, Revilla N, Zaninetti C, Galera AM, Sánchez-Fuentes A, Zámora-Cánovas A, Bohdan N, Padilla J, Marín-Quilez A, Rodriguez-Alen A, Fuster JL, Greinacher A, Vicente V, Bastida JM, Rivera J, Lozano ML.Src-related thrombocytopenia: a fine line between a megakaryocyte dysfunction and an immune-mediated disease. Blood Adv. 2022 Sep 13;6(17):5244-5255. doi: 10.1182/bloodadvances.2021005446. PMID: 35349645
López-Gálvez R, Roldán V, Marín F.Diagnostic and therapeutic potential of miRNAs in cardiovascular disease: a clinical reality? Rev Esp Cardiol (Engl Ed). 2022 Sep;75(9):704-705. doi: 10.1016/j.rec.2022.02.008. Epub 2022 Apr 20. PMID: 35461793
Gorog DA, Gue YX, Chao TF, Fauchier L, Ferreiro JL, Huber K, Konstantinidis SV, Lane DA, Marin F, Oldgren J, Potpara T, Roldan V, Rubboli A, Sibbing D, Tse HF, Vilahur G, Lip GYH. Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper.Thromb Haemost. 2022 Oct;122(10):1625-1652. doi: 10.1055/s-0042-1750385. Epub 2022 Jul 6.PMID: 35793691
de la Morena-Barrio ME, Corral J, López-García C, Jiménez-Díaz VA, Miñano A, Juan-Salvadores P, Esteve-Pastor MA, Baz-Alonso JA, Rubio AM, Sarabia-Tirado F, García-Navarro M, García-Lara J, Marín F, Vicente V, Pinar E, Cánovas SJ, de la Morena G. Contact pathway in surgical and transcatheter aortic valve replacement. Front Cardiovasc Med. 2022 Jul 22;9:887664. doi: 10.3389/fcvm.2022.887664. eCollection 2022. PMID: 35935621
Zaragoza-Huesca D, Nieto-Olivares A, García-Molina F, Ricote G, Montenegro S, Sánchez-Cánovas M, Garrido-Rodríguez P, Peñas-Martínez J, Vicente V, Martínez F, Lozano ML, Carmona-Bayonas A, Martínez-Martínez I. Implication of Hepsin from Primary Tumor in the Prognosis of Colorectal Cancer Patients. Cancers (Basel). 2022 Jun 24;14(13):3106. doi: 10.3390/cancers14133106 PMID: 35804878
de Los Reyes-García AM, Rivera-Caravaca JM, Zapata-Martínez L, Águila S, Véliz-Martínez A, García-Barberá N, Gil-Perez P, Guijarro-Carrillo PJ, Orenes-Piñero E, López-García C, Lozano ML, Marín F, Martínez C, González-Conejero R. MiR-146a Contributes to Thromboinflammation and Recurrence in Young Patients with Acute Myocardial Infarction. J Pers Med. 2022 Jul 20;12(7):1185. doi: 10.3390/jpm12071185.PMID: 35887682
Dalby A, Mezzano D, Rivera J, Watson SP, Morgan NV. Introduction of an ancient founder glycoprotein VI (GP6) mutation into the Chilean population. Blood Adv. 2022 Aug 22:bloodadvances.2022008531. doi: 10.1182/bloodadvances.2022008531. Online ahead of print. PMID: 359946344
Bravo-Pérez C, Toderici M, Chambers JE, Martínez-Menárguez JA, Garrido- Rodriguez P, Pérez-Sanchez H, de la Morena-Barrio B, Padilla J, Miñano A, Cifuentes-Riquelme R, Vicente V, Lozano ML, Marciniak SJ, de la Morena-Barrio ME, Corral J. Full-length antithrombin frameshift variant with aberrant C-terminus causes endoplasmic reticulum retention with a dominant-negative effect. JCI Insight. 2022 Oct 10;7(19):e161430. doi: 10.1172/jci.insight.161430. PMID: 36214221.
Bastida JM, Malvestiti S, Boeckelmann D, Palma-Barqueros V, Wolter M, Lozano ML, Glonnegger H, Benito R, Zaninetti C, Sobotta F, Schilling FH, Morgan NV, Freson K, Rivera J, Zieger B. A Novel GATA1 Variant in the C-Terminal Zinc Finger Compared with the Platelet Phenotype of Patients with A Likely Pathogenic Variant in the N-Terminal Zinc Finger. Cells. 2022 Oct 14;11(20):3223. doi: 10.3390/cells11203223. PMID: 36291092.
Bravo-Pérez C, Toderici M, Chambers JE, Martínez-Menárguez JA, Garrido- Rodriguez P, Pérez-Sanchez H, de la Morena-Barrio B, Padilla J, Miñano A, Cifuentes-Riquelme R, Vicente V, Lozano ML, Marciniak SJ, de la Morena-Barrio ME, Corral J. Full-length antithrombin frameshift variant with aberrant C-terminus causes endoplasmic reticulum retention with a dominant-negative effect. JCI Insight. 2022 Oct 10;7(19):e161430. doi: 10.1172/jci.insight.161430. PMID: 36214221.
Drakeford C, Aguila S, Roche F, Hokamp K, Fazavana J, Cervantes MP, Curtis AM, Hawerkamp HC, Dhami SPS, Charles-Messance H, Hackett EE, Chion A, Ward S, Ahmad A, Schoen I, Breen E, Keane J, Murphy R, Preston RJS, O'Sullivan JM, Sheedy FJ, Fallon P, O'Donnell JS. von Willebrand factor links primary hemostasis to innate immunity. Nat Commun. 2022 Nov 3;13(1):6320. doi: 10.1038/s41467-022-33796-7. PMID: 36329021
Martínez-Cuadrón D, Megías-Vericat JE, Serrano J, Martínez-Sánchez P, Rodríguez-Arbolí E, Gil C, Aguiar E, Bergua Burgues JM, Lopez-Lorenzo JL, Bernal T, Espadana A, Colorado M, Rodríguez-Medina C, López-Pavia M, Tormo M, Algarra JL, Amigo ML, Sayas MJ, Labrador J, Rodríguez-Gutiérrez JI, Benavente C, Costilla-Barriga L, García-Boyero R, Lavilla E, Vives S, Herrera P, García D, Herráez-Albendea MM, Esteves GV, Gómez-Roncero MI, Cabello A, Bautista G, Balerdi A, Mariz J, Boluda B, Sanz MA, Montesinos P. Treatment patterns and outcomes of 2310 patients with secondary acute myeloid leukemia: a PETHEMA registry study. Blood Adv. 2021 Nov 18:bloodadvances.2021005335. doi: 10.1182/bloodadvances.2021005335. PMID: 34794172
Abrisqueta P, Loscertales J, Terol MJ, Ramírez Payer Á, Ortiz M, Pérez I, Cuellar-García C, Fernández de la Mata M, Rodríguez A, Lario A, Delgado J, Godoy A, Arguiñano Pérez JM, Berruezo MJ, Oliveira A, Hernández-Rivas JÁ, García Malo MD, Medina Á, García Martin P, Osorio S, Baltasar P, Fernández-Zarzoso M, Marco F, Vidal Manceñido MJ, Smucler Simonovich A, López Rubio M, Jarque I, Suarez A, Fernández Álvarez R, Lancharro Anchel A, Ríos E, Losada Castillo MDC, Pérez Persona E, García Muñoz R, Ramos R, Yáñez L, Bello JL, Loriente C, Acha D, Villanueva M. Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study). Clin Lymphoma Myeloma Leuk. 2021 Dec;21(12):e985-e999. doi: 10.1016/j.clml.2021.07.022. PMID: 34511320
González-Rincón J, Garcia-Vela JA, Gómez S, Fernández-Cuevas B, Nova-Gurumeta S, Pérez-Sanz N, Alcoceba M, González M, Anguita E, López-Jiménez J, González-Barca E, Yáñez L, Pérez-Persona E, de la Serna J, Fernández-Zarzoso M, Deben G, Peñalver FJ, Fernández MC, de Oteyza JP, Andreu MÁ, Ruíz-Guinaldo MÁ, Paz-Arias R, García-Malo MD, Recasens V, Collado R, Córdoba R, Navarro-Matilla B, Sánchez-Beato M, García-Marco JA. Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM). PLoS One. 2021 Sep 10;16(9):e0257353. doi: 10.1371/journal.pone.0257353. PMID: 34506616
Bravo-Pérez C, Sola M, Teruel-Montoya R, García-Malo MD, Ortuño FJ, Vicente V, de Arriba F, Jerez A. Minimal Residual Disease in Multiple Myeloma: Something Old, Something New.Cancers (Basel). 2021 Aug 27;13(17):4332. doi: 10.3390/cancers13174332.PMID: 34503142
Martín I, Villamón E, Abellán R, Calasanz MJ, Irigoyen A, Sanz G, Such E, Mora E, Gutiérrez M, Collado R, García-Serra R, Vara M, Blanco ML, Oiartzabal I, Álvarez S, Bernal T, Granada I, Xicoy B, Jerez A, Calabuig M, Diez R, Gil Á, Díez-Campelo M, Solano C, Tormo M; Spanish Group of Myelodysplastic Syndromes (GESMD). Myelodysplastic syndromes with 20q deletion: incidence, prognostic value and impact on response to azacitidine of ASXL1 chromosomal deletion and genetic mutations. Br J Haematol. 2021 Aug;194(4):708-717. doi: 10.1111/bjh.17675. PMID: 34296432
Ribera JM, Morgades M, Genescà E, Chapchap EC, Montesinos P, Acuña-Cruz E, Gil C, García-Cadenas I, Barba P, González-Campos J, Queipo de Llano MP, Torrent A, Ribera J, Granada I, Bernal T, Díaz-Beyá M, Amigo ML, Coll R, Tormo M, Vall-Llovera F, Gómez-Centurión I, Sánchez-Sánchez MJ, Soria B, Cladera A, Artola MT, Garcia-Guiñon A, Giménez-Conca A, Amador ML, Martínez-Sánchez P, Algarra JL, Vidal MJ, Alonso N, Maluquer C, Llorente L, García-Boyero R, Ciudad J, Feliu E, Orfao A; on behalf of the PETHEMA Group. Outcomes and prognostic factors of adults with refractory or relapsed T-cell acute lymphoblastic leukemia included in measurable residual disease-oriented trials. Hematol Oncol. 2021 Oct;39(4):529-538. doi: 10.1002/hon.2910. PMID: 34405901
Marcé S, Xicoy B, García O, Cabezón M, Estrada N, Vélez P, Boqué C, Sagüés M, Angona A, Teruel-Montoya R, Ferrer-Marín F, Amat P, Hernández-Boluda JC, Ibarra MM, Anguita E, Cortés M, Fernández-Ruiz A, Fontanals S, Zamora L, On Behalf Of The Grupo Español de Leucemia Mieloide Crónica Gelmc. Impact of BCR-ABL1 Transcript Type on Response, Treatment-Free Remission Rate and Survival in Chronic Myeloid Leukemia Patients Treated with Imatinib. J Clin Med. 2021 Jul 16;10(14):3146. doi: 10.3390/jcm10143146. PMID: 34300312.
Amat P, López-Corral L, Goterris R, Pérez A, López O, Heras I, Arbona C, Viguria MC, Hernández-Boluda JC, Martínez-Ruiz F, Martínez A, Solano C. Biomarker profile predicts clinical efficacy of extracorporeal photopheresis in steroid-resistant acute and chronic graft-vs-host disease after allogenic hematopoietic stem cell transplant. J Clin Apher. 2021 Oct;36(5):697-710. doi: 10.1002/jca.21918. PMID: 34185332
Genescà E, Morgades M, González-Gil C, Fuster-Tormo F, Haferlach C, Meggendorfer M, Montesinos P, Barba P, Gil C, Coll R, Moreno MJ, Martínez-Carballeira D, García-Cadenas I, Vives S, Ribera J, González-Campos J, Díaz-Beya M, Mercadal S, Artola MT, Cladera A, Tormo M, Bermúdez A, Vall-Llovera F, Martínez-Sánchez P, Amigo ML, Monsalvo S, Novo A, Cervera M, García-Guiñon A, Ciudad J, Cervera J, Hernández-Rivas JM, Granada I, Haferlach T, Orfao A, Solé F, Ribera JM. Adverse prognostic impact of complex karyotype (≥3 cytogenetic alterations) in adult T-cell acute lymphoblastic leukemia (T-ALL). Leuk Res. 2021 Oct;109:106612. doi: 10.1016/j.leukres.2021.106612. PMID: 34139642
Alameda D, Goicoechea I, Vicari M, Arriazu E, Nevone A, Rodriguez S, Lasa M, Puig N, Cedena MT, Alignani D, Garate S, Lara-Astiaso D, Vilas-Zornoza A, Sarvide S, Ocio EM, Lecumberri R, Garcia de Coca A, Labrador J, Gonzalez ME, Palomera L, Gironella M, Cabañas V, Casanova M, Oriol A, Krsnik I, Perez-Montaña A, de la Rubia J, de la Puerta JE, de Arriba F, Fazio VM, Martinez-Lopez J, Lahuerta JJ, Mateos MV, Odero MD, Prosper F, Weiner A, Amit I, Nuvolone M, San Miguel JF, Paiva B. Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development. Blood. 2021 Oct 28;138(17):1583-1589. doi: 10.1182/blood.2020009754. PMID: 34133718
Boluda B, Martínez-Cuadrón D, Algarra L, Cano I, Sayas MJ, Acuña-Cruz E, Blanco A, Marco-Ayala J, DeLapuerta R, Díaz-González Á, Tormo M, Rodríguez-Veiga R, García R, Piñana JL, López-Pavía M, Barragán E, Amigo ML, Sargas C, López A, Solana-Altabella A, Gil C, Megías-Vericat JE, Sanz MA, Montesinos P. Evolving patterns of care and outcomes in relapsed/refractory FLT3 mutated acute myeloid leukemia adult patients. Leuk Lymphoma. 2021 Nov;62(11):2727-2736. doi: 10.1080/10428194.2021.1938031. PMID: 34121593
Bravo-Perez C, García-Torralba E, Lopez-Poveda MJ, Ortuño FJ. CD56- and CD117-positive neuroendocrine neoplasm presenting with leukemic phase and bone marrow infiltration mimicking acute leukemia. Int J Lab Hematol. 2021 Aug;43(4):536-537. doi: 10.1111/ijlh.13578. PMID: 34086417
Mariana Bastos Oreiro , Reyes Martín , Pilar Gomez , Nieves López Muñoz , Antonia Rodriguez , Marta Liébana , Belén Navarro , Blanca Sánchez-González , Pilar Marí , Jaime Pérez de Oteiza , Antonio Gutiérrez , Leyre Bento, Eva Domingo Doménech, María Jesús Vidal, Raquel Del Campo, Elena Pérez Ceballos, María Infante, Alicia Roldán, Daniel García Belmonte, Miriam Santero, Anna Sureda, Ramón García Sanz, On Behalf Of The Geltamo Group. SEGHI Study: Defining the Best Surveillance Strategy in Hodgkin Lymphoma after First-Line Treatment. Cancers (Basel). 2021 May 17;13(10):2412. doi: 10.3390/cancers13102412. PMID: 34067616
Puig N, Hernández MT, Rosiñol L, González E, de Arriba F, Oriol A, González-Calle V, Escalante F, de la Rubia J, Gironella M, Ríos R, García-Sánchez R, Arguiñano JM, Alegre A, Martín J, Gutiérrez NC, Calasanz MJ, Martín ML, Couto MDC, Casanova M, Arnao M, Pérez-Persona E, Garzón S, González MS, Martín-Sánchez G, Ocio EM, Coleman M, Encinas C, Vale AM, Teruel AI, Cortés-Rodríguez M, Paiva B, Cedena MT, San-Miguel JF, Lahuerta JJ, Bladé J, Niesvizky R, Mateos MV. Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial. Blood Cancer J. 2021 May 21;11(5):101. doi: 10.1038/s41408-021-00490-8. PMID: 34021118
Barbui T, De Stefano V, Carobbio A, Iurlo A, Alvarez-Larran A, Cuevas B, Ferrer Marín F, Vannucchi AM, Palandri F, Harrison C, Sibai H, Griesshammer M, Bonifacio M, Elli EM, Trotti C, Koschmieder S, Carli G, Benevolo G, Ianotto JC, Goel S, Falanga A, Betti S, Cattaneo D, Arellano-Rodrigo E, Mannelli L, Vianelli N, Doyle A, Gupta V, Wille K, Tremblay D, Mascarenhas J. Direct oral anticoagulants for myeloproliferative neoplasms: results from an international study on 442 patients. Leukemia. 2021 Oct;35(10):2989-2993. doi: 10.1038/s41375-021-01279-1. PMID: 34012132
Marcé S, Xicoy B, García O, Cabezón M, Estrada N, Vélez P, Boqué C, Sagüés M, Angona A, Teruel-Montoya R, Ferrer-Marín F, Amat P, Hernández-Boluda JC, Ibarra MM, Anguita E, Cortés M, Fernández-Ruiz A, Fontanals S, Zamora L, On Behalf Of The Grupo Español de Leucemia Mieloide Crónica Gelmc. Impact of BCR-ABL1 Transcript Type on Response, Treatment-Free Remission Rate and Survival in Chronic Myeloid Leukemia Patients Treated with Imatinib. J Clin Med. 2021 Jul 16;10(14):3146. doi: 10.3390/jcm10143146. PMID: 34300312
Bueno F, Solano C, Vázquez L, Giménez E, de la Cámara R, Albert E, Rovira M, Espigado I, Martín Calvo C, López-Jiménez J, Suárez-Lledó M, Chinea A, Esquirol A, Pérez A, Bermúdez A, Saldaña R, Heras I, González-Huerta AJ, Torrado T, Batlle M, Jiménez S, Vallejo C, Barba P, Cuesta MÁ, Duarte R, Piñana JL, Navarro D; Spanish Group of Hematopoietic Transplantation, Cell Therapy (GETH). Assessment of the association between cytomegalovirus DNAemia and subsequent acute graft-versus-host disease in allogeneic peripheral blood stem cell transplantation: A multicenter study from the Spanish hematopoietic transplantation and cell therapy group. Transpl Infect Dis. 2021 Aug;23(4):e13627. doi: 10.1111/tid.13627. PMID: 33908148
Bento L, Gutiérrez A, Novelli S, Montoro J, Piñana JL, López-Corral L, Cabrero M, Martín-Sancho A, Gutiérrez-García G, Ortiz-Moscovich M, Bastos-Oreiro M, Dorado N, Pérez A, Hernani R, Ferrà C, Parody R, García-Cadenas I, Herrera P, Rodríguez G, Rodríguez N, Martín C, Yáñez L, Zanabili J, Varela MR, López-Godino O, Heras I, Español I, Martínez C, Pérez-Simón JA, Solano C, Sureda A, Sierra J, Sampol A, Caballero D; Grupo Español de Trasplante Hematopoyético (GETH) and Grupo Español de Linfoma y Trasplante Autólogo (GELTAMO). Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study. Bone Marrow Transplant. 2021 Aug;56(8):1919-1928. doi: 10.1038/s41409-021-01264-3. PMID: 33767400
Bravo-Perez C, Fernández-Caballero M, Soler-Espejo E, Garcia-Torralba E, Sorigue M, García-Malo MD, Jerez A, Vicente V, Roldán V, de Arriba F. Heparin versus aspirin thromboprophylaxis adds independent value to IMPEDE-VTE score for venous thrombosis prediction in multiple myeloma. J Thromb Thrombolysis. 2021 Oct;52(3):848-853. doi: 10.1007/s11239-021-02407-5. PMID: 33649980
Parra Salinas I, Bermudez A, López Corral L, Lopez Godino O, Móles-Poveda P, Martín G, Costilla Barriga L, Ferrá Coll C, Márquez-Malaver F, Ortí G, Zudaire Ripa MT, Rifon J, Martinez C; Spanish Group of Hematopoietic Transplantation (GETH). Treatment of steroid-refractory chronic graft-versus-host disease with imatinib: Real-life experience of the Spanish group of hematopoietic transplantation (GETH). Clin Transplant. 2021 May;35(5):e14255. doi: 10.1111/ctr.14255. PMID: 33595866
Paiva B, Vidriales MB, Sempere A, Tarín F, Colado E, Benavente C, Cedena MT, Sánchez J, Caballero-Velazquez T, Cordón L, Garces JJ, Simoes C, Martínez-Cuadrón D, Bernal T, Botella C, Grille S, Serrano J, Rodríguez-Medina C, Algarra L, Alonso-Domínguez JM, Amigo ML, Barrios M, García-Boyero R, Colorado M, Pérez-Oteyza J, Pérez-Encinas M, Costilla-Barriga L, Sayas MJ, Pérez O, González-Díaz M, Pérez-Simón JA, Martínez-López J, Sossa C, Orfao A, San Miguel JF, Sanz MÁ, Montesinos P; PETHEMA (Programa para el Estudio de la Terapéutica en Hemopatías Malignas) cooperative study group. Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia. Leukemia. 2021 Aug;35(8):2358-2370. doi: 10.1038/s41375-021-01126-3. PMID: 33526859
Pleyer L, Leisch M, Kourakli A, Padron E, Maciejewski JP, Xicoy Cirici B, Kaivers J, Ungerstedt J, Heibl S, Patiou P, Hunter AM, Mora E, Geissler K, Dimou M, Jimenez Lorenzo MJ, Melchardt T, Egle A, Viniou AN, Patel BJ, Arnan M, Valent P, Roubakis C, Bernal Del Castillo T, Galanopoulos A, Calabuig Muñoz M, Bonadies N, Medina de Almeida A, Cermak J, Jerez A, Montoro MJ, Cortés A, Avendaño Pita A, Lopez Andrade B, Hellstroem-Lindberg E, Germing U, Sekeres MA, List AF, Symeonidis A, Sanz GF, Larcher-Senn J, Greil R. Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study. Lancet Haematol. 2021 Feb;8(2):e135-e148. doi: 10.1016/S2352-3026(20)30374-4. PMID: 33513373
Ferrer-Marín F, Cuenca-Zamora EJ, Guijarro-Carrillo PJ, Teruel-Montoya R. Emerging Role of Neutrophils in the Thrombosis of Chronic Myeloproliferative Neoplasms. Int J Mol Sci. 2021 Jan 24;22(3):1143. doi: 10.3390/ijms22031143.PMID: 33498945
Solano C, Vázquez L, Giménez E, de la Cámara R, Albert E, Rovira M, Espigado I, Calvo CM, López-Jiménez J, Suárez-Lledó M, Chinea A, Esquirol A, Pérez A, Bermúdez A, Saldaña R, Heras I, González-Huerta AJ, Torrado T, Batlle M, Jiménez S, Vallejo C, Barba P, Cuesta MÁ, Piñana JL, Navarro D; Spanish Group of Hematopoietic Transplantation and Cell Therapy (GETH). Clinical outcomes of allogeneic hematopoietic stem cell transplant recipients developing Cytomegalovirus DNAemia prior to engraftment. Bone Marrow Transplant. 2021 Jun;56(6):1281-1290. doi: 10.1038/s41409-020-01157-x. PMID: 33319853
Montoro J, Chorão P, Bento L, Cabrero M, Martín C, Novelli S, Cadenas IG, Gutiérrez G, López-Godino O, Ferrá C, Bastos-Oreiro M, Pérez A, Parody R, Pérez Simón JA, Yañez L, Sánchez A, Zanabili J, Varela MR, Córdoba R, Zudaire T, Jiménez-Ubieto A, Sanz J, Sureda A, Caballero D, Piñana JL; GETH and GELTAMO Group. Risk factors and outcomes of follicular lymphoma after allogeneic hematopoietic stem cell transplantation using HLA-matched sibling, unrelated, and haploidentical-related donors. Bone Marrow Transplant. 2021 Apr;56(4):992-996. doi: 10.1038/s41409-020-01161-1. PMID: 33311593
Pérez Encinas MM, Sobas M, Gómez-Casares MT, Abuin Blanco A, Noya Pereira MS, Raya JM, Andrade-Campos MM, Álvarez Larrán A, Lewandowski K, Łukasz S, Hernández Boluda JC, Ferrer-Marín F, Fox ML, Gołos A, Gasior Kabat M, Magro Mazo E, Czyż A, Martín Martín A, Bellosillo Paricio B, Quinteiro García C, González Martín JM, Stuckey R. The risk of thrombosis in essential thrombocythemia is associated with the type of CALR mutation: A multicentre collaborative study. Eur J Haematol. 2021 Mar;106(3):371-379. doi: 10.1111/ejh.13561. PMID: 33275803
Sargas C, Ayala R, Chillón MC, Larráyoz MJ, Carrillo-Cruz E, Bilbao C, Yébenes-Ramírez M, Llop M, Rapado I, García-Sanz R, Vázquez I, Soria E, Florido-Ortega Y, Janusz K, Botella C, Serrano J, Martínez-Cuadrón D, Bergua J, Amigo ML, Martínez-Sánchez P, Tormo M, Bernal T, Herrera-Puente P, García R, Algarra L, Sayas MJ, Costilla-Barriga L, Pérez-Santolalla E, Marchante I, Lavilla-Rubira E, Noriega V, Alonso-Domínguez JM, Sanz MÁ, Sánchez-Garcia J, Gómez-Casares MT, Pérez-Simón JA, Calasanz MJ, González-Díaz M, Martínez-López J, Barragán E, Montesinos P. Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project. Haematologica. 2021 Dec 1;106(12):3079-3089. doi: 10.3324/haematol.2020.263806. PMID: 33179471
Ribera JM, Morgades M, Ciudad J, Montesinos P, Esteve J, Genescà E, Barba P, Ribera J, García-Cadenas I, Moreno MJ, Martínez-Carballeira D, Torrent A, Martínez-Sánchez P, Monsalvo S, Gil C, Tormo M, Artola MT, Cervera M, González-Campos J, Rodríguez C, Bermúdez A, Novo A, Soria B, Coll R, Amigo ML, López-Martínez A, Fernández-Martín R, Serrano J, Mercadal S, Cladera A, Giménez-Conca A, Peñarrubia MJ, Abella E, Vall-Llovera F, Hernández-Rivas JM, Garcia-Guiñon A, Bergua JM, de Rueda B, Sánchez-Sánchez MJ, Serrano A, Calbacho M, Alonso N, Méndez-Sánchez JÁ, García-Boyero R, Olivares M, Barrena S, Zamora L, Granada I, Lhermitte L, Feliu E, Orfao A. Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome-negative adult lymphoblastic leukemia. Blood. 2021 Apr 8;137(14):1879-1894. doi: 10.1182/blood.2020007311. PMID: 33150388
Martínez-Cuadrón D, Serrano J, Gil C, Tormo M, Martínez-Sánchez P, Pérez-Simón JA, García-Boyero R, Rodríguez-Medina C, López-Pavía M, Benavente C, Bergua J, Lavilla-Rubira E, Amigo ML, Herrera P, Alonso-Domínguez JM, Bernal T, Colorado M, Sayas MJ, Algarra L, Vidriales MB, Rodríguez-Macías G, Vives S, Pérez-Encinas MM, López A, Noriega V, García-Fortes M, Ramos F, Rodríguez-Gutiérrez JI, Costilla-Barriga L, Labrador J, Boluda B, Rodríguez-Veiga R, Martínez-López J, Sanz MA, Montesinos P. Evolving treatment patterns and outcomes in older patients (≥60 years) with AML: changing everything to change nothing? Leukemia. 2021 Jun;35(6):1571-1585. doi: 10.1038/s41375-020-01058-4. PMID: 33077867
Piñana JL, Xhaard A, Tridello G, Passweg J, Kozijn A, Polverelli N, Heras I, Perez A, Sanz J, Berghuis D, Vázquez L, Suárez-Lledó M, Itäla-Remes M, Ozcelik T, Iturrate Basarán I, Karakukcu M, Al Zahrani M, Choi G, Cuesta Casas MA, Batlle Massana M, Viviana A, Blijlevens N, Ganser A, Kuskonmaz B, Labussière-Wallet H, Shaw PJ, Yegin ZA, González-Vicent M, Rocha V, Ferster A, Knelange N, Navarro D, Mikulska M, de la Camara R, Styczynski J. Seasonal Human Coronavirus Respiratory Tract Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation. J Infect Dis. 2021 May 20;223(9):1564-1575. doi: 10.1093/infdis/jiaa553. PMID: 32860509
Novelli S, Bento L, Garcia I, Prieto L, López L, Gutierrez G, Hernani R, Pérez A, Esquirol A, Solano C, Bastos M, Dorado N, Rodríguez N, Rodríguez G, Piñana JL, Montoro J, Herrera P, Luna A, Parody R, Martín C, García E, López O, Heras I, Zanabili J, Moraleda JM, Yañez L, Gutierrez A, Zudaire T, Córdoba R, Varela R, Ferra C, Martínez J, Martínez C, Gonzalez-Barca E, Martino R, Caballero D; GELTAMO and GETH. Allogeneic Stem Cell Transplantation in Mature T Cell and Natural Killer/T Neoplasias: A Registry Study from Spanish GETH/GELTAMO Centers. Transplant Cell Ther. 2021 Jun;27(6):493.e1-493.e8. doi: 10.1016/j.jtct.2021.03.014. PMID: 33857447
Melaiu O, Macauda A, Sainz J, Calvetti D, Facioni MS, Maccari G, Ter Horst R, Netea MG, Li Y, Grząśko N, Moreno V, Jurczyszyn A, Jerez A, Watek M, Varkonyi J, Garcia-Sanz R, Kruszewski M, Dudziński M, Kadar K, Jacobsen SEH, Mazur G, Andersen V, Rybicka M, Zawirska D, Raźny M, Zaucha JM, Ostrovsky O, Iskierka-Jazdzewska E, Reis RM, Stępień A, Beider K, Nagler A, Druzd-Sitek A, Marques H, Martìnez-Lopez J, Lesueur F, Avet-Loiseau H, Vangsted AJ, Krawczyk-Kulis M, Butrym A, Jamroziak K, Dumontet C, Vogel U, Rymko M, Pelosini M, Subocz E, Szombath G, Sarasquete ME, Silvestri R, Morani F, Landi S, Campa D, Canzian F, Gemignani F. Common gene variants within 3'-untranslated regions as modulators of multiple myeloma risk and survival. Int J Cancer. 2021 Apr 15;148(8):1887-1894. doi: 10.1002/ijc.33377. PMID: 33152124
Macauda A, Giaccherini M, Sainz J, Gemignani F, Sgherza N, Sánchez-Maldonado JM, Gora-Tybor J, Martinez-Lopez J, Carreño-Tarragona G, Jerez A, Spadano R, Gołos A, Jurado M, Hernández-Mohedo F, Mazur G, Tavano F, Butrym A, Várkonyi J, Canzian F, Campa D. Do myeloproliferative neoplasms and multiple myeloma share the same genetic susceptibility loci? Int J Cancer. 2021 Apr 1;148(7):1616-1624. doi: 10.1002/ijc.33337. PMID: 33038278
Solano C, Vázquez L, Giménez E, de la Cámara R, Albert E, Rovira M, Espigado I, Calvo CM, López-Jiménez J, Suárez-Lledó M, Chinea A, Esquirol A, Pérez A, Bermúdez A, Saldaña R, Heras I, González-Huerta AJ, Torrado T, Bautista G, Batlle M, Jiménez S, Vallejo C, Barba P, Cuesta MÁ, Piñana JL, Navarro D. Cytomegalovirus DNAemia and risk of mortality in allogeneic hematopoietic stem cell transplantation: Analysis from the Spanish Hematopoietic Transplantation and Cell Therapy Group. Am J Transplant. 2021 Jan;21(1):258-271. doi: 10.1111/ajt.16147. PMID: 32812351
Alvarez-Larrán A, Angona A, Andrade-Campos M, Soledad Noya M, Teresa Gómez-Casares M, Cuevas B, Caballero G, García-Hernández C, García-Gutiérrez V, Palomino A, Ferrer-Marín F, Isabel Mata-Vázquez M, Moretó A, Magro E, Murillo I, Manuel Alonso-Domínguez J, María Guerra J, Guerrero L, María Raya J, Pérez-Encinas M, Carreño-Tarragona G, Fox L, Pastor-Galán I, Bellosillo B, Hernández-Boluda JC; MPN Spanish Group (GEMFIN). Cytoreductive treatment in patients with CALR-mutated essential thrombocythaemia: a study comparing indications and efficacy among genotypes from the Spanish Registry of Essential Thrombocythaemia. Br J Haematol. 2021 Mar;192(6):988-996. doi: 10.1111/bjh.16988. Epub 2020 Aug 3. PMID: 32745264
Cuenca I, Alameda D, Sanchez-Vega B, Gomez-Sanchez D, Alignani D, Lasa M, Onecha E, Lecumberri R, Prosper F, Ocio EM, González ME, García de Coca A, De La Rubia J, Gironella M, Palomera L, Oriol A, Casanova M, Cabañas V, Taboada F, Pérez-Montaña A, De Arriba F, Puig N, Carreño-Tarragona G, Barrio S, Enrique de la Puerta J, Ramirez-Payer A, Krsnik I, Bargay JJ, Lahuerta JJ, Mateos MV, San-Miguel JF, Paiva B, Martinez-Lopez J. Immunogenetic characterization of clonal plasma cells in systemic light-chain amyloidosis. Leukemia. 2021 Jan;35(1):245-249. doi: 10.1038/s41375-020-0800-6. PMID: 32203144
Bravo-Pérez C, de la Morena-Barrio ME, de la Morena-Barrio B, Miñano A, Padilla J, Cifuentes R, Garrido P, Vicente V, Corral J. Molecular and clinical characterization of transient antithrombin deficiency: A new concept in congenital thrombophilia. Am J Hematol. 2021 Nov 20. doi: 10.1002/ajh.26413. PMID: 34800304
Lozano ML. New developments in the diagnosis of primary immune thrombocytopenia. Blood Coagul Fibrinolysis. 2021 Oct 11. doi: 10.1097/MBC.0000000000001095. PMID: 34636811
Balduini C, Freson K, Greinacher A, Gresele P, Kühne T, Scully M, Bakchoul T, Coppo P, Dovc Drnovsek T, Godeau B, Gruel Y, Rao AK, Kremer Hovinga JA, Makris M, Matzdorff A, Mumford A, Pecci A, Raslova H, Rivera J, Roberts I, Scharf RE, Semple JW, Van Geet C. The EHA Research Roadmap: Platelet Disorders. Hemasphere. 2021 Jun 30;5(7):e601. doi: 10.1097/HS9.0000000000000601. PMID: 34476343
Bravo-Pérez C, Serna MJ, Esteban J, Fernandez-Mellid E, Fontanes-Trabazo E, Lorenzo A, Calviño-Suárez M, Miñano A, Padilla J, Roldán V, Vicente V, Corral J, de la Morena-Barrio ME. Anticoagulant therapy in patients with congenital FXI deficiency. Blood Adv. 2021 Oct 26;5(20):4083-4086. doi: 10.1182/bloodadvances.2021005695. PMID: 34597376
Frelinger AL 3rd, Rivera J, Connor DE, Freson K, Greinacher A, Harrison P, Kunishima S, Lordkipanidzé M, Michelson AD, Ramström S, Gresele P. Consensus recommendations on flow cytometry for the assessment of inherited and acquired disorders of platelet number and function: Communication from the ISTH SSC Subcommittee on Platelet Physiology. J Thromb Haemost. 2021 Dec;19(12):3193-3202. doi: 10.1111/jth.15526. PMID: 34580997
Palma-Barqueros V, Bury L, Kunishima S, Lozano ML, Rodríguez-Alen A, Revilla N, Bohdan N, Padilla J, Fernández-Pérez MP, de la Morena-Barrio ME, Marín-Quiles A, Benito R, López-Fernández MF, Marcellini S, Zamora-Cánovas A, Vicente V, Martínez C, Gresele P, Bastida JM, Rivera J. Expanding the genetic spectrum of TUBB1-related thrombocytopenia. Blood Adv. 2021 Dec 28;5(24):5453-5467. doi: 10.1182/bloodadvances.2020004057. PMID: 34516618
Jimenez-Marco T, Castrillo A, Hierro-Riu F, Vicente V, Rivera J. Frozen and cold-stored platelets: reconsidered platelet products. Platelets. 2021 Aug 22:1-8. doi: 10.1080/09537104.2021.1967917. PMID: 34423718
Parrado A, Rubio G, Serrano M, De la Morena-Barrio ME, Ibáñez-Micó S, Ruiz-Lafuente N, Schwartz-Albiez R, Esteve-Solé A, Alsina L, Corral J, Hernández-Caselles T. Dissecting the transcriptional program of phosphomannomutase 2 deficient cells: B-LCL as a valuable model for congenital disorders of glycosylation studies. Glycobiology. 2021 Aug 18:cwab087. doi: 10.1093/glycob/cwab087. PMID: 34420056
Ding WY, Rivera-Caravaca JM, Marin F, Torp-Pedersen C, Roldán V, Lip GYH. Prediction of Residual Stroke Risk in Anticoagulated Patients with Atrial Fibrillation: mCARS. J Clin Med. 2021 Jul 29;10(15):3357. doi: 10.3390/jcm10153357. PMID: 34362143
Megy K, Downes K, Morel-Kopp MC, Bastida JM, Brooks S, Bury L, Leinoe E, Gomez K, Morgan NV, Othman M, Ouwehand WH, Perez Botero J, Rivera J, Schulze H, Trégouët DA, Freson K. GoldVariants, a resource for sharing rare genetic variants detected in bleeding, thrombotic, and platelet disorders: Communication from the ISTH SSC Subcommittee on Genomics in Thrombosis and Hemostasis. J Thromb Haemost. 2021 Oct;19(10):2612-2617. doi: 10.1111/jth.15459. PMID: 34355501
de la Morena-Barrio ME, Gindele R, Bravo-Pérez C, Ilonczai P, Zuazu I, Speker M, Oláh Z, Rodríguez-Sevilla JJ, Entrena L, Infante MS, de la Morena-Barrio B, García JM, Schlammadinger Á, Cifuentes-Riquelme R, Mora-Casado A, Miñano A, Padilla J, Vicente V, Corral J, Bereczky Z. High penetrance of inferior vena cava system atresia in severe thrombophilia caused by homozygous antithrombin Budapest 3 variant: Description of a new syndrome. Am J Hematol. 2021 Nov 1;96(11):1363-1373. doi: 10.1002/ajh.26304. PMID: 34324211
Alcaraz MJ, Alcaraz A, Teruel-Montoya R, Campillo JA, de la Torre A, Muñoz Á, Tomás C, Puche G, Báguena C, Cano A, Minguela A, Bernal E. Subclinical atherosclerosis and immune activation in young HIV-infected patients with telomere shortening. Aging (Albany NY). 2021 Jul 26;13(14):18094-18105. doi: 10.18632/aging.203350. PMID: 34310343
Lozano ML, Segú-Vergés C, Coma M, Álvarez-Roman MT, González-Porras JR, Gutiérrez L, Valcárcel D, Butta N Elucidating the Mechanism of Action of the Attributed Immunomodulatory Role of Eltrombopag in Primary Immune Thrombocytopenia: An In Silico Approach. Int J Mol Sci. 2021 Jun 27;22(13):6907. doi: 10.3390/ijms22136907. PMID: 34199099
Lozano ML, Sanz MA, Vicente V; Grupo Español de PTI (GEPTI). Guidelines of the Spanish ITP Group for the diagnosis, treatment and follow-up of patients with immune thrombopenia. Med Clin (Barc). 2021 Aug 27;157(4):191-198. doi: 10.1016/j.medcli.2021.03.017. PMID: 34088525 Proietti M, Esteve-Pastor MA, Rivera-Caravaca JM, Roldán V, Roldán Rabadán I, Muñiz J, Cequier Á, Bertomeu-Martínez V, Badimón L, Anguita M, Lip GYH, Marín F; FANTASIIA Study Investigators. Relationship between multimorbidity and outcomes in atrial fibrillation. Exp Gerontol. 2021 Oct 1;153:111482. doi: 10.1016/j.exger.2021.111482. PMID: 34303775
Ding WY, Rivera-Caravaca JM, Marín F, Li G, Roldán V, Lip GYH. Number needed to treat for net effect of anticoagulation in atrial fibrillation: Real-world vs. clinical-trial evidence. Br J Clin Pharmacol. 2021 Jun 30. doi: 10.1111/bcp.14961. PMID: 34192808
Palma-Barqueros V, Revilla N, Sánchez A, Zamora Cánovas A, Rodriguez-Alén A, Marín-Quílez A, González-Porras JR, Vicente V, Lozano ML, Bastida JM, Rivera J. Inherited Platelet Disorders: An Updated Overview. Int J Mol Sci. 2021 Apr 26;22(9):4521. doi: 10.3390/ijms22094521.PMID: 33926054
Bastida JM, Gonzalez-Porras JR, Rivera J, Lozano ML. Role of Thrombopoietin Receptor Agonists in Inherited Thrombocytopenia. Int J Mol Sci. 2021 Apr 21;22(9):4330. doi: 10.3390/ijms22094330. PMID: 33919295
de la Morena-Barrio ME, Bravo-Pérez C, Miñano A, de la Morena-Barrio B, Fernandez-Perez MP, Bernal E, Gómez-Verdu JM, Herranz MT, Vicente V, Corral J, Lozano ML. Prognostic value of thrombin generation parameters in hospitalized COVID-19 patients. Sci Rep. 2021 Apr 8;11(1):7792. doi: 10.1038/s41598-021-85906-y. PMID: 33833254
Barrachina MN, Izquierdo I, Hermida-Nogueira L, Morán LA, Pérez A, Arroyo AB, García-Barberá N, González-Conejero R, Troitiño S, Eble JA, Rivera J, Martínez C, Loza MI, Domínguez E, García Á. The PI3Kδ Inhibitor Idelalisib Diminishes Platelet Function and Shows Antithrombotic Potential. Int J Mol Sci. 2021 Mar 24;22(7):3304. doi: 10.3390/ijms22073304. PMID: 33804911
de la Morena-Barrio ME, Bravo-Pérez C, de la Morena-Barrio B, Orlando C, Cifuentes R, Padilla J, Miñano A, Herrero S, Marcellini S, Revilla N, Bernal E, Gómez-Verdú JM, Jochmans K, Herranz MT, Vicente V, Corral J, Lozano ML. A pilot study on the impact of congenital thrombophilia in COVID-19. Eur J Clin Invest. 2021 May;51(5):e13546. doi: 10.1111/eci.13546. PMID: 33738814
López-Gálvez R, de la Morena-Barrio ME, Miñano A, Pathak M, Marcos C, Emsley J, Caballero T, López-Trascasa M, Vicente V, Corral J, López-Lera A. Thrombin in the Activation of the Fluid Contact Phase in Patients with Hereditary Angioedema Carrying the F12 P.Thr309Lys Variant. Clin Rev Allergy Immunol. 2021 Jun;60(3):357-368. doi: 10.1007/s12016-021-08840-x. PMID: 33725261
Águila S, de Los Reyes-García AM, Fernández-Pérez MP, Reguilón-Gallego L, Zapata-Martínez L, Ruiz-Lorente I, Vicente V, González-Conejero R, Martínez C. MicroRNAs as New Regulators of Neutrophil Extracellular Trap Formation. Int J Mol Sci. 2021 Feb 20;22(4):2116. doi: 10.3390/ijms22042116. PMID: 33672737
Peñas-Martínez J, Barrachina MN, Cuenca-Zamora EJ, Luengo-Gil G, Bravo SB, Caparrós-Pérez E, Teruel-Montoya R, Eliseo-Blanco J, Vicente V, García Á, Martínez-Martínez I, Ferrer-Marín F. Qualitative and Quantitative Comparison of Plasma Exosomes from Neonates and Adults. Int J Mol Sci. 2021 Feb 15;22(4):1926. doi: 10.3390/ijms22041926. PMID: 33672065
Camelo-Castillo A, Rivera-Caravaca JM, Orenes-Piñero E, Ramírez-Macías I, Roldán V, Lip GYH, Marín F. Gut Microbiota and the Quality of Oral Anticoagulation in Vitamin K Antagonists Users: A Review of Potential Implications. J Clin Med. 2021 Feb 11;10(4):715. doi: 10.3390/jcm10040715. PMID: 33670220
Marín-Quílez A, García-Tuñón I, Fernández-Infante C, Hernández-Cano L, Palma-Barqueros V, Vuelta E, Sánchez-Martín M, González-Porras JR, Guerrero C, Benito R, Rivera J, Hernández-Rivas JM, Bastida JM. Characterization of the Platelet Phenotype Caused by a Germline RUNX1 Variant in a CRISPR/Cas9-Generated Murine Model. Thromb Haemost. 2021 Sep;121(9):1193-1205. doi: 10.1055/s-0041-1723987. PMID: 33626581
Águila S, Noto R, Luengo-Gil G, Espín S, Bohdan N, de la Morena-Barrio ME, Peñas J, Rodenas MC, Vicente V, Corral J, Manno M, Martínez-Martínez I. N-Glycosylation as a Tool to Study Antithrombin Secretion, Conformation, and Function. Int J Mol Sci. 2021 Jan 6;22(2):516. doi: 10.3390/ijms22020516. PMID: 33419227
Ferrer-Marín F, Sola-Visner M. Neonatal platelet physiology and implications for transfusion. Platelets. 2021 Aug 16:1-9. doi: 10.1080/09537104.2021.1962837. PMID: 34392772
Arroyo AB, Águila S, Fernández-Pérez MP, Reyes-García AML, Reguilón-Gallego L, Zapata-Martínez L, Vicente V, Martínez C, González-Conejero R. miR-146a in Cardiovascular Diseases and Sepsis: An Additional Burden in the Inflammatory Balance? Thromb Haemost. 2021 Sep;121(9):1138-1150. doi: 10.1055/a-1342-3648. PMID: 33352593
Fernández-Pérez MP, Águila S, Reguilón-Gallego L, de Los Reyes-García AM, Miñano A, Bravo-Pérez C, de la Morena ME, Corral J, García-Barberá N, Gómez-Verdú JM, Bernal E, Herranz MT, Vicente V, Martínez C, González-Conejero R, Lozano ML. Neutrophil extracellular traps and von Willebrand factor are allies that negatively influence COVID-19 outcomes. Clin Transl Med. 2021 Jan;11(1):e268. doi: 10.1002/ctm2.268. PMID: 33463053
Palma-Barqueros V, Crescente M, de la Morena ME, Chan MV, Almarza E, Revilla N, Bohdan N, Miñano A, Padilla J, Allan HE, Maffucci T, Edin ML, Zeldin DC, Mesa-Nuñez C, Damian C, Marín-Quilez A, Benito R, Martínez-Martínez I, Bermejo N, Casas-Aviles I, Rodríguez-Alen A, González-Porras JR, Hernández-Rivas JM, Vicente V, Corral J, Lozano ML, Warner TD, Bastida JM, Rivera J. A novel genetic variant in PTGS1 affects N-glycosylation of cyclooxygenase-1 causing a dominant-negative effect on platelet function and bleeding diathesis. Am J Hematol. 2021 Mar 1;96(3):E83-E88. doi: 10.1002/ajh.26076. PMID: 33326144
Ding WY, Rivera-Caravaca JM, Shantsila A, Marin F, Gupta D, Roldán V, Lip GYH. Outcomes in VKA-treated patients with atrial fibrillation and chronic kidney disease: Clinical trials vs 'real-world' Int J Clin Pract. 2021 Apr;75(4):e13888. doi: 10.1111/ijcp.13888. PMID: 33283377
Lozano ML. Avatrombopag for the management of thrombocytopenia in patients with chronic liver disease. Rev Esp Enferm Dig. 2021 Feb;113(2):136-140. doi: 10.17235/reed.2020.7309/2020. PMID: 33233913
Lozano ML, Mingot-Castellano ME, Perera MM, Jarque I, Campos-Alvarez RM, González-López TJ, Carreño-Tarragona G, Bermejo N, Lopez-Fernandez MF, de Andrés A, Valcarcel D, Casado-Montero LF, Alvarez-Roman MT, Orts MI, Novelli S, González-Porras JR, Bolaños E, López-Ansoar E, Orna-Montero E, Vicente V. A decade of changes in management of immune thrombocytopenia, with special focus on elderly patients. Blood Cells Mol Dis. 2021 Feb;86:102505. doi: 10.1016/j.bcmd.2020.102505. PMID: 32979651
Orlando C, de la Morena-Barrio B, Pareyn I, Vanhoorelbeke K, Martínez-Martínez I, Vicente V, Corral J, Jochmans K, de la Morena-Barrio ME. Antithrombin p.Thr147Ala: The First Founder Mutation in People of African Origin Responsible for Inherited Antithrombin Deficiency. Thromb Haemost. 2021 Feb;121(2):182-191. doi: 10.1055/s-0040-1716531. PMID: 32920809
Arroyo AB, Fernández-Pérez MP, Del Monte A, Águila S, Méndez R, Hernández-Antolín R, García-Barber N, de Los Reyes-García AM, González-Jiménez P, Arcas MI, Vicente V, Menéndez R, Andrés V, González-Conejero R, Martínez C. miR-146a is a pivotal regulator of neutrophil extracellular trap formation promoting thrombosis. Haematologica. 2021 Jun 1;106(6):1636-1646. doi: 10.3324/haematol.2019.240226. PMID: 32586906
Palma-Barqueros V, Bohdan N, Revilla N, Vicente V, Bastida JM, Rivera J. PTGS1 gene variations associated with bleeding and platelet dysfunction. Platelets. 2021 Jul 4;32(5):710-716. doi: 10.1080/09537104.2020.1782370. PMID: 32584621
Páramo JA, Lozano ML, González-Porras JR, Mateo J. Current status of diagnosis and treatment of heparin-induced thrombocytopenia (HIT). Med Clin (Barc). 2021 Jul 23:S0025-7753(21)00363-8. English, Spanish. doi: 10.1016/j.medcli.2021.05.020
Ocio EM, Motlló C, Rodríguez-Otero P, Martínez-López J, Cejalvo MJ, Martín-Sánchez J, Bladé J, García-Malo MD, Dourdil MV, García-Mateo A, de Arriba F, García-Sanz R, de la Rubia J, Oriol A, Lahuerta JJ, San-Miguel JF, Mateos MV. Filanesib in combination with pomalidomide and dexamethasone in refractory MM patients: safety and efficacy, and association with alpha 1-acid glycoprotein (AAG) levels. Phase Ib/II Pomdefil clinical trial conducted by the Spanish MM group. Br J Haematol. 2020 Jun 5. doi: 10.1111/bjh.16788. PMID: 32501528
Kim D, Park G, Huuhtanen J, Lundgren S, Khajuria RK, Hurtado AM, Muñoz-Calleja C, Cardeñoso L, Gómez-García de Soria V, Chen-Liang TH, Eldfors S, Ellonen P, Hannula S, Kankainen M, Bruck O, Kreutzman A, Salmenniemi U, Lönnberg T, Jerez A, Itälä-Remes M, Myllymäki M, Keränen MAI, Mustjoki S. Somatic mTOR mutation in clonally expanded T lymphocytes associated with chronic graft versus host disease. Nat Commun. 2020;11(1):2246. PMID: 32382059
Ribera JM, García O, Chapchap EC, Gil C, González-Campos J, Barba P, Amigo ML, Moreno MJ, Lavilla E, Alonso N, Bergua JM, Tormo M, Ribera J, Sierra M, Martínez-Carballeira D, Mercadal S, Hernández-Rivas JM, Vall-Llovera F, Genescà E, Cladera A, Novo A, Abella E, García-Cadenas I, Monteserín C, Bermúdez A, Piernas S, Montesinos P, López JL, García-Guiñón A, Serrano A, Martínez MP, Olivares M, López A, Serrano J; PETHEMA Group, Spanish Society of Hematology. Treatment of Frail Older Adults and Elderly Patients With Philadelphia Chromosome-negative Acute Lymphoblastic Leukemia: Results of a Prospective Trial With Minimal Chemotherapy. Clin Lymphoma Myeloma Leuk. 2020 Apr 5:S2152-2650(20)30144-0. doi: 10.1016/j.clml.2020.03.011. PMID: 32336676
Fuster JL, Molinos-Quintana A, Fuentes C, Fernández JM, Velasco P, Pascual T, Rives S, Dapena JL, Sisinni L, López-Godino O, Palomo P, Villa-Alcázar M, Bautista F, González-Vicent M, López-Duarte M, García-Morín M, Ramos-Elbal E, Ramírez M; Leukemia Working Group of the Spanish Society of Pediatric Hematology, Oncology (SEHOP). Blinatumomab and inotuzumab for B cell precursor acute lymphoblastic leukaemia in children: a retrospective study from the Leukemia Working Group of the Spanish Society of Pediatric Hematology and Oncology (SEHOP). Br J Haematol. 2020 Apr 21. doi: 10.1111/bjh.16647. Online ahead of print. PMID: 32314348
Maia C, Puig N, Cedena MT, Goicoechea I, Valdes-Mas R, Vazquez I, Chillon MC, Aguirre P, Sarvide S, Gracia-Aznárez FJ, Alkorta G, Calasanz MJ, Garcia-Sanz R, Gonzalez M, Gutierrez NC, Martinez-Lopez J, Perez JJ, Merino J, Moreno C, Burgos L, Alignani D, Botta C, Prosper F, Matarraz S, Orfao A, Oriol A, Teruel AI, de Paz R, de Arriba F, Hernandez MT, Palomera L, Martinez R, Rosiñol L, Mateos MV, Lahuerta JJ, Blade J, San Miguel JF, Paiva B. Biological and clinical significance of dysplastic hematopoiesis in patients with newly diagnosed multiple myeloma. Blood. 2020 Jun 25;135(26):2375-2387. PMID: 32299093
Rodríguez-Medina C, Martínez-Cuadrón D, Cano I, Gil C, Tormo M, Del Pilar Martínez-Sánchez M, Del Castillo TB, Serrano-López J, Benavente C, Herrera-Puente P, García-Boyero R, Lavilla-Rubira E, Amigo ML, Sayas-Lloris M, Bergua-Burgues JM, Pérez-Simón JA, Rodríguez G, Espadana A, Vidriales-Vicente B, Fernández R, López-Lorenzo JL, López M, García-Fortes M, Labrador Gómez J, Colorado-Araujo M, Sossa-Melo CL, Aguilar E, Montesinos Fernández P. Performance of prognostic scoring systems in elderly patients with acute myeloid leukaemia on intensive chemotherapy: A PETHEMA registry study. Leuk Res. 2020 Mar 23;92:106352. doi: 10.1016/j.leukres.2020.106352. PMID: 32240863
Tarragona G, Barrio S, Enrique de la Puerta J, Ramirez-Payer A, Krsnik I, Bargay JJ, Lahuerta JJ, Mateos MV, San-Miguel JF, Paiva B, Lopez JM. Immunogenetic characterization of clonal plasma cells in systemic light-chain amyloidosis. Leukemia. 2020 Mar 19. doi: 10.1038/s41375-020-0800-6. PMID: 32203144
Díaz-Santa J, Rodríguez-Romanos R, Osca G, Pratcorona M, Garrido A, Coll R, Moret C, Escoda L, Tormo M, Heras I, Arnan M, Vives S, Salamero O, Lloveras N, Bargay J, Sampol A, Cruz D, Garcia A, Quiñones T, Esteve J, Sierra J, Gallardo D; on the behalf of CETLAM Group. UGT1A1 genotype influences clinical outcome in patients with intermediate-risk acute myeloid leukemia treated with cytarabine-based chemotherapy. Leukemia. 2020 Mar 9. doi: 10.1038/s41375-020-0784-2. PMID: 32152464
Alvarez-Larrán A, Pereira A, Magaz M, Hernández-Boluda JC, Garrote M, Cuevas B, Ferrer-Marín F, Gómez-Casares MT, García-Gutiérrez V, Mata-Vázquez MI, Turon F, Hernandez-Gea V, Arellano-Rodrigo E, Cervantes F, García-Pagán JC; GEMFIN and REHEVASC groups. Natural history of polycythemia vera and essential thrombocythemia presenting with splanchnic vein thrombosis. Ann Hematol. 2020 Apr;99(4):791-798. doi: 10.1007/s00277-020-03965-z. PMID: 32086587
Bastos-Oreiro M, Muntañola A, Panizo C, Gonzalez-Barca E, de Villambrosia SG, Córdoba R, López JLB, González-Sierra P, Terol MJ, Gutierrez A, Grande C, Ramirez MJ, Iserte L, Perez E, Navarro B, Gomez P, Salar A, Luzardo H, López A, Del Campo R, García-Belmonte D, Vida MJ, Infante M, Queizan-Hernandez JA, Novelli S, Moreno M, Penarrubia M, Gómez J, Domingo A, Donato E, Viguria MC, López F, Rodriguez MJ, Pardal E, Noriega V, Andreu R, Peñalver J, Martín A, Caballero D, López-Guillermo A. RELINF: prospective epidemiological registry of lymphoid neoplasms in Spain. A project from the GELTAMO group. Ann Hematol. 2020 Apr;99(4):799-808. PMID: 32076827
Suárez-González J, Triviño JC, Bautista G, García-Marco JA, Figuera Á, Balas A, Vicario JL, Ortuño FJ, Teruel R, Álamo JM, Carbonell D, Andrés-Zayas C, Dorado N, Rodríguez-Macías G, Kwon M, Díez-Martín JL, Martínez-Laperche C, Buño I; Spanish Group for Hematopoietic Transplantation (GETH). Exome sequencing reveals heterogeneous clonal dynamics in donor cell myeloid neoplasms after stem cell transplantation. Haematologica. 2020 Feb 20:haematol.2019.234609. doi: 10.3324/haematol.2019.234609. Online ahead of print. PMID: 32079696
Martínez C, Carpio C, Heras I, Ríos-Herranz E, Buch J, Gutierrez A, Romero S, Zeberio I, García-García I, Rodriguez-Izquierdo A, Alonso R, Bargay J, Barrenetxea C, Domingo-Doménech E, de Haro ME, Palomera L, García-Sanz R; Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO). Potential Survival Benefit for Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation after Nivolumab Therapy for Relapse/Refractory Hodgkin Lymphoma: Real-Life Experience in Spain. Biol Blood Marrow Transplant. 2020 Feb 14:S1083-8791(20)30087-2. doi: 10.1016/j.bbmt.2020.02.003. PMID: 32068094
Ribera JM, Morgades M, Montesinos P, Tormo M, Martínez-Carballeira D, González-Campos J, Gil C, Barba P, García-Boyero R, Coll R, Pedreño M, Ribera J, Mercadal S, Vives S, Novo A, Genescà E, Hernández-Rivas JM, Bergua J, Amigo ML, Vall-Llovera F, Martínez-Sánchez P, Calbacho M, García-Cadenas I, Garcia-Guiñon A, Sánchez-Sánchez MJ, Cervera M, Feliu E, Orfao A; PETHEMA Group, Spanish Society of Hematology. A pediatric regimen for adolescents and young adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: Results of the ALLRE08 PETHEMA trial. Cancer Med. 2020 Apr;9(7):2317-2329. PMID: 32022463
Pastor-Galán I, Hernández-Boluda JC, Correa JG, Alvarez-Larrán A, Ferrer-Marín F, Raya JM, Ayala R, Velez P, Pérez-Encinas M, Estrada N, García-Gutiérrez V, Fox ML, Payer A, Kerguelen A, Cuevas B, Durán MA, Ramírez MJ, Gómez-Casares MT, Mata-Vázquez MI, Mora E, Martínez-Valverde C, Arbelo E, Angona A, Magro E, Antelo ML, Somolinos N, Cervantes F; en representación del Grupo Español de Enfermedades Mieloproliferativas Filadelfia Negativas (GEMFIN). Clinico-biological characteristics of patients with myelofibrosis: an analysis of 1,000 cases from the Spanish Registry of Myelofibrosis. Med Clin (Barc). 2020 Jan 21:S0025-7753(19)30716-X. doi: 10.1016/j.medcli.2019.11.007. PMID: 31980217
Oarbeascoa G, Lozano ML, Guerra LM, Amunarriz C, Saavedra CA, Garcia-Gala JM, Viejo A, Revilla N, Acosta Fleitas C, Arroyo JL, Martinez Revuelta E, Galego A, Hernandez-Maraver D, Kwon M, Diez-Martin JL, Pascual C; Grupo Español de Aféresis – Spanish Apheresis Group. Retrospective Multicenter Study of Extracorporeal Photopheresis in Steroid-Refractory Acute and Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2020 Apr;26(4):651-658. PMID: 31917270
Bravo-Perez C, Pajares I, Muiña B, Escobar H, Amigo ML, Garcia-Malo MD, Garcia J, Rodriguez-Pinilla SM, Piris MA, Ortuño FJ. Double hit B cell precursor leukemia/lymphoma in a patient with a prior diagnosis of follicular lymphoma: a diagnostic and therapeutic dilemma. Ann Hematol. 2020 Feb;99(2):391-393. doi: 10.1007/s00277-019-03897-3. Epub 2019 Dec 20. PMID: 31858188
Genescà E, Morgades M, Montesinos P, Barba P, Gil C, Guàrdia R, Moreno MJ, Martínez-Carballeira D, García-Cadenas I, Vives S, Ribera J, González-Campos J, González-Gil C, Zamora L, Ramírez JL, Díaz-Beya M, Mercadal S, Artola MT, Cladera A, Tormo M, Bermúdez A, Vall-Llovera F, Martínez P, Amigo ML, Monsalvo S, Novo A, Cervera M, García-Guiñon A, Juncà J, Ciudad J, Orfao A, Ribera JM. Unique clinico-biological, genetic and prognostic features of adult early T-cell precursor acute lymphoblastic leukemia. Haematologica. 2020 Jun;105(6):e294-e297. PMID: 31537688
Ferrer-Marín F, Arroyo AB, Bellosillo B, Cuenca EJ, Zamora L, Hernández-Rivas JM, Hernández-Boluda JC, Fernandez-Rodriguez C, Luño E, García Hernandez C, Kerguelen A, Fiallo-Suárez DV, Gómez-Casares MT, Ayala R, Vélez P, Boqué C, García-Gutierrez V, Arrizabalaga B, Estrada N, Cifuentes R, Arcas I, de Los Reyes-García AM, Besses C, Vicente V, Alvarez-Larrán A, Teruel-Montoya R, González-Conejero R, Martínez C; GEMFIN Group. miR-146a rs2431697 identifies myeloproliferative neoplasm patients with higher secondary myelofibrosis progression risk. Leukemia. 2020 Feb 27. doi: 10.1038/s41375-020-0767-3. PMID: 32107471
Cuenca I, Alameda D, Sanchez-Vega B, Gomez-Sanchez D, Alignani D, Lasa M, Onecha E, Lecumberri R, Prosper F, Ocio EM, González ME, García de Coca A, De La Rubia J, Gironella M, Palomera L, Oriol A, Casanova M, Cabañas V, Taboada F, Pérez-Montaña A, De Arriba F, Puig N, Carreño-Gonzalez-Rodriguez AP, Lopez-Corral L, Fajardo DFM, Gonzalez-Huerta AJ, Palomo P, Bermudez A, Ripa TZ, Santos-Diaz P, Gonzalez-Muñiz S, Zanabilli J, Ubieto AJ, de Arriba F, Arnao-Herraiz M, Sordo-Bahamonde C, López-Soto A, Gonzalez S, Rosiñol L, Mateos MV. Daratumumab is a safe and effective rescue therapy for multiple myeloma patients who relapse after allo-HSCT. Bone Marrow Transplant. 2020 Feb;55(2):461-463. doi: 10.1038/s41409-019-0525-1. PMID: 30988379
Garabet L, Ghanima W, Rangberg A, Teruel-Montoya R, Martinez C, Lozano ML, Nystrand CF, Bussel JB, Sandset PM, Jonassen CM. Circulating microRNAs in patients with immune thrombocytopenia before and after treatment with thrombopoietin-receptor agonists. Platelets. 2020;31(2):198-205. PMID: 30885035
Barba P, Morgades M, Montesinos P, Gil C, Fox ML, Ciudad J, Moreno MJ, González-Campos J, Genescà E, Martínez-Carballeira D, Martino R, Vives S, Guardia R, Mercadal S, Artola MT, Cladera A, Tormo M, Esteve J, Bergua J, Vall-Llovera F, Ribera J, Martínez-Sanchez P, Amigo ML, Bermúdez A, Calbacho M, Hernández-Rivas JM, Feliu E, Orfao A, Ribera JM. Increased survival due to lower toxicity for high-risk T-cell acute lymphoblastic leukemia patients in two consecutive pediatric-inspired PETHEMA trials. Eur J Haematol. 2019 Jan;102(1):79-86. doi: 10.1111/ejh.13178. Epub 2018 Nov 22.PMID: 30267597
Solano C, Vázquez L, Giménez E, de la Cámara R, Albert E, Rovira M, Espigado I, Calvo CM, López-Jiménez J, Suárez-Lledó M, Chinea A, Esquirol A, Pérez A, Bermúdez A, Saldaña R, Heras I, González-Huerta AJ, Torrado T, Batlle M, Jiménez S, Vallejo C, Barba P, Cuesta MÁ, Piñana JL, Navarro D; Spanish Group of Hematopoietic Transplantation and Cell Therapy (GETH). Clinical outcomes of allogeneic hematopoietic stem cell transplant recipients developing Cytomegalovirus DNAemia prior to engraftment. Bone Marrow Transplant. 2020 Dec 15. doi: 10.1038/s41409-020-01157-x. PMID: 33319853
Montoro J, Chorão P, Bento L, Cabrero M, Martín C, Novelli S, Cadenas IG, Gutiérrez G, López-Godino O, Ferrá C, Bastos-Oreiro M, Pérez A, Parody R, Pérez Simón JA, Yañez L, Sánchez A, Zanabili J, Varela MR, Córdoba R, Zudaire T, Jiménez-Ubieto A, Sanz J, Sureda A, Caballero D, Piñana JL; GETH and GELTAMO Group.. Risk factors and outcomes of follicular lymphoma after allogeneic hematopoietic stem cell transplantation using HLA-matched sibling, unrelated, and haploidentical-related donors.. Bone Marrow Transplant. 2020 Dec 12. doi: 10.1038/s41409-020-01161-1. Online ahead of print.. PMID: 33311593
Puig N, Corchete-Sánchez LA, Pérez-Morán JJ, Dávila J, Paíno T, de la Rubia J, Oriol A, Martín-Sánchez J, de Arriba F, Bladé J, Blanchard MJ, González-Calle V, García-Sanz R, Paiva B, Lahuerta JJ, San-Miguel JF, Mateos MV, Ocio EM. Pembrolizumab as Consolidation Strategy in Patients with Multiple Myeloma: Results of the GEM-Pembresid Clinical Trial. Cancers (Basel). 2020 Dec 3;12(12):E3615 PMID: 33287189 Pérez Encinas MM, Sobas M, Gómez-Casares MT, Abuin Blanco A, Noya Pereira MS, Raya JM, Andrade-Campos MM, Álvarez Larrán A, Lewandowki K, Łukasz S, Hernández Boluda JC, Ferrer-Marín F, Fox ML, Gołos A, Gasior Kabat M, Magro Mazo E, Czyż A, Martín Martín A, Bellosillo Paricio B, Quinteiro García C, González Martín JM, Stuckey R. The risk of thrombosis in essential thrombocythemia is associated with the type of CALR mutation: A multicentre collaborative study. Eur J Haematol. 2020 Dec 4. doi: 10.1111/ejh.13561. PMID: 33275803.
Lozano ML, Godeau B, Grainger J, Matzdorff A, Rodeghiero F, Hippenmeyer J, Kuter DJ. Romiplostim in adults with newly diagnosed or persistent immune thrombocytopenia. Expert Rev Hematol. 2020 Dec;13(12):1319-1332. doi: 10.1080/17474086.2020.1850253. Epub 2020 Nov 30. PMID: 33249935 Lozano ML. Avatrombopag for the management of thrombocytopenia in patients with chronic liver disease. Rev Esp Enferm Dig. 2020 Nov 25. Epub ahead of print. PMID: 33233913.
Sargas C, Ayala R, Chillón MC, Larráyoz MJ, Carrillo-Cruz E, Bilbao C, Yébenes-Ramírez M, Llop M, Rapado I, García-Sanz R, Vázquez I, Soria E, Florido-Ortega Y, Janusz K, Botella C, Serrano J, Martínez-Cuadrón D, Bergua J, Amigo ML, Martínez-Sánchez P, Tormo M, Bernal T, Herrera-Puente P, García R, Algarra L, Sayas MJ, Costilla-Barriga L, Pérez-Santolalla E, Marchante I, Lavilla-Rubira E, Noriega V, Alonso-Domínguez JM, Sanz MÁ, Sánchez-Garcia J, Gómez-Casares MT, Pérez-Simón JA, Calasanz MJ, González-Díaz M, Martínez-López J, Barragán E, Montesinos P. Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project. Haematologica. 2020 Nov 12;Online ahead of print. doi: 10.3324/haematol.2020.263806. PMID: 33179471
Melaiu O, Macauda A, Sainz J, Calvetti D, Facioni MS, Maccari G, Ter Horst R, Netea MG, Li Y, Grząśko N, Moreno V, Jurczyszyn A, Jerez A, Watek M, Varkonyi J, Garcia-Sanz R, Kruszewski M, Dudziński M, Kadar K, Jacobsen SEH, Mazur G, Andersen V, Rybicka M, Zawirska D, Raźny M, Zaucha JM, Ostrovsky O, Iskierka-Jazdzewska E, Reis RM, Stępień A, Beider K, Nagler A, Druzd-Sitek A, Marques H, Martìnez-Lopez J, Lesueur F, Avet-Loiseau H, Vangsted AJ, Krawczyk-Kulis M, Butrym A, Jamroziak K, Dumontet C, Vogel U, Rymko M, Pelosini M, Subocz E, Szombath G, Sarasquete ME, Silvestri R, Morani F, Landi S, Campa D, Canzian F, Gemignani F. Common gene variants within 3'-untranslated regions as modulators of multiple myeloma risk and survival. Int J Cancer. 2020 Nov 5. doi: 10.1002/ijc.33377. PMID: 33152124
Ribera JM, Morgades M, Ciudad J, Montesinos P, Esteve J, Genesca E, Barba P, Ribera J, García Cadenas I, Moreno MJ, Martínez-Carballeira D, Torrent A, Martínez-Sánchez P, Monsalvo S, Gil C, Tormo M, Artola MT, Cervera M, González-Campos J, Rodríguez-Medina C, Bermúdez A, Novo A, Soria B, Coll R, Amigo ML, López A, Fernández Martín R, Serrano J, Mercadal S, Cladera A, Giménez-Conca AD, Peñarrubia MJ, Abella E, Vall-Llovera F, Hernández-Rivas JM, Garcia A, Bergua Burgues JM, de Rueda B, Sánchez-Sánchez MJ, Serrano A, Calbacho M, Alonso Vence N, Méndez-Sánchez JÁ, García-Boyero R, Olivares M, Barrena S, Zamora L, Granada I, Lhermitte L, Feliu E, Orfao A. Chemotherapy or Allogeneic Transplantation in High-Risk Philadelphia Chromosome-Negative Adult Lymphoblastic Leukemia. Blood. 2020 Nov 4:blood.2020007311. doi: 10.1182/blood.2020007311. PMID: 33150388
Hurtado López AM, Chen-Liang TH, Zurdo M, Carrillo-Tornel S, Panadero J, Salido EJ, Beltrán V, Muiña B, Amigo M, Navarro-Villamor N, Cifuentes R, Calabria I, Antón AI, Teruel R, Muro M, Vicente V, Jerez A. Cancer testis antigens in myelodysplastic syndromes revisited: a targeted RNA-seq approach. Oncoimmunology. 2020 Oct 1;9(1):1824642. PMID: 33101773
Martínez-Cuadrón D, Serrano J, Gil C, Tormo M, Martínez-Sánchez P, Pérez-Simón JA, García-Boyero R, Rodríguez-Medina C, López-Pavía M, Benavente C, Bergua J, Lavilla-Rubira E, Amigo ML, Herrera P, Alonso-Domínguez JM, Bernal T, Colorado M, Sayas MJ, Algarra L, Vidriales MB, Rodríguez-Macías G, Vives S, Pérez-Encinas MM, López A, Noriega V, García-Fortes M, Ramos F, Rodríguez-Gutiérrez JI, Costilla-Barriga L, Labrador J, Boluda B, Rodríguez-Veiga R, Martínez-López J, Sanz MA, Montesinos P. Evolving treatment patterns and outcomes in older patients (≥60 years) with AML: changing everything to change nothing? Leukemia. 2020 Oct 19. doi: 10.1038/s41375-020-01058-4. Online ahead of print. PMID: 33077867
Macauda A, Giaccherini M, Sainz J, Gemignani F, Sgherza N, Sánchez-Maldonado JM, Gora-Tybor J, Martinez-Lopez J, Carreño-Tarragona G, Jerez A, Spadano R, Gołos A, Jurado M, Hernández-Mohedo F, Mazur G, Tavano F, Butrym A, Várkonyi J, Canzian F, Campa D. Do myeloproliferative neoplasms and multiple myeloma share the same genetic susceptibility loci?. Int J Cancer. 2020 Oct 10. doi: 10.1002/ijc.33337. PMID: 33038278
Lozano ML, Mingot-Castellano ME, Perera MM, Jarque I, Campos-Alvarez RM, González-López TJ, Carreño-Tarragona G, Bermejo N, Lopez-Fernandez MF, de Andrés A, Valcarcel D, Casado-Montero LF, Alvarez-Roman MT, Orts MI, Novelli S, González-Porras JR, Bolaños E, López-Ansoar E, Orna-Montero E, Vicente V. A decade of changes in management of immune thrombocytopenia, with special focus on elderly patients. Blood Cells Mol Dis. 2021 Feb;86:102505. doi: 10.1016/j.bcmd.2020.102505. Epub 2020 Sep 20. PMID: 32979651
Castrillo A, Arroyo JL, Romón Í, Rivera J Compliance with temperature and time requirements during in-hospital distribution of blood components: A national survey among transfusion services. Blood Component Production and Processing Working Group of the Spanish Society of Blood Transfusion and Cellular Therapy (SETS). Transfus Apher Sci. 2020 Dec;59(6):102908.. PMID: 32921561
Giaccherini M, Macauda A, Sgherza N, Sainz J, Gemignani F, Maldonado JMS, Jurado M, Tavano F, Mazur G, Jerez A, Góra-Tybor J, Gołos A, Mohedo FH, Lopez JM, Várkonyi J, Spadano R, Butrym A, Canzian F, Campa DFree Genetic polymorphisms associated with telomere length and risk of developing myeloproliferative neoplasms. Blood Cancer J. 2020 Sep 1;10(8):89. doi: 10.1038/s41408-020-00356-5. PMID: 32873778
Piñana JL, Xhaard A, Tridello G, Passweg J, Kozijn A, Polverelli N, Heras I, Perez A, Sanz J, Berghuis D, Vázquez L, Suárez-Lledó M, Itäla-Remes M, Ozcelik T, Iturrate Basarán I, Karakukcu M, Al Zahrani M, Choi G, Cuesta Casas MA, Batlle Massana M, Viviana A, Blijlevens N, Ganser A, Kuskonmaz B, Labussière-Wallet H, Shaw PJ, Arzu Yegin Z, González-Vicent M, Rocha V, Ferster A, Knelange N, Navarro D, Mikulska M, de la Camara R, Styczynski J. Seasonal human coronaviruses respiratory tract infection in recipients of allogeneic hematopoietic stem cell transplantation. Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation and Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH). J Infect Dis. 2020 Aug 29:jiaa553. doi: 10.1093/infdis/jiaa553. PMID: 32860509
Silvana Novelli , Alejandro Martín , Jose Javier Sánchez , Manuel Espeso , Anna Mozos , Javier Briones . Management experience of advanced-stage mycosis fungoides/Sézary syndrome: a retrospective study from Spanish haematology referral units. Eur J Dermatol . 2020 Aug 1;30(4):397-403. PMID: 32815814
Solano C, Vázquez L, Giménez E, de la Cámara R, Albert E, Rovira M, Espigado I, Calvo CM, López-Jiménez J, Suárez-Lledó M, Chinea A, Esquirol A, Pérez A, Bermúdez A, Saldaña R, Heras I, González-Huerta AJ, Torrado T, Bautista G, Batlle M, Jiménez S, Vallejo C, Barba P, Cuesta MÁ, Piñana JL, Navarro D. Cytomegalovirus DNAemia and risk of mortality in allogeneic hematopoietic stem cell transplantation: Analysis from the Spanish Hematopoietic Transplantation and Cell Therapy Group. Am J Transplant. 2020 Jun 17. doi: 10.1111/ajt.16147. PMID: 32812351
Rios SJ, Martínez-Montesinos L, Aroca C, Teruel-Montoya R, Ferrer-Marín F.. Successful ovarian stimulation and pregnancy in an infertile woman with chronic myeloid leukemia.. J Assist Reprod Genet. 2020 Oct;37(10):2473-2476. PMID: 32766925
Alvarez-Larrán A, Angona A, Andrade-Campos M, Soledad Noya M, Teresa Gómez-Casares M, Cuevas B, Caballero G, García-Hernández C, García-Gutiérrez V, Palomino A, Ferrer-Marín F, Isabel Mata-Vázquez M, Moretó A, Magro E, Murillo I, Manuel Alonso-Domínguez J, María Guerra J, Guerrero L, María Raya J, Pérez-Encinas M, Carreño-Tarragona G, Fox L, Pastor-Galán I, Bellosillo B, Hernández-Boluda JC; MPN Spanish Group (GEMFIN). Cytoreductive treatment in patients with CALR-mutated essential thrombocythaemia: a study comparing indications and efficacy among genotypes from the Spanish Registry of Essential Thrombocythaemia. Br J Haematol. 2020 Aug 3. doi: 10.1111/bjh.16988. PMID: 32745264
Hernández-Boluda JC, Pereira A, Alvarez-Larran A, Martín AA, Benzaquen A, Aguirre L, Mora E, González P, Mora J, Dorado N, Sampol A, García-Gutiérrez V, López-Godino O, Fox ML, Reguera JL, Pérez-Encinas M, Pascual MJ, Xicoy B, Parody R, González-Pinedo L, Español I, Avendaño A, Correa JG, Vallejo C, Jurado M, García-Cadenas I, Osorio S, Durán MA, Sánchez-Guijo F, Cervantes F, Piñana JL.. Predicting Survival after Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: Performance of the Myelofibrosis Transplant Scoring System (MTSS) and Development of a New Prognostic Model. Biol Blood Marrow Transplant. 2020 Dec;26(12):2237-2244. . PMID: 32717433
Ocio EM, Motlló C, Rodríguez-Otero P, Martínez-López J, Cejalvo MJ, Martín-Sánchez J, Bladé J, García-Malo MD, Dourdil MV, García-Mateo A, de Arriba F, García-Sanz R, de la Rubia J, Oriol A, Lahuerta JJ, San-Miguel JF, Mateos MV. Filanesib in combination with pomalidomide and dexamethasone in refractory MM patients: safety and efficacy, and association with alpha 1-acid glycoprotein (AAG) levels. Phase Ib/II Pomdefil clinical trial conducted by the Spanish MM group. Br J Haematol. 2020 Jun 5. doi: 10.1111/bjh.16788. PMID: 32501528
Kim D, Park G, Huuhtanen J, Lundgren S, Khajuria RK, Hurtado AM, Muñoz-Calleja C, Cardeñoso L, Gómez-García de Soria V, Chen-Liang TH, Eldfors S, Ellonen P, Hannula S, Kankainen M, Bruck O, Kreutzman A, Salmenniemi U, Lönnberg T, Jerez A, Itälä-Remes M, Myllymäki M, Keränen MAI, Mustjoki S. Somatic mTOR mutation in clonally expanded T lymphocytes associated with chronic graft versus host disease. Nat Commun. 2020;11(1):2246. PMID: 32382059
Ribera JM, García O, Chapchap EC, Gil C, González-Campos J, Barba P, Amigo ML, Moreno MJ, Lavilla E, Alonso N, Bergua JM, Tormo M, Ribera J, Sierra M, Martínez-Carballeira D, Mercadal S, Hernández-Rivas JM, Vall-Llovera F, Genescà E, Cladera A, Novo A, Abella E, García-Cadenas I, Monteserín C, Bermúdez A, Piernas S, Montesinos P, López JL, García-Guiñón A, Serrano A, Martínez MP, Olivares M, López A, Serrano J; PETHEMA Group, Spanish Society of Hematology. Treatment of Frail Older Adults and Elderly Patients With Philadelphia Chromosome-negative Acute Lymphoblastic Leukemia: Results of a Prospective Trial With Minimal Chemotherapy. Clin Lymphoma Myeloma Leuk. 2020 Apr 5:S2152-2650(20)30144-0. doi: 10.1016/j.clml.2020.03.011. PMID: 32336676
Fuster JL, Molinos-Quintana A, Fuentes C, Fernández JM, Velasco P, Pascual T, Rives S, Dapena JL, Sisinni L, López-Godino O, Palomo P, Villa-Alcázar M, Bautista F, González-Vicent M, López-Duarte M, García-Morín M, Ramos-Elbal E, Ramírez M; Leukemia Working Group of the Spanish Society of Pediatric Hematology, Oncology (SEHOP). Blinatumomab and inotuzumab for B cell precursor acute lymphoblastic leukaemia in children: a retrospective study from the Leukemia Working Group of the Spanish Society of Pediatric Hematology and Oncology (SEHOP). Br J Haematol. 2020 Apr 21. doi: 10.1111/bjh.16647. PMID: 32314348
Maia C, Puig N, Cedena MT, Goicoechea I, Valdes-Mas R, Vazquez I, Chillon MC, Aguirre P, Sarvide S, Gracia-Aznárez FJ, Alkorta G, Calasanz MJ, Garcia-Sanz R, Gonzalez M, Gutierrez NC, Martinez-Lopez J, Perez JJ, Merino J, Moreno C, Burgos L, Alignani D, Botta C, Prosper F, Matarraz S, Orfao A, Oriol A, Teruel AI, de Paz R, de Arriba F, Hernandez MT, Palomera L, Martinez R, Rosiñol L, Mateos MV, Lahuerta JJ, Blade J, San Miguel JF, Paiva B. Biological and clinical significance of dysplastic hematopoiesis in patients with newly diagnosed multiple myeloma. Blood. 2020 Jun 25;135(26):2375-2387. PMID: 32299093
Rodríguez-Medina C, Martínez-Cuadrón D, Cano I, Gil C, Tormo M, Del Pilar Martínez-Sánchez M, Del Castillo TB, Serrano-López J, Benavente C, Herrera-Puente P, García-Boyero R, Lavilla-Rubira E, Amigo ML, Sayas-Lloris M, Bergua-Burgues JM, Pérez-Simón JA, Rodríguez G, Espadana A, Vidriales-Vicente B, Fernández R, López-Lorenzo JL, López M, García-Fortes M, Labrador Gómez J, Colorado-Araujo M, Sossa-Melo CL, Aguilar E, Montesinos Fernández P. Performance of prognostic scoring systems in elderly patients with acute myeloid leukaemia on intensive chemotherapy: A PETHEMA registry study. Leuk Res. 2020 Mar 23;92:106352. doi: 10.1016/j.leukres.2020.106352. PMID: 32240863
Tarragona G, Barrio S, Enrique de la Puerta J, Ramirez-Payer A, Krsnik I, Bargay JJ, Lahuerta JJ, Mateos MV, San-Miguel JF, Paiva B, Lopez JM. Immunogenetic characterization of clonal plasma cells in systemic light-chain amyloidosis. Leukemia. 2020 Mar 19. doi: 10.1038/s41375-020-0800-6. PMID: 32203144
Díaz-Santa J, Rodríguez-Romanos R, Osca G, Pratcorona M, Garrido A, Coll R, Moret C, Escoda L, Tormo M, Heras I, Arnan M, Vives S, Salamero O, Lloveras N, Bargay J, Sampol A, Cruz D, Garcia A, Quiñones T, Esteve J, Sierra J, Gallardo D; on the behalf of CETLAM Group. UGT1A1 genotype influences clinical outcome in patients with intermediate-risk acute myeloid leukemia treated with cytarabine-based chemotherapy. Leukemia. 2020 Mar 9. doi: 10.1038/s41375-020-0784-2. PMID: 32152464
Ferrer-Marín F, Arroyo AB, Bellosillo B, Cuenca EJ, Zamora L, Hernández-Rivas JM, Hernández-Boluda JC, Fernandez-Rodriguez C, Luño E, García Hernandez C, Kerguelen A, Fiallo-Suárez DV, Gómez-Casares MT, Ayala R, Vélez P, Boqué C, García-Gutierrez V, Arrizabalaga B, Estrada N, Cifuentes R, Arcas I, de Los Reyes-García AM, Besses C, Vicente V, Alvarez-Larrán A, Teruel-Montoya R, González-Conejero R, Martínez C; GEMFIN Group. miR-146a rs2431697 identifies myeloproliferative neoplasm patients with higher secondary myelofibrosis progression risk. Leukemia. 2020 Feb 27. doi: 10.1038/s41375-020-0767-3. PMID: 32107471
Alvarez-Larrán A, Pereira A, Magaz M, Hernández-Boluda JC, Garrote M, Cuevas B, Ferrer-Marín F, Gómez-Casares MT, García-Gutiérrez V, Mata-Vázquez MI, Turon F, Hernandez-Gea V, Arellano-Rodrigo E, Cervantes F, García-Pagán JC; GEMFIN and REHEVASC groups. Natural history of polycythemia vera and essential thrombocythemia presenting with splanchnic vein thrombosis. Ann Hematol. 2020 Apr;99(4):791-798. doi: 10.1007/s00277-020-03965-z. PMID: 32086587
Suárez-González J, Triviño JC, Bautista G, García-Marco JA, Figuera Á, Balas A, Vicario JL, Ortuño FJ, Teruel R, Álamo JM, Carbonell D, Andrés-Zayas C, Dorado N, Rodríguez-Macías G, Kwon M, Díez-Martín JL, Martínez-Laperche C, Buño I; Spanish Group for Hematopoietic Transplantation (GETH). Exome sequencing reveals heterogeneous clonal dynamics in donor cell myeloid neoplasms after stem cell transplantation. Haematologica. 2020 Feb 20:haematol.2019.234609. doi: 10.3324/haematol.2019.234609. Online ahead of print. PMID: 32079696
Bastos-Oreiro M, Muntañola A, Panizo C, Gonzalez-Barca E, de Villambrosia SG, Córdoba R, López JLB, González-Sierra P, Terol MJ, Gutierrez A, Grande C, Ramirez MJ, Iserte L, Perez E, Navarro B, Gomez P, Salar A, Luzardo H, López A, Del Campo R, García-Belmonte D, Vida MJ, Infante M, Queizan-Hernandez JA, Novelli S, Moreno M, Penarrubia M, Gómez J, Domingo A, Donato E, Viguria MC, López F, Rodriguez MJ, Pardal E, Noriega V, Andreu R, Peñalver J, Martín A, Caballero D, López-Guillermo A. RELINF: prospective epidemiological registry of lymphoid neoplasms in Spain. A project from the GELTAMO group. Ann Hematol. 2020 Apr;99(4):799-808. PMID: 32076827
Martínez C, Carpio C, Heras I, Ríos-Herranz E, Buch J, Gutierrez A, Romero S, Zeberio I, García-García I, Rodriguez-Izquierdo A, Alonso R, Bargay J, Barrenetxea C, Domingo-Doménech E, de Haro ME, Palomera L, García-Sanz R; Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO). Potential Survival Benefit for Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation after Nivolumab Therapy for Relapse/Refractory Hodgkin Lymphoma: Real-Life Experience in Spain. Biol Blood Marrow Transplant. 2020 Feb 14:S1083-8791(20)30087-2. doi: 10.1016/j.bbmt.2020.02.003. PMID: 32068094
Ribera JM, Morgades M, Montesinos P, Tormo M, Martínez-Carballeira D, González-Campos J, Gil C, Barba P, García-Boyero R, Coll R, Pedreño M, Ribera J, Mercadal S, Vives S, Novo A, Genescà E, Hernández-Rivas JM, Bergua J, Amigo ML, Vall-Llovera F, Martínez-Sánchez P, Calbacho M, García-Cadenas I, Garcia-Guiñon A, Sánchez-Sánchez MJ, Cervera M, Feliu E, Orfao A; PETHEMA Group, Spanish Society of Hematology. A pediatric regimen for adolescents and young adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: Results of the ALLRE08 PETHEMA trial. Cancer Med. 2020 Apr;9(7):2317-2329. PMID: 32022463
Pastor-Galán I, Hernández-Boluda JC, Correa JG, Alvarez-Larrán A, Ferrer-Marín F, Raya JM, Ayala R, Velez P, Pérez-Encinas M, Estrada N, García-Gutiérrez V, Fox ML, Payer A, Kerguelen A, Cuevas B, Durán MA, Ramírez MJ, Gómez-Casares MT, Mata-Vázquez MI, Mora E, Martínez-Valverde C, Arbelo E, Angona A, Magro E, Antelo ML, Somolinos N, Cervantes F; en representación del Grupo Español de Enfermedades Mieloproliferativas Filadelfia Negativas (GEMFIN). Clinico-biological characteristics of patients with myelofibrosis: an analysis of 1,000 cases from the Spanish Registry of Myelofibrosis. Med Clin (Barc). 2020 Jan 21:S0025-7753(19)30716-X. doi: 10.1016/j.medcli.2019.11.007. PMID: 31980217
Oarbeascoa G, Lozano ML, Guerra LM, Amunarriz C, Saavedra CA, Garcia-Gala JM, Viejo A, Revilla N, Acosta Fleitas C, Arroyo JL, Martinez Revuelta E, Galego A, Hernandez-Maraver D, Kwon M, Diez-Martin JL, Pascual C; Grupo Español de Aféresis – Spanish Apheresis Group. Retrospective Multicenter Study of Extracorporeal Photopheresis in Steroid-Refractory Acute and Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2020 Apr;26(4):651-658. PMID: 31917270
Bravo-Perez C, Pajares I, Muiña B, Escobar H, Amigo ML, Garcia-Malo MD, Garcia J, Rodriguez-Pinilla SM, Piris MA, Ortuño FJ. Double hit B cell precursor leukemia/lymphoma in a patient with a prior diagnosis of follicular lymphoma: a diagnostic and therapeutic dilemma. Ann Hematol. 2020 Feb;99(2):391-393. doi: 10.1007/s00277-019-03897-3. Epub 2019 Dec 20. PMID: 31858188
Genescà E, Morgades M, Montesinos P, Barba P, Gil C, Guàrdia R, Moreno MJ, Martínez-Carballeira D, García-Cadenas I, Vives S, Ribera J, González-Campos J, González-Gil C, Zamora L, Ramírez JL, Díaz-Beya M, Mercadal S, Artola MT, Cladera A, Tormo M, Bermúdez A, Vall-Llovera F, Martínez P, Amigo ML, Monsalvo S, Novo A, Cervera M, García-Guiñon A, Juncà J, Ciudad J, Orfao A, Ribera JM. Unique clinico-biological, genetic and prognostic features of adult early T-cell precursor acute lymphoblastic leukemia. Haematologica. 2020 Jun;105(6):e294-e297. PMID: 31537688
Gonzalez-Rodriguez AP, Lopez-Corral L, Fajardo DFM, Gonzalez-Huerta AJ, Palomo P, Bermudez A, Ripa TZ, Santos-Diaz P, Gonzalez-Muñiz S, Zanabilli J, Ubieto AJ, de Arriba F, Arnao-Herraiz M, Sordo-Bahamonde C, López-Soto A, Gonzalez S, Rosiñol L, Mateos MV. Daratumumab is a safe and effective rescue therapy for multiple myeloma patients who relapse after allo-HSCT. Bone Marrow Transplant. 2020 Feb;55(2):461-463. doi: 10.1038/s41409-019-0525-1. PMID: 30988379
Garabet L, Ghanima W, Rangberg A, Teruel-Montoya R, Martinez C, Lozano ML, Nystrand CF, Bussel JB, Sandset PM, Jonassen CM. Circulating microRNAs in patients with immune thrombocytopenia before and after treatment with thrombopoietin-receptor agonists. Platelets. 2020;31(2):198-205. PMID: 30885035
Bravo-Pérez C, de la Morena-Barrio ME, Palomo A, Entrena L, de la Morena-Barrio B, Padilla J, Miñano A, Navarro E, Cifuentes R, Corral J, Vicente V. Genotype-phenotype gradient of SERPINC1 variants in a single family reveals a severe compound antithrombin deficiency in a dead embryo. Br J Haematol. 2020 Jul 19. doi: 10.1111/bjh.16963. Online ahead of print. PMID: 32686144
Rivera-Caravaca JM, Esteve-Pastor MA, Camelo-Castillo A, Ramírez-Macías I, Lip GYH, Roldán V, Marín F. Treatment strategies for patients with atrial fibrillation and anticoagulant-associated intracranial hemorrhage: an overview of the pharmacotherapy. Expert Opin Pharmacother. 2020 Jul 13:1-15. doi: 10.1080/14656566.2020.1789099. PMID: 32658596
Arroyo AB, Fernández-Pérez MP, Del Monte A, Águila S, Méndez R, Hernández-Antolín R, García-Barber N, de Los Reyes-García AM, González-Jiménez P, Arcas MI, Vicente V, Menéndez R, Andrés V, González-Conejero R, Martínez C. miR-146a is a pivotal regulator of neutrophil extracellular trap formation promoting thrombosis. Haematologica. 2020 Jun 25:haematol.2019.240226. doi: 10.3324/haematol.2019.240226. PMID: 32586906
Palma-Barqueros V, Bohdan N, Revilla N, Vicente V, Bastida JM, Rivera J. PTGS1 gene variations associated with bleeding and platelet dysfunction. Platelets. 2020 Jun 25:1-7. doi: 10.1080/09537104.2020.1782370. PMID: 32584621
Bastida JM, Benito R, González-Porras JR, Rivera J. ABCG5 and ABCG8 gene variations associated with sitosterolemia and platelet dysfunction. Platelets. 2020 Jun 16:1-5. doi: 10.1080/09537104.2020.1779926. PMID: 32546081
de la Morena-Barrio ME, Sabater M, de la Morena-Barrio B, Ruhaak RL, Miñano A, Padilla J, Toderici M, Roldán V, Gimeno JR, Vicente V, Corral J. ALG12-CDG: An unusual patient without intellectual disability and facial dysmorphism, and with a novel variant. Mol Genet Genomic Med. 2020 Jun 12:e1304. doi: 10.1002/mgg3.1304. PMID: 32530140
Camelo-Castillo A, Rivera-Caravaca JM, Marín F, Vicente V, Lip GYH, Roldán V. Predicting Adverse Events beyond Stroke and Bleeding with the ABC-Stroke and ABC-Bleeding Scores in Patients with Atrial Fibrillation: The Murcia AF Project. Thromb Haemost. 2020 Jun 7. doi: 10.1055/s-0040-1712914. PMID: 32506417
Vivas D, Roldán V, Esteve-Pastor MA, Roldán I, Tello-Montoliu A, Ruiz-Nodar JM, Cosín-Sales J, María Gámez J, Consuegra L, Luis Ferreiro J, Marín F, Arrarte V, Anguita M, Cequier Á, Pérez-Villacastín J. Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology. Rev Esp Cardiol. 2020 Apr 22. doi: 10.1016/j.recesp.2020.04.006. PMID: 32327870
Roldán Rabadán I, Esteve-Pastor MA, Anguita Sánchez M, Muñiz J, Ruiz Ortiz M, Marín F, Roldán V, Quesada MA, Camacho Siles J, Cequier Fillat A, Bertomeu Martinez V, Martínez Sellés M, Badimón L; FANTASIIA Study Investigators. Influence of sex on long-term prognosis in patients with atrial fibrillation treated with oral anticoagulants. Results from the prospective, nationwide FANTASIIA study. Eur J Intern Med. 2020 Apr 14:S0953-6205(20)30118-7. doi: 10.1016/j.ejim.2020.04.012. PMID: 32303456
Bauduer F, de la Morena-Barrio ME, Salloum-Asfar S, de la Morena-Barrio B, Padilla J, Miñano A, Vicente V, Carbonell P, Corral J, Esteban J. When genetic and surname analyses meet historical sources: The C56R mutation associated with factor XI deficiency as a marker of human migration during the Spanish Reconquista. Med Hypotheses. 2020 Aug;141:109709. doi: 10.1016/j.mehy.2020.109709. PMID: 32278893
Baiges A, de la Morena-Barrio ME, Turon F, Miñano A, Alberto Ferrusquía J, Magaz M, Reverter JC, Vicente V, Hernández-Gea V, Corral J, García-Pagán JC. Congenital antithrombin deficiency in patients with splanchnic vein thrombosis. Liver Int. 2020 May;40(5):1168-1177. doi: 10.1111/liv.14342. PMID: 31885188
Garabet L, Henriksson CE, Lozano ML, Ghanima W, Bussel J, Brodin E, Fernández-Pérez MP, Martínez C, González-Conejero R, Mowinckel MC, Sandset PM. Markers of endothelial cell activation and neutrophil extracellular traps are elevated in immune thrombocytopenia but are not enhanced by thrombopoietin receptor agonists. Thromb Res. 2020 Jan;185:119-124. doi: 10.1016/j.thromres.2019.11.031. PMID: 31805421
Palma-Barqueros V, Torregrosa JM, Caparrós-Pérez E, Mota-Pérez N, Bohdan N, Llanos MDC, Begonja AJ, Sola-Visner M, Vicente V, Teruel-Montoya R, Rivera J, Ferrer-Marín F. Developmental Differences in Platelet Inhibition Response to Prostaglandin E1. Neonatology. 2020;117(1):15-23. PMID: 31786577
Paciullo F, Bury L, Noris P, Falcinelli E, Melazzini F, Orsini S, Zaninetti C, Abdul-Kadir R, Obeng-Tuudah D, Heller PG, Glembotsky AC, Fabris F, Rivera J, Lozano ML, Butta N, Favier R, Cid AR, Fouassier M, Podda GM, Santoro C, Grandone E, Henskens Y, Nurden P, Zieger B, Cuker A, Devreese K, Tosetto A, De Candia E, Dupuis A, Miyazaki K, Othman M, Gresele P. Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study. Haematologica. 2020 Jul;105(7):1948-1956. PMID: 31558677
Palma-Barqueros V, Crescente M, de la Morena ME, Chan MV, Almarza E, Revilla N, Bohdan N, Miñano A, Padilla J, Allan HE, Maffucci T, Edin ML, Zeldin DC, Mesa-Nuñez C, Damian C, Marín-Quilez A, Benito R, Martínez-Martínez I, Bermejo N, Casas-Aviles I, Alen AR, González-Porras JR, Hernández-Rivas JM, Vicente V, Corral J, Lozano ML, Warner TD, Bastida JM, Rivera J. A novel genetic variant in PTGS1 affects N-glycosylation of cyclooxygenase-1 causing a dominant-negative effect. Am J Hematol. 2020 Dec 16. doi: 10.1002/ajh.26076. Online ahead of print. PMID: 33326144
Rivera-Caravaca JM, Teruel-Montoya R, Roldán V, Cifuentes-Riquelme R, Crespo-Matas JA, de Los Reyes-García AM, Águila S, Fernández-Pérez MP, Reguilón-Gallego L, Zapata-Martínez L, García-Barberá N, Vicente V, Marín F, Martínez C, González-Conejero R. Pilot Study on the Role of Circulating miRNAs for the Improvement of the Predictive Ability of the 2MACE Score in Patients with Atrial Fibrillation. J Clin Med. 2020 Nov 12;9(11):3645. PMID: 33198388
Rivera-Caravaca JM, Roldán V, Vicente V, Lip GYH, Marín F. Particulate Matter and Temperature: Increased Risk of Adverse Clinical Outcomes in Patients With Atrial Fibrillation Mayo Clin Proc. 2020 Nov;95(11):2360-2369. PMID: 33153628 Corvillo F, de la Morena-Barrio ME, Marcos-Bravo C, López-Trascasa M, Vicente V, Emsley J, Caballero T, Corral J, López-Lera A. The FXII c.-4T>C Polymorphism as a Disease Modifier in Patients With Hereditary Angioedema Due to the FXII p.Thr328Lys Variant. Front Genet. 2020 Sep 10;11:1033. doi: 10.3389/fgene.2020.01033. eCollection 2020. PMID: 33133137
López-Gálvez R, de la Morena-Barrio ME, López-Lera A, Pathak M, Miñano A, Serrano M, Borgel D, Roldán V, Vicente V, Emsley J, Corral J. Factor XII in PMM2-CDG patients: role of N-glycosylation in the secretion and function of the first element of the contact pathway Orphanet J Rare Dis. 2020 Oct 9;15(1):280. PMID: 33036649
de la Morena-Barrio ME. Commentary on Acquired Factor XI Deficiency during SARS-CoV-2 Infection: Not Only Thrombosis. TH Open. 2020 Sep 13;4(3):e231-e232. doi: 10.1055/s-0040-1716839. eCollection 2020 Jul. PubMed PMID: 32939440
Orlando C, de la Morena-Barrio B, Pareyn I, Vanhoorelbeke K, Martínez-Martínez I, Vicente V, Corral J, Jochmans K, de la Morena-Barrio ME. Antithrombin p.Thr147Ala: The First Founder Mutation in People of African Origin Responsible for Inherited Antithrombin Deficiency. Thromb Haemost. 2020 Sep 13. doi: 10.1055/s-0040-1716531. PMID: 32920809
Rivera-Caravaca JM, Vílchez JA, Rodríguez-Rojas C, Albadalejo-Otón MD, Gil-Pérez P, Lopez-García C, Veliz-Martínez A, Roldán V, Marín F. Influence of the matrix type over the concentration of GDF-15. J Investig Med. 2020 Dec;68(8):1402-1404. PMID: 32907909
Squizzato A, Gallo A, Levi M, Iba T, Levy JH, Erez O, Ten Cate H, Solh Z, Gando S, Vicente V, Di Nisio M. Underlying disorders of disseminated intravascular coagulation: Communication from the ISTH SSC Subcommittees on Disseminated Intravascular Coagulation and Perioperative and Critical Care Thrombosis and Hemostasis. J Thromb Haemost. 2020 Sep;18(9):2400-2407. PMID: 32881338
Rivera-Caravaca JM, Gil-Perez P, Lopez-García C, Veliz-Martínez A, Quintana-Giner M, Romero-Aniorte AI, Fernandez-Redondo C, Muñoz L, Quero E, Esteve-Pastor MA, Lip GYH, Roldán V, Marín F.. A nurse-led atrial fibrillation clinic: Impact on anticoagulation therapy and clinical outcomes. Int J Clin Pract. 2020 Dec;74(12):e13634. doi: 10.1111/ijcp.13634. Epub 2020 Aug 25.. PMID: 32745337
Bravo-Pérez C, de la Morena-Barrio ME, Palomo A, Entrena L, de la Morena-Barrio B, Padilla J, Miñano A, Navarro E, Cifuentes R, Corral J, Vicente V. Genotype-phenotype gradient of SERPINC1 variants in a single family reveals a severe compound antithrombin deficiency in a dead embryo. Br J Haematol. 2020 Jul 19. doi: 10.1111/bjh.16963. Online ahead of print. PMID: 32686144
Rivera-Caravaca JM, Esteve-Pastor MA, Camelo-Castillo A, Ramírez-Macías I, Lip GYH, Roldán V, Marín F. Treatment strategies for patients with atrial fibrillation and anticoagulant-associated intracranial hemorrhage: an overview of the pharmacotherapy. Expert Opin Pharmacother. 2020 Jul 13:1-15. doi: 10.1080/14656566.2020.1789099. PMID: 32658596
Arroyo AB, Fernández-Pérez MP, Del Monte A, Águila S, Méndez R, Hernández-Antolín R, García-Barber N, de Los Reyes-García AM, González-Jiménez P, Arcas MI, Vicente V, Menéndez R, Andrés V, González-Conejero R, Martínez C. miR-146a is a pivotal regulator of neutrophil extracellular trap formation promoting thrombosis. Haematologica. 2020 Jun 25:haematol.2019.240226. doi: 10.3324/haematol.2019.240226. PMID: 32586906
Palma-Barqueros V, Bohdan N, Revilla N, Vicente V, Bastida JM, Rivera J. PTGS1 gene variations associated with bleeding and platelet dysfunction. Platelets. 2020 Jun 25:1-7. doi: 10.1080/09537104.2020.1782370. PMID: 32584621
Bastida JM, Benito R, González-Porras JR, Rivera J. ABCG5 and ABCG8 gene variations associated with sitosterolemia and platelet dysfunction. Platelets. 2020 Jun 16:1-5. doi: 10.1080/09537104.2020.1779926. PMID: 32546081
de la Morena-Barrio ME, Sabater M, de la Morena-Barrio B, Ruhaak RL, Miñano A, Padilla J, Toderici M, Roldán V, Gimeno JR, Vicente V, Corral J. ALG12-CDG: An unusual patient without intellectual disability and facial dysmorphism, and with a novel variant. Mol Genet Genomic Med. 2020 Jun 12:e1304. doi: 10.1002/mgg3.1304. PMID: 32530140
Camelo-Castillo A, Rivera-Caravaca JM, Marín F, Vicente V, Lip GYH, Roldán V. Predicting Adverse Events beyond Stroke and Bleeding with the ABC-Stroke and ABC-Bleeding Scores in Patients with Atrial Fibrillation: The Murcia AF Project. Thromb Haemost. 2020 Jun 7. doi: 10.1055/s-0040-1712914. PMID: 32506417
Vivas D, Roldán V, Esteve-Pastor MA, Roldán I, Tello-Montoliu A, Ruiz-Nodar JM, Cosín-Sales J, María Gámez J, Consuegra L, Luis Ferreiro J, Marín F, Arrarte V, Anguita M, Cequier Á, Pérez-Villacastín J. Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology. Rev Esp Cardiol. 2020 Apr 22. doi: 10.1016/j.recesp.2020.04.006. PMID: 32327870
Roldán Rabadán I, Esteve-Pastor MA, Anguita Sánchez M, Muñiz J, Ruiz Ortiz M, Marín F, Roldán V, Quesada MA, Camacho Siles J, Cequier Fillat A, Bertomeu Martinez V, Martínez Sellés M, Badimón L; FANTASIIA Study Investigators. Influence of sex on long-term prognosis in patients with atrial fibrillation treated with oral anticoagulants. Results from the prospective, nationwide FANTASIIA study. Eur J Intern Med. 2020 Apr 14:S0953-6205(20)30118-7. doi: 10.1016/j.ejim.2020.04.012. PMID: 32303456
Bauduer F, de la Morena-Barrio ME, Salloum-Asfar S, de la Morena-Barrio B, Padilla J, Miñano A, Vicente V, Carbonell P, Corral J, Esteban J. When genetic and surname analyses meet historical sources: The C56R mutation associated with factor XI deficiency as a marker of human migration during the Spanish Reconquista. Med Hypotheses. 2020 Aug;141:109709. doi: 10.1016/j.mehy.2020.109709. PMID: 32278893
Baiges A, de la Morena-Barrio ME, Turon F, Miñano A, Alberto Ferrusquía J, Magaz M, Reverter JC, Vicente V, Hernández-Gea V, Corral J, García-Pagán JC. Congenital antithrombin deficiency in patients with splanchnic vein thrombosis. Liver Int. 2020 May;40(5):1168-1177. doi: 10.1111/liv.14342. PMID: 31885188
Garabet L, Henriksson CE, Lozano ML, Ghanima W, Bussel J, Brodin E, Fernández-Pérez MP, Martínez C, González-Conejero R, Mowinckel MC, Sandset PM. Markers of endothelial cell activation and neutrophil extracellular traps are elevated in immune thrombocytopenia but are not enhanced by thrombopoietin receptor agonists. Thromb Res. 2020 Jan;185:119-124. doi: 10.1016/j.thromres.2019.11.031. PMID: 31805421
Palma-Barqueros V, Torregrosa JM, Caparrós-Pérez E, Mota-Pérez N, Bohdan N, Llanos MDC, Begonja AJ, Sola-Visner M, Vicente V, Teruel-Montoya R, Rivera J, Ferrer-Marín F. Developmental Differences in Platelet Inhibition Response to Prostaglandin E1. Neonatology. 2020;117(1):15-23. PMID: 31786577
Lozano ML, Garabet L, Fernandez-Perez MP, De Los Reyes-García AM, Diaz-Lozano P, Garcia-Barbera N, Aguila S, Vicente V, Ghanima W, Martinez C, Gonzalez-Conejero R. Platelet activation and neutrophil extracellular trap (NET) formation in immune thrombocytopenia: is there an association? Platelets. 2020 Oct 2;31(7):906-912. PMID: 31762368.
Paciullo F, Bury L, Noris P, Falcinelli E, Melazzini F, Orsini S, Zaninetti C, Abdul-Kadir R, Obeng-Tuudah D, Heller PG, Glembotsky AC, Fabris F, Rivera J, Lozano ML, Butta N, Favier R, Cid AR, Fouassier M, Podda GM, Santoro C, Grandone E, Henskens Y, Nurden P, Zieger B, Cuker A, Devreese K, Tosetto A, De Candia E, Dupuis A, Miyazaki K, Othman M, Gresele P. Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study. Haematologica. 2020 Jul;105(7):1948-1956. PMID: 31558677
Caballero JC, Sánchez Barba M, Hernández Sánchez JM, Such E, Janusz K, Sanz G, Cabrero M, Chillón C, Cervera J, Hurtado AM, Jerez A, Calderón Cabrera C, Valcárcel D, Lumbreras E, Abáigar M, López Cadenas F, Hernández Rivas JM, Del Cañizo MC, Díez Campelo M. Chronic graft-versus-host disease could ameliorate the impact of adverse somatic mutations in patients with myelodysplastic syndromes and hematopoietic stem cell transplantation. Ann Hematol. 2019 Jul 16. doi: 10.1007/s00277-019-03751-6. [Epub ahead of print] PMID:31312927
Pertesi M, Vallée M, Wei X, Revuelta MV, Galia P, Demangel D, Oliver J, Foll M, Chen S, Perrial E, Garderet L, Corre J, Leleu X, Boyle EM, Decaux O, Rodon P, Kolb B, Slama B, Mineur P, Voog E, Le Bris C, Fontan J, Maigre M, Beaumont M, Azais I, Sobol H, Vignon M, Royer B, Perrot A, Fuzibet JG, Dorvaux V, Anglaret B, Cony-Makhoul P, Berthou C, Desquesnes F, Pegourie B, Leyvraz S, Mosser L, Frenkiel N, Augeul-Meunier K, Leduc I, Leyronnas C, Voillat L, Casassus P, Mathiot C, Cheron N, Paubelle E, Moreau P, Bignon YJ, Joly B, Bourquard P, Caillot D, Naman H, Rigaudeau S, Marit G, Macro M, Lambrecht I, Cliquennois M, Vincent L, Helias P, Avet-Loiseau H, Moreno V, Reis RM, Varkonyi J, Kruszewski M, Vangsted AJ, Jurczyszyn A, Zaucha JM, Sainz J, Krawczyk-Kulis M, Wątek M, Pelosini M, Iskierka-Jażdżewska E, Grząśko N, Martinez-Lopez J, Jerez A, Campa D, Buda G, Lesueur F, Dudziński M, García-Sanz R, Nagler A, Rymko M, Jamroziak K, Butrym A, Canzian F, Obazee O, Nilsson B, Klein RJ, Lipkin SM, McKay JD, Dumontet C. Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma. Leukemia. 2019 Apr 9. doi: 10.1038/s41375-019-0452-6. PMID: 30967618
Campa D, Martino A, Macauda A, Dudziński M, Suska A, Druzd-Sitek A, Raab MS, Moreno V, Huhn S, Butrym A, Sainz J, Szombath G, Rymko M, Marques H, Lesueur F, Vangsted AJ, Vogel U, Kruszewski M, Subocz E, Buda G, Iskierka-Jażdżewska E, Ríos R, Merz M, Schöttker B, Mazur G, Perrial E, Martinez-Lopez J, Butterbach K, García Sanz R, Goldschmidt H, Brenner H, Jamroziak K, Reis RM, Kadar K, Dumontet C, Wątek M, Haastrup EK, Helbig G, Jurczyszyn A, Jerez A, Varkonyi J, Barington T, Grzasko N, Zaucha JM, Andersen V, Zawirska D, Canzian F. Leuk Lymphoma. 2019 Jul;60(7):1803-1811. doi: 10.1080/10428194.2018.1551536. Epub 2019 Jan 11. PMID: 30633655
Fernández-Caballero M, Salmerón D, Dolores Chirlaque M, Chen-Liang TH, Hurtado AM, García Malo MD, Ortuño FJ, Roldán V, Vicente V, Jerez A, De Arriba F. Eur J Clin Invest. 2019 Feb;49(2):e13050. doi: 10.1111/eci.13050. Epub 2018 Dec 7.PMID: 30422316
López-Corral L, Caballero-Velázquez T, López-Godino O, Rosiñol L, Pérez-Vicente S, Fernandez-Avilés F, Krsnik I, Morillo D, Heras I, Morgades M, Rifon JJ, Sampol A, Iniesta F, Ocio EM, Martin J, Rovira M, Cabero M, Castilla-Llorente C, Ribera JM, Torres-Juan M, Moraleda JM, Martinez C, Vázquez A, Gutierrez G, Caballero D, San Miguel JF, Mateos MV, Pérez-Simón JA. Response to Novel Drugs before and after Allogeneic Stem Cell Transplantation in Patients with Relapsed Multiple Myeloma. Biol Blood Marrow Transplant. 2019 May 3. pii: S1083-8791(19)30282-4. doi: 10.1016/j.bbmt.2019.04.026. [Epub ahead of print] PMID: 31054983
Carrillo-Cruz E, García-Lozano JR, Márquez-Malaver FJ, Sánchez-Guijo FM, Montero Cuadrado I, Ferra I Coll C, Valcárcel D, López-Godino O, Cuesta M, Parody R, López-Corral L, Alcoceba M, Caballero-Velázquez T, Rodríguez-Gil A, Bejarano-García JA, Ramos TL, Pérez-Simón JA. Vitamin D Modifies the Incidence of Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation Depending on the Vitamin D Receptor (VDR) Polymorphisms. Clin Cancer Res. 2019 Aug 1;25(15):4616-4623. doi: 10.1158/1078-0432.CCR-18-3875. Epub 2019 May 1. PMID: 31043390
Bastida JM, López-Godino O, Vicente-Sánchez A, Bonanad-Boix S, Xicoy-Cirici B, Hernández-Sánchez JM, Such E, Cervera J, Caballero-Berrocal JC, López-Cadenas F, Arnao-Herráiz M, Rodríguez I, Llopis-Calatayud I, Jiménez MJ, Del Cañizo-Roldán MC, Díez-Campelo M. Hidden myelodysplastic syndrome (MDS): A prospective study to confirm or exclude MDS in patients with anemia of uncertain etiology. Int J Lab Hematol. 2019 Feb;41(1):109-117. doi: 10.1111/ijlh.12933. Epub 2018 Oct 5. PMID: 30290085
Ribera JM, García O, Moreno MJ, Barba P, García-Cadenas I, Mercadal S, Montesinos P, Barrios M, González-Campos J, Martínez-Carballeira D, Gil C, Ribera J, Vives S, Novo A, Cervera M, Serrano J, Lavilla E, Abella E, Tormo M, Amigo ML, Artola MT, Genescà E, Bravo P, García-Belmonte D, García-Guiñón A, Hernández-Rivas JM, Feliu E; PETHEMA Group of the Spanish Society of Hematology. Incidence and outcome after first molecular versus overt recurrence in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia included in the ALL Ph08 trial from the Spanish PETHEMA Group. Cancer. 2019 Aug 15;125(16):2810-2817. doi: 10.1002/cncr.32156. Epub 2019 Apr 23. PMID: 31012967
Patel RM, Josephson CD, Shenvi N, Maheshwari A, Easley KA, Stowell S, Sola-Visner M, Ferrer-Marin F. Platelet transfusions and mortality in necrotizing enterocolitis. Transfusion. 2019 Mar;59(3):981-988. doi: 10.1111/trf.15112. Epub 2018 Dec 30. PMID: 30597571
Hernández-Boluda JC, Pereira A, Pastor-Galán I, Alvarez-Larrán A, Savchuk A, Puerta JM, Sánchez-Pina JM, Collado R, Díaz-González A, Angona A, Sagüés M, García-Gutiérrez V, Boqué C, Osorio S, Vallansot R, Palomera L, Mendizábal A, Casado LF, Pérez-Encinas M, Pérez-López R, Ferrer-Marín F, Sánchez-Guijo F, García C, Heras NL, López-Lorenzo JL, Cervantes F, Steegmann JL; Grupo Español de Leucemia Mieloide Crónica (GELMC). Feasibility of treatment discontinuation in chronic myeloid leukemia in clinical practice: results from a nationwide series of 236 patients. Blood Cancer J. 2018 Dec 2;8(10):91. doi: 10.1038/s41408-018-0125-0. PMID: 30504932
Gonzalez-Rodriguez AP, Lopez-Corral L, Fajardo DFM, Gonzalez-Huerta AJ, Palomo P, Bermudez A, Ripa TZ, Santos-Diaz P, Gonzalez-Muñiz S, Zanabilli J, Ubieto AJ, de Arriba F, Arnao-Herraiz M, Sordo-Bahamonde C, López-Soto A, Gonzalez S, Rosiñol L, Mateos MV. Daratumumab is a safe and effective rescue therapy for multiple myeloma patients who relapse after allo-HSCT. Bone Marrow Transplant. 2019 Apr 15. doi: 10.1038/s41409-019-0525-1. [Epub ahead of print] PMID: 30988379
Rodríguez-Otero P, Mateos MV, Martínez-López J, Hernández MT, Ocio EM, Rosiñol L, Martínez R, Teruel AI, Gutiérrez NC, Bargay J, Bengoechea E, González Y, de Oteyza JP, Gironella M, Nuñez-Córdoba JM, Encinas C, Martín J, Cabrera C, Palomera L, de Arriba F, Cedena MT, Puig N, Oriol A, Paiva B, Bladé J, Lahuerta JJ, San Miguel JF. Predicting long-term disease control in transplant-ineligible patients with multiple myeloma: impact of an MGUS-like signature. Blood Cancer J. 2019 Mar 18;9(4):36. doi: 10.1038/s41408-019-0176-x. PMID: 30886139
Rodríguez-Otero P, Mateos MV, Martínez-López J, Martín-Calvo N, Hernández MT, Ocio EM, Rosiñol L, Martínez R, Teruel AI, Gutiérrez NC, Bargay J, Bengoechea E, González Y, de Oteyza JP, Gironella M, Encinas C, Martín J, Cabrera C, Palomera L, de Arriba F, Cedena MT, Paiva B, Puig N, Oriol A, Bladé J, Lahuerta JJ, Miguel JFS. Correction: Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability role. Leukemia. 2019 Apr;33(4):1056. doi: 10.1038/s41375-019-0408-x. PMID: 30846864
Puig N, Paiva B, Lasa M, Burgos L, Perez JJ, Merino J, Moreno C, Vidriales MB, Toboso DG, Cedena MT, Ocio EM, Lecumberri R, García de Coca A, Labrador J, Gonzalez ME, Palomera L, Gironella M, Cabañas V, Casanova M, Oriol A, Krsnik I, Pérez-Montaña A, de la Rubia J, de la Puerta JE, de Arriba F, Prosper F, Martinez-Lopez J, Lecrevisse Q, Verde J, Mateos MV, Lahuerta JJ, Orfao A, San Miguel JF. Flow cytometry for fast screening and automated risk assessment in systemic light-chain amyloidosis. Leukemia. 2019 May;33(5):1256-1267. doi: 10.1038/s41375-018-0308-5. Epub 2018 Dec 12. PMID: 30542145
Curran D, Matthews S, Rowley SD, Young JH, Bastidas A, Anagnostopoulos A, Barista I, Chandrasekar PH, Dickinson M, Idrissi ME, Heras I, Milliken ST, Coll JM, Matilla MBN, Oostvogels L, Piątkowska-Jakubas B, Quiel D, Sabry W, Schwartz S, Selleslag DLD, Sullivan KM, Theunissen K, Yegin ZA, Yeh SP, Zaja F, Szer J; ZOE-HSCT Study group collaborators. Recombinant zoster vaccine significantly reduces the impact on quality of life caused by herpes zoster in adult autologous hematopoietic stem cell transplant recipients: a randomized placebo-controlled trial (ZOE-HSCT). Biol Blood Marrow Transplant. 2019 Aug 5. pii: S1083-8791(19)30508-7. doi: 10.1016/j.bbmt.2019.07.036. PMID: 31394276
García-Cadenas I, Yáñez L, Jarque I, Martino R, Pérez-Simón JA, Valcárcel D, Sanz J, Bermúdez A, Muñoz C, Calderón-Cabrera C, García E, Alonso L, Suárez-Lledó M, González Vicent M, Heras I, Viguria MC, Batlle M, Vázquez L, López J, Solano C; Spanish group of blood and marrow transplantation (GETH). Frequency, characteristics, and outcome of PTLD after allo-SCT: A multicenter study from the Spanish group of blood and marrow transplantation (GETH). Eur J Haematol. 2019 Jun;102(6):465-471. doi: 10.1111/ejh.13226. Epub 2019 Apr 10. PMID: 30828868
Jiménez-Ubieto A, Grande C, Caballero D, Yáñez L, Novelli S, Hernández-Garcia MT, Manzanares M, Arranz R, Ferreiro JJ, Bobillo S, Mercadal S, Galeo A, Jiménez JL, Moraleda JM, Vallejo C, Albo C, Pérez E, Marrero C, Magnano L, Palomera L, Jarque I, Rodriguez A, Lorza L, Martín A, Coria E, López-Guillermo A, Salar A, José Lahuerta J; GELTAMO (Grupo Español de Linfomas y Trasplantes de Médula Ósea) Cooperative Study Group. Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure without the need for immunotherapy. Hematol Oncol Stem Cell Ther. 2019 Jul 9. pii: S1658-3876(19)30052-4. doi: 10.1016/j.hemonc.2019.06.001. [Epub ahead of print] PMID: 31319058
García-Marco JA, López Jiménez J, Recasens V, Fernández Zarzoso M, González-Barca E, Somolinos De Marcos N, Ramírez MJ, Peñalver Parraga FJ, Yañez L, De La Serna Torroba J, Garcia Malo MD, Deben Ariznavarreta G, Perez Persona E, Ruiz Guinaldo MA, De Paz Arias R, Bañas Llanos E, Jarque I, Fernandez Valle MDC, Carral Tatay A, Perez De Oteyza J, Donato Martin E, Perez Fernández I, Martinez Martinez R, Andreu Costa MA, Champ D, García Suarez J, González Diaz M, Ferrer S, Carbonell F, García-Vela JA; GELLC (Grupo Español de Leucemia Linfocítica Crónica) Study Group. High prognostic value of measurable residual disease detection by flow cytometry in chronic lymphocytic leukemia patients treated with front-line fludarabine, cyclophosphamide, and rituximab, followed by a three-year rituximab maintenance. Haematologica. 2019 Mar 19. pii: haematol.2018.204891. doi: 10.3324/haematol.2018.204891. PMID: 30890600
Oarbeascoa G, Lozano ML, Guerra LM, Amunarriz C, Saavedra CA, Garcia-Gala JM, Viejo A, Revilla N, Fleitas CA, Arroyo JL, Revuelta EM, Galego A, Hernandez-Maraver D, Kwon M, Diez-Martin JL, Pascual C; Grupo Español de Aféresis – Spanish Apheresis Group (GEA). Retrospective multicenter study of extracorporeal photopheresis in steroid-refractory acute and chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2020 Jan 6. pii: S1083-8791(20)30001-X. doi: 10.1016/j.bbmt.2019.12.769. PMID: 31917270
Bravo-Perez C, Pajares I, Muiña B, Escobar H, Amigo ML, Garcia-Malo MD, Garcia J, Rodriguez-Pinilla SM, Piris MA, Ortuño FJ. Double hit B cell precursor leukemia/lymphoma in a patient with a prior diagnosis of follicular lymphoma: a diagnostic and therapeutic dilemma. Ann Hematol. 2019 Dec;98(12):2837-2839. doi: 10.1007/s00277-019-03829-1. Epub 2019 Nov 11. PMID: 31712881
Lamolda M, Montes R, Simón I, Perales S, Martínez-Navajas G, Lopez-Onieva L, Ríos-Pelegrina R, Del Moral RG, Griñan-Lison C, Marchal JA, Lozano ML, Ramos-Mejia V, Rivera J, Bastida JM, Real PJ. GENYOi005-A: An induced pluripotent stem cells (iPSCs) line generated from a patient with Familial Platelet Disorder with associated Myeloid Malignancy (FPDMM) carrying a p.Thr196Ala variant. Stem Cell Res. 2019 Dec;41:101603. doi: 10.1016/j.scr.2019.101603. Epub 2019 Oct 15. PMID: 31698193
Genescà E, Morgades M, Montesinos P, Barba P, Gil C, Guàrdia R, Moreno MJ, Martínez-Carballeira D, García-Cadenas I, Vives S, Ribera J, González-Campos J, González-Gil C, Zamora L, Ramírez JL, Díaz-Beya M, Mercadal S, Artola MT, Cladera A, Tormo M, Bermúdez A, Vall-Llovera F, Martínez P, Amigo ML, Monsalvo S, Novo A, Cervera M, García-Guiñon A, Juncà J, Ciudad J, Orfao A, Ribera JM. Unique clinico-biological, genetic and prognostic features of adult early T cell precursor acute lymphoblastic leukemia. Haematologica. 2019 Sep 19. pii: haematol.2019.225078. doi: 10.3324/haematol.2019.225078. PMID: 31537688
Rosiñol L, Oriol A, Rios R, Sureda A, Blanchard MJ, Hernández MT, Martínez-Martínez R, Moraleda JM, Jarque I, Bargay J, Gironella M, de Arriba F, Palomera L, González-Montes Y, Martí JM, Krsnik I, Arguiñano JM, González ME, González AP, Casado LF, López-Anglada L, Paiva B, Mateos MV, San Miguel JF, Lahuerta JJ, Bladé J. Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myeloma. Blood. 2019 Oct 17;134(16):1337-1345. doi: 10.1182/blood.2019000241. PMID: 31484647
Esteve-Pastor MA, Roldán V, Rivera-Caravaca JM, Ramírez-Macías I, Lip GYH, Marín F. The Use of Biomarkers in Clinical Management Guidelines: A Critical Appraisal. Thromb Haemost. 2019 Dec;119(12):1901-1919. doi: 10.1055/s-0039-1696955. PMID: 31499565
Curran D, Matthews S, Rowley SD, Young JH, Bastidas A, Anagnostopoulos A, Barista I, Chandrasekar PH, Dickinson M, El Idrissi M, Heras I, Milliken ST, Monserrat Coll J, Navarro Matilla MB, Oostvogels L, Piątkowska-Jakubas B, Quiel D, Sabry W, Schwartz S, Selleslag DLD, Sullivan KM, Theunissen K, Yegin ZA, Yeh SP, Zaja F, Szer J; ZOE-HSCT Study group collaborators. Recombinant Zoster Vaccine Significantly Reduces the Impact on Quality of Life Caused by Herpes Zoster in Adult Autologous Hematopoietic Stem Cell Transplant Recipients: A Randomized Placebo-Controlled Trial (ZOE-HSCT). Biol Blood Marrow Transplant. 2019 Dec;25(12):2474-2481. doi: 10.1016/j.bbmt.2019.07.036. PMID: 31394276
Jiménez-Ubieto A, Grande C, Caballero D, Yáñez L, Novelli S, Hernández-Garcia MT, Manzanares M, Arranz R, Ferreiro JJ, Bobillo S, Mercadal S, Galeo A, Jiménez JL, Moraleda JM, Vallejo C, Albo C, Pérez E, Marrero C, Magnano L, Palomera L, Jarque I, Rodriguez A, Lorza L, Martín A, Coria E, López-Guillermo A, Salar A, José Lahuerta J; GELTAMO (Grupo Español de Linfomas y Trasplantes de Médula Ósea) Cooperative Study Group. Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure without the need for immunotherapy. Hematol Oncol Stem Cell Ther. 2019 Dec;12(4):194-203. doi: 10.1016/j.hemonc.2019.06.001. PMID: 31319058
Cuenca-Zamora EJ, Ferrer-Marín F, Rivera J, Teruel-Montoya R. Tubulin in Platelets: When the Shape Matters. Int J Mol Sci. 2019 Jul 16;20(14). pii: E3484. doi: 10.3390/ijms20143484. Review. PMID: 31315202
Pascreau T, de la Morena-Barrio ME, Lasne D, Serrano M, Bianchini E, Kossorotoff M, Boddaert N, Bruneel A, Seta N, Vicente V, de Lonlay P, Corral J, Borgel D. Elevated thrombin generation in patients with congenital disorder of glycosylation and combined coagulation factor deficiencies. J Thromb Haemost. 2019 Jul 4. doi: 10.1111/jth.14559. PMID: 31271700
Martos L, Fernández-Pardo Á, López-Fernández MF, Ibáñez F, Herrero S, Tàssies D, González-Porras JR, Solmoirago MJ, Costa MJ, Reverter JC, Marco P, Roldán V, Lecumberri R, Velasco F, Oto J, Iruin G, Alonso MN, Vayá A, Bonanad S, Ferrando F, Martí E, Cid AR, Plana E, Oña F, Cuesta I, González-López TJ, España F, Medina P, Navarro S; Working Group of the Spanish Society of Thrombosis Haemostasis (SETH). Identification of 58 Mutations (26 Novel) in 94 of 109 Symptomatic Spanish Probands with Protein C Deficiency. Thromb Haemost. 2019 Jun 29. doi: 10.1055/s-0039-1692440. PMID: 31254973
Garcia Garcia Y, de Juan Ferré A, Mendiola C, Barretina-Ginesta MP, Gaba Garcia L, Santaballa Bertrán A, Bover Barcelo I, Gil-Martin M, Manzano A, Rubio Pérez MJ, Romeo Marin M, Arqueros Núñez C, García-Martínez E, Gonzalez Martin A. Efficacy and safety results from GEICO 1205, a randomized phase II trial of neoadjuvant chemotherapy with or without bevacizumab for advanced epithelial ovarian cancer. Int J Gynecol Cancer. 2019 Jul;29(6):1050-1056. doi: 10.1136/ijgc-2019-000256. PMID: 31263024
Wójcik M, de la Morena-Barrio ME, Michalik J, Wypasek E, Kopytek M, Corral J, Undas A. A series of 10 Polish patients with thromboembolic events and antithrombin deficiency: two new c.1154-1 G>C and c.1219-534 A>G SERPINC1 gene splicing mutations. Blood Coagul Fibrinolysis. 2019 Jul;30(5):193-198. doi: 10.1097/MBC.0000000000000816. PMID: 31157679
Bravo-Pérez C, Vicente V, Corral J. Management of antithrombin deficiency: an update for clinicians. Expert Rev Hematol. 2019 Jun;12(6):397-405. doi:10.1080/17474086.2019.1611424. Epub 2019 May 22. PMID: 31116611
Rivera-Caravaca JM, Marín F, Vilchez JA, Gálvez J, Esteve-Pastor MA, Vicente V, Lip GYH, Roldán V. Refining Stroke and Bleeding Prediction in Atrial Fibrillation by Adding Consecutive Biomarkers to Clinical Risk Scores. Stroke. 2019 Jun;50(6):1372-1379. doi: 10.1161/STROKEAHA.118.024305. Epub 2019 May 14. PMID: 31084333
de la Morena-Barrio ME, Salloum-Asfar S, Esteban J, de la Morena-Barrio B, Altisent C, Martin-Fernández L, Gueguen P, Padilla J, Miñano A, Parra R, Vicente V, Vidal F, Bauduer F, Carbonell P, Corral J. Archeogenetics of F11 p.Cys38Arg: a 5400-year-old mutation identified in different southwestern European countries. Blood. 2019 Jun 13;133(24):2618-2622. doi: 10.1182/blood.2019000055. Epub 2019 May 1. PMID: 31043424
Bastida JM, Benito R, Lozano ML, Marín-Quilez A, Janusz K, Martín-Izquierdo M, Hernández-Sánchez J, Palma-Barqueros V, Hernández-Rivas JM, Rivera J, González-Porras JR. Molecular Diagnosis of Inherited Coagulation and Bleeding Disorders. Semin Thromb Hemost. 2019 Apr 30. doi: 10.1055/s-0039-1687889. PMID: 31041795
Bastida JM, Morais S, Palma-Barqueros V, Benito R, Bermejo N, Karkucak M, Trapero-Marugan M, Bohdan N, Pereira M, Marin-Quilez A, Oliveira J, Yucel Y, Santos R, Padilla J, Janusz K, Lau C, Martin-Izquierdo M, Couto E, Francisco Ruiz-Pividal J, Vicente V, Hernández-Rivas JM, González-Porras JR, Luisa Lozano M, Lima M, Rivera J. Identification of novel variants in ten patients with Hermansky-Pudlak syndrome by high-throughput sequencing. Ann Med. 2019 Mar;51(2):141-148. doi: 10.1080/07853890.2019.1587498. Epub 2019 Apr 16. PMID: 30990103
de la Morena-Barrio B, Orlando C, de la Morena-Barrio ME, Vicente V, Jochmans K, Corral J. Incidence and features of thrombosis in children with inherited antithrombin deficiency. Haematologica. 2019 Apr 11. pii: haematol.2018.210666. doi: 10.3324/haematol.2018.210666. PMID: 30975910
De la Morena-Barrio B, Borràs N, Rodríguez-Alén A, de la Morena-Barrio ME, García-Hernández JL, Padilla J, Bravo-Pérez C, Miñano A, Rollón N, Corral J, Vidal F, Vicente V. Identification of the first large intronic deletion responsible of type I antithrombin deficiency not detected by routine molecular diagnostic methods. Br J Haematol. 2019 Aug;186(4):e82-e86. doi: 10.1111/bjh.15913. Epub 2019 Apr 2. PMID: 30941754
Bravo-Perez C, Ródenas T, Esteban J, de la Morena-Barrio ME, Salloum-Asfar S, de la Morena-Barrio B, Miñano A, Vicente V, Corral J. Gynaecological and obstetrical bleeding in Caucasian women with congenital factor XI deficiency: Results from a twenty-year, retrospective, observational study. Med Clin (Barc). 2019 Mar 26. pii: S0025-7753(19)30123-X. doi: 10.1016/j.medcli.2019.01.029. [Epub ahead of print] PMID: 30926156
Reyes-García AML, Aroca A, Arroyo AB, García-Barbera N, Vicente V, González-Conejero R, Martínez C. Neutrophil extracellular trap components increase the expression of coagulation factors. Biomed Rep. 2019 Mar;10(3):195-201. doi: 10.3892/br.2019.1187. Epub 2019 Jan 23.PMID: 30906549
Danese E, Raimondi S, Montagnana M, Tagetti A, Langaee T, Borgiani P, Ciccacci C, Carcas AJ, Borobia AM, Tong HY, Dávila-Fajardo C, Rodrigues Botton M, Bourgeois S, Deloukas P, Caldwell MD, Burmester JK, Berg RL, Cavallari LH, Drozda K, Huang M, Zhao LZ, Cen HJ, Gonzalez-Conejero R, Roldan V, Nakamura Y, Mushiroda T, Gong IY, Kim RB, Hirai K, Itoh K, Isaza C, Beltrán L, Jiménez-Varo E, Cañadas-Garre M, Giontella A, Kringen MK, Haug KBF, Gwak HS, Lee KE, Minuz P, Lee MTM, Lubitz SA, Scott S, Mazzaccara C, Sacchetti L, Genç E, Özer M, Pathare A, Krishnamoorthy R, Paldi A, Siguret V, Loriot MA, Kutala VK, Suarez-Kurtz G, Perini J, Denny JC, Ramirez AH, Mittal B, Rathore SS, Sagreiya H, Altman R, Shahin MHA, Khalifa SI, Limdi NA, Rivers C, Shendre A, Dillon C, Suriapranata IM, Zhou HH, Tan SL, Tatarunas V, Lesauskaite V, Zhang Y, Maitland-van der Zee AH, Verhoef TI, de Boer A, Taljaard M, Zambon CF, Pengo V, Zhang JE, Pirmohamed M, Johnson JA, Fava C. Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 Individuals. Clin Pharmacol Ther. 2019 Jun;105(6):1477-1491. doi: 10.1002/cpt.1323. Epub 2019 Feb 17. PMID: 30506689
Palma-Barqueros V, Ruiz-Pividal J, Bohdan N, Vicente V, Bastida JM, Lozano M, Rivera J. RASGRP2 gene variations associated with platelet dysfunction and bleeding. Platelets. 2019;30(4):535-539. doi: 10.1080/09537104.2019.1585528. Epub 2019 Mar 8. PMID: 30849270
Garabet L, Ghanima W, Rangberg A, Teruel-Montoya R, Martinez C, Lozano ML, Nystrand CF, Bussel JB, Sandset PM, Jonassen CM. Circulating microRNAs in patients with immune thrombocytopenia before and after treatment with thrombopoietin-receptor agonists. Platelets. 2019 Mar 18:1-8. doi: 10.1080/09537104.2019.1585527. PMID: 30885035
Teruel-Montoya R, Luengo-Gil G, Vallejo F, Yuste JE, Bohdan N, García-Barberá N, Espín S, Martínez C, Espín JC, Vicente V, Martínez-Martínez I. Differential miRNA expression profile and proteome in plasma exosomes from patients with paroxysmal nocturnal hemoglobinuria. Sci Rep. 2019 Mar 5;9(1):3611. doi: 10.1038/s41598-019-40453-5. PMID: 30837665
Martínez-Monseny AF, Bolasell M, Callejón-Póo L, Cuadras D, Freniche V, Itzep DC, Gassiot S, Arango P, Casas-Alba D, de la Morena E, Corral J, Montero R, Pérez-Cerdá C, Pérez B, Artuch R, Jaeken J, Serrano M; and the CDG Spanish Consortium. AZATAX: Acetazolamide safety and efficacy in cerebellar syndrome in PMM2 congenital disorder of glycosylation (PMM2-CDG). Ann Neurol. 2019 May;85(5):740-751. doi: 10.1002/ana.25457. Epub 2019 Mar 22. PMID: 30873657
Altassan R, Péanne R, Jaeken J, Barone R, Bidet M, Borgel D, Brasil S, Cassiman D, Cechova A, Coman D, Corral J, Correia J, de la Morena-Barrio ME, de Lonlay P, Dos Reis V, Ferreira CR, Fiumara A, Francisco R, Freeze H, Funke S, Gardeitchik T, Gert M, Girad M, Giros M, Grünewald S, Hernández-Caselles T, Honzik T, Hutter M, Krasnewich D, Lam C, Lee J, Lefeber D, Marques-de-Silva D, Martinez AF, Moravej H, Õunap K, Pascoal C, Pascreau T, Patterson M, Quelhas D, Raymond K, Sarkhail P, Schiff M, Seroczyńska M, Serrano M, Seta N, Sykut-Cegielska J, Thiel C, Tort F, Vals MA, Videira P, Witters P, Zeevaert R, Morava E. International clinical guidelines for the management of phosphomannomutase 2-congenital disorders of glycosylation: Diagnosis, treatment and follow up. J Inherit Metab Dis. 2019 Jan;42(1):5-28. doi: 10.1002/jimd.12024. Review. Erratum in: J Inherit Metab Dis. 2019 May;42(3):577. PMID: 30740725
Davizon-Castillo P, McMahon B, Aguila S, Bark D, Ashworth K, Allawzi A, Campbell RA, Montenont E, Nemkov T, D'Alessandro A, Clendenen N, Shih L, Sanders NA, Higa K, Cox A, Padilla-Romo Z, Hernandez G, Wartchow E, Trahan GD, Nozik-Grayck E, Jones K, Pietras E, DeGregori J, Rondina MT, Di Paola J. TNF-alpha driven inflammation and mitochondrial dysfunction define the platelet hyperreactivity of aging. Blood. 2019 Jul 16. pii: blood.2019000200. doi: 10.1182/blood.2019000200. PMID: 31311815
Aguila S, Lavin M, Dalton N, Patmore S, Chion A, Trahan GD, Jones KL, Keenan C, Brophy TM, O'Connell NM, Ryan K, Byrne M, Nolan M, Patel A, Preston RJS, James P, Di Paola J, O'Sullivan JM, O'Donnell JS. Increased galactose expression and enhanced clearance in patients with low von Willebrand factor. Blood. 2019 Apr 4;133(14):1585-1596. doi: 10.1182/blood-2018-09-874636. Epub 2019 Feb 15. PMID: 30770394
Aguila S, O'Donnell JS. Novel therapies for hemophilia A - the role of the von Willebrand factor chaperone. J Thromb Haemost. 2019 Mar;17(3):426-428. doi: 10.1111/jth.14353. Epub 2019 Jan 16. PMID: 30652400
Martínez-Martínez I. Trehalose: is it a potential inhibitor of antithrombin polymerization? Biosci Rep. 2019 Jun 18;39(6). pii: BSR20190567. doi: 10.1042/BSR20190567. Print 2019 Jun 28. PMID: 31147454
Baiges A, de la Morena-Barrio ME, Turon F, Miñano A, Ferrusquía JA, Magaz M, Reverter JC, Vicente V, Hernández-Gea V, Corral J, García-Pagán JC. Congenital antithrombin deficiency in patients with splanchnic vein thrombosis. Liver Int. 2019 Dec 29. doi: 10.1111/liv.14342. PMID: 31885188
Rivera-Caravaca JM, Marín F, Esteve-Pastor MA, Gálvez J, Lip GYH, Vicente V, Roldán V.Murcia atrial fibrillation project II: protocol for a prospective observational study in patients with atrial fibrillation. BMJ Open. 2019 Dec 15;9(12):e033712. doi: 10.1136/bmjopen-2019-033712. PMID: 31843852
Lee RH, Piatt R, Dhenge A, Lozano ML, Palma-Barqueros V, Rivera J, Bergmeier W. Impaired hemostatic activity of healthy transfused platelets in inherited and acquired platelet disorders: Mechanisms and implications. Sci Transl Med. 2019 Dec 11;11(522). pii: eaay0203. doi: 10.1126/scitranslmed.aay0203. PMID: 31826978
Garabet L, Henriksson CE, Lozano ML, Ghanima W, Bussel J, Brodin E, Fernández-Pérez MP, Martínez C, González-Conejero R, Mowinckel MC, Sandset PM. Markers of endothelial cell activation and neutrophil extracellular traps are elevated in immune thrombocytopenia but are not enhanced by thrombopoietin receptor agonists. Thromb Res. 2019 Nov 30;185:119-124. doi: 10.1016/j.thromres.2019.11.031. PMID: 31805421
Palma-Barqueros V, Torregrosa JM, Caparrós-Pérez E, Mota-Pérez N, Bohdan N, Llanos MDC, Begonja AJ, Sola-Visner M, Vicente V, Teruel-Montoya R, Rivera J, Ferrer-Marín F. Developmental Differences in Platelet Inhibition Response to Prostaglandin E1. Neonatology. 2019 Nov 29:1-9. doi: 10.1159/000504173. PMID: 31786577
Lozano ML, Garabet L, Fernandez-Perez MP, De Los Reyes-García AM, Diaz-Lozano P, Garcia-Barbera N, Aguila S, Vicente V, Ghanima W, Martinez C, Gonzalez-Conejero R. Platelet activation and neutrophil extracellular trap (NET) formation in immune thrombocytopenia: is there an association? Platelets. 2019 Nov 24:1-7. doi: 10.1080/09537104.2019.1696456. PMID: 31762368
Lozano ML, Mingot-Castellano ME, Perera MM, Jarque I, Campos-Alvarez RM, González-López TJ, Carreño-Tarragona G, Bermejo N, Lopez-Fernandez MF, de Andrés A, Valcarcel D, Casado-Montero LF, Alvarez-Roman MT, Orts MI, Novelli S, Revilla N, González-Porras JR, Bolaños E, Rodríguez-López MA, Orna-Montero E, Vicente V. Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia. Sci Rep. 2019 Nov 13;9(1):16680. doi: 10.1038/s41598-019-53209-y. PMID: 31723222
Vallejo F, Yuste JE, Teruel-Montoya R, Luengo-Gil G, Bohdan N, Espín S, García-Barberá N, Martínez C, Vicente V, Espín JC, Martínez-Martínez I. First exploratory study on the metabolome from plasma exosomes in patients with paroxysmal nocturnal hemoglobinuria. Thromb Res. 2019 Nov;183:80-85. doi: 10.1016/j.thromres.2019.10.001. PMID: 31671376
Papareddy P, Rossnagel M, Doreen Hollwedel F, Kilic G, Veerla S, Naudin C, Smeds E, Westman J, Martinez-Martinez I, Egesten A, de la Morena-Barrio ME, Corral J, Linder A, Artoni A, Abbattista M, Novembrino C, Herbert Brakebusch C, Martinelli I, Kasetty G, Herwald H.A human antithrombin isoform dampens inflammatory responses and protects from organ damage during bacterial infection. Nat Microbiol. 2019 Dec;4(12):2442-2455. doi: 10.1038/s41564-019-0559-6. PMID: 31548687
Paciullo F, Bury L, Noris P, Falcinelli E, Melazzini F, Orsini S, Zaninetti C, Abdul-Kadir R, Obeng-Tuudah D, Heller P, Glembotsky AC, Fabris F, Rivera J, Lozano ML, Butta N, Favier R, Cid AR, Fouassier M, Podda GM, Santoro C, Grandone E, Henskens Y, Nurden P, Zieger B, Cuker A, Devreese K, Tosetto A, De Candia E, Dupuis A, Miyazaki K, Othman M, Gresele P. Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study. Haematologica. 2019 Sep 26. pii: haematol.2019.227876. doi: 10.3324/haematol.2019.227876. PMID: 31558677
Mingot-Castellano ME, Román MTÁ, Fernández Fuertes LF, González-López TJ, Guinea de Castro JM, Jarque I, López-Fernández MF, Lozano ML, Sánchez González B, Ferreiras DV, González Porras JR. Management of Adult Patients with Primary Immune Thrombocytopenia (ITP) in Clinical Practice: A Consensus Approach of the Spanish ITP Expert Group. Adv Hematol. 2019 Aug 22;2019:4621416. doi: 10.1155/2019/4621416. PMID: 31534457
Luengo-Gil G, García-Andreo AB, Ortega-Sabater C, Bohdan N, Espín S, Peñas-Martínez J, Martínez-Planes E, García-Hernández Á, Vicente V, Quintanilla M, Martínez-Martínez I. Antithrombin is incorporated into exosomes produced by antithrombin non-expressing cells. Biochimie. 2019 Oct;165:245-249. doi: 10.1016/j.biochi.2019.08.010. PMID: 31445073
Jiménez-Ubieto A, Grande C, Caballero D, Yáñez L, Novelli S, Hernández-Garcia MT, Manzanares M, Arranz R, Ferreiro JJ, Bobillo S, Mercadal S, Galeo A, Jiménez JL, Moraleda JM, Vallejo C, Albo C, Pérez E, Marrero C, Magnano L, Palomera L, Jarque I, Martínez-Sánchez P, Martín A, Coria E, López-Guillermo A, Salar A, Lahuerta JJ; GELTAMO (Grupo Español de Linfomas y Trasplantes de Médula Ósea) Cooperative Study Group. Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure who reach complete response after rescue treatment. Hematol Oncol. 2018 Dec;36(5):765-772. doi: 10.1002/hon.2553. Epub 2018 Sep 12. PMID: 30129233
Fernández-Caballero M, Salmerón D, Chirlaque MD, Salmerón D, Chen-Liang TH, Hurtado AM, García Malo MD, Ortuño FJ, Roldán V, Vicente V, Jerez A, De Arriba F. Increasing Therapy Related Myeloid Neoplasms in Multiple Myeloma. Eur J Clin Invest. 2018 Nov 13:e13050. doi: 10.1111/eci.13050. [Epub ahead of print] PMID: 30422316
Revilla N, Corral J, Miñano A, Mingot-Castellano ME, Campos RM, Velasco F, Gonzalez N, Galvez E, Berrueco R, Fuentes I, Gonzalez-Lopez TJ, de la Morena-Barrio ME, Gonzalez-Porras JR, Vicente V, Lozano ML. Multirefractory primary immune thrombocytopenia; targeting the decreased sialic acid content. Platelets. 2018 Oct 8:1-9. doi: 10.1080/09537104.2018.1513476. [Epub ahead of print] PMID: 30296193
Bastida JM, López-Godino O, Vicente-Sánchez A, Bonanad-Boix S, Xicoy-Cirici B, Hernández-Sánchez JM, Such E, Cervera J, Caballero-Berrocal JC, López-Cadenas F, Arnao-Herráiz M, Rodríguez I, Llopis-Calatayud I, Jiménez MJ, Del Cañizo-Roldán MC, Díez-Campelo M. Hidden myelodysplastic syndrome (MDS): A prospective study to confirm or exclude MDS in patients with anemia of uncertain etiology. Int J Lab Hematol. 2018 Oct 5. doi: 10.1111/ijlh.12933. PMID: 30290085
Barba P, Morgades M, Montesinos P, Gil C, Fox ML, Ciudad J, Moreno MJ, González-Campos J, Genescà E, Martínez-Carballeira D, Martino R, Vives S, Guardia R, Mercadal S, Artola MT, Cladera A, Tormo M, Esteve J, Bergua J, Vall-Llovera F, Ribera J, Martínez-Sanchez P, Amigo ML, Bermúdez A, Calbacho M, Hernández-Rivas JM, Feliu E, Orfao A, Ribera JM; PETHEMA Group. Increased Survival due to Lower Toxicity for High Risk T-cell Acute Lymphoblastic Leukemia Patients in 2 consecutive Pediatric-Inspired PETHEMA Trials. Eur J Haematol. 2018 Sep 29. doi: 10.1111/ejh.13178. [Epub ahead of print] PMID: 30267597
Iniesta P, Revilla N, Chen-Liang TH, Hurtado AM, Vicente V, Heras I, Jerez A, Lozano ML. An early increase of CD56bright natural killer subset as dominant effect and predictor of response to extracorporeal photopheresis for graft-versus-host disease. Transfusion. 2018 Sep 27. doi: 10.1111/trf.14964. [Epub ahead of print] PMID: 30260547
Jiménez-Ubieto A, Grande C, Caballero D, Yáñez L, Novelli S, Hernández-Garcia MT, Manzanares M, Arranz R, Ferreiro JJ, Bobillo S, Mercadal S, Galeo A, Jiménez JL, Moraleda JM, Vallejo C, Albo C, Pérez E, Marrero C, Magnano L, Palomera L, Jarque I, Martínez-Sánchez P, Martín A, Coria E, López-Guillermo A, Salar A, Lahuerta JJ; GELTAMO (Grupo Español de Linfomas y Trasplantes de Médula Ósea) Cooperative Study Group. Hematol Oncol. 2018 Dec;36(5):765-772. doi: 10.1002/hon.2553. PMID: PMID: 30129233
Martínez-Laperche C, Buces E, Aguilera-Morillo MC, Picornell A, González-Rivera M, Lillo R, Santos N, Martín-Antonio B, Guillem V, Nieto JB, González M, de la Cámara R, Brunet S, Jiménez-Velasco A, Espigado I, Vallejo C, Sampol A, Bellón JM, Serrano D, Kwon M, Gayoso J, Balsalobre P, Urbano-Izpizua Á, Solano C, Gallardo D, Díez-Martín JL, Romo J, Buño I; GVHD/Immunotherapy Committee of the Spanish Group for Hematopoietic Transplantation. A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms. Blood Adv. 2018 Jul 24;2(14):1719-1737. doi: 10.1182/bloodadvances.2017011502. PMID: 30030270
Santos N, Rodríguez-Romanos R, de la Cámara R, Brunet S, Nieto JB, Buño I, Martínez C, Jiménez-Velasco A, Vallejo C, González M, Solano C, Ferrá C, Sampol A, Pérez-Simón JA, López-Jiménez J, Díez JL, Gallardo D; GvHD/Immunotherapy Working Party of the Spanish Group of Hematopoietic Transplant (GETH). PD-1 genotype of the donor is associated with acute graft-versus-host disease after HLA-identical sibling donor stem cell transplantation. Ann Hematol. 2018 Nov;97(11):2217-2224. doi: 10.1007/s00277-018-3438-y. Epub 2018 Jul 17. PMID: 30019128
Jiménez-Ubieto A, Grande C, Caballero D, Yáñez L, Hernández-Garcia MT, Novelli S, Arranz R, Ferreiro JJ, Bobillo S, Mercadal S, Galeo A, Jiménez JL, Moraleda JM, Vallejo C, Albo C, Pérez E, Marrero C, Magnano L, Palomera L, Jarque I, Martínez-Sánchez P, Martín A, Coria E, López-Guillermo A, Salar A, Lahuerta JJ; GELTAMO (Grupo Español de Linfomas y Trasplantes de Médula Ósea) Cooperative Study Group. Secondary malignancies and survival outcomes after autologous stem cell transplantation for follicular lymphoma in the pre-rituximab and rituximab eras: a long-term follow-up analysis from the Spanish GELTAMO registry. Bone Marrow Transplant. 2018 Jun;53(6):780-783. doi: 10.1038/s41409-018-0096-6. PMID: 29362504
Alvarez-Larran A, Martínez D, Arenillas L, Rubio A, Arellano-Rodrigo E, Hernández Boluda JC, Papaleo N, Caballero G, Martínez C, Ferrer-Marín F, Mata MI, Pérez-Encinas M, Durán MA, Alonso JM, Carreño-Tarragona G, Alonso JM, Noya S, Magro E, Pérez R, López-Guerra M, Pastor-Galán I, Cervantes F, Besses C, Colomo L, Rozman M. Essential thrombocythaemia with mutation in MPL: clinicopathological correlation and comparison with JAK2V617F-mutated and CALR-mutated genotypes. J Clin Pathol. 2018 Jun 22. pii: jclinpath-2018-205227. doi: 10.1136/jclinpath-2018-205227. PMID: 29934356
Hurtado AM, Luengo-Gil G, Chen-Liang TH, Amaral F, Batta K, Palomo L, Lumbreras E, Przychodzen B, Caparros E, Amigo ML, Dıez-Campelo M, Zamora L, Salido Fierrez EJ, Maciejewski JP, Ortuño FJ, Vicente V, Del Canizo M, Sole F, Ferrer-Marin F, Wiseman DH, Jerez A. Transcriptomic rationale for synthetic lethality-targeting ERCC1 and CDKN1A in chronic myelomonocytic leukaemia. Br J Haematol. 2018 May 24. doi: 10.1111/bjh.15408. PMID: 29797327
Hardy AT, Palma-Barqueros V, Watson SK, Malcor JD, Eble JA, Gardiner EE, Blanco JE, Guijarro-Campillo R, Delgado JL, Lozano ML, Teruel-Montoya R, Vicente V, Watson SP, Rivera J, Ferrer-Marín F. Significant Hypo-Responsiveness to GPVI and CLEC-2 Agonists in Pre-Term and Full-Term Neonatal Platelets and following Immune Thrombocytopenia. Thromb Haemost. 2018 Jun;118(6):1009-1020. doi: 10.1055/s-0038-1646924. PMID: 29695020
Hernández-Boluda JC, Pereira A, Correa JG, Alvarez-Larrán A, Ferrer-Marín F, Raya JM, Martínez-López J, Velez P, Pérez-Encinas M, Estrada N, García-Gutiérrez V, Fox ML, Payer A, Kerguelen A, Cuevas B, Durán MA, Ramírez MJ, Gómez-Casares MT, Mata-Vázquez MI, Mora E, Gómez M, Cervantes F. Prognostic risk models for transplant decision-making in myelofibrosis. Ann Hematol. 2018 May;97(5):813-820. doi: 10.1007/s00277-018-3240-x. PMID: 29396714
Lorenz V, Ramsey H, Liu ZJ, Italiano J Jr, Hoffmeister K, Bihorel S, Mager D, Hu Z, Slayton WB, Kile BT, Sola-Visner M, Ferrer-Marin F. Developmental Stage-Specific Manifestations of Absent TPO/c-MPL Signalling in Newborn Mice. Thromb Haemost. 2017 Dec;117(12):2322-2333. doi: 10.1160/TH17-06-0433. PMID: 29212120
Fernández-Muñoz H, Plaza EM, Rivera-Caravaca JM, Candela MJ, Romera M, De Arriba F, Lozano ML, Vicente V, Heras I, Castilla-Llorente C, Rivera J. Comparative assessment of prophylactic transfusions of platelet concentrates obtained by the PRP or buffy-coat methods, in patients undergoing allogeneic hematopoietic stem cell transplantation. Hematology. 2018 Mar 27:1-7. doi: 10.1080/10245332.2018. 1455434. PMID: 29582705
Gayoso J, Balsalobre P, Kwon M, Herrera P, Bermúdez A, Sampol A, Jiménez S, López-Corral L, Serrano D, Piñana JL, Pascual MJ, Heras I, Bento L, Varela R, Humala K, Zabalza A, Laiglesia A, Bastos-Oreiro M, Pérez-Corral A, Martínez-Laperche C, Buño I, Díez-Martín JL; GETH (Grupo Español de Trasplante Hematopoyético) Spain. Busulfan based myeloablative conditioning regimens for haploidentical transplantation in high risk acute leukemias and myelodysplastic syndromes. Eur J Haematol. 2018 May 30. doi: 10.1111/ejh.13103. PMID: 29846964
Fernández-Muñoz H, Castilla-Llorente C, Plaza EM, Martínez-Millán C, Heras I, Iniesta P, Amigo ML, Ferrer-Marin F, Candela MJ, Lozano ML, Vicente V, Rivera J. Quality assessment and transfusion efficacy of buffy coat-derived platelet concentrates washed with platelet additive solution. Blood Transfus. 2018 May;16(3):273-278. doi: 10.2450/2017.0277-16. Epub 2017 Apr 13. PMID: 28488971
Chen-Liang TH, Casado-Prieto AM, Campos-Rodríguez V, Hurtado AM, Amigo ML, García-Malo MD, Vicente V, Ortuño FJ, Jerez A. An increased percentage of myeloid CD34+ bone marrow cells stratifies intermediate IPSS-R myelodysplastic syndrome patients into prognostically significant groups. Int J Lab Hematol. 2018 May 18. doi: 10.1111/ijlh.12860. PMID: 29774987
Martínez-Losada C, Serrano-López J, Serrano-López J, Noguera NI, Garza E, Piredda L, Lavorgna S, Irno Consalvo MA, Ottone T, Alfonso V, Peinado JR, Garcia-Ortiz MV, Morales-Ruiz T, Jérez A, Hurtado AM, Montesinos P, Cervera J, Such E, Ibañez M, Sempere A, Sanz MÁ, Lo Coco F, Sánchez-García J. Clonal genetic evolution at relapse of favorable-risk acute myeloid leukemia with NPM1 mutation is associated with phenotypic changes and worse outcomes. Haematologica. 2018 Apr 5. pii: haematol.2018.188433. doi: 10.3324/haematol.2018.188433. PMID: 29622659
Xicoy B, Triguero A, Such E, García O, Jiménez MJ, Arnán M, Bernal T, Diaz-Beya M, Valcárcel D, Pedro C, Ramos F, Amigo ML, Collado R, Palomo L, Ardanaz MT, Cedena MT, Grau J, Zamora L, Sanz G.The division of chronic myelomonocytic leukemia (CMML)-1 into CMML-0 and CMML-1 according to 2016 World Health Organization (WHO) classification has no impact in outcome in a large series of patients from the Spanish group of MDS. Leuk Res. 2018 May 9;70:34-36. doi: 10.1016/j.leukres.2018.05.003. PMID: 29775844
Chen-Liang TH, Casado-Prieto AM, Campos-Rodríguez V, Hurtado AM, Amigo ML, García-Malo MD, Vicente V, Ortuño FJ, Jerez A.An increased percentage of myeloid CD34+ bone marrow cells stratifies intermediate IPSS-R myelodysplastic syndrome patients into prognostically significant groups. Int J Lab Hematol. 2018 May 18. doi: 10.1111/ijlh.12860.PMID: 29774987
Ribera JM, García O, Gil C, Mercadal S, García-Cadenas I, Montesinos P, Barba P, Vives S, González-Campos J, Tormo M, Esteve J, López A, Moreno MJ, Ribera J, Alonso N, Bermúdez A, Amigo ML, Genescà E, García D, Vall-Llovera F, Bergua JM, Guàrdia R, Monteserín MC, Bernal T, Calbacho M, Martínez MP, Feliu E; PETHEMA Group. Comparison of intensive, pediatric-inspired therapy with non-intensive therapy in older adults aged 55-65 years with Philadelphia chromosome-negative acute lymphoblastic leukemia. Leuk Res. 2018 May;68:79-84. doi: 10.1016/j.leukres.2018.03.010. PMID: 29574396
Ribera JM, Morgades M, Montesinos P, Martino R, Barba P, Soria B, Bermúdez A, Moreno MJ, González-Campos J, Vives S, Gil C, Abella E, Guàrdia R, Martínez-Carballeira D, Martínez-Sánchez P, Amigo ML, Mercadal S, Serrano A, López-Martínez A, Vall-Llovera F, Sánchez-Sánchez MJ, Peñarrubia MJ, Calbacho M, Méndez JA, Bergua J, Cladera A, Tormo M, García-Belmonte D, Feliu E, Ciudad J, Orfao A; PETHEMA Group, Spanish Society of Hematology. Efficacy and safety of native versus pegylated Escherichia coli asparaginase for treatment of adults with high-risk, Philadelphia chromosome-negative acute lymphoblastic leukemia. Leuk Lymphoma. 2018 Jul;59(7):1634-1643. doi: 10.1080/10428194.2017.1397661. PMID:29165013
Afram G, Simón JAP, Remberger M, Caballero-Velázquez T, Martino R, Piñana JL, Ringden O, Esquirol A, Lopez-Corral L, Garcia I, López-Godino O, Sierra J, Caballero D, Ljungman P, Vazquez L, Hägglund H. Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting. Med Oncol. 2018 Apr 25;35(6):79. doi: 10.1007/s12032-018-1127-2. PMID: 29696461
Hernández-Boluda JC, Pereira A, Correa JG, Alvarez-Larrán A, Ferrer-Marín F, Raya JM, Martínez-López J, Velez P, Pérez-Encinas M, Estrada N, García-Gutiérrez V, Fox ML, Payer A, Kerguelen A, Cuevas B, Durán MA, Ramírez MJ, Gómez-Casares MT, Mata-Vázquez MI, Mora E, Gómez M, Cervantes F.Prognostic risk models for transplant decision-making in myelofibrosis. Ann Hematol. 2018 Jan 25. doi: 10.1007/s00277-018-3240-x. PMID: 29396714
Lorenz V, Ramsey H, Liu ZJ, Italiano J Jr., Hoffmeister K, Bihorel S, Mager D, Hu Z, Slayton WB, Kile BT, Sola-Visner M, Ferrer-Marin F. Developmental Stage-Specific Manifestations of Absent TPO/c-MPL Signalling in Newborn Mice. Thromb Haemost. 2017 Dec;117(12):2322-2333. doi: 10.1160/TH17-06-0433. PMID: 29212120
Osorio S, Escudero-Vilaplana V, Reguilón-Gallego L, Gómez-Centurión I, Díez JL, Ferrer-Marín F. Severe liver toxicity in a chronic myeloid leukemia patient probably induced by a drug interaction between imatinib and sertraline. J Oncol Pharm Pract. 2017 Jan 1:1078155217735689. doi: 10.1177/1078155217735689.PMID: 29065786
Rodríguez-Otero P, Mateos MV, Martínez-López J, Martín-Calvo N, Hernández MT, Ocio EM, Rosiñol L, Martínez R, Teruel AI, Gutiérrez NC, Bargay J, Bengoechea E, González Y, de Oteyza JP, Gironella M, Encinas C, Martín J, Cabrera C, Palomera L, de Arriba F, Cedena MT, Paiva B, Puig N, Oriol A, Bladé J, Lahuerta JJ, San Miguel JF. Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability role. Leukemia. 2018 Feb 23. doi: 10.1038/s41375-018-0072-6. PMID: 29515235
Guillem V, Calabuig M, Brunet S, Esteve J, Escoda L, Gallardo D, Ribera JM, Queipo de Llano MP, Arnan M, Pedro C, Amigo ML, Martí-Tutusaus JM, García-Guiñón A, Bargay J, Sampol A, Salamero O, Font L, Talarn C, Hoyos M, Díaz-Beyá M, Garrido A, Navarro B, Nomdédeu J, Sierra J, Tormo M. Bone marrow VEGFC expression is associated with multilineage dysplasia and several prognostic markers in adult acute myeloid leukemia, but not with survival. Leuk Lymphoma. 2018 Jan 18:1-11. doi: 10.1080/10428194.2017.1422858.PMID: 29345176
Mateos MV, Dimopoulos MA, Cavo M, Suzuki K, Jakubowiak A, Knop S, Doyen C, Lucio P, Nagy Z, Kaplan P, Pour L, Cook M, Grosicki S, Crepaldi A, Liberati AM, Campbell P, Shelekhova T, Yoon SS, Iosava G, Fujisaki T, Garg M, Chiu C, Wang J, Carson R, Crist W, Deraedt W, Nguyen H, Qi M, San-Miguel J; ALCYONE Trial Investigators. Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma. N Engl J Med. 2018 Feb 8;378(6):518-528. doi: 10.1056/NEJMoa1714678. PMID: 2923113
de la Morena-Barrio ME, Wypasek E, Owczarek D, Miñano A, Vicente V, Corral J, Undas A. MPI-CDG with transient hypoglycosylation and antithrombin deficiency. Haematologica. 2018 Dec 13. pii: haematol.2018.211326. doi: 10.3324/haematol.2018.211326. [Epub ahead of print] PMID: 30545931
Vera M, Torramade-Moix S, Martin-Rodriguez S, Cases A, Cruzado JM, Rivera J, Escolar G, Palomo M, Diaz-Ricart M. Antioxidant and Anti-Inflammatory Strategies Based on the Potentiation of Glutathione Peroxidase Activity Prevent Endothelial Dysfunction in Chronic Kidney Disease. Cell Physiol Biochem. 2018 Nov 27;51(3):1287-1300. doi: 10.1159/000495540. [Epub ahead of print] PMID: 30481789
Ríos SJ, Rivera-Caravaca JM, Aroca-Valverde C, Reguilón-Gallego L, Castillo-Rodríguez M, Esteve-Pastor MA, Vicente V, Marín F, Roldán V. Efficacy and Safety of Peri-procedural Bridging Therapy with Low Molecular Weight Heparin in Atrial Fibrillation Patients under Vitamin K Antagonists. QJM. 2018 Oct 31. doi: 10.1093/qjmed/hcy250. [Epub ahead of print] PMID: 30380132
Westbury SK, Downes K, Burney C, Lozano ML, Obaji SG, Toh CH, Sevivas T, Morgan NV, Erber WN, Kempster C, Moore SF, Thys C, Papadia S, Ouwehand WH; NIHR BioResource–Rare Diseases, Laffan MA, Gomez K, Freson K, Rivera J, Mumford AD. Phenotype description and response to thrombopoietin receptor agonist in DIAPH1-related disorder. Blood Adv. 2018 Sep 25;2(18):2341-2346. doi: 10.1182/bloodadvances.2018020370. PMID: 30232087
Esteve-Pastor MA, Rivera-Caravaca JM, Roldán V, Orenes-Piñero E, Romiti GF, Romanazzi I, Bai Y, Carmo J, Proietti M, Marín F, Lip GYH. Estimated Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants Compared With Optimally Acenocoumarol Anticoagulated "Real-World" in Patients With Atrial Fibrillation. Am J Cardiol. 2018 Sep 1;122(5):785-792. doi: 10.1016/j.amjcard.2018.05.012. Epub 2018 Jun 2. PMID: 30049460
Rivera J, Lozano ML. Performance and usefulness of platelet aggregation testing. Platelets. 2018 Nov;29(7):637. doi: 10.1080/09537104.2018.1498665. Epub 2018 Jul 23. PMID: 30036107
Navarro-Fernández J, Eugenia de la Morena-Barrio M, Martínez-Alonso E, Dybedal I, Toderici M, Bohdan N, Miñano A, Heimdal K, Abildgaard U, Martínez-Menárguez JÁ, Corral J, Vicente V.Biochemical and cellular consequences of the antithrombin p.Met1? mutation identified in a severe thrombophilic family. Oncotarget. 2018 Sep 4;9(69):33202-33214. PMID: 30237862
Asunción Esteve-Pastor M, Miguel Rivera-Caravaca J, Roldán V, Vicente V, Valdés M, Marín F, Lip GYH. Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores. Thromb Haemost. 2017 Oct;117(10):1848-1858. doi: 10.1160/TH17-07-0478. Epub 2017 Nov 8. PMID: 30151818
de la Morena-Barrio ME, López-Gálvez R, Martínez-Martínez I, Asenjo S, Sevivas TS, López MF, Wypasek E, Entrena L, Vicente V, Corral J. Defects of splicing in antithrombin deficiency. Res Pract Thromb Haemost. 2017 Jul 14;1(2):216-222. doi: 10.1002/rth2.12025. eCollection 2017 Oct. PMID: 30046692
Corral J, de la Morena-Barrio ME, Vicente V. The genetics of antithrombin. Thromb Res. 2018 Jul 5;169:23-29. doi: 10.1016/j.thromres.2018.07.008. [Epub ahead of print] PMID: 30005274
Del Monte A, Arroyo AB, Andrés-Manzano MJ, García-Barberá N, Caleprico MS, Vicente V, Roldán V, González-Conejero R, Martínez C, Andrés V. miR-146a deficiency in hematopoietic cells is not involved in the development of atherosclerosis. PLoS One. 2018 Jun 14;13(6):e0198932. doi: 10.1371/journal.pone.0198932. PMID: 29902229
De Los Reyes-García AM, Arroyo AB, Teruel-Montoya R, Vicente V, Lozano ML, González-Conejero R, Martínez C. MicroRNAs as potential regulators of platelet function and bleeding diatheses. Platelets. 2018 May 22:1-6. doi: 10.1080/09537104.2018.1475635. PMID: 29787683
Rivera-Caravaca JM, Esteve-Pastor MA, Marín F, Valdés M, Vicente V, Roldán V, Lip GYH. A Propensity Score Matched Comparison of Clinical Outcomes in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Comparing the "Real-World" vs Clinical Trials. Mayo Clin Proc. 2018 May 2. pii: S0025-6196(18)30117-4. doi: 10.1016/j.mayocp.2018.01.028.PMID: 29730090
Arroyo AB, de Los Reyes-García AM, Teruel-Montoya R, Vicente V, González-Conejero R, Martínez C. microRNAs in the haemostatic system: More than witnesses of thromboembolic diseases? Thromb Res. 2018 Jun;166:1-9. doi: 10.1016/j.thromres.2018.03.021. PMID: 29649766
Serna MJ, Rivera-Caravaca JM, Gonzalez-Conejero R, Esteve-Pastor MA, Valdés M, Vicente V, Lip GYH, Roldán V, Marín F. Pharmacogenetics of vitamin K antagonists and bleeding risk prediction in atrial fibrillation. Eur J Clin Invest. 2018 Jun;48(6):e12929. doi: 10.1111/eci.12929. Epub 2018 Apr 17. PMID: 29577257
Rivera-Caravaca JM, Roldán V, Romera M, Esteve-Pastor MA, Valdés M, Lip GYH, Vicente V, Marín F. Soluble Fibrin Monomer Complex and Prediction of Cardiovascular Events in Atrial Fibrillation: The Observational Murcia Atrial Fibrillation Project. J Gen Intern Med. 2018 Jun;33(6):847-854. doi: 10.1007/s11606-017-4279-4.PMID: 29569024
de la Morena-Barrio B, de la Morena-Barrio ME, Padilla J, Teruel-Montoya R, Asenjo S, Wypasek E, Undas A, Miñano A, Vicente V, Corral J. Identification of a New Mechanism of Antithrombin Deficiency Hardly Detected by Current Methods: Duplication of SERPINC1 Exon 6. Thromb Haemost. 2018 May;118(5):939-941. doi: 10.1055/s-0038-1637721. Epub 2018 Mar 21. PMID: 29564838
Abad F, de la Morena-Barrio ME, Fernández-Breis JT, Corral J. Lost in Translation: Bioinformatic Analysis of Variations Affecting the Translation Initiation Codon in the Human Genome. Bioinformatics. 2018 Jun 1. doi: 10.1093/bioinformatics/bty453. PMID: 29868922
Zeng W, Hu B, Tang L, You YY, Toderici M, Eugenia de la Morena-Barrio M, Corral J, Hu Y. Correction: Recurrent mutations in a SERPINC1 hotspot associate with venous thrombosis without apparent antithrombin deficiency. Oncotarget. 2018 Feb 16;9(13):11428. doi: 10.18632/oncotarget.24519. PMID: 29542734
Rivera J, Gardiner EE. An exit strategy for new platelets. Blood. 2018 Mar 8;131(10):1041-1042. doi: 10.1182/blood-2018-01-826453. PMID: 29519929
Pérez-Sánchez C, Arias-de la Rosa I, Aguirre MÁ, Luque-Tévar M, Ruiz-Limón P, Barbarroja N, Jiménez-Gómez Y, Ábalos-Aguilera MC, Collantes-Estévez E, Segui P, Velasco F, Herranz MT, Lozano-Herrero J, Hernandez-Vidal MJ, Martínez C, González-Conejero R, Radin M, Sciascia S, Cecchi I, Cuadrado MJ, López-Pedrera C. Circulating microRNAs as biomarkers of disease and typification of the atherothrombotic status in antiphospholipid syndrome. Haematologica. 2018 May;103(5):908-918. doi: 10.3324/haematol.2017.184416. PMID: 29545345
Vivas D, Roldán I, Ferrandis R, Marín F, Roldán V, Tello-Montoliu A, Ruiz-Nodar JM, Gómez-Doblas JJ, Martín A, Llau JV, Ramos-Gallo MJ, Muñoz R, Arcelus JI, Leyva F, Alberca F, Oliva R, Gómez AM, Montero C, Arikan F, Ley L, Santos-Bueso E, Figuero E, Bujaldón A, Urbano J, Otero R, Hermida JF, Egocheaga I, Llisterri JL, Lobos JM, Serrano A, Madridano O, Ferreiro JL; Perioperative and Periprocedural Management of Antithrombotic Therapy: Consensus Document . Rev Esp Cardiol (Engl Ed). 2018 Jul;71(7):553-564. doi: 10.1016/j.rec.2018.01.029. PMID: 29887180
Marín F, Roldán V. Oral anticoagulation and comorbidities; too many details for clinical practice? Int J Cardiol. 2018 Aug 1;264:93-94. doi: 10.1016/j.ijcard.2018.03.115. No abstract available. PMID: 29776577
Roldán V, Marín F. Optimizing Vitamin K Antagonist Treatment in Patients with Mechanical Heart Valve Prosthesis. Thromb Haemost. 2018 May;118(5):806-807. doi: 10.1055/s-0038-1641737. PMID: 29625499
Rivera-Caravaca JM, Roldán V, Esteve-Pastor MA, Valdés M, Vicente V, Marín F, Lip GYH.Prediction of long-term net clinical outcomes using the TIMI-AF score: Comparison with CHA2DS2-VASc and HAS-BLED. Am Heart J. 2018 Mar;197:27-34. doi: 10.1016/j.ahj.2017.11.004. Epub 2017 Nov 10. PMID: 29447781
Arroyo AB, de Los Reyes-García AM, Rivera-Caravaca JM, Valledor P, García-Barberá N, Roldán V, Vicente V, Martínez C, González-Conejero R.MiR-146a Regulates Neutrophil Extracellular Trap Formation That Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation. Arterioscler Thromb Vasc Biol. 2018 Feb 8. pii: ATVBAHA.117.310597. doi: 10.1161/ATVBAHA.117.310597. [Epub ahead of print]. PMID: 29437577
Rivera-Caravaca JM, Marín F, Esteve-Pastor MA, Valdés M, Vicente V, Roldán V, Lip GYH.Antiplatelet therapy combined with acenocoumarol in relation to major bleeding, ischaemic stroke and mortality. Int J Clin Pract. 2018 Feb 12. doi: 10.1111/ijcp.13069. [Epub ahead of print]. PMID: 29436121
Salloum-Asfar S, de la Morena-Barrio ME, Esteban J, Miñano A, Aroca C, Vicente V, Roldán V, Corral J.Assessment of two contact activation reagents for the diagnosis of congenital factor XI deficiency. Thromb Res. 2018 Jan 3;163:64-70. doi: 10.1016/j.thromres.2017.12.023. [Epub ahead of print]. PMID: 29367083
Rivera-Caravaca JM, Roldán V, Esteve-Pastor MA, Valdés M, Vicente V, Marín F, Lip GYH.Reduced Time in Therapeutic Range and Higher Mortality in Atrial Fibrillation Patients Taking Acenocoumarol. Clin Ther. 2018 Jan;40(1):114-122. doi: 10.1016/j.clinthera.2017.11.014. Epub 2017 Dec 21. PMID: 29275065
Esteve-Pastor MA, Rivera-Caravaca JM, Roldán V, Vicente V, Romiti GF, Romanazzi I, Proietti M, Valdés M, Marín F, Lip GYH. Estimated absolute effects on efficacy and safety outcomes of using non-vitamin K antagonist oral anticoagulants in 'real-world' atrial fibrillation patients: A comparison with optimally acenocoumarol anticoagulated patients. Int J Cardiol. 2018 Mar 1;254:125-131. doi: 10.1016/j.ijcard.2017.11.087. Epub 2017 Dec 14. PMID: 29248163
Zeng W, Hu B, Tang L, You YY, Toderici M, Eugenia de la Morena-Barrio M, Corral J, Hu Y. Correction: Recurrent mutations in a SERPINC1 hotspot associate with venous thrombosis without apparent antithrombin deficiency. Oncotarget. 2018 Feb 16;9(13):11428. doi: 10.18632/oncotarget.24519. eCollection 2018 Feb 16. PMID: 29542734
Pastori D, Rivera-Caravaca JM, Esteve-Pastor MA, Roldán V, Marín F, Pignatelli P, Violi F, Lip GYH. Comparison of the 2MACE and TIMI-AF Scores for Composite Clinical Outcomes in Anticoagulated Atrial Fibrillation Patients. Circ J. 2018 Mar 16. doi: 10.1253/circj.CJ-17-1318. PMID: 29553090
Esteve-Pastor MA, Orenes-Piñero E, Roldán V, Lacunza-Ruiz J, Valdés M, Marín F. Intra-ventricular thrombus resolution after anticoagulation therapy with rivaroxaban in patient with poor anticoagulation quality. Cardiol J. 2018;25(1):151-154. doi: 10.5603/CJ.2018.0014.PMID: 29512103
Esteve-Pastor MA, Rivera-Caravaca JM, Roldán-Rabadán I, Roldán V, Muñiz J, Raña-Míguez P, Ruiz-Ortiz M, Cequier Á, Bertomeu-Martínez V, Badimón L, Anguita M, Lip GYH, Marín F; FANTASIIA Study Investigators. Relation of Renal Dysfunction to Quality of Anticoagulation Control in Patients with Atrial Fibrillation: The FANTASIIA Registry. Thromb Haemost. 2018 Feb;118(2):279-287. doi: 10.1160/TH17-06-0416. Epub 2018 Jan 29. PMID: 29443369
Rivera J, Gardiner EE. An exit strategy for new platelets. Blood. 2018 Mar 8;131(10):1041-1042. doi: 10.1182/blood-2018-01-826453. PMID: 29519929
Perez-Sánchez C, Arias-de la Rosa I, Aguirre MÁ, Luque-Tévar M, Ruiz-Limón P, Barbarroja N, Jiménez-Gómez Y, Ábalos-Aguilera MC, Collantes-Estévez E, Segui P, Velasco F, Herranz MT, Lozano-Herrero J, Hernandez-Vidal MJ, Martínez C, González-Conejero R, Radin M, Sciascia S, Cecchi I, Cuadrado MJ, López-Pedrera C. Circulating microRNAs as biomarkers of disease and typification of the atherothrombotic status in Antiphospholipid Syndrome. Haematologica. 2018 Mar 15. pii: haematol.2017.184416. doi: 10.3324/haematol.2017.184416.PMID: 29545345
Español I, Romera M, Gutiérrez-Meca MD, García MDC, Tejedor A, Martínez A, Ibáñez J, De Arriba F, Minguela A, Iturbe T, López MD. Carfilzomib and dexamethasone for extramedullary myeloma with pleuropericardial involvement. Clin Case Rep. 2017 Jun 22;5(8):1258-1260. doi: 10.1002/ccr3.1015. eCollection 2017 Aug. PMID: 28781837
Ribera JM, Morgades M, Montesinos P, Martino R, Barba P, Soria B, Bermúdez A, Moreno MJ, González-Campos J, Vives S, Gil C, Abella E, Guàrdia R, Martínez-Carballeira D, Martínez-Sánchez P, Amigo ML, Mercadal S, Serrano A, López-Martínez A, Vall-Llovera F, Sánchez-Sánchez MJ, Peñarrubia MJ, Calbacho M, Méndez JA, Bergua J, Cladera A, Tormo M, García-Belmonte D, Feliu E, Ciudad J, Orfao A; PETHEMA Group, Spanish Society of Hematology. Efficacy and safety of native versus pegylated Escherichia coli asparaginase for treatment of adults with high-risk, Philadelphia chromosome-negative acute lymphoblastic leukemia. Leuk Lymphoma. 2017 Nov 22:1-10. doi: 10.1080/10428194.2017.1397661. [Epub ahead of print] PMID: 29165013
Gallardo D, Bosch-Vizcaya A, Rodríguez-Romanos R, Santos N, Buño I, de la Cámara R, Brunet S, Jiménez-Velasco A, González M, Nieto JB, Martínez-Laperche C, Vallejo C, Ferrá C, Sampol A, López-Jiménez J, Pérez-Simón JA, Martínez C, Díez JL. Donor CTLA-4 Genotype Modulates the Immune Response to Minor Histocompatibility Antigen Mismatches. Biol Blood Marrow Transplant. 2017 Dec;23(12):2042-2047. doi: 10.1016/j.bbmt.2017.08.003. Epub 2017 Aug 4. PMID: 28827064
Salar A, Domingo-Domenech E, Panizo C, Nicolás C, Bargay J, Muntañola A, Canales M, Bello JL, Sancho JM, Tomás JF, Rodríguez MJ, Peñalver J, Grande C, Sánchez-Blanco JJ, Palomera L, Arranz R, Conde E, García M, García JF, Caballero D, Montalbán C. Long-term results of a phase 2 study of rituximab and bendamustine for mucosa-associated lymphoid tissue lymphoma. Blood. 2017 Oct 12;130(15):1772-1774. doi: 10.1182/blood-2017-07-795302. PMID: 28801448
Motlló C, Ribera JM, Morgades M, Granada I, Montesinos P, Mercadal S, González-Campos J, Moreno MJ, Barba P, Cervera M, Barrios M, Novo A, Bernal T, Hernández-Rivas JM, Abella E, Amigo ML, Tormo M, Martino R, Lavilla E, Bergua J, Serrano A, García-Belmonte D, Guàrdia R, Grau J, Feliu E; PETHEMA Group, Spanish Society of Hematology. Frequency and prognostic significance of additional cytogenetic abnormalities to the Philadelphia chromosome in young and older adults with acute lymphoblastic leukemia. Leuk Lymphoma. 2018 Jan;59(1):146-154. doi: 10.1080/10428194.2017.1326596. PMID: 2855425
Sanikommu SR, Clemente MJ, Chomczynski P, Afable MG 2nd, Jerez A, Thota S, Patel B, Hirsch C, Nazha A, Desamito J, Lichtin A, Pohlman B, Sekeres MA, Radivoyevitch T, Maciejewski JP. Clinical features and treatment outcomes in large granular lymphocytic leukemia (LGLL). Leuk Lymphoma. 2018 Feb;59(2):416-422. doi: 10.1080/10428194.2017.1339880. PMID: 28633612
Osorio S, Escudero-Vilaplana V, Reguilón-Gallego L, Gómez-Centurión I, Díez JL, Ferrer-Marín F. Severe liver toxicity in a chronic myeloid leukemia patient probably induced by a drug interaction between imatinib and sertraline. J Oncol Pharm Pract. 2017 Jan 1:1078155217735689. doi: 10.1177/1078155217735689. PMID: 29065786
Hernández-Boluda JC, Pereira A, Correa JG, Alvarez-Larrán A, Ferrer-Marín F, Raya JM, Martínez-López J, Pérez-Encinas M, Estrada N, Velez P, Fox ML, García-Gutiérrez V, Payer A, Kerguelen A, Cuevas B, Durán MA, Ramírez MJ, Gómez-Casares MT, Mata-Vázquez MI, Mora E, Martínez-Valverde C, Gómez M, Cervantes F. Performance of the myelofibrosis secondary to PV and ET-prognostic model (MYSEC-PM) in a series of 262 patients from the Spanish registry of myelofibrosis. Leukemia. 2017 Sep 22. doi: 10.1038/leu.2017.297. PMID: 28935991
Alonso-Dominguez JM, Casado LF, Anguita E, Gomez-Casares MT, Buño I, Ferrer-Marín F, Arenas A, Del Orbe R, Ayala R, Llamas P, Salgado RN, Osorio S, Sanchez-Godoy P, Burgaleta C, Mahíllo-Fernández I, Garcia-Gutierrez V, Steegmann JL, Martinez-Lopez J. PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phase. PLoS One. 2017 Jul 13;12(7):e0181366. doi: 10.1371/journal.pone.0181366. PMID: 28704552
Alvarez-Larrán A, Senín A, Fernández-Rodríguez C, Pereira A, Arellano-Rodrigo E, Gómez M, Ferrer-Marin F, Martínez-López J, Camacho L, Colomer D, Angona A, Navarro B, Cervantes F, Besses C, Bellosillo B, Hernández-Boluda JC. Impact of genotype on leukaemic transformation in polycythaemia vera and essential thrombocythaemia. Br J Haematol. 2017 Sep;178(5):764-771. doi: 10.1111/bjh.14762. PMID: 28542718
Hernández-Boluda JC, Correa JG, Alvarez-Larrán A, Ferrer-Marín F, Raya JM, Martínez-López J, Velez P, Pérez-Encinas M, Estrada N, García-Gutiérrez V, Fox ML, Luño E, Kerguelen A, Cuevas B, Durán MA, Ramírez MJ, Gómez-Casares M, Mata-Vázquez MI, Regadera A, Pereira A, Cervantes F; Grupo Español de Enfermedades Mieloproliferativas Filadelfia Negativas (GEMFIN). Clinical characteristics, prognosis and treatment of myelofibrosis patients with severe thrombocytopenia. Br J Haematol. 2017 Apr 17. doi: 10.1111/bjh.14601. PMID: 28419426
Hernández-Boluda JC, Correa JG, García-Delgado R, Martínez-López J, Alvarez-Larrán A, Fox ML, García-Gutiérrez V, Pérez-Encinas M, Ferrer-Marín F, Mata-Vázquez MI, Raya JM, Estrada N, García S, Kerguelen A, Durán MA, Albors M, Cervantes F.Predictive factors for anemia response to erythropoiesis-stimulating agents in myelofibrosis. Eur J Haematol. 2017 Apr;98(4):407-414. doi: 10.1111/ejh.12846. PMID: 28009442
Alvarez-Larrán A, Pérez-Encinas M, Ferrer-Marín F, Hernández-Boluda JC, Ramírez MJ, Martínez-López J, Magro E, Cruz Y, Mata MI, Aragües P, Fox ML, Cuevas B, Montesdeoca S, Hernández-Rivas JA, García-Gutiérrez V, Gómez-Casares MT, Steegmann JL, Durán MA, Gómez M, Kerguelen A, Bárez A, García MC, Boqué C, Raya JM, Martínez C, Albors M, García F, Burgaleta C, Besses C; Grupo Español de Neoplasias Mieloproliferativas Filadelfia Negativas. Risk of thrombosis according to need of phlebotomies in patients with polycythemia vera treated with hydroxyurea. Haematologica. 2017 Jan;102(1):103-109. doi: 10.3324/haematol.2016.152769. PMID: 27686377
Español I, Romera M, Gutiérrez-Meca MD, García MDC, Tejedor A, Martínez A, Ibáñez J, De Arriba F, Minguela A, Iturbe T, López MD. Carfilzomib and dexamethasone for extramedullary myeloma with pleuropericardial involvement. Clin Case Rep. 2017 Jun 22;5(8):1258-1260. doi: 10.1002/ccr3.1015. PMID: 28781837
Chen-Liang TH, Martín-Santos T, Jerez A, Rodríguez-García G, Senent L, Martínez-Millán C, Muiña B, Orero M, Teruel A, Martín A, Gómez-Espuch J, Kennedy K, Benet C, Raya JM, Fernández-González M, de la Cruz F, Guinot M, Villegas C, Ballester I, Baile M, Moya M, López-Jiménez J, Frutos L, Navarro JL, Uña J, Fernández-López R, Igua C, Contreras J, Sánchez-Vañó R, Cozar MDP, Tamayo P, Mucientes J, Sánchez-Blanco JJ, Pérez-Ceballos E, Ortuño FJ. Bone marrow biopsy superiority over PET/CT in predicting progression-free survival in a homogeneously-treated cohort of diffuse large B-cell lymphoma. Cancer Med. 2017 Sep 27. doi: 10.1002/cam4.1205. PMID: 28960797
Gutiérrez-Cívicos R, Hurtado AM, Torres-Moreno D, Sanchez-Blanco JJ, Español I, Consuegra-Sánchez L, Perez-Ceballos E, Gutiérrez-Meca MD, Jerez A, Conesa-Zamora P. Rituximab response in follicular lymphoma is associated with the rs20575 polymorphism in TRAILR1 extrinsic apoptosis trigger. Pharmacogenet Genomics. 2017 Feb;27(2):70-77. doi: 10.1097/FPC.0000000000000262. PMID: 27977511
Kharfan-Dabaja MA, Parody R, Perkins J, Lopez-Godino O, Lopez-Corral L, Vazquez L, Caballero D, Falantes J, Shapiro J, Ortí G, Barba P, Valcárcel D, Esquirol A, Martino R, Piñana JL, Solano C, Tsalatsanis A, Pidala J, Anasetti C, Perez-Simón JA. Tacrolimus plus sirolimus with or without ATG as GVHD prophylaxis in HLA-mismatched unrelated donor allogeneic stem cell transplantation. Bone Marrow Transplant. 2017 Mar;52(3):438-444. doi: 10.1038/bmt.2016.269. PMID: 27819684
Gallardo D, Bosch-Vizcaya A, Rodríguez-Romanos R, Santos N, Buño I, de la Cámara R, Brunet S, Jiménez-Velasco A, González M, Nieto JB, Martínez-Laperche C, Vallejo C, Ferrá C, Sampol A, López-Jiménez J, Pérez-Simón JA, Martínez C, Díez JL; GvHD/Immunotherapy Committee of the Spanish Hematopoietic Transplant Group. Donor CTLA-4 Genotype Modulates the Immune Response to Minor Histocompatibility Antigen Mismatches. Biol Blood Marrow Transplant. 2017 Aug 4. pii: S1083-8791(17)30618-3. doi: 10.1016/j.bbmt.2017.08.003. PMID: 28827064
Kwon M, Bautista G, Balsalobre P, Sánchez-Ortega I, Montesinos P, Bermúdez A, de Laiglesia A, Herrera P, Martin C, Humala K, Zabalza A, Torres M, Bento L, Corral LL, Heras I, Serrano D, Buño I, Anguita J, Regidor C, Duarte R, Cabrera R, Gayoso J, Diez-Martin JL. Haplo-Cord transplantation compared to haploidentical transplantation with post-transplant cyclophosphamide in patients with AML. Bone Marrow Transplant. 2017 Mar 27. doi: 10.1038/bmt.2017.36. PMID: 28346415
Cabrero M, Martin A, Briones J, Gayoso J, Jarque I, López J, Grande C, Heras I, Arranz R, Bernal T, Perez-Lopez E, López-Godino O, Conde E, Caballero D. Phase II Study of Yttrium-90-Ibritumomab Tiuxetan as Part of Reduced-Intensity Conditioning (with Melphalan, Fludarabine ± Thiotepa) for Allogeneic Transplantation in Relapsed or Refractory Aggressive B Cell Lymphoma: A GELTAMO Trial. Biol Blood Marrow Transplant. 2017 Jan;23(1):53-59. doi: 10.1016/j.bbmt.2016.10.003. PMID: 27771496
Lahuerta JJ, Paiva B, Vidriales MB, Cordón L, Cedena MT, Puig N, Martinez-Lopez J, Rosiñol L, Gutierrez NC, Martín-Ramos ML, Oriol A, Teruel AI, Echeveste MA, de Paz R, de Arriba F, Hernandez MT, Palomera L, Martinez R, Martin A, Alegre A, De la Rubia J, Orfao A, Mateos MV, Blade J, San-Miguel JF. Depth of Response in Multiple Myeloma: A Pooled Analysis of Three PETHEMA/GEM Clinical Trials. J Clin Oncol. 2017 May 12:JCO2016692517. doi: 10.1200/JCO.2016.69.2517. PMID: 28498784
Rosiñol L, Oriol A, Teruel AI, de la Guía AL, Blanchard M, de la Rubia J, Granell M, Sampol M, Palomera L, González Y, Etxebeste M, Martínez-Martínez R, Hernández MT, de Arriba F, Alegre A, Cibeira M, Mateos M, Martínez-López J, Lahuerta JJ, San Miguel J, Bladé J. Bortezomib and thalidomide maintenance after stem cell transplantation for multiple myeloma: a PETHEMA/GEM trial. Leukemia. 2017 Feb 14. doi: 10.1038/leu.2017.35. PMID: 28111466.
Mateos MV, Oriol A, Martínez-López J, Teruel AI, Bengoechea E, Palomera L, de Arriba F, Esseltine DL, Cakana A, Pei L, van de Velde H, Miguel JS. Outcomes with two different schedules of bortezomib, melphalan, and prednisone (VMP) for previously untreated multiple myeloma: matched pair analysis using long-term follow-up data from the phase 3 VISTA and PETHEMA/GEM05 trials. Ann Hematol. 2016 Dec;95(12):2033-2041. PMID: 27738789.
González-Gascón Y Marín I, Martín AÁ, Hernández-Sanchez M, Robledo C, Hermosín ML, de Las Heras N, Lacalle L, Galende J, de Arriba F, Rodríguez-Vicente AE, Hernández JÁ, Hernández-Rivas JM. Hyperdiploidy as a rare event that accompanies poor prognosis markers in CLL. Eur J Haematol. 2017 Feb;98(2):142-148. doi: 10.1111/ejh.12812.
Calvo X, Arenillas L, Luño E, Senent L, Arnan M, Ramos F, Pedro C, Tormo M, Montoro J, Díez-Campelo M, Blanco ML, Arrizabalaga B, Xicoy B, Bonanad S, Jerez A, Nomdedeu M, Ferrer A, Sanz GF, Florensa L. Enumerating bone marrow blasts from nonerythroid cellularity improves outcome prediction in myelodysplastic syndromes and permits a better definition of the intermediate risk category of the Revised International Prognostic Scoring System (IPSS-R). Am J Hematol. 2017 Jul;92(7):614-621. doi: 10.1002/ajh.24732. PMID: 28370234
Hosono N, Makishima H, Mahfouz R, Przychodzen B, Yoshida K, Jerez A, LaFramboise T, Polprasert C, Clemente MJ, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Sanada M, Cui E, Verma AK, McDevitt MA, List AF, Saunthararajah Y, Sekeres MA, Boultwood J, Ogawa S, Maciejewski JP. Recurrent genetic defects on chromosome 5q in myeloid neoplasms. Oncotarget. 2017 Jan 24;8(4):6483-6495. doi: 10.18632/oncotarget.14130. PMID: 28031539
Gutiérrez-Cívicos R, Hurtado AM, Torres-Moreno D, Sanchez-Blanco JJ, Español I, Consuegra-Sánchez L, Perez-Ceballos E, Gutiérrez-Meca MD, Jerez A, Conesa-Zamora P.Rituximab response in follicular lymphoma is associated with the rs20575 polymorphism in TRAILR1 extrinsic apoptosis trigger. Pharmacogenet Genomics. 2017 Feb;27(2):70-77. doi: 10.1097/FPC.0000000000000262. PMID: 27977511
Motlló C, Ribera JM, Morgades M, Granada I, Montesinos P, Mercadal S, González-Campos J, Moreno MJ, Barba P, Cervera M, Barrios M, Novo A, Bernal T, Hernández-Rivas JM, Abella E, Amigo ML, Tormo M, Martino R, Lavilla E, Bergua J, Serrano A, García-Belmonte D, Guàrdia R, Grau J, Feliu E; PETHEMA Group, Spanish Society of Hematology. Frequency and prognostic significance of additional cytogenetic abnormalities to the Philadelphia chromosome in young and older adults with acute lymphoblastic leukemia. Leuk Lymphoma. 2017 May 30:1-9. doi: 10.1080/10428194.2017.1326596. PMID: 28554259
Sanchez R, Ayala R, Alonso RA, Martínez MP, Ribera J, García O, Sanchez-Pina J, Mercadal S, Montesinos P, Martino R, Barba P, González-Campos J, Barrios M, Lavilla E, Gil C, Bernal T, Escoda L, Abella E, Amigo ML, Moreno MJ, Bravo P, Guàrdia R, Hernández-Rivas JM, García-Guiñón A, Piernas S, Ribera JM, Martínez-López J.Clinical characteristics of patients with central nervous system relapse in BCR-ABL1-positive acute lymphoblastic leukemia: the importance of characterizing ABL1 mutations in cerebrospinal fluid. Ann Hematol. 2017 Jul;96(7):1069-1075. doi: 10.1007/s00277-017-3002-1. PMID: 28451802
Motlló C, Ribera JM, Morgades M, Granada I, Montesinos P, Brunet S, Bergua J, Tormo M, García-Boyero R, Sarrà J, Del Potro E, Grande C, Barba P, Bernal T, Amigo ML, Grau J, Cervera J, Feliu E. Frequency and prognostic significance of t(v;11q23)/KMT2A rearrangements in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols. Leuk Lymphoma. 2017 Jan;58(1):145-152. PMID: 27122129
Martínez C, Jorge AS, Pereira A, Moreno M, Núñez J, Gayoso J, Gonzalez-Medina J, Revilla N, Sampol A, Domingo-Domenech E, de la Cruz F, Morales A, Rodriguez-Salazar MJ, Valiente S, Pérez-Ceballos E, de Oteyza JP, García-Sanz R. Comorbidities, not age, are predictive of survival after autologous hematopoietic cell transplantation for relapsed/refractory Hodgkin's lymphoma in patients older than 50 years. Ann Hematol. 2017 Jan;96(1):9-16. doi: 10.1007/s00277-016-2832-6. PMID: 27752822
Puiggros A, Collado R, Calasanz MJ, Ortega M, Ruiz-Xivillé N, Rivas-Delgado A, Luño E, González T, Navarro B, García-Malo M, Valiente A, Hernández JÁ, Ardanaz MT, Piñan MÁ, Blanco ML, Hernández-Sánchez M, Batlle-López A, Salgado R, Salido M, Ferrer A, Abrisqueta P, Gimeno E, Abella E, Ferrá C, Terol MJ, Ortuño F, Costa D, Moreno C, Carbonell F, Bosch F, Delgado J, Espinet B. Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of TP53/ ATM FISH deletions. Oncotarget. 2017 Apr 21. doi: 10.18632/oncotarget.17350. PMID: 28493833
Baptista MJ, Granada I, Morgades M, Calasanz MJ, Canals J, Robles De Castro D, Luño E, Ruiz-Xivillé N, Rodríguez-Hernández I, González T, Terol MJ, Valiente A, Ortuño F, Garcia-Malo MD, Piñan MÁ, Oliveira AC, Talavera M, Buño I, Batlle-López A, Moreno C, Ferra C, Solé F. Monosomal karyotype in chronic lymphocytic leukemia: Association with clinical and biological features and potential prognostic significance. Am J Hematol. 2017 Jul;92(7):E132-E135. doi: 10.1002/ajh.24754. PMID: 28383114
Cid AR, Montesinos P, Sánchez-Guiu I, Haya S, Lorenzo JI, Sanz J, Moscardo F, Puig N, Planelles D, Bonanad S, Sanz GF, Vicente V, González-Manchón C, Lozano ML, Rivera J, Sanz MA. Allogeneic hematopoietic cell transplantation in an adult patient with Glanzmann thrombasthenia. Clin Case Rep. 2017 Oct 5;5(11):1887-1890. doi: 10.1002/ccr3.1206. eCollection 2017 Nov. PMID: 29152293
Rivera-Caravaca JM, Marín F, Esteve-Pastor MA, Raña-Míguez P, Anguita M, Muñiz J, Cequier Á, Bertomeu-Martínez V, Valdés M, Vicente V, Lip GYH, Roldán V. Usefulness of the 2MACE Score to Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation. Am J Cardiol. 2017 Dec 15;120(12):2176-2181. doi: 10.1016/j.amjcard.2017.09.003. Epub 2017 Sep 19. PMID: 29111209
Caparrós-Pérez E, Teruel-Montoya R, Palma-Barquero V, Torregrosa JM, Blanco JE, Delgado JL, Lozano ML, Vicente V, Sola-Visner M, Rivera J, Martínez C, Ferrer-Marín F. Down Regulation of the Munc18b-syntaxin-11 Complex and β1-tubulin Impairs Secretion and Spreading in Neonatal Platelets. Thromb Haemost. 2017 Nov;117(11):2079-2091. doi: 10.1160/TH17-04-0241. Epub 2017 Nov 30. PMID: 29044293
Zeng W, Hu B, Tang L, You YY, Toderici M, de la Morena-Barrio ME, Corral J, Hu Y.Recurrent mutations in a SERPINC1 hotspot associate with venous thrombosis without apparent antithrombin deficiency. Oncotarget. 2017 Sep 28;8(48):84417-84425. doi: 10.18632/oncotarget.21365. eCollection 2017 Oct 13. PMID: 29137435
Esteve-Pastor MA, Rivera-Caravaca JM, Roldán-Rabadán I, Roldán V, Muñiz J, Raña-Míguez P, Ruiz-Ortiz M, Cequier Á, Bertomeu-Martínez V, Badimón L, Anguita M, Lip GYH, Marín F Quality of oral anticoagulation with vitamin K antagonists in 'real-world' patients with atrial fibrillation: a report from the prospective multicentre FANTASIIA registry. Europace. 2017 Oct 31. doi: 10.1093/europace/eux314. [Epub ahead of print]. PMID: 29095971
Esteve-Pastor MA, Rivera-Caravaca JM, Shantsila A, Roldán V, Lip GYH, Marín F. Assessing Bleeding Risk in Atrial Fibrillation Patients: Comparing a Bleeding Risk Score Based Only on Modifiable Bleeding Risk Factors against the HAS-BLED Score. The AMADEUS Trial. Thromb Haemost. 2017 Dec;117(12):2261-2266. doi: 10.1160/TH17-10-0710. Epub 2017 Dec 6. No abstract available. PMID: 29212113
Esteban J, de la Morena-Barrio ME, Salloum-Asfar S, Padilla J, Miñano A, Roldán V, Soria JM, Vidal F, Corral J, Vicente V.High incidence of FXI deficiency in a Spanish town caused by 11 different mutations and the first duplication of F11: Results from the Yecla study. Haemophilia. 2017 Sep 27. doi: 10.1111/hae.13356. PMID: 28960694
Rivera-Caravaca JM, Roldán V, Esteve-Pastor MA, Valdés M, Vicente V, Lip GYH, Marín F. Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation. Sci Rep. 2017 Sep 21;7(1):12066. doi: 10.1038/s41598-017-11683-2. PMID: 28935868
Roldán V, Rivera-Caravaca JM, Shantsila A, García-Fernández A, Esteve-Pastor MA, Vilchez JA, Romera M, Valdés M, Vicente V, Marín F, Lip GYH. Enhancing the 'real world' prediction of cardiovascular events and major bleeding with the CHA2DS2-VASc and HAS-BLED scores using multiple biomarkers. Ann Med. 2017 Sep 18:1-9. doi: 10.1080/07853890.2017.1378429. PMID: 28892413
Vicente V, Martín A, Lecumberri R, Coll-Vinent B, Suero C, González-Porras JR, Marco P, Mateo J, Roldán V, Soulard S, Crespo C, Camats M; Grupo DECOVER. Clinical perspectives on the management of bleeding in patients on oral anticoagulants: the DECOVER Study (DElphi Consensus on oral COagulation and therapy action reVERsal). Emergencias. 2017 Feb;29(1):18-26. PMID: 28825264
de la Morena-Barrio ME, Ballesta-Martínez MJ, López-Gálvez R, Antón AI, López-González V, Martínez-Ribot L, Padilla J, Miñano A, García-Algar O, Del Campo M, Corral J, Guillén-Navarro E, Vicente V. Genetic predisposition to fetal alcohol syndrome: association with congenital disorders of N-glycosylation. Pediatr Res. 2017 Sep 20. doi: 10.1038/pr.2017.201. PMID: 28820871
Caparrós-Pérez E, Teruel-Montoya R, López-Andreo MJ, Llanos MC, Rivera J, Palma-Barqueros V, Blanco JE, Vicente V, Martínez C, Ferrer-Marín F. Comprehensive comparison of neonate and adult human platelet transcriptomes. PLoS One. 2017 Aug 16;12(8):e0183042. doi: 10.1371/journal.pone.0183042. eCollection 2017. PMID: 28813466
Esteve-Pastor MA, Rivera-Caravaca JM, Roldan V, Vicente V, Valdés M, Marín F, Lip GYH. Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores. The Murcia Atrial Fibrillation Project. Thromb Haemost. 2017 Oct 5;117(10):1848-1858. doi: 10.1160/TH17-07-0478. PMID: 28799620
Takeichi T, Torrelo A, Lee JYW, Ohno Y, Lozano ML, Kihara A, Liu L, Yasuda Y, Ishikawa J, Murase T, Rodrigo AB, Fernández-Crehuet P, Toi Y, Mellerio J, Rivera J, Vicente V, Kelsell DP, Nishimura Y, Okuno Y, Kojima D, Ogawa Y, Sugiura K, Simpson MA, McLean WHI, Akiyama M, McGrath JA. Biallelic Mutations in KDSR Disrupt Ceramide Synthesis and Result in a Spectrum of Keratinization Disorders Associated with Thrombocytopenia. J Invest Dermatol. 2017 Nov;137(11):2344-2353. doi: 10.1016/j.jid.2017.06.028. PMID: 28774589
Sevivas T, Bastida JM, Paul DS, Caparros E, Palma-Barqueros V, Coucelo M, Marques D, Ferrer-Marín F, González-Porras JR, Vicente V, Hernández-Rivas JM, Watson SP, Lozano ML, Bergmeier W, Rivera J. Identification of two novel mutations in RASGRP2 affecting platelet CalDAG-GEFI expression and function in patients with bleeding diathesis. Platelets. 2017 Aug 1:1-4. doi: 10.1080/09537104.2017.1336214PMID: 28762304
Águila S, Izaguirre G, Martínez-Martínez I, Vicente V, Olson ST, Corral J. Disease-causing mutations in the serpin antithrombin reveal a key domain critical for inhibiting protease activities. J Biol Chem. 2017 Oct 6;292(40):16513-16520. doi: 10.1074/jbc.M117.787325. PMID: 28743742
Rivera-Caravaca JM, Roldán V, Esteve-Pastor MA, Valdés M, Vicente V, Lip GYH, Marín F. Long-Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC-Stroke and CHA2DS2-VASc Scores. J Am Heart Assoc. 2017 Jul 20;6(7). pii: e006490. doi: 10.1161/JAHA.117.006490. PMID: 28729407
Bastida JM, Benito R, Janusz K, Díez-Campelo M, Hernández-Sánchez JM, Marcellini S, Girós M, Rivera J, Lozano ML, Hortal A, Hernández-Rivas JM, González-Porras JR. Two novel variants of the ABCG5 gene cause xanthelasmas and macrothrombocytopenia: a brief review of hematologic abnormalities of sitosterolemia. J Thromb Haemost. 2017 Sep;15(9):1859-1866. doi: 10.1111/jth.13777. Epub 2017 Aug 5. PMID: 28696550
Proietti M, Hijazi Z, Andersson U, Connolly SJ, Eikelboom JW, Ezekowitz MD, Lane DA, Oldgren J, Roldan V, Yusuf S, Wallentin L; RE-LY Investigators. Comparison of Bleeding Risk Scores in Patients with Atrial Fibrillation:Insights from the RE-LY Trial. J Intern Med. 2017 Oct 16. doi: 10.1111/joim.12702. PMID: 29044861
Rivera-Caravaca JM, Esteve-Pastor MA, Roldán V, Marín F, Lip GYH. Non-vitamin K antagonist oral anticoagulants: impact of non-adherence and discontinuation. Expert Opin Drug Saf. 2017 Sep;16(9):1051-1062. doi: 10.1080/14740338.2017.1351542. Epub 2017 Jul 12. PMID: 28678553
García-Fernández A, Roldán V, Marín F. Strategies for prediction and early detection of atrial fibrillation: present and future. Europace. 2017 Apr 1;19(4):515-517. doi: 10.1093/europace/euw131. PMID: 28431067
Bastida JM, Lozano ML, Benito R, Janusz K, Palma-Barqueros V, Del Rey M, Hernández-Sánchez JM, Riesco S, Bermejo N, González-García H, Rodriguez-Alén A, Aguilar C, Sevivas T, López-Fernández MF, Marneth AE, van der Reijden BA, Morgan NV, Watson SP, Vicente V, Hernández-Rivas JM, Rivera J, González-Porras JR; Project; Group of the Castilla y Leon Society of Thrombosis and Haemostasis. Introducing high-throughput sequencing into mainstream of genetic diagnosis practice in inherited platelet disorders. Haematologica. 2017 Oct 5. pii: haematol.2017.171132. doi: 10.3324/haematol.2017.171132. PMID: 28983057
García-Fernández A, Roldán V, Marín F. Strategies for prediction and early detection of atrial fibrillation: present and future. Europace. 2017 Apr 1;19(4):515-517. doi: 10.1093/europace/euw131. PMID: 28431067
Roldán V, Marín F.Predicting bleeding risk after coronary surgery: Let's focus on modifiable risk factors and simple, practical decision making. Thromb Haemost. 2017 Apr 3;117(4):647-649. doi: 10.1160/TH17-02-0131. PMID: 28276568
Rivera-Caravaca JM, Viedma-Viedma I, Roldán V . Factors Affecting the Quality of Anticoagulation With Vitamin K Antagonists in Venous Thromboembolism Patients. Biol Res Nurs. 2017 Mar;19(2):198-205. doi: 10.1177/1099800416671211. PMID: 27680769
Arribas F; SEC Working Group for the 2016 ESC Guidelines for the Management of Atrial Fibrillation:, Arribas F, Roldán I, Luis Merino J, Roldán V, Arenal Ÿ, Tamargo J, Ruiz-Granell R, Mont L, Anguita M, Marín F; Reviewers for the 2016 ESC Guidelines for the Management of Atrial Fibrillation:, Barrios Alonso V, Barón G, Esquivias, Cosín Sales J, Díaz Infante E, Escobar Cervantes C, Ferreiro Gutiérrez JL, Guerra Ramos JM, Jiménez Candil FJ, Pérez Castellano N, Sambola Ayala A, Tello Montoliu A; SEC Guidelines Committee:, San Román A, Alfonso F, Arribas F, Evangelista A, Ferreira I, Jiménez M, Marín F, de Isla LP, Rodríguez Padial L, Sánchez PL, Sionis A, Vázquez R. Comments on the 2016 ESC Guidelines for the Management of Atrial Fibrillation. Rev Esp Cardiol (Engl Ed). 2017 Jan;70(1):2-8. doi: 10.1016/j.rec.2016.11.032. PMID: 28038728
Esteve-Pastor MA, García-Fernández A, Roldán V, Marín F. Evaluation of HAS-BLED and ORBIT Bleeding Risk Scores in Nonvalvular Atrial Fibrillation Patients Receiving Oral Anticoagulants. Rev Esp Cardiol (Engl Ed). 2017 Feb;70(2):132-133. doi: 10.1016/j.rec.2016.11.006. PMID: 28034682
García-Fernández A, Roldán V, Rivera-Caravaca JM, Lip GY, Marín F. Applicability of the modified CHA2DS2-VASc score for stroke risk stratification in Caucasian atrial fibrillation patients. Eur J Intern Med. 2017 Mar;38:e21-e22. doi: 10.1016/j.ejim.2016.11.006. PMID: 27863991
Wypasek E, Corral J, Alhenc-Gelas M, Sydor W, Iwaniec T, Celińska-Lowenhoff M, Potaczek DP, Blecharczyk A, Zawilska K, Musiał J, Undas A.Genetic characterization of antithrombin, protein C and protein S deficiencies in Polish patients. Pol Arch Intern Med. 2017 Jun 13. doi: 10.20452/pamw.4045. PMID: 28607330
Vossen CY, van Hylckama Vlieg A, Teruel-Montoya R, Salloum-Asfar S, de Haan H, Corral J, Reitsma P, Koeleman BPC, Martínez C.Identification of coagulation gene 3'UTR variants that are potentially regulated by microRNAs. Br J Haematol. 2017 Jun;177(5):782-790. doi: 10.1111/bjh.14629. PMID: 28444748
Orsini S, Noris P, Bury L, Heller PG, Santoro C, Kadir RA, Butta NC, Falcinelli E, Cid AR, Fabris F, Fouassier M, Miyazaki K, Lozano ML, Zuñiga P, Flaujac C, Podda GM, Bermejo N, Favier R, Henskens Y, De Maistre E, De Candia E, Mumford AD, Ozdemir NG, Eker I, Nurden P, Bayart S, Lambert MP, Bussel J, Zieger B, Tosetto A, Melazzini F, Glembotsky AC, Pecci A, Cattaneo M, Schlegel N, Gresele P.Bleeding risk of surgery and its prevention in patients with inherited platelet disorders. The Surgery in Platelet disorders And Therapeutic Approach (SPATA) study. Haematologica. 2017 Apr 6. pii: haematol.2016.160754. doi: 10.3324/haematol.2016.160754. PMID: 28385783
Pérez-Sánchez C, Ruiz-Limón P, Aguirre MA, Jiménez-Gómez Y, Arias-de la Rosa I, Ábalos-Aguilera MC, Rodriguez-Ariza A, Castro-Villegas MC, Ortega-Castro R, Segui P, Martinez C, Gonzalez-Conejero R, Rodríguez-López S, Gonzalez-Reyes JA, Villalba JM, Collantes-Estévez E, Escudero A, Barbarroja N, López-Pedrera C.Diagnostic potential of NETosis-derived products for disease activity, atherosclerosis and therapeutic effectiveness in Rheumatoid Arthritis patients. J Autoimmun. 2017 Apr 29. pii: S0896-8411(17)30043-4. doi: 10.1016/j.jaut.2017.04.007. PMID: 28465139
Laquente B, Calsina-Berna A, Carmona-Bayonas A, Jiménez-Fonseca P, Peiró I, Carrato A. Supportive care in pancreatic ductal adenocarcinoma. Clin Transl Oncol. 2017 Jun 13. doi: 10.1007/s12094-017-1682-6. PMID: 28612201
Fernández-Muñoz H, Castilla-Llorente C, Plaza EM, Martínez-Millán C, Heras I, Iniesta P, Amigo ML, Ferrer-Marin F, Candela MJ, Lozano ML, Vicente V, Rivera J.Quality assessment and transfusion efficacy of buffy coat-derived platelet concentrates washed with platelet additive solution.Blood Transfus. 2017 Apr 13:1-6. doi: 10.2450/2017.0277-16.PMID: 28488971
Lopez-Onieva L, Lamolda M, Montes R, Lozano ML, Vicente V, Rivera J, Ramos-Mejía V, Real PJ. Induced pluripotent stem cells derived from Bernard-Soulier Syndrome patient's peripheral blood cells with a p.Phe55Ser mutation in the GPIX gene. Stem Cell Res. 2017 Apr;20:10-13. doi: 10.1016/j.scr.2017.02.001. PMID: 28395735
Rivera-Caravaca JM, Roldán V, Esteve-Pastor MA, Valdés M, Vicente V, Lip GY, Marín F.Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients. Thromb Haemost. 2017 Mar 23. doi: 10.1160/TH16-12-0961. PMID: 28331926
Revilla N, de la Morena-Barrio ME, Miñano A, López-Gálvez R, Toderici M, Padilla J, García-Avello Á, Lozano ML, Lefeber DJ, Corral J, Vicente V. Transient desialylation in combination with a novel antithrombin deficiency causing a severe and recurrent thrombosis despite anticoagulation therapy. Sci Rep. 2017 Mar 17;7:44556. doi: 10.1038/srep44556. PMID: 28303970
B Arroyo A, Salloum-Asfar S, Pérez-Sánchez C, Teruel-Montoya R, Navarro S, García-Barberá N, Luengo-Gil G, Roldán V, Hansen JB, López-Pedrera C, Vicente V, González-Conejero R, Martínez C. Regulation of TFPIα expression by miR-27a/b-3p in human endothelial cells under normal conditions and in response to androgens. Sci Rep. 2017 Feb 27;7:43500. doi: 10.1038/srep43500. PMID: 28240250
de la Morena-Barrio M, Sandoval E, Llamas P, Wypasek E, Toderici M, Navarro-Fernández J, Rodríguez-Alen A, Revilla N, López-Gálvez R, Miñano A, Padilla J, de la Morena-Barrio B, Cuesta J, Corral J, Vicente VHigh levels of latent antithrombin in plasma from patients with antithrombin deficiency. Thromb Haemost. 2017 May 3;117(5):880-888. doi: 10.1160/TH16-11-0866. PMID: 28229161
García-Fernández A, Roldán V, Rivera-Caravaca JM, Hernández-Romero D, Valdés M, Vicente V, Lip GY, Marín F.Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation?. Sci Rep. 2017 Jan 30;7:41565. doi: 10.1038/srep41565. PMID: 28134282
Lopez-Onieva L, Machuca C, Lamolda M, Montes R, Lozano ML, Vicente V, Rivera J, Ramos-Mejía V, Real PJ. Generation of a human induced pluripotent stem cell (iPSC) line from a Bernard-Soulier syndrome patient with the mutation p.Asn45Ser in the GPIX gene. Stem Cell Res. 2016 Nov;17(3):603-606. doi: 10.1016/j.scr.2016.11.012. PMID: 27934591
Bastida JM, Del Rey M, Revilla N, Benito R, Perez-Andrés M, González B, Riesco S, Janusz K, Padilla J, Hortal Benito-Sendin A, Bueno D, Blanco E, Hernández-Rivas M, Vicente V, Rivera J, González-Porras R, Lozano ML. Wiskott-Aldrich syndrome in a child presenting with macrothrombocytopenia. Platelets. 2017 Jun;28(4):417-420. doi: 10.1080/09537104.2016.1246715. PMID: 27885891
Caballero-Velázquez T, Montero I, Sánchez-Guijo F, Parody R, Saldaña R, Valcarcel D, López-Godino O, Ferra I Coll C, Cuesta M, Carrillo-Vico A, Sánchez-Abarca LI, López-Corral L, Márquez-Malaver FJ, Pérez-Simón JA; GETH (Grupo Español de Trasplante Hematopoyético).IMMUNOMODULATORY EFFECT OF VITAMIN D AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: RESULTS OF A PROSPECTIVEMULTICENTER CLINICAL TRIAL. Clin Cancer Res. 2016 Dec 1;22(23):5673-5681
Parody R, López-Corral L, Lopez-Godino O, Martinez C, Martino R, Solano C, Barba P, Caballero D, García-Cadenas I, Piñana JL, Marquez-Malaver FJ, Vazquez L, Esquirol A, Boluda JC, Sanchez-Guijo F, Pérez-Simon JA. GVHD PROPHYLAXIS WITH TACROLIMUS PLUS SIROLIMUS AFTER REDUCED INTENSITY CONDITIONING ALLOGENEIC TRANSPLANTATION: RESULTS OF A MULTICENTER STUDY. Bone Marrow Transplant. 2016 Nov;51(11):1524-1526
Velasco-Guardado A, Mora-Soler A, López-Corral L, López-Godino O, Vázquez-López L, Blanco-Muñez O, Pérez-López E, Rodríguez-Pérez A, Caballero-Barrigón D. POTENTIAL PROTECTIVE EFFECT OF HELICOBACTER PYLORI ON THE DEVELOPMENT OF GASTROINTESTINAL GRAFT VERSUS HOST DISEASE. Bone Marrow Transplant. 2016 Jun;51(6):819-24.
Hernández-Boluda JC, Martínez-Trillos A, García-Gutiérrez V, Ferrer-Marín F,Xicoy B, Alvarez-Larrán A, Kerguelen A, Barba P, Gómez M, Herrera JC, Correa JG, Cervantes F. Long-term results of prednisone treatment for the anemia of myelofibrosis. Leuk Lymphoma. 2016; 57 (1): 120-4.
M, Barba P, Mata MI, González-Porras JR, Ferrer-Marín F, García-Gutiérrez V, Magro E, Moreno M, Kerguelen A, Pérez-Encinas M, Estrada N, Ayala R, Besses C, Pereira A; Grupo Español de Enfermedades Mieloproliferativas Filadelfia Negativas(GEMFIN).
Santos N, Rodríguez-Romanos R, Nieto JB, Buño I, Vallejo C, Jiménez-Velasco A, Brunet S, Buces E, López-Jiménez J, González M, Ferrá C, Sampol A, de la Cámara R, Martínez C, Gallardo D. UGT2B17 minor histocompatibility mismatch and clinical outcome after HLA-identical sibling donor stem cell transplantation. Bone Marrow Transplant. 2016; 51 (1): 79-82.
Bosch-Vizcaya A, Rodriguez-Romanos R, Nieto JB, de la Cámara R, Brunet S, Vallejo C, Osca-Gelis G, Martínez-Laperche C, Buño I, Urbano-Ispizúa Á, González M, Jiménez-Velasco A, Gallardo D. Effect of mismatching for mHA UTA2-1 on clinical outcome after HLA-identical sibling donor allo-SCT.Bone Marrow Transplant. 2015; 50 (2): 298-300.
Muñoz-Ballester J, Chen-Liang TH, Hurtado AM, Heras I, de Arriba F, García-Malo MD, Iniesta P, Lozano ML, Nieto JB, Ortuño FJ, Osma MD, Padilla J, Teruel-Montoya R, Vicente V, Castilla-Llorente C, Jerez A. Persistent cytotoxic T lymphocyte expansions after allogeneic haematopoietic stem cell transplantation: kinetics, clinical impact and absence of STAT3 mutations.Br J Haematol. 2016; 172 (6): 937-946.
Torregrosa JM, Ferrer-Marín F, Lozano ML, Moreno MJ, Martinez C, Anton AI, Rivera J, Vicente V.Impaired leucocyte activation is underlining the lower thrombotic risk of essential thrombocythaemia patients with CALR mutations as compared with those with the JAK2 mutation.Br J Haematol.2016;172 (5): 813-815.
Ribera JM, García O, Oriol A, Gil C, Montesinos P, Bernal T, González-Campos J, Lavilla E, Ribera J, Brunet S, Martínez MP, Tormo M, Genescà E, Barba P, Sarrà J, Monteserín MC, Soria B, Colorado M, Cladera A, García-Guiñón A, Calbacho M, Serrano A, Ortín X, Pedreño M, Amigo ML, Escoda L, Feliu E; PETHEMA Group, Spanish Society of Hematology. Feasibility and results of subtype-oriented protocols in older adults and fit elderly patients with acute lymphoblastic leukemia: Results of three prospective parallel trials from the PETHEMA group.Leuk Res. 2016; 41:12-20.
Xicoy B, Germing U, Jimenez MJ, Garcia O, Garcia R, Schemenau J, Pedro C, Luño E, Bernal T, González B, Strupp C, Ardanaz M, Kuendgen A, Cedena MT, Neukirchen J, Calabuig M, Brunet S, Medina A, Amigo ML, Ramos F, Callejas M, Díez-Campelo M, Bailén A, Collado R, Vicente A, Arnan M, Valcarcel D, Arilla MJ, Zamora L, Benlloch L, Sanz G. Response to erythropoietic-stimulating agents in patients with chronic myelomonocytic leukemia.Eur J Haematol. 2016; 97 (1): 33-38.
Peñalver FJ, Delgado J, Loscertales J, Sastre JL, Peña A, Olave MT, Osorio S, de la Fuente A, Salar A, Grande C, Pérez Ceballos E, Debén G, Echeveste A, Casado F, de la Rubia J, Lahuerta JJ, Mateos MV. Recommendations on the clinical use of bendamustine in lymphoproliferative syndromes and multiple myeloma. Eur J Haematol. 2016; 96 (5): 532-540.
Paiva B, Mateos MV, Sanchez-Abarca LI, Puig N, Vidriales MB, López-Corral L, Corchete LA, Hernandez MT, Bargay J, de Arriba F, De La Rubia J, Teruel AI, Giraldo P, Rosiñol L, Prosper F, Oriol A, Hernández J, Esteves G, Lahuerta JJ, Blade J, Perez- Simon JA, San Miguel JF. Immune status of high-risk smoldering multiple myeloma patients and its therapeutic modulation under LenDex: a longitudinal analysis.Blood 2016; 127 (9): 1151-1162.
Gómez M, Guillem V, Pereira A, Ferrer-Marín F, Álvarez-Larrán A, Kerguelen A, Estrada N, Martínez-López J, Angona A, Amat P, Navarro B, Besses C, Hernández- Boluda JC. Risk factors for non-melanoma skin cancer in patients with essential thrombocythemia and polycythemia vera. Eur J Haematol. 2016; 96 (3): 285-290. Álvarez-Román MT, Rivas Pollmar MI, Bernardino JI, Lozano ML, Martín-Salces M, Fernández-Bello I, Jiménez-Yuste V, Butta NV. Thrombopoietin receptor agonists in conjunction with oseltamivir for immune thrombocytopenia.AIDS. 2016; 30 (7): 1141-1142.
Motlló C, Ribera JM, Morgades M, Granada I, Montesinos P, Brunet S, Bergua J, Tormo M, García-Boyero R, Sarrà J, Del Potro E, Grande C, Barba P, Bernal T, Amigo ML, Grau J, Cervera J, Feliu E; PETHEMA Group, Spanish Society of Hematology. Frequency and prognostic significance of t(v;11q23)/KMT2A rearrangements in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols. Leuk Lymphoma. 2016; 27:1-8.
Gutiérrez-Cívicos R, Hurtado AM, Torres-Moreno D, Sanchez-Blanco JJ, Español I, Consuegra-Sánchez L, Perez-Ceballos E, Gutiérrez-Meca MD, Jerez A, Conesa-Zamora P. A polymorphism in FASL is associated with rituximab response in follicular lymphoma patients. Am J Hematol. 2016; 91 (6):E305-7
Lozano ML, Revilla N, Gonzalez-Lopez TJ, Novelli S, González-Porras JR, Sánchez- Gonzalez B, Bermejo N, Pérez S, Lucas FJ, Álvarez MT, Arilla MJ, Perera M, do Nascimento J, Campos RM, Casado LF, Vicente V. Real-life management of primary immune thrombocytopenia (ITP) in adult patients and adherence to practice guidelines. Ann Hematol. 2016; 95 (7): 1089-98.
Besses C, Hernández-Boluda JC, Pérez Encinas M, Raya JM, Hernández-Rivas JM, Jiménez Velasco A, Martínez Lopez J, Vicente V, Burgaleta C; Current opinion and consensus statement regarding the diagnosis, prognosis, and treatment of patients with essential thrombocythemia: a survey of the Spanish Group of Ph-negative Myeloproliferative Neoplasms (GEMFIN) using the Delphi method.GEMFIN. Ann Hematol. 2016; 95 (5):719-32.
Villegas A, Arrizabalaga B, Bonanad S, Colado E, Gaya A, González A, Jarque I, Núñez R, Ojeda E, Orfao A, Ribera JM, Vicente V, Urbano-Ispizua Á; Spanish consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria Grupo de Trabajo de HPN de la Sociedad Española de Hematología y Hemoterapia. Med Clin (Barc). 2016;146(6):278.e1-7.
Paiva B, Corchete LA, Vidriales MB, Puig N, Maiso P, Rodriguez I, Alignani D, Burgos L, Sanchez ML, Barcena P, Echeveste MA, Hernandez MT, García-Sanz R, Ocio EM, Oriol A, Gironella M, Palomera L, De Arriba F, Gonzalez Y, Johnson SK, Epstein J, Barlogie B, Lahuerta JJ, Blade J, Orfao A, Mateos MV, San Miguel JF; Phenotypic and genomic analysis of multiple myeloma minimal residual disease tumor cells: a new model to understand chemoresistance. Grupo Español de Mieloma/Programa para el Estudio de la Terapéutica en Hemopatías Malignas (GEM/PETHEMA) Cooperative Study Groups. Blood. 2016;127 (15):1896-906.
D.Navarro,P. Amat, R. de la Cámara, J. López, L. Vázquez, D. Serrano, J. Nieto,. Rovira, J. L Piñana, E. Giménez, and C. Solano. Efficacy and Safety of a Preemptive Antiviral Therapy Strategy Based on Combined Virological and Immunological Monitoring for Active Cytomegalovirus Infection in Allogeneic Stem Cell Transplant Recipients. Open Forum Infectious Diseases 2016 May 18;3(2):ofw107.
Corrales I, Solano C, Amat P, Giménez E, de la Cámara R, Nieto J, López J, García-Noblejas A, Piñana JL, Navarro D. IL28B genetic variation and cytomegalovirus-specific T-cell immunity in allogeneic stem cell transplant recipients. J Med Virol. 2016 Sep 3. doi: 10.1002/jmv.24676.
Cabrero M, Martín A, Briones J, Gayoso J, Jarque I, López J, Grande C, Heras I, Arranz R, Bernal T, Perez-Lopez E, López-Godino O, Conde E, Caballero D. Phase II Study of Yjrium-90-Ibritumomab Tiuxetan as Part of Reduced-Intensity CondiMoning (with Melphalan, Fludarabine ± Thiotepa) for Allogeneic TransplantaMon in Relapsed or Refractory Aggressive B Cell Lymphoma: A GELTAMO Trial. Biol Blood Marrow Transplant. 2016 Oct 19. pii: S1083-8791
Gayoso J, Balsalobre P, Pascual MJ, Castilla-Llorente C, López-Corral L, Kwon M, Serrano D, Piñana JL, Herrera P, Ferrá C, Pascual C, Heras I, Montesinos P, Zabalza A, Bento L, Figuera A, Buño I, Díez-Martín JL. Busulfan-based reduced intensity condiMoning regimens for haploidentical transplantation in relapsed/refractory Hodgkin lymphoma: Spanish multicenter experience. Bone Marrow Transplant. 2016 Oct;51(10):1307-1312.
Mateos MV, Oriol A, Martínez-López J, Teruel AI, Bengoechea E, Palomera L, de Arriba F, Esseltine DL, Cakana A, Pei L, van de Velde H, Miguel JS. Outcomes with two different schedules of bortezomib, melphalan, and prednisone (VMP) for previously untreated multiple myeloma: matched pair analysis using long-term follow-up data from the phase 3 VISTA and PETHEMA/GEM05 trials. Ann Hematol. 2016 Dec;95(12):2033-2041.
Mateos MV, Hernández MT, Giraldo P, de la Rubia J, de Arriba F, Corral LL, Rosiñol L, Paiva B, Palomera L, Bargay J, Oriol A, Prosper F, López J, Arguiñano JM, Quintana N, García JL, Bladé J, Lahuerta JJ, Miguel JF. Lenalidomide plus dexamethasone versus observation in patients with high-risk smouldering multiple myeloma (QuiRedex): longterm follow-up of a randomised, controlled, phase 3 trial. Lancet Oncol. 2016 Aug;17(8):1127-36.
Dimopoulos MA, Palumbo A, Corradini P, Cavo M, Delforge M, Di Raimondo F, Weisel KC, Oriol A, Hansson M, Vacca A, Blanchard MJ, Goldschmidt H, Doyen C, Kaiser M, Petrini M, Anyla P, Cafro AM, Raymakers R, San-Miguel J, de Arriba F, Knop S, Röllig C, Ocio EM, Morgan G, Miller N, Simcock M, Peluso T, Herring J, Sternas L, Zaki MH, Moreau P. Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUS (MM-010): a phase 3b study in refractory multiple myeloma. Blood. 2016 Jul 28;128(4):497-503.
Paiva B, Corchete LA, Vidriales MB, Puig N, Maiso P, Rodriguez I, Alignani D, Burgos L, Sanchez ML, Barcena P, Echeveste MA, Hernandez MT, García-Sanz R, Ocio EM, Oriol A, Gironella M, Palomera L, De Arriba F, Gonzalez Y, Johnson SK, Epstein J, Barlogie B, Lahuerta JJ, Blade J, Orfao A, Mateos MV, San Miguel JF. Phenotypic and genomic analysis of mulMple myeloma minimal residual disease tumor cells: a new model to understand chemoresistance. Blood. 2016 Apr 14;127(15):1896-906.
Paiva B, Mateos MV, Sanchez-Abarca LI, Puig N, Vidriales MB, López-Corral L, Corchete LA, Hernandez MT, Bargay J, de Arriba F, de la Rubia J, Teruel AI, Giraldo P, Rosiñol L, Prosper F, Oriol A, Hernández J, Esteves G, Lahuerta JJ, Bladé J, Perez-Simon JA, San Miguel JF. Immune status of high-risk smoldering multiple myeloma paMents and its therapeuMc modulation under LenDex: a longitudinal analysis. Blood. 2016 Mar 3;127(9):1151-62.
Vagace JM, Cardesa R, Corbacho A, Vázquez T, de la Maya MD, Gonzalez FA, Nieto JB, UrruMa E, Gómez MJ, Pascual T, Aguinaco MR, Gervasini G. EMopathological mechanisms and clinical characterisMcs of hyperhemolysis syndrome in Spanish paMents with thalassemia. Ann Hematol. 2016 Sep;95(9):1419-27.
Santos N, Rodríguez-Romanos R, Nieto JB, Buño I, Vallejo C, Jiménez-Velasco A, Brunet S, Buces E, López-Jiménez J, González M, Ferrá C, Sampol A, de la Cámara R, Martínez C, Gallardo D. UGT2B17 minor histocompatibility mismatch and clinical outcome after HLA-idenMcal sibling donor stem cell transplantaMon. Bone Marrow Transplant. 2016 Jan;51(1):79-82.
Ribera JM, García O, Oriol A, Gil C, Montesinos P, Bernal T, González-Campos J, Lavilla E, Ribera J, Brunet S, Martínez MP, Tormo M, Genescà E, Barba P, Sarrà J, Monteserín MC, Soria B, Colorado M, Cladera A, García-Guiñón A, Calbacho M, Serrano A, Ornn X, Pedreño M, Amigo ML, Escoda L, Feliu E. Feasibility and results of subtype-oriented protocols in older adults and fit elderly paMents with acute lymphoblastic leukemia: Results of three prospective parallel trials from the PETHEMA group. Leuk Res. 2016 Feb;41:12-20.
Xicoy B, Germing U, Jimenez MJ, Garcia O, Garcia R, Schemenau J, Pedro C, Luño E, Bernal T, González B, Strupp C, Ardanaz M, Kuendgen A, Cedena MT, Neukirchen J, Calabuig M, Brunet S, Medina A, Amigo ML, Ramos F, Callejas M, Díez-Campelo M, Bailén A, Collado R, Vicente A, Arnan M, Valcarcel D, Arilla MJ, Zamora L, Benlloch L, Sanz G. Response to erythropoietic-stimulating agents in patients with chronic myelomonocytic leukemia. Eur J Haematol. 2016 Jul;97(1):33-8.
Martínez C, Díaz-López A, Rodriguez-Calvillo M, García-Sanz R, Terol MJ, Pérez-Ceballos E, Jiménez MJ, Cantalapiedra A, Domingo-Domenech E, Rodriguez MJ, Sampol A, Espeso M, López FJ, Briones J, García JF, Sureda A. Phase II trial of ofatumumab plus ESHAP (O-ESHAP) as salvage treatment for paMents with relapsed or refractory classical Hodgkin lymphoma after first-line chemotherapy. Br J Haematol. 2016 Sep;174(6): 859-67.
GuMérrez-Cívicos R, Hurtado AM, Torres-Moreno D, Sanchez-Blanco JJ, Español I, Consuegra-Sánchez L, Perez-Ceballos E, GuMérrez-Meca MD, Jerez A, Conesa-Zamora P. A polymorphism in FASL is associated with rituximab response in follicular lymphoma patients. Am J Hematol. 2016 Jun;91(6):E305-7.
Marnn-Marnn L, Almeida J, Pomares H, González-Barca E, Bravo P, Giménez T, Heras C, Queizán JA, Pérez-Ceballos E, Martínez V, Alonso N, Calvo C, Álvarez R, Caballero MD, Orfao A. BlasMc plasmacytoid dendriMc cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapy. Oncotarget. 2016 Mar 1;7(9):10174-81.
Peñalver FJ, Delgado J, Loscertales J, Sastre JL, Peña A, Olave MT, Osorio S, de la Fuente A, Salar A, Grande C, Pérez Ceballos E, Debén G, Echeveste A, Casado F, de la Rubia J, Lahuerta JJ, Mateos MV. Recommendations on the clinical use of bendamustine in lymphoproliferaMve syndromes and multiple myeloma. Eur J Haematol. 2016 May; 96(5):532-40.
Calvo X, Arenillas L, Luño E, Senent L, Arnan M, Ramos F, Ardanaz MT, Pedro C, Tormo M, Montoro J, Díez-Campelo M, Arrizabalaga B, Xicoy B, Bonanad S, Jerez A, Nomdedeu B, Ferrer A, Sanz GF, Florensa LErythroleukemia shares biological features and outcome with myelodysplasMc syndromes with excess blasts: a rationale for its inclusion into future classifications of myelodysplastic syndromes. Mod Pathol. 2016 Dec;29(12): 1541-1551.
Arenillas L, Calvo X, Luño E, Senent L, Alonso E, Ramos F, Ardanaz MT, Pedro C, Tormo M, Marco V, Montoro J, Díez-Campelo M, Brunet S, Arrizabalaga B, Xicoy B, Andreu R, Bonanad S, Jerez A, Nomdedeu B, Ferrer A, Sanz GF, Florensa L. Considering Bone Marrow Blasts From Nonerythroid Cellularity Improves the Prognostic Evaluation of Myelodysplastic Syndromes. J Clin Oncol. 2016 Sep 20;34(27):3284-92.
Flores MA, Fortea P, Trinidad EM, García D, Soler G, Ortuño FJ, Zapata AG, Alonso- Colmenar LM. EphrinA4 plays a critical role in α4 and αL mediated survival of human CLL cells during extravasaMon. Oncotarget. 2016 Jul 26;7(30):48481-48500.
Alvarez-Larrán A, Pereira A, Guglielmelli P, Hernández-Boluda JC, Arellano-Rodrigo E, Ferrer-Marín F, Samah A, Griesshammer M, Kerguelen A, Andreasson B, Burgaleta C, Schwarz J, García-GuMérrez V, Ayala R, Barba P, Gómez-Casares MT, Paoli C, Drexler B, Zweegman S, McMullin MF, Samuelsson J, Harrison C, Cervantes F, Vannucchi AM, Besses C. AnMplatelet therapy versus observaMon in low-risk essential thrombocythemia with a CALR mutation. Haematologica. 2016 Aug;101(8):926-31
Alvarez-Larrán A, Kerguelen A, Hernández-Boluda JC, Pérez-Encinas M, Ferrer-Marín F, Bárez A, Martínez-López J, Cuevas B, Mata MI, García-Gutiérrez V, Aragües P, Montesdeoca S, Burgaleta C, Caballero G, Hernández-Rivas JA, Durán MA, Gómez- Casares MT, Besses C. Frequency and prognosMc value of resistance/intolerance to hydroxycarbamide in 890 patients with polycythaemia vera. Br J Haematol. 2016 Mar; 172(5):786-93.
Gómez M, Guillem V, Pereira A, Ferrer-Marín F, Álvarez-Larrán A, Kerguelen A, Estrada N, Martínez-López J, Angona A, Amat P, Navarro B, Besses C, Hernández-Boluda JC. Risk factors for non-melanoma skin cancer in paMents with essenMal thrombocythemia and polycythemia vera. Eur J Haematol. 2016 Mar;96(3):285-90
Hernández-Boluda JC, Martínez-Trillos A, García-Gutiérrez V, Ferrer-Marín F, Xicoy B, Alvarez-Larrán A, Kerguelen A, Barba P, Gómez M, Herrera JC, Correa JG, Cervantes F. Long-term results of prednisone treatment for the anemia of myelofibrosis. Leuk Lymphoma. 2016;57(1):120-4
Motlló C, Ribera JM, Morgades M, Granada I, Montesinos P, Brunet S, Bergua J, Tormo M, García-Boyero R, Sarrà J, Del Potro E, Grande C, Barba P, Bernal T, Amigo ML, Grau J, Cervera J, Feliu E Frequency and prognostic significance of t(v;11q23)/KMT2A rearrangements in adult paMents with acute lymphoblasMc leukemia treated with riskadapted protocols. Leuk Lymphoma. 2017 Jan;58(1):145-152.
Macauda A, Calvey D, Maccari G, Hemminki K, FörsM A, Goldschmidt H, Weinhold N, Houlston R, Andersen V, Vogel U, Buda G, Varkonyi J, Sureda A, Martínez Lopez J, Watek M, Butrym A, Sarasquete ME, Dudziński M, Jurczyszyn A, Druzd-Sitek A, Kruszewski M, Subocz E, Petrini M, Iskierka-Jażdżewska E, Raźny M, Szombath G, Marques H, Zawirska D, Chraniuk D, Halka J, Hove Jacobsen SE, Mazur G, García Sanz R, Dumontet C, Moreno V, Stępień A, Beider K, Pelosini M, Manuel Reis R, Krawczyk-Kulis M, Rymko M, Avet- Loiseau H, Lesueur F, Grząśko N, Ostrovsky O, Jamroziak K, Vangsted AJ, Jerez A, Tomczak W, Zaucha JM, Kadar K, Sainz J, Nagler A, Landi S, Gemignani F, Canzian F. IdentificaMon of miRSNPs associated with the risk of multiple myeloma. Int J Cancer. 2017 Feb 1;140(3):526-534.
Torregrosa JM, Ferrer-Marín F, Lozano ML, Moreno MJ, Martínez C, Anton AI,Rivera J, Vicente V. Impaired leucocyte activation is underlining the lower thrombotic risk of essential thrombocythaemia patients with CALR mutations as compared with those with the JAK2 mutaMon. Br J Haematol. 2016 Mar;172(5):813-5. Muñoz-Ballester J, Chen-Liang TH, Hurtado AM, Heras I, de Arriba F,García-Malo MD, Iniesta P, Lozano ML, Nieto JB, Ortuño FJ, Osma Mdel M, Padilla J, Teruel-Montoya R, Vicente V, Castilla-Llorente C, Jerez A. Persistent cytotoxic T lymphocyte expansions after allogeneic haematopoietic stem cell transplantation: kinetics, clinical impact and absence of STAT3 mutations. Br J Haematol. 2016 Mar;172(6):937-46.
Cervantes F, Correa JG, Pérez I, García-GuMérrez V, Redondo S, Colomer D, Jiménez- Velasco A, Steegmann JL, Sánchez-Guijo F, Ferrer-Marín F, Pereira A, Osorio S . Imatinib dose reducMon in paMents with chronic myeloid leukemia in sustained deep molecular response. Ann Hematol. 2016 Oct 8.
González-Gascón Y Marín I, Martín AÁ, Hernández-Sanchez M, Robledo C, Hermosín ML, de Las Heras N, Lacalle L, Galende J, de Arriba F, Rodríguez-Vicente AE, Hernández JÁ, Hernández-Rivas JM. Hyperdiploidy as a rare event that accompanies poor prognosis markers in CLL. Eur J Haematol. 2016 Sep 26. doi: 10.1111/ejh.12812.
Martínez C, Jorge AS, Pereira A, Moreno M, Núñez J, Gayoso J, Gonzalez-Medina J, Revilla N, Sampol A, Domingo-Domenech E, de la Cruz F, Morales A, Rodriguez-Salazar MJ, Valiente S, Pérez-Ceballos E, de Oteyza JP, García-Sanz R. Comorbidities, not age, are predicMve of survival a}er autologous hematopoietic cell transplantation for relapsed/refractory Hodgkin's lymphoma in patients older than 50 years. Ann Hematol. 2016 Oct 18.
Ríos-Tamayo R, Lupiañez CB, Campa D, Hielscher T, Weinhold N, Martínez-López J, Jerez A, Landi S, Jamroziak K, Dumontet C, Wątek M, Lesueur F, Reis RM, Marques H, Jurczyszyn A, Vogel U, Buda G, García-Sanz R, Orciuolo E, Petrini M, Vangsted AJ, Gemignani F, Försti A, Goldschmidt H, Hemminki K, Canzian F, Jurado M, Sainz J. A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: Results from the IMMEnSE consortium and meta-analysis. Oncotarget. 2016 Jul 18. doi: 10.18632/oncotarget.10665.
Blanco G, Puiggros A, Baliakas P, Athanasiadou A, García-Malo M, Collado R, Xochelli A, Rodríguez-Rivera M, Ortega M, Calasanz MJ, Luño E, Vargas M, Grau J, Martínez- Laperche C, Valiente A, Cervera J, Anagnostopoulos A, Gimeno E, Abella E, Stalika E, Hernández-Rivas JM, Ortuño FJ, Robles D, Ferrer A, Ivars D, González M, Bosch F, Abrisqueta P, Stamatopoulos K, Espinet B. Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberraMons. Oncotarget. 2016 Nov 4doi:10.18632/oncotarget. 13106.
Alvarez-Larrán A, Pérez-Encinas M, Ferrer-Marin F, Hernández-Boluda JC, Ramírez MJ, Martínez-López J, Magro E, Cruz Y, Mata MI, Aragües P, Fox ML, Cuevas B, Montesdeoca S, Hernández-Rivas JA, García-GuMérrez V, Gómez-Casares MT, Steegmann JL, Durán MA, Gómez M, Kerguelen A, Bárez A, García MC, Boqué C, Raya JM, Martínez C, Albors M, Garcia F, Burgaleta C, Besses CRisk of thrombosis according to need of phlebotomies in paMents with polycythemia vera treated with hydroxyurea. Haematologica. 2016 Sep 29. pii: haematol.2016.152769.
Squizzato A, Hunt BJ, Kinasewitz GT, Wada H, Ten Cate H, Thachil J, Levi M, Vicente V, D'Angelo A, Di Nisio M.Supportive management strategies for disseminated intravascular coagulation. An international consensus. ThrombHaemost. 2016;115 (5): 896-904.
Cerezo-Manchado JJ, Roldán V, Corral J, Rosafalco M, Antón AI, Padilla J, Vicente V, González-ConejeroR. Genotype-guided therapy improves initial acenocoumarol dosing. Results from a prospective randomised study. ThrombHaemost. 2016; 115 (1):117-25.
Bastida JM, Del Rey M, Lozano ML, Sarasquete ME, Benito R, Fontecha ME, Fisac R, García-Frade LJ, Aguilar C, Martínez MP, Pardal E, Aguilera C, Pérez B, Ramos R, Cardesa MR, Martin-Antorán JM, Silvestre LA, Cebeira MJ, Bermejo N, Riesco S, Mendoza MC, García-Sanz R, González-Díaz M, Hernández-Rivas JM, González- Porras JR. Design and application of a 23-gene panel by next-generation sequencing for inherited coagulation bleeding disorders. Haemophilia. 2016;22:590-7.
Ali HO, Arroyo AB, González-Conejero R, Stavik B, Iversen N, Sandset PM, Martínez C, Skretting G. The role of microRNA-27a/b and microRNA-494 in estrogen-mediated downregulation of tissue factor pathway inhibitor α. J Thromb Haemost. 2016;14:1226-37.
Lopez-Onieva L, Montes R, Lamolda M, Romero T, Ayllon V, Lozano ML, Vicente V, Rivera J, Ramos-Mejía V, Real PJ. Generation of induced pluripotent stem cells (iPSCs) from a Bernard-Soulier syndrome patient carrying a W71R mutation in the GPIX gene. Stem Cell Res. 2016;16 (3): 692-5.
Bohdan N, Espín S, Águila S, Teruel-Montoya R, Vicente V, Corral J, Martínez- Martínez I. Heparanase Activates Antithrombin through the Binding to Its Heparin Binding Site. PLoS One. 2016; 11 (6): e0157834. Martos L, Bonanad S, Ramón LA, Cid AR, Bonet E, Corral J, Miralles M, España F, Navarro S, Medina P. A simplified assay for the quantification of circulating activated protein C. Clin Chim Acta. 2016; 459:101-4.
Salloum-Asfar S, Arroyo AB, Teruel-Montoya R, García-Barberá N, Roldán V, Vicente V, Martínez C, González-Conejero R. MiRNA-Based Regulation of Hemostatic Factors through Hepatic Nuclear Factor-4 Alpha. PLoS One. 2016; 11 (5):e0154751.
Navarro-Fernández J, de la Morena-Barrio ME, Padilla J, Miñano A, Bohdan N, Águila S, Martínez-Martínez I, Sevivas TS, de Cos C, Fernández-Mosteirín N, Llamas P, Asenjo S, Medina P, Souto JC, Overvad K, Kristensen SR, Corral J, Vicente V. Antithrombin Dublin (p.Val30Glu): a relatively common variant with moderate thrombosis risk of causing transient antithrombin deficiency. Thromb Haemost. 2016; 116 (1): 146-54.
Toderici M, de la Morena-Barrio ME, Padilla J, Miñano A, Antón AI, Iniesta JA, Herranz MT, Fernández N, Vicente V, Corral J. Identification of Regulatory Mutations in SERPINC1 Affecting Vitamin D Response Elements Associated with Antithrombin Deficiency. PLoS One. 2016 22; 11 (3): e0152159.
García-Botella A, Asenjo S, De la Morena-Barrio ME, Corral J, Bolaños E, Carlin PS, López ES, García AJ. First case with antithrombin deficiency, mesenteric vein thrombosis and pregnancy: Multidisciplinary diagnosis and successful management. Thromb Res. 2016; 144:72-75.
Tello-Montoliu A, Rivera J, Hernández-Romero D, Silvente A, Jover E, Quintana M, Orenes-Piñero E, Hurtado J, Ferreiro JL, Marín F, Valdés M. Platelet reactivity over time in coronary artery disease patients treated with a bioabsorbable everolimus-eluting scaffold. Platelets.2016 Jun 2:1-7.Epub ahead of print.
de la Morena-Barrio ME, Martínez-Martínez I, de Cos C, Wypasek E, Roldán V, Undas A, van Scherpenzeel M, Lefeber DJ, Toderici M, Sevivas T, España F, Jaeken J, Corral J, Vicente V. Hypoglycosylation is a common finding in antithrombin deficiency in the absence of a SERPINC1 gene defect. J Thromb Haemost. 2016 May 23. doi: 10.1111/ jth.13372. Epub ahead of print.
García-Fernández A, Roldán V, Rivera-Caravaca JM, Lip GY, Marín F. Applicability of the modified CHA2DS2-VASc score for stroke risk straMficaMon in Caucasian atrial fibrillation patients. Eur J Intern Med. 2016 Nov 15. pii: S0953-6205(16)30402-2.
Esteve-Pastor MA, García-Fernández A, Macías M, Sogorb F, Valdés M, Roldán V, Muñiz J, Badimon L, Roldán I, Bertomeu-Martínez V, Cequier Á, Lip GY, Anguita M, Marín F. Is the ORBIT Bleeding Risk Score Superior to the HAS-BLED Score in Anticoagulated Atrial fibrillation patients? Circ J. 2016 Sep 23;80(10):2102-8.
Pinyol C, Cepeda JM, Roldan I, Roldan V, Jimenez S, Gonzalez P, Soto J. A SystemaMc Literature Review on the Cost-EffecMveness of Apixaban for Stroke PrevenMon in Nonvalvular Atrial fibrillation. Cardiol Ther. 2016 Dec;5(2):171-186.
Roldan V, Marín F. Assessment of bleeding risk in acute ill medical patients. An essenMal part of venous thromboembolism prevenMon. Thromb Haemost. 2016 Aug 30;116(3): 403-4.
García-Fernández A, Marín F, Roldán V, Galcerá-Jornet E, Martínez-Martínez JG, Valdés M, Sogorb F, Lip GY. The HAS-BLED score predicts long-term major bleeding and death in Anticoagulated non-valvular atrial fibrillation patients undergoing electrical cardioversion. Int J Cardiol. 2016 Aug 15;217:42-8.
Allende M, Molina E, Guruceaga E, Tamayo I, González-Porras JR, Gonzalez-López TJ, Toledo E, Rabal O, Ugarte A, Roldán V, Rivera J, Oyarzabal J, Montes R, Hermida J. Hsp70 protects from stroke in atrial fibrillation patients by prevenMng thrombosis without increased bleeding risk. Cardiovasc Res. 2016 Jun 1;110(3):309-18.
García-Fernández A, Marín F, Roldán V, Gómez-Sansano JM, Hernández-Romero D, Valdés M, Martínez-Martínez JG, Sogorb-Garri F, Lip GY. Long-Term Predictors of Thromboembolic Events in Nonvalvular Atrial fibrillation patients Undergoing Electrical Cardioversion. Circ J. 2016;80(3):605-12.
Andreu-Cayuelas JM, Pastor-Pérez FJ, Puche CM, Mateo-Martínez A, García-Alberola A, Flores-Blanco PJ, Valdés M, Lip GY, Roldán V, Manzano-Fernández S. Impact of VariaMons in Kidney Function on Nonvitamin K Oral Anticoagulant Dosing in patients With Atrial fibrillation and Recent Acute Heart Failure. Rev Esp Cardiol (Engl Ed). 2016 Feb;69(2):134-40.
Hernández-Romero D, Lahoz Á, Roldan V, Jover E, Romero-Aniorte AI, Martínez CM, Jara-Rubio R, Arribas JM, Garcia-Alberola A, Cánovas S, Valdés M, Marín F.
Von Willebrand factor is associated with atrial fibrillation development in ischaemic patients a}er cardiac surgery. Europace. 2016 Sep;18(9):1328-34.
Esteve-Pastor MA, Roldán V, Valdés M, Lip GY, Marín F. The SAMe-TT2R2 score and decision-making between a vitamin K antagonist or a non-vitamin K antagonist oral Anticoagulant in patients with atrial fibrillation. Expert Rev Cardiovasc Ther. 2016;14(2): 177-87.
Álvarez-Román MT, Rivas Pollmar MI, Bernardino JI, Lozano ML, Marn n-Salces M, Fernández-Bello I, Jiménez-Yuste V, Buja NV. Thrombopoietin receptor agonists in conjuncMon with oseltamivir for immune thrombocytopenia. AIDS. 2016 Apr 24;30(7): 1141-2.
Bastida JM, Del Rey M, Lozano ML, Sarasquete ME, Benito R, Fontecha ME, Fisac R, García-Frade LJ, Aguilar C, Martínez MP, Pardal E, Aguilera C, Pérez B, Ramos R, Cardesa MR, MarMn-Antorán JM, Silvestre LA, Cebeira MJ, Bermejo N, Riesco S, Mendoza MC, García-Sanz R, González-Díaz M, Hernández-Rivas JM, González-Porras JR. Design and applicaMon of a 23-gene panel by next-generaMon sequencing for inherited coagulaMon bleeding disorders. Haemophilia. 2016 Jul;22(4):590-7.
Watson SP, Daly ME, Harrison P, Lowe GC, Paterson A, Rivera J, Warner TD, Morgan NV. ISTH Advanced Training Course on platelet bleeding disorders: How should they be invesMgated? Platelets. 2016 Dec;27(8):719-721.
Tello-Montoliu A, Rivera J, Hernández-Romero D, Silvente A, Jover E, Quintana M, Orenes-Piñero E, Hurtado J, Ferreiro JL, Marín F, Valdés M. Platelet reactivity over time in coronary artery disease patients treated with a bioabsorbable everolimus-eluMng scaffold. Platelets. 2016 Dec;27(8):777-783.
Tang L, Zeng W, Wang QY, Toderici M, de la Morena-Barrio ME, Corral J, Hu Y. Predominant mutations in a hotspot of SERPINC1 associated with venous thromboembolism in the Chinese population: a case-control study. Lancet. 2016 Oct; 388 Suppl 1:S39.
Martos L, Bonanad S, Ramón LA, Cid AR, Bonet E, Corral J, Miralles M, España F, Navarro S, Medina P. A simplified assay for the quanMficaMon of circulating activated protein C. Clin Chim Acta. 2016 Aug 1;459:101-4.
Ali HO, Arroyo AB, González-Conejero R, Stavik B, Iversen N, Sandset PM, Martínez C, Skreyng G. The role of microRNA-27a/b and microRNA-494 in estrogen-mediated downregulaMon of Mssue factor pathway inhibitor α. J Thromb Haemost. 2016 Jun; 14(6):1226-37.
Pérez-Sánchez C, Aguirre MA, Ruiz-Limón P, Barbarroja N, Jiménez-Gómez Y, de la Rosa IA, Rodriguez-Ariza A, Collantes-Estévez E, Segui P, Velasco F, Cuadrado MJ, Teruel R, González-Conejero R, Martínez C, López-Pedrera Ch. Atherothrombosis-associated microRNAs in AnMphospholipid syndrome and Systemic Lupus Erythematosus patients'. Sci Rep. 2016 Aug 9;6:31375.
Lopez-Onieva L, Montes R, Lamolda M, Romero T, Ayllon V, Lozano ML, Vicente Rivera J, Ramos-Mejía V, Real PJ. GeneraMon of induced pluripotent stem cells(iPSCs) from a Bernard-Soulier syndrome paMent carrying a W71R mutation in the GPIX gene. Stem Cell Res. 2016 May;16(3):692-5.
Lozano ML, Cook A, Bastida JM, Paul DS, Iruin G, Cid AR, Adan-Pedroso R, González- Porras J, Hernández-Rivas JM, Fletcher SJ, Johnson B, Morgan N, Ferrer-Marin F, Vicente V, Sondek J, Watson SP, Bergmeier W, Rivera J. Novel mutations in RASGRP2, which encodes CalDAG-GEFI, abrogate Rap1 acMvaMon, causing platelet dysFunction. Blood. 2016 Sep 1;128(9):1282-9.
Lozano ML, Revilla N, Gonzalez-Lopez TJ, Novelli S, González-Porras JR, Sánchez- Gonzalez B, Bermejo N, Pérez S, Lucas FJ, Álvarez MT, Arilla MJ, Perera M, do Nascimento J, Campos RM, Casado LF, Vicente V. Real-life management of primary immune thrombocytopenia (ITP) in adult patients and adherence to pracMce guidelines. Ann Hematol. 2016 Jun;95(7):1089-98.
Lopez-Onieva L, Machuca C, Lamolda M, Montes R, Lozano ML, Vicente V, Rivera J, Ramos-Mejía V, Real PJ. GeneraMon of a human induced pluripotent stem cell(iPSC) line from a Bernard-Soulier syndrome paMent with the mutation p.Asn45Ser in the GPIX gene. Stem Cell Res. 2016 Nov 8;17(3):603-606.
Johnson B, Lowe GC, Fujerer J, Lordkipanidzé M, MacDonald D, Simpson MA, Sanchez- Guiú I, Drake S, Bem D, Leo V, Fletcher SJ, Dawood B, Rivera J, Allsup D, Biss T, Bolton- Maggs PH, Collins P, Curry N, Grimley C, James B, Makris M, Motwani J, Pavord S, Talks K, Thachil J, Wilde J, Williams M, Harrison P, Gissen P, Mundell S, Mumford A, Daly ME, Watson SP, Morgan NV.Whole exome sequencing idenMfies geneMc variants in inherited thrombocytopenia with secondary qualitaMve Function defects. Haematologica. 2016 Oct;101(10):1170-1179.
Bastida JM, Del Rey M, Revilla N, Benito R, Perez-Andrés M, González B, Riesco S, Janusz K, Padilla J, Benito-Sendin AH, Bueno D, Blanco E, Hernández-Rivas M, Vicente V, Rivera J, González-Porras R, Lozano ML. Wiskoj-Aldrich syndrome in a child presenMng with macrothrombocytopenia. Platelets. 2016 Nov 25:1-4.
García-Fernández A, Roldán V, Marín F. Strategies for prediction and early detecMon of atrial fibrillation: present and future. Europace. 2016 Jul 7. pii: euw131.
Rivera-Caravaca JM, Viedma-Viedma I, Roldán V.Factors AffecMng the Quality of AnMcoagulaMon With Vitamin K Antagonists in Venous Thromboembolism patients. Biol Res Nurs. 2016 Sep 28. pii: 1099800416671211.
Salloum-Asfar S, Arroyo AB, Teruel-Montoya R, García-Barberá N, Roldán V, Vicente V, Martínez C, González-Conejero R. MiRNA-Based Regulation of Hemostatic Factors through Hepatic Nuclear Factor-4 Alpha. PLoS One. 2016 May 2;11(5):e0154751
Esteve-Pastor MA, Roldán V, Valdés M, Lip GY, Marín F.The SAMe-TT2R2 score and decision-making between a vitamin K antagonist or a non-vitamin K antagonist oral anticoagulant in patients with atrial fibrillation.Expert Rev Cardiovasc Ther. 2016; 14 (2): 177-87.
Lozano ML, Cook A, Bastida JM, Paul DS, Iruin G, Cid AR, Adan-Pedroso R, González-Porras JR, Hernández-Rivas JM, Fletcher SJ, Johnson B, Morgan N, Ferrer- Marin F, Vicente V, Sondek J, Watson SP, Bergmeier W, Rivera J. Novel mutations in RASGRP2 encoding for CalDAG-GEFI abrogate Rap1 activation causing platelet dysfunction. Blood. 2016 May 27. pii: blood-2015-11-683102. Epub ahead of print.
Oral anticoagulation to prevent thrombosis recurrence in polycythemia vera and essential thrombocythemia. Ann Hematol. 2015; 94 (6): 911-8. Torregrosa JM, Soler G, Cancio S, Ferrer-Marin F. Concurrent lymphoid and Philadelphia chromosome-negative myeloproliferative neoplasms. Med Clin (Barc). 2015; 145 (7): 318-9.
Noriega V, Martínez-Laperche C, Buces E, Pion M, Sánchez-Hernández N, Martín- Antonio B, Guillem V, Bosch-Vizcaya A, Bento L, González-Rivera M, Balsalobre P, Kwon M, Serrano D, Gayoso J, de la Cámara R, Brunet S, Rojas-Contreras R, Nieto JB, Martínez C, Gónzalez M, Espigado I, Vallejo JC, Sampol A, Jiménez-Velasco A, Urbano-Ispizua A, Solano C, Gallardo D, Díez-Martín JL, Buño I; Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH).The Genotype of the Donor for the (GT)n Polymorphism in the Promoter/Enhancer of FOXP3 Is Associated with the Development of Severe Acute GVHD but Does Not Affect the GVL Effect after Myeloablative HLA-Identical Allogeneic Stem Cell Transplantation.PLoS One. 2015; 10 (10): e0140454.
Lopez A, Mateos MV, Oriol A, Valero M, Martínez J, Lorenzo JI, Perez M, Martínez R, de Paz R, Granell M, De Arriba F, Blanchard MJ, Peñalver FJ, Bello JL, Martín ML, Bargay J, Blade J, Lahuerta JJ, San Miguel JF, de la Rubia J. Pajerns of relapse and outcome of elderly multiple myeloma patients treated as front-line therapy with novel agents combinaMons. Leuk Res Rep. 2015 Sep 24;4(2):64-9.
Hurtado AM, Chen-Liang TH, Przychodzen B, Hamedi C, Muñoz-Ballester J, Dienes B, García-Malo MD, Antón AI, de Arriba F, Teruel-Montoya R, Ortuño FJ, Vicente V, Maciejewski JP, Jerez A.Prognostic signature and clonality pattern of recurrently mutated genes in inactive chronic lymphocytic leukemia. Blood Cancer J. 2015;5:e342.
Noriega V, Martínez-Laperche C, Buces E, Pion M, Sánchez-Hernández N, Martín- Antonio B, Guillem V, Bosch-Vizcaya A, Bento L, González-Rivera M, Balsalobre P, Kwon M, Serrano D, Gayoso J, de la Cámara R, Brunet S, Rojas-Contreras R, Nieto JB, Martínez C, Gónzalez M, Espigado I, Vallejo JC, Sampol A, Jiménez-Velasco A, Urbano-Ispizua A, Solano C, Gallardo D, Díez-Martín JL, Buño I.The Genotype of the Donor for the (GT)n Polymorphism in the Promoter/Enhancer of FOXP3 Is Associated with the Development of Severe Acute GVHD but Does Not Affect the GVL Effect a}er MyeloablaMve HLAIden Mcal Allogeneic Stem Cell Transplantation. PLoS One. 2015 Oct 16;10(10):e0140454.
Sánchez Guiu IM, Martínez-Martinez I, Martínez C, Navarro-Fernandez J, García- Candel F, Ferrer-Marín F, Vicente V, Watson SP, Andrews RK, Gardiner EE, Lozano ML, Rivera J.An atypical IgM class platelet cold agglutinin induces GPVI-dependent aggregation of human platelets.ThrombHaemost. 2015 Aug; 114 (2):313-24.
Soler G, Bernal-Vicente A, Antón AI, Torregrosa JM, Caparrós-Pérez E, Sánchez- Serrano I, Martínez-Pérez A, Sánchez-Vega B, Vicente V, Ferrer-Marin F.The JAK2 46/1 haplotype does not predispose to CALR-mutated myeloproliferative neoplasms. Ann Hematol. 2015; 94 (5):789-94.
Castro-Villegas C, Pérez-Sánchez C, Escudero A, Filipescu I, Verdu M, Ruiz-Limón P, Aguirre MA, Jiménez-Gomez Y, Font P, Rodriguez-Ariza A, Peinado JR, Collantes- Estévez E, González-Conejero R, Martinez C, Barbarroja N, López-Pedrera C.Circulating miRNAs as potential biomarkers of therapy effectiveness in rheumatoid arthritis patients treated with anti-TNFα. Arthritis Res Ther. 2015 Mar 9;17:49.
Ortuño FJ, Sola M.Extreme dyserythropoiesis in the setting of acute erythroid leucemia. Blood. 2015 Sep 10;126(11):1391
Chen-Liang TH, Martin-Santos T, Jerez A, Senent L, Orero MT, Remigia MJ, Muiña B, Romera M, Fernandez-Muñoz H, Raya JM, Fernandez-Gonzalez M, Lancharro A, Villegas C, Carlos Herrera J, Frutos L, Luis Navarro J, Uña J, Igua C, Sanchez-Vaño R, CozarMdel P, Contreras J, Sanchez-Blanco JJ, Perez-Ceballos E, Ortuño FJ.The role of bone marrow biopsy and FDG-PET/CT in identifying bone marrow infiltration in the initial diagnosis of high grade non-Hodgkin B-cell lymphoma and Hodgkin lymphoma.Accuracy in a multicenter series of 372 patients. Am J Hematol. 2015;90 (8): 686-90.
Varney ME, Niederkorn M, Konno H, Matsumura T, Gohda J, Yoshida N, Akiyama T, Christie S, Fang J, Miller D, Jerez A, Karsan A, Maciejewski JP, Meetei RA, Inoue J, Starczynowski DT. Loss of Tifab, a del(5q) MDS gene, alters hematopoiesis through derepression of Toll-like receptor-TRAF6 signaling. J Exp Med. 2015; 212 (11): 1967-85.
Bilori B, Thota S, Clemente MJ, Patel B, Jerez A, Afable Ii M, Maciejewski JP.Tofacitinib as a novel salvage therapy for refractory T-cell large granular lymphocytic leukemia. Leukemia. 2015; 29 (12):2427-9.
Saumell S, Solé F, Arenillas L, Montoro J, Valcárcel D, Pedro C, Sanzo C, Luño E, Giménez T, Arnan M, Pomares H, De Paz R, Arrizabalaga B, Jerez A, Martínez AB, Sánchez-Castro J, Rodríguez-Gambarte JD, Raya JM, Ríos E, Rodríguez-Rivera M, Espinet B, Florensa L.Trisomy 8, a Cytogenetic Abnormality in Myelodysplastic Syndromes, Is Constitutional or Not?. PLoSOne. 2015; 10 (6):e0129375.
Ríos R, Lupiañez CB, Campa D, Martino A, Martínez-López J, Martínez-Bueno M, Varkonyi J, García-Sanz R, Jamroziak K, Dumontet C, Cayuela AJ, Wętek M, Landi S, Rossi AM, Lesueur F, Reis RM, Moreno V, Marques H, Jurczyszyn A, Andersen V, Vogel U, Buda G, Orciuolo E, Jacobsen SE, Petrini M, Vangsted AJ, Gemignani F, Canzian F, Jurado M, Sainz J. Type 2 diabetes-related variants influence the risk of developing multiple myeloma: results from the IMMEnSE consortium. Endocr Relat Cancer. 2015; 22 (4):545-59.
Chen-Liang TH, Jerez A, Florensa L, Ortuño FJ.Neoplastic mastocytosis evolving from a poor prognosis acute myeloid leukemia.Med Clin (Barc). 2015; 144 (12):571-2.
McGraw KL, Zhang LM, Rollison DE, Basiorka AA, Fulp W, Rawal B, Jerez A, Billingsley DL, Lin HY, Kurtin SE, Yoder S, Zhang Y, Guinta K, Mallo M, Solé F, Calasanz MJ, Cervera J, Such E, González T, Nevill TJ, Haferlach T, Smith AE, Kulasekararaj A, Mufti G, Karsan A, Maciejewski JP, Sokol L, Epling-Burnette PK, Wei S. List AF The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes. Blood Cancer J. 2015; 5:e291.
Rajala HL, Olson T, Clemente MJ, Lagström S, Ellonen P, Lundan T, Hamm DE, Zaman SA, Lopez Marti JM, Andersson EI, Jerez A, Porkka K, Maciejewski JP, Loughran TP, Mustjoki S. The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia.Haematologica. 2015; 100 (1):91-9.
Lopez A, Mateos MV, Oriol A, Valero M, Martínez J, Lorenzo JI, Perez M, Martinez R, de Paz R, Granell M, De Arriba F, Blanchard MJ, Peñalver FJ, Bello JL, Martin ML, Bargay J, Blade J, Lahuerta JJ, San Miguel JF, de la Rubia J. Patterns of relapse and outcome of elderly multiple myeloma patients treated as front-line therapy with novel agents combinations.Leuk Res. 2015; 4 (2):64-9.
Martínez-López J, Paiva B, López-Anglada L, Mateos MV, Cedena T, Vidríales MB, Sáez-Gómez MA, Contreras T, Oriol A, Rapado I, Teruel AI, Cordón L, Blanchard MJ, Bengoechea E, Palomera L, de Arriba F, Cueto-Felgueroso C, Orfao A, Bladé J, San Miguel JF, Lahuerta JJ; Spanish Multiple Myeloma Group / Program for the Study of Malignant Blood Diseases Therapeutics (GEM / PETHEMA) Cooperative Study Group. Critical analysis of the stringent complete response in multiple myeloma: contribution of sFLC and bone marrow clonality. Blood. 2015; 126 (7):858-62.
Mateos MV, Oriol A, Rosiñol L, de Arriba F, Puig N, Martín J, Martínez-López J, Echeveste MA, Sarrá J, Ocio E, Ramírez G, Martínez R, Palomera L, Payer A, Iglesias R, de la Rubia J, Alegre A, Chinea AI, Bladé J, Lahuerta JJ, San Miguel JF. Bendamustine, bortezomib and prednisone for the treatment of patients with newly diagnosed multiple myeloma: results of a prospective phase 2 Spanish/PETHEMA trial.Haematologica. 2015; 100 (8):1096-102.
Bernal T, Martínez-Camblor P, Sánchez-García J, de Paz R, Luño ENomdedeu B, Ardanaz MT, Pedro C, Amigo ML, Xicoy B, del Cañizo C, Tormo M, Bargay J, Valcárcel D, Brunet S, Benlloch L, Sanz G; Spanish Group on Myelodysplastic Syndromes; PETHEMA Foundation; Spanish Society of Hematology. Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: results from the Spanish registry. Leukemia. 2015; 29 (9):1875-81.
Díaz-Beyá M, Brunet S, Nomdedéu J, Pratcorona M, Cordeiro A, Gallardo D, Escoda L, Tormo M, Heras I, Ribera JM, Duarte R, de Llano MP, Bargay J, Sampol A, Nomdedeu M, Risueño RM, Hoyos M, Sierra J, Monzo M, Navarro A, Esteve J; Cooperative AML group CETLAM. The lincregion, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature. RNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature.Oncotarget. 2015; 6 (31):31613-27.
Díaz-Beyá M, Brunet S, Nomdedéu J, Cordeiro A, Tormo M, Escoda L, Ribera JM, Arnan M, Heras I, Gallardo D, Bargay J, Queipo de Llano MP, Salamero O, Martí JM, Sampol A, Pedro C, Hoyos M, Pratcorona M, Castellano JJ, Nomdedeu M, Risueño RM, Sierra J, Monzó M, Navarro A, Esteve J. The expression level of BAALCassociated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia.Blood Cancer J. 2015; 5:e352.
García-Dabrio MC, Hoyos M, Brunet S, Tormo M, Ribera JM, Esteve J, Gallardo D, Duarte RF, de Llano MP, Bargay J, Martí-Tutusaus JM, Heras I, Garcia A, Salamero O, Aventin A, Lecrevisse Q, Orfao A, Sierra J, Nomdedéu JF.Complex measurements may be required to establish the prognostic impact of immunophenotypic markers in AML.Am J Clin Pathol. 2015; 144 (3):484-92.
Martino R, Bautista G, Parody R, García I, Esquirol A, Rovira M, Cabrera JR, Regidor C, Fores R, García-Marco JA, Serrano D, Barba P, Heras I, Marquez-Malaver FJ, Sánchez-Ortega I, Duarte R, Saavedra S, Sierra J, Vazquez L; Infectious/Non-infectious Complications Subcommittee of the Grupo Español de Trasplante Hematopoyético. Severe infections after single umbilical cord blood transplantation in adults with or without the co-infusion of CD34+ cells from a third-party donor: results of a multicenter study from the GrupoEspañol de TrasplanteHematopoyético (GETH). Transpl Infect Dis. 2015; 17 (2):221-33.
Díaz-Beyá M, Brunet S, Nomdedéu J, Pratcorona M, Cordeiro A, Gallardo D, Escoda L, Tormo M, Heras I, Ribera JM, Duarte R, de Llano MP, Bargay J, Sampol A, Nomdedeu M, Risueño RM, Hoyos M, Sierra J, Monzo M, Navarro A, Esteve J; Cooperative AML group CETLAM. The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediaterisk cytogenetic category, and is associated with a distinctive microRNA signature.Oncotarget. 2015; 6 (31):31613-27.
Díaz-Beyá M, Brunet S, Nomdedéu J, Cordeiro A, Tormo M, Escoda L, Ribera JM, Arnan M, Heras I, Gallardo D, Bargay J, Queipo de Llano MP, Salamero O, Martí JM, Sampol A, Pedro C, Hoyos M, Pratcorona M, Castellano JJ, Nomdedeu M, Risueño RM, Sierra J, Monzó M, Navarro A, Esteve J. The expression level of BAALCassociated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia.Blood Cancer J. 2015; 5:e352.
García-Dabrio MC, Hoyos M, Brunet S, Tormo M, Ribera JM, Esteve J, Gallardo D, Duarte RF, de Llano MP, Bargay J, Martí-Tutusaus JM, Heras I, Garcia A, Salamero O, Aventin A, Lecrevisse Q, Orfao A, Sierra J, Nomdedéu JF.Complex measurements may be required to establish the prognostic impact of immunophenotypic markers in AML.Am J Clin Pathol. 2015; 144 (3):484-92.
Fox ML, Barba P, Heras I, López-Parra M, González-Vicent M, de la Cámara R, Batlle M, Parody R, Vallejo C, Ruiz-Camps I, Vázquez L; Infectious and Non-Infectious Complicatio ns Subcommittee of the Spanish Haematopoietic Transplant Group (GrupoEspañol de TrasplanteHematopoyético; GETH). A registry-based study of non- Aspergillus mould infections in recipients of allogeneic haematopoietic cell transplantation.Clin Microbiol Infect. 2015; 21(1):e1-3.
Parody R, Martino R, de la Cámara R, García-Noblejas A, Esquirol A, Garcia-Cadenas I, Villaescusa T, Caballero D, Rovira M, Fernandez-Avilés F, Marquez-Malaver FJ, Espigado I, Castilla-Llorente C, Heras I, Cabero MA, Cabrera JR, Barba P, Valcarcel D, Sánchez-Ortega I, Duarte RF, Serrano D, Carretero F, Vazquez L.Fungal and viral infections after allogeneic hematopoietic transplantation from unrelated donors in adults: improving outcomes over time.Bone Marrow Transplant. 2015; 50 (2):274-81.
Aguado JM, Vázquez L, Fernández-Ruiz M, Villaescusa T, Ruiz-Camps I, Barba P, Silva JT, Batlle M, Solano C, Gallardo D, Heras I, Polo M, Varela R, Vallejo C, Olave T, López-Jiménez J, Rovira M, Parody R, Cuenca-Estrella M; PCRAGA Study Group; Spanish Stem Cell Transplantation Group; Study Group of Medical Mycology of the Spanish Society of Clinical Microbiology and Infectious Diseases; Spanish Network for Research in Infectious Diseases. Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based Aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: a randomized controlled trial. Clin Infect Dis. 2015; 60 (3):405-14
Ferrà C, Sanz J, Díaz-Pérez MA, Morgades M, Gayoso J, Cabrera JR, Villaescusa T, Sampol MA, Fernández-Avilés F, Solano C, Ortín M, Duarte R, Cuesta M, Heras I, de la Serna J, Moraleda JM, Barrenetxea C, González-Vicent M, Sanz G, Ribera JM; Grupo Español de Trasplante Hematopoyético (Geth) Spanish Society of Hematology.Outcome of graft failure after allogeneic stem cell transplant: study of 89 patients. Leuk Lymphoma. 2015; 56 (3): 656-62.
Liu ZJ, Bussel JB, Lakkaraja M, Ferrer-Marin F, Ghevaert C, Feldman HA, McFarland JG, Chavda C, Sola-Visner M. Suppression of in vitro megakaryopoiesis by maternal sera containing anti-HPA-1a antibodies. Blood. 2015 Sep 3;126(10):1234-6.
Braza-Boïls A, Salloum-Asfar S, Marí-Alexandre J, Arroyo AB, González-Conejero R, Barceló-Molina M, García-Oms J, Vicente V, Estellés A, Gilabert-Estellés J, Martínez C.Peritoneal fluid modifies the microRNA expression profile in endometrial and endometriotic cells from women with endometriosis. Hum Reprod. 2015; 30 (10): 2292-302.
de la Morena-Barrio ME, García A, Martínez-Martínez I, Miñano A, Padilla J, Navarro- Fernández J, Roldán V, Águila S, Iniesta JA, Corral J, Vicente V.A new method to quantify β-antithrombinglycoform in plasma reveals increased levels during the acute stroke event. Thromb Res. 2015; 136 (3): 634-41.
Roldán V, Cancio S, Gálvez J, Valdés M, Vicente V, Marín F, Lip GY. The SAMe- TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective 'Real-world' Inception Cohort Study. Am J Med. 2015; 128 (11): 1237-43.
Corral J, Vicente V.Puzzling questions on antithrombin: Diagnostic limitations and real incidence in venous and arterial thrombosis. Thromb Res. 2015; 135 (6):1047-8. Martínez C, Antón AI, Bernal A, Lozano ML, Ferrer-Marin F, Corral J, Iniesta JA, Vicente V, Rivera J. Evaluation of Novel Platelet Polymorphisms in Stroke. Dichotomic Effect of rs5443 in GNB3. J Clin Neurol. 2015; 11 (1):102-3.
Aguila S, Martínez-Martínez I, Dichiara G, Gutiérrez-Gallego R, Navarro-Fernández J, Vicente V, Corral J.Increased N-glycosylation efficiency by generation of an aromatic sequon on N135 of antithrombin. PLoS One. 2014; 9 (12): e114454. Manzano-Fernández S, Andreu-Cayuelas JM, Marín F, Orenes-Piñero E, Gallego P, Valdés M, Vicente V, Lip GY, Roldán V.Comparison of estimated glomerular filtration rate equations for dosing new oral anticoagulants in patients with atrial fibrillation. Rev Esp Cardiol (Engl Ed). 2015;68 (6): 497-504.
Nadir Y, Hoffman R, Corral J, Barak Y, Hasin T, Keren-Politansky A, Brenner B. A novel mutation of antithrombin deficiency in six family siblings and the clinical combat. Thromb Haemost. 2015; 114 (4): 859-61.
Cieśla M, Wypasek E, Corral J, Alhenc-Gelas M. Antithrombin Katowice: exon 1 deletion in the SERPINC1 gene associated with type I antithrombin deficiency. Blood Coagul Fibrinolysis. 2015; 26 (1): 95-7.
Liu ZJ, Bussel JB, Lakkaraja M, Ferrer-Marin F, Ghevaert C, Feldman HA,McFarland JG, Chavda C, Sola-Visner M. Suppression of in vitro megakaryopoiesis by maternal sera containing anti-HPA-1a antibodies. Blood. 2015; 126 (10): 1234-6.
Fletcher SJ, Johnson B, Lowe GC, Bem D, Drake S, Lordkipanidzé M, Guiú IS, Dawood B, Rivera J, Simpson MA, Daly ME, Motwani J, Collins PW, Watson SP, Morgan NV; UK Genotyping and Phenotyping of Platelets study group. SLFN14 mutations underlie thrombocytopenia with excessive bleeding and platelet secretion defects. J Clin Invest. 2015; 125 (9): 3600-5.
Heidbuchel H, Berti D, Campos M, Desteghe L, Freixo AP, Nunes AR, Roldán V, Toschi V, Lassila R. Implementation of non-vitamin K antagonist oral anticoagulants in daily practice: the need for comprehensive education for professionals and patients.Thromb J. 2015; 13:22.
Sticherling C, Marin F, Birnie D, Boriani G, Calkins H, Dan GA, Gulizia M, Halvorsen S, Hindricks G, Kuck KH, Moya A, Potpara T, Roldan V, Tilz R, Lip GY. Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS).Europace. 2015; 17 (8): 1197-214.
Orenes-Piñero E, Pineda J, Roldán V, Hernández-Romero D, Marco P, Tello-Montoliu A, Sogorb F, Valdés M, Lip GY, Marín F.Effects of Body Mass Index on the Lipid Profile and Biomarkers of Inflammation and a Fibrinolytic and Prothrombotic State.J Atheroscler Thromb. 2015; 22 (6): 610-7.
Roldán V, Marín F. The importance of excellence in the quality of anticoagulation control whilst taking vitamin K antagonists. Thromb Haemost. 2015;113(4): 671-3. Marín F, Roldán V.Biomarkers: GDF-15 and risk stratification in atrial fibrillation. Nat Rev Cardiol. 2015; 12 (1):8-9.
Salloum-Asfar S, Boelen A, Reitsma PH, van Vlijmen BJ. The itimediate and late effects of thyroid hormone (triiodothyronine) on murine coagulation gene transcription.PLoS One. 2015; 10 (5): e0127469.
Jover E, Marín F, Quintana M, Pérez-Andreu J, Hurtado JA, Rodríguez C, Martínez- González J, González-Conejero R, Valdés M, Hernández-Romero D. CALU polymorphism A29809G affects calumenin availability involving vascular calcification.. J Mol Cell Cardiol.2015; 82: 218-27.
